{"generated_at":"2026-10-23T08:53:18.125Z","count":1311,"rows":[{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary","rationale":"The contract explicitly disclaims fiduciary duty, stating that ESI acts as an independent contractor and that neither the plan nor the sponsor intends for ESI to be a plan fiduciary, leaving ESI free to act in its own interest.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not require a named officer to certify quarterly and annually that all direct and indirect compensation has been disclosed and remitted to the plan.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no signed ownership and affiliate disclosure exhibit in the contract, and no requirement for the PBM to update such an exhibit within 30 days of any change in ownership or control.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 112","evidence_quote":"1.28. “Specialty Product List” means the list of Specialty Products applicable to Sponsor and maintained and updated by ESI from time to time.","rationale":"Definitions rely on vendor discretion and algorithms rather than economic function. Specialty products are defined by a list maintained by ESI, and generic or brand status is determined by ESI's proprietary Brand/Generic Algorithm.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"unclear","confidence":0.95,"page_ref":"Pages 35 to 38","evidence_quote":null,"rationale":"The rebate exhibit (Exhibit C-3) is heavily redacted, making it impossible to determine if 100% of manufacturer revenue is passed through to the plan.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Exhibit C-2 (Claims Reimbursement Rates) is heavily redacted, obscuring the reimbursement rates and dispensing fees for affiliate pharmacies.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Because the claims reimbursement pricing guarantees in Exhibit C-2 are redacted, it is unclear if the contract applies a benchmark ceiling or cheapest lawful option.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Exhibit C-2 is redacted, concealing the pricing terms and whether members are protected by cash price guarantees and deductible credits.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Although a MAC List is defined in the Scope of Services, the pricing terms in Exhibit C-2 are redacted, making it impossible to see if a single MAC list applies to both plan and pharmacy reimbursement.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Exhibit C-2 (Claims Reimbursement Rates) is heavily redacted. Without the pricing schedules, it is impossible to verify if the plan pays exactly what the pharmacy is paid.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure","rationale":"The contract explicitly states that ESI and its affiliates retain all proprietary rights and beneficial interest to revenues described in the Financial Disclosure, meaning these revenues do not flow to the plan.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 110","evidence_quote":"The drugs\nand supplies included on the Formulary will be modified by ESI from time to time","rationale":"The plan sponsor has the discretion to elect not to implement formulary changes, but the default mechanism allows the PBM to modify the formulary over time.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a lowest net cost standard for formulary decisions and lacks any requirement for an annual book of business comparison.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no network protections visible in the unredacted text preventing retroactive clawbacks, volume-conditioned reimbursement, or steering into PBM-owned pharmacies.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"unclear","confidence":0.95,"page_ref":"Pages 21 to 39","evidence_quote":null,"rationale":"Because the entirety of Exhibit C (Program Pricing Terms) is heavily redacted, any potential most favored pricing or market check clauses cannot be assessed.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"bad","confidence":0.9,"page_ref":"Page 3","evidence_quote":"Auditing representatives selected by the A&M\nSystem (the “Auditor’) and approved by ESI, whose approval shall not be unreasonably withheld","rationale":"The plan's audit rights are compromised because they must obtain ESI's approval for their selected auditor. Additionally, the audit is limited to once annually.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not state that the plan sponsor is the sole owner of all claims, rebate, and eligibility data, nor does it restrict the PBM from reusing or reselling plan data.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"unclear","confidence":0.95,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Exhibit C, which would contain administrative services and clinical program fees and corresponding performance guarantees, is redacted.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract lacks self-executing enforcement mechanisms like automatic liquidated damages for missed guarantees, and there is no two-strikes exit clause for regulatory integrity failures.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The contract requires all amendments to be in writing and signed by both parties, preventing the PBM from making unilateral changes.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"partial","confidence":0.95,"page_ref":"Page 5","evidence_quote":"Without restricting any other legal, contractual or equitable remedies otherwise available, the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"The plan may terminate the contract without cause with 90 days' notice, but it does not explicitly protect against forfeiture of earned amounts or name a regulatory integrity event as grounds for termination.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"unclear","confidence":0.95,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Exhibit D (Specialty Drugs Under the Mail Order Pharmacy Program) is completely blacked out, blocking any analysis of specialty drug pricing controls.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it to be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"The PBM designates the contract's pricing terms and specialty exhibits as confidential and proprietary to exempt them from the Texas Public Information Act, restricting the government from fully disclosing its costs.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"The contract expressly rejects fiduciary status except for the narrow appeals function. It also describes the economic bargain as arm's length and lets ESI act for itself, not solely for the plan and members. This directly contradicts the loyalty and care obligation in the model.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"bad","confidence":0.97,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure","rationale":"The referenced Financial Disclosure is only in the unproduced proposal and may be updated by ESI. The contract affirmatively reserves beneficial ownership of these revenue streams instead of requiring complete disclosure and remittance. It also contains no named officer certification made quarterly and annually.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.91,"page_ref":"Page 6","evidence_quote":"ESI agrees to provide the A&M System reasonable advance notice prior to the effective date of any merger, acquisition, business reorganization, or other change of ESI management or ownership.","rationale":"The contract identifies several operating affiliates and requires advance notice of ownership or management changes. It does not contain a signed, comprehensive ownership and affiliate exhibit covering every parent, subsidiary, purchasing entity, rebate aggregator, mail pharmacy, and specialty pharmacy. It also lacks the model's 30-day refresh requirement.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"unclear","confidence":0.93,"page_ref":"Pages 35 to 37","evidence_quote":null,"rationale":"The rebate exhibit's amounts, payment terms, and conditions are substantially blacked out on pages 35 to 37. Visible scope definitions do not show a comprehensive economic definition of manufacturer revenue or rebates. The hidden rebate conditions prevent a reliable determination of whether fees, price protection, and other value can be relabeled outside pass-through obligations.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.94,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges that neither it, any Member, nor the Plan, has a right to receive, or possesses any beneficial interest in, any such fees or revenues; provided, that ESI will pay A&M System amounts equal to the amounts expressly set forth in this Contract.","rationale":"The contract limits the plan to amounts expressly promised and denies it a beneficial interest in other ESI and affiliate revenue. That reservation contradicts a complete pass-through of manufacturer revenue of every kind. The rebate percentages and timing are also blacked out, but the visible retained-revenue clause is independently adverse.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"unclear","confidence":0.98,"page_ref":"Pages 25 to 106","evidence_quote":null,"rationale":"Mail and specialty ingredient cost guarantees begin on page 25, and the specialty and mail order exhibit spans pages 53 to 106. Those provisions are heavily or fully blacked out. Because affiliate pharmacy rates and acquisition-cost mechanics would be located there, the produced text does not permit a reliable verdict.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"unclear","confidence":0.97,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"The claims reimbursement rates and general pricing terms are located on pages 24 to 34 and are substantially blacked out. The visible text does not show whether a public benchmark ceiling applies claim by claim in every channel. Redaction, rather than simple silence, prevents the determination.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"unclear","confidence":0.9,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"The visible scope defines usual and customary price and permits a member-submitted cash claim, but it does not reveal the operative reimbursement formula. The claims pricing pages that could establish a cash-price cap are substantially blacked out. The produced text also does not reveal whether all cash purchases receive deductible and out-of-pocket credit or whether accumulator adjustments apply.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.94,"page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules developed or selected by ESI.","rationale":"The definition gives ESI control to develop or select the MAC list. The produced agreement does not require one disclosed list for both plan billing and pharmacy payment, a fixed update schedule, or a pharmacy appeal process. PBM control without those safeguards permits the spread mechanism the model clause is designed to prevent.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"unclear","confidence":0.96,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"The audit protocol says what happens if the sponsor has a pass-through pricing arrangement, but it does not establish that this agreement actually uses one. The operative claims reimbursement and general pricing terms on pages 24 to 34 are substantially blacked out. Those redactions prevent a determination of whether the plan always pays exactly the pharmacy payment plus a disclosed fee.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.86,"page_ref":"Page 115","evidence_quote":"owned subsidiaries and affiliates act on their own behalf, and not for the benefit of or as agents for A&M System, Members or the Plan.","rationale":"The contract permits ESI and its affiliates to negotiate and retain revenue for their own benefit, subject only to amounts expressly promised elsewhere. It contains no pass-through rule for purchasing entities, volume credits, supplier payments, or affiliated aggregators. That structure permits related-entity revenue to remain outside the plan.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The sponsor selects or adopts the formulary and retains final authority over claim coverage. However, ESI may modify the formulary over time, including because of rebate arrangements, and additions or deletions are automatically adopted unless the sponsor opts out. That is weaker than affirmative sponsor approval of every change with supporting net-cost analysis.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"The formulary provisions on pages 110, 113 to 115, and 120 address selection, changes, prior authorization, and Medicare requirements. They do not require a lowest-net-cost standard for this plan, an annual comparison with ESI's book of business, or disclosure when a costlier drug is placed above a cheaper equivalent. No such standard appears elsewhere in the produced text.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"bad","confidence":0.94,"page_ref":"Page 112","evidence_quote":"Subject to Applicable Law, ESI will make Members aware of the ability to fill their prescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings","rationale":"The contract affirmatively authorizes ESI to promote its own mail pharmacy to members. It also states that ESI maintains multiple networks and may consolidate or migrate clients among them. The produced text has no any-willing-pharmacy right or general ban on retroactive clawbacks, so the affiliate-promotion permission directly conflicts with the model's anti-steering rule.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The fixed-pricing and renewal provisions on pages 2, 4, and 5 do not promise pricing as favorable as ESI gives comparable clients. The pricing exhibits on pages 21 to 52 show no visible market-check heading or remedy. No annual market check with a meet, credit, or release remedy appears in the produced text.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.99,"page_ref":"Page 127","evidence_quote":"The Sponsor may select an initial number of manufacturer contracts to enable Sponsor to audit fifty percent (50%) of the total Rebate payments due to Sponsor for two (2) calendar quarters during the twenty-four (24) month period immediately preceding the audit","rationale":"The plan has annual audit rights for claims, rebates, performance guarantees, and regulatory compliance. Those rights are constrained by a single combined annual audit, a 24-month window, restricted auditor qualifications, sampling limits, and review of only half of rebate payments for two quarters. ESI also bars copying contracts and may review the auditor's notes, making the rights materially weaker than the model.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.98,"page_ref":"Page 8","evidence_quote":"with respect to ESI: ESI’s reporting and other web-based applications, eligibility and adjudication systems, system formats and databanks, clinical or formulary management operations or programs, fraud, waste and abuse tools and programs, anonymized claims data","rationale":"The agreement treats anonymized claims data and several data systems as ESI property. The BAA additionally permits data aggregation and use, creation, and disclosure of de-identified health information. Those rights contradict sole sponsor ownership and the model's prohibition on PBM reuse, licensing, or sale of plan data.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"unclear","confidence":0.97,"page_ref":"Pages 39 to 52","evidence_quote":null,"rationale":"The audit protocol confirms that performance guarantees exist and are reviewed after true-up. The administrative services, clinical program fees, and related guarantee terms on pages 39 to 52 are almost entirely blacked out. The produced text therefore does not reveal measurement frequency, plan-specific measures, cash reconciliation, or whether remedies are capped credits.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.94,"page_ref":"Page 127","evidence_quote":"Sponsor agrees that once audit results are accepted by both parties, the audit shall be considered closed and final. To the extent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding adjustments to Sponsor through credits to a future invoice(s).","rationale":"Claims errors can produce reprocessing and invoice credits, and a material breach can support termination after a cure period. The credit process depends on mutually accepted audit results rather than operating automatically. The agreement does not provide a two-strikes exit or automatic damages for late reports and repeated integrity failures.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"good","confidence":0.99,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The agreement requires every amendment to be written and signed by both parties. Pricing also remains unchanged during the term except as required by law or by written agreement. These provisions prevent ESI from changing economic terms merely by notice, portal posting, or an unsigned updated exhibit.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"good","confidence":0.96,"page_ref":"Page 5","evidence_quote":"Without restricting any other legal, contractual or equitable remedies otherwise available, the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"The sponsor has a clear termination-for-convenience right on 90 days' notice, and the clause states no termination penalty. Other provisions permit termination for uncured material breach and several compliance or integrity failures. Final EGWP amounts may be delayed for reconciliation, but the text does not provide for forfeiture of earned amounts.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"unclear","confidence":0.99,"page_ref":"Pages 53 to 106","evidence_quote":null,"rationale":"Page 53 identifies Exhibit D as Specialty Drugs Under the Mail Order Pharmacy Program. The next 53 pages, which contain the exhibit's substance, are fully blacked out. Specialty definitions, drug-level ceilings, channel rates, and acquisition-cost treatment at ESI-affiliated pharmacies therefore cannot be evaluated.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 109","evidence_quote":"The Contract, Exhibit C (Program Pricing Terms), Exhibit D (Specialty Drugs Under the Mail Specialty Drugs Under the Mail Order Pharmacy Program), and Exhibit E (Clarifications)","rationale":"ESI designates the core pricing, specialty, mail order, and clarification materials as confidential or proprietary and claims they may be exempt from public disclosure. The Texas Public Information Act process remains available, but ESI reserves the right to oppose release. The resulting production blacked out the very economic terms taxpayers would need to assess.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 11","evidence_quote":"Claim Administrator is not the plan administrator of Employer’s employee benefit plan and is not a fiduciary of Employer, the plan administrator or of the Plan.","rationale":"Section 5.2 on page 11 states flatly that the Claim Administrator is not a fiduciary of the Employer, the plan administrator or the Plan, and Section 5.3 describes its role as a contract claims administrator and service provider only. Section 5.1 adds that it will not accept any allocation or delegation of responsibilities under the Plan. On the pharmacy side, Exhibit 7 Section 4 on page 43 says Prime and the Claim Administrator contract with manufacturers on their own behalf and for their own benefit and not on behalf of Employer, and Exhibit 6 item 15 on page 42 repeats that recovery work is not undertaken as a fiduciary. The model contract makes the PBM owe loyalty and care solely to the plan and disgorge anything retained in breach. This agreement does the opposite, so the verdict is bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"DISC","verdict":"partial","confidence":0.6,"page_ref":"Page 28","evidence_quote":"Claim Administrator hereby informs Employer and all Covered Persons that it owns a significant portion of the equity of Prime","rationale":"The agreement contains real disclosure language. Exhibit 3 Sections 4 and 5 on pages 27 and 28 disclose that the Claim Administrator owns a significant portion of Prime, that it receives rebates, payments, discounts and allowances from pharmacies and manufacturers, that Prime charges administrative fees to pharmacies and manufacturers, and that manufacturer administrative fees are capped at 5.5 percent of WAC with a promise to advise if that changes. Exhibit 7 Section 1 on page 43 repeats the ownership and fee categories, and Section 6.2 on page 12 offers an annual list of affiliated providers and vendors on request. What is missing is everything the model term requires beyond categories: no dollar amounts, no quarterly or annual accounting of what was received on this plan's claims, no disclosure of broker or consultant payments, and no officer certification. Disclosure of existence without amounts or certification is partial.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"OWN","verdict":"partial","confidence":0.6,"page_ref":"Page 12","evidence_quote":"Upon Employer request (not more than once per calendar year), Claim Administrator will provide a list of such entities to Employer.","rationale":"Section 6.2 on page 12 acknowledges that the Claim Administrator or its subsidiaries or affiliates may hold ownership interests in providers and in vendors serving the agreement, and offers a list of such entities on request no more than once a year. Page 28 discloses ownership of a significant portion of Prime's equity and says mail order and specialty pharmacies may be operated by an affiliate of or partially owned by Prime, and page 43 repeats the Prime ownership statement. The model asks for a signed exhibit naming every owner, parent, subsidiary, affiliate, GPO, rebate aggregator, mail order and specialty pharmacy, refreshed within thirty days of any change. Here there is no exhibit, the list is only available on request, it is limited to once a year, and no refresh obligation exists, so the protection is present but materially weaker than the model.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"DEF","verdict":"bad","confidence":0.85,"page_ref":"Page 49","evidence_quote":"Rebates do not include Manufacturer Administration Fees or fees retained by a group purchasing organization for its role in securing Rebates and/or Manufacturer Administrative Fees.","rationale":"Exhibit 7 Section 11 on pages 47 to 49 defines the key economic terms, and the definitions run against the plan. Rebate on page 49 starts broadly as any discount or other remuneration from a manufacturer but then carves out Manufacturer Administration Fees and any fee a group purchasing organization retains, which is exactly the relabeling the model definitions are built to prevent. Specialty Drugs on page 49 are whatever list Prime or the Claim Administrator determines, subject to change, rather than a functional test. Brand and Generic on pages 47 and 48 are tied to Medi-Span multi source codes but can be overridden in the Additional Provisions of the missing BPA Addendum. Business Confidential Information on page 15 sweeps in cost and pricing information. Because the definitions actively exclude value from the rebate concept and leave classification to the vendor, the verdict is bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 28","evidence_quote":"it and its Plan have no right to, or legal interest in, any portion of the rebates, payments, discounts and/or other allowances provided by the PBM or such manufacturers","rationale":"Exhibit 3 Section 5.2 on page 28 says rebate negotiation is conducted for the benefit of the Claim Administrator and not for the benefit of Employer or Covered Persons, that the Employer and its Plan have no right to or legal interest in any portion of the rebates, payments, discounts or allowances, and that the Employer consents to the Claim Administrator retaining all of them. In place of pass through the Employer gets a Rebate Credit paid from the Claim Administrator's own assets notwithstanding actual rebates, in an amount set in the missing ASO BPA, paid prospectively as a monthly billing credit and ending at termination (pages 28 and 47). Exhibit 7 Section 4 on pages 43 and 44 repeats that Prime or the Claim Administrator retains all right, title and interest in rebates and manufacturer administrative fees. The model requires one hundred percent of manufacturer revenue paid quarterly. This is the opposite, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"NAC","verdict":"bad","confidence":0.85,"page_ref":"Page 27","evidence_quote":"Prime may keep as its fee a portion of the discounts and/or other allowances that it has negotiated with the mail-order and/or specialty pharmacy.","rationale":"The agreement acknowledges affiliated dispensing channels and expressly permits margin on them. Page 28 says the mail order and specialty pharmacy will be operated through a third party which may be an affiliate of or partially owned by Prime, and page 46 says Specialty Drugs may be provided by Prime, an affiliate of Prime, or another Specialty Pharmacy under arrangement with Prime or the Claim Administrator. Page 27 states that for mail order and specialty Prime may keep as its fee a portion of the discounts it negotiated with those pharmacies, and that the pharmacy pass through to the Claim Administrator applies except for mail and specialty drugs. Pricing for these claims is whatever the missing BPA Addendum sets (page 46). The model prices affiliate claims at net acquisition cost plus a stated dispensing fee with no retained margin. This text permits retained margin in the affiliate channel, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"CEIL","verdict":"unclear","confidence":0.55,"page_ref":"Page 46","evidence_quote":"Employer will reimburse Claim Administrator for Claims submitted under the pharmacy program based on the pricing set forth in the BPA Addendum.","rationale":"The produced text never states that plan cost on a claim cannot exceed a published benchmark or cash price. Page 46 Section 10 says the Employer reimburses at the pricing set forth in the BPA Addendum, and page 14 Section 7.2(b) says the Allowable Amount for participating pharmacies is the cost mutually agreed in the PBM Fee Schedule Addendum. Exhibit 7 defines Usual and Customary on page 49 as the cash price a pharmacy would charge including discounts, which suggests a lesser of test may exist in the addendum pricing, but the addendum is not included so the text does not show whether any ceiling applies or whether it is tested claim by claim or in aggregate. The exhibit title on page 43, Guaranteed Traditional Aggregate Pricing Arrangement, points toward aggregate rather than claim level measurement. Because the term would live in an explicitly referenced but omitted attachment, the verdict is unclear rather than missing.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"CASH","verdict":"missing","confidence":0.7,"page_ref":null,"evidence_quote":null,"rationale":"I looked for cash price protection, deductible credit for cash purchases and accumulator language in Section 7.2(b) on page 14, Exhibit 3 Section 4 on page 27, Exhibit 7 Section 10 on pages 46 and 47 and the Exhibit 7 definitions on pages 47 to 49. The text explains how member deductibles and coinsurance are calculated, using Prime's negotiated fees and discounts for retail and mail or specialty drugs (page 27), says the Employer is not charged when member cost share covers one hundred percent of the claim and that zero balance logic is not employed (page 46), and defines Usual and Customary as the pharmacy cash price (page 49). None of this guarantees that a member never pays more than the cash price, none of it credits cash purchases toward the deductible or out of pocket maximum, and nothing addresses accumulator adjustments against manufacturer assistance. The subject is not addressed, so the verdict is missing.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"MAC","verdict":"bad","confidence":0.8,"page_ref":"Page 44","evidence_quote":"Prime’s MAC List will only be made available for viewing at Prime’s corporate headquarters or another secured location designated by Prime.","rationale":"Exhibit 7 Section 6(c) on page 44 describes the MAC Lists as Prime's proprietary databases identifying a recommended maximum allowable cost, and the definitions on page 48 say the MAC List is established by Prime and updated from time to time in accordance with the exhibit and the BPA Addendum. Employer representatives may view the list only after thirty days written request, only under Prime's non disclosure agreement, no more than four times a calendar year, and only at Prime's headquarters or another secured location. Nothing says a single list governs both what the plan pays and what pharmacies receive; on the contrary Section 6(a) on the same page has the Employer acknowledge that the Claim Administrator and Prime keep all or part of the discounts negotiated with network pharmacies. No pharmacy appeal path or timelines appear. The model requires one disclosed list with scheduled updates and appeals. This text withholds the list and permits two sided pricing, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 44","evidence_quote":"it has taken into consideration that Claim Administrator and/or Prime will keep all or a portion of the discounts and/or other allowances that Claims Administrator or its pharmacy benefits manager has negotiated with the Network Participant.","rationale":"Spread pricing is written into the agreement. Exhibit 7 Section 6(a) on page 44 has the Employer acknowledge, as part of negotiating the deal, that the Claim Administrator and/or Prime will keep all or a portion of the discounts and allowances negotiated with network pharmacies, while Prime reimburses those pharmacies under their separate Network Contract. Exhibit 3 Section 4.3 on page 27 says pharmacy discounts are passed through only to the Claim Administrator, not to the Employer, and that for mail and specialty Prime keeps a portion as its fee. Page 46 says the Employer pays the pricing in the missing BPA Addendum rather than what the pharmacy was paid, and the exhibit is titled a Guaranteed Traditional Aggregate Pricing Arrangement on page 43. The model requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee. This permits the retained difference in every channel, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 28","evidence_quote":"rebates collected by PBM and paid to Claim Administrator will be net of any fee the group purchasing organization may retain for its role in securing rebates.","rationale":"The agreement anticipates a group purchasing organization and lets its take stay outside the plan. Exhibit 3 Section 5.2 on page 28 says the PBM may contract with manufacturers through a group purchasing organization and that rebates paid to the Claim Administrator will be net of any fee the GPO retains. Exhibit 7 Section 4 on page 43 says Prime negotiates directly or through a group purchasing organization, and the rebate definition on page 49 excludes fees retained by a GPO. The Manufacturer Administration Fee definition on page 48 likewise covers fees received directly or through a GPO, and page 44 says the Employer has no right, title or interest in those fees. Even the rebates that survive the GPO deduction go to the Claim Administrator, not the plan. The model requires purchase discounts, volume credits and supplier payments received by any related purchasing entity to flow to the plan on disclosed drivers. This text does the opposite, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"FORM","verdict":"bad","confidence":0.6,"page_ref":"Page 43","evidence_quote":"Claim Administrator utilizes its own Drug List and Prime supports Claim Administrator in the development, maintenance and updating of such Drug List.","rationale":"Exhibit 7 Section 3 on page 43 says the Claim Administrator uses its own Drug List, that Prime supports its development, maintenance and updating, and that Prime performs exception reviews and supports the Claim Administrator's Pharmacy and Therapeutics and Business Committees. The Employer's only stated role is selecting a designated Drug List, and it agrees the Claim Administrator may promote dispensing consistent with that list. Exhibit 1 on page 18 has the Employer accept the Claim Administrator's standard utilization management criteria. There is no approval right over formulary changes, no lowest net cost analysis and no quarterly utilization management outcomes by drug. Because the same party controls the formulary and, under pages 28 and 43, keeps all rebates that page 43 says are based on formulary status and market share, the structure permits the harm the model term guards against. I weighed partial for the selection right but settled on bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"LNC","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"I looked for a lowest net cost standard, an annual book of business comparison and disclosure of drugs placed above cheaper equivalents in Exhibit 7 Sections 1 through 4 on pages 43 and 44, the Drug List and Utilization Management definitions on pages 48 and 49, and the rebate disclosures in Exhibit 3 Sections 4 and 5 on pages 27 and 28. The text says Prime provides Drug List management in accordance with NCQA and URAC standards (page 43), which is a process accreditation and not a cost standard, and it discloses that rebate arrangements are based on formulary status and market share (page 43), which describes the incentive without constraining it. The Expected Rebates projection on page 28 is a revenue forecast for the Claim Administrator, not a net cost comparison for the plan. No lowest net cost obligation, comparison report or placement disclosure appears anywhere, so missing.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"NET","verdict":"bad","confidence":0.75,"page_ref":"Page 46","evidence_quote":"Specialty Drugs may be provided by Prime, an affiliate of Prime, or other Specialty Pharmacy that has a written arrangement with Prime or Claim Administrator.","rationale":"The pharmacy network belongs to Prime. Exhibit 7 Section 6(a) on page 44 makes Prime responsible for providing and maintaining the network and for reimbursing pharmacies under its own Network Contracts, and Section 6(f) provides for pharmacy claims audits, which are recoveries after adjudication. Specialty Pharmacy is defined on page 49 as a pharmacy designated by the Claim Administrator or PBM to dispense by mail from central locations, and page 46 says Specialty Drugs may be provided by Prime or an affiliate of Prime, with mail order likewise routed through a Prime designated pharmacy. There is no any willing pharmacy clause, no claim finality protection, and no prohibition on steering into affiliated channels. The one member protection, on page 44, is that pharmacies may not switch to a higher cost product without a request. The general statement on page 26 that provider choice belongs to the Covered Person does not override the channel design, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"MFN","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I looked for most favored client pricing, a market check and a meet, credit or release remedy in Exhibit 2 Section 3 on page 22, Exhibit 7 Sections 7 through 10 on pages 45 to 47 and the termination provisions on pages 11 and 46. The only repricing mechanics in the text run in the Claim Administrator's favor: service charges may be changed on enrollment or benefit variances (page 22), benefit design changes can void addendum pricing and force renegotiation (page 45), and AWP methodology changes trigger automatic adjustment to restore the vendor's economic position (page 45). The Employer's only lever is a ninety day termination right at the end of a Guarantee Period or Fee Schedule Period (pages 11 and 46). Nothing gives the plan pricing at least as good as comparable clients or a right to test the market during the term, so the verdict is missing.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"AUD","verdict":"bad","confidence":0.7,"page_ref":"Page 5","evidence_quote":"Contingency fee based audits are not supported by Claim Administrator. Audit samples will be limited to no more than three hundred (300) Claims.","rationale":"An audit right exists but it is fenced on every side. Section 2.10 on pages 5 and 6 allows the Employer or an agent subject to the Claim Administrator's approval to audit on ninety days notice, bars contingency fee auditors, caps samples at three hundred claims, refuses reprocessing based on extrapolation, limits audits to one per twelve months and a two year lookback, charges all costs to the Employer and requires an Audit Agreement with a promise not to disclose proprietary information. Exhibit 7 Section 6(g) on pages 44 and 45 lets the Employer audit Prime only through the Claim Administrator, with records withheld where Prime is contractually prohibited and no material copied or removed. Reporting under Exhibit 1 on page 19 is standard format only, and Section 3.7 on page 7 excludes Business Confidential Information, which page 15 defines to include pricing and discounts, from the records the Employer may obtain. The model bars withholding data as proprietary; this text authorizes it, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"DATA","verdict":"bad","confidence":0.8,"page_ref":"Page 7","evidence_quote":"provide to Employer, a copy of all Claim determination records, excluding any and all of the Business Confidential Information of Claim Administrator, other Blue Cross and/or Blue Shield companies, or Claim Administrator’s subsidiaries, affiliates, and vendors","rationale":"Nowhere does the agreement say the Employer or the Plan owns claims, eligibility, accumulator or rebate data. Section 3.7 on page 7 gives the Employer only a right to request copies of claim determination records for three years after termination, with Business Confidential Information excluded, format to be agreed, preparation costs borne by the Employer and retention governed by the Claim Administrator's changeable policy. Section 3.3 on page 6 lets the Claim Administrator decide in its sole discretion whether to release data to the Employer's own consultants, who must sign the Claim Administrator's data exchange agreement and treat the data as the Claim Administrator's confidential information. Section 3.8 on page 7 lets the Claim Administrator and the Association use de identified data for industry improvement activities. Section 3.5 has the Employer agree not to contest the Claim Administrator's ownership of its Business Confidential Information. The model makes the sponsor sole owner with machine readable delivery on request; this is the reverse, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"PERF","verdict":"unclear","confidence":0.6,"page_ref":"Page 46","evidence_quote":"then applicable network discount and/or minimum Rebate guarantees set forth in the BPA Addendum will not be effective for such Guarantee Period.","rationale":"The text confirms that network discount and minimum Rebate guarantees exist, but places them entirely in the BPA Addendum, which is not part of the posted document. Exhibit 7 Section 9(f) on page 46 says those guarantees are voided for a Guarantee Period if the Employer terminates the exhibit early or the Claim Administrator terminates for breach or non payment. Page 27 says a portion of Prime's fees are tied to performance standards for claims processing, customer service and mail order processing, but that arrangement runs between Prime and the Claim Administrator and no remedy flows to the Employer. Nothing in the produced text shows how guarantees are measured, whether on plan specific or book of business data, whether reconciliation is in cash and whether shortfalls are paid dollar for dollar or capped. Because the terms would live in the explicitly referenced but omitted addendum, the verdict is unclear.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"ENF","verdict":"bad","confidence":0.8,"page_ref":"Page 11","evidence_quote":"This provision precludes Employer from filing an action at law or in equity and from having any dispute covered by this Agreement heard by a judge or jury.","rationale":"There is no self executing remedy anywhere in the text. No liquidated damages or automatic credits attach to missed guarantees or late reports, and the only automatic financial penalties run against the Employer: a daily late charge equal to twelve percent per annum on page 24 and suspension of claim payments on page 23. Enforcement by the Employer requires written notice and a ninety day cure period under Section 4.9 on page 10, then informal negotiation and confidential binding arbitration under Section 4.11 on pages 10 and 11, which precludes any court action or jury and caps liability under Section 4.10 at the benefits that should have been paid. Termination for material breach under Section 6.1(c) on page 11 is available only after the cure period, and no two strikes or regulatory integrity exit exists. The model makes remedies automatic and gives a defined exit after a repeat failure; this text forces the plan to arbitrate, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"AMD","verdict":"bad","confidence":0.85,"page_ref":"Page 12","evidence_quote":"any amendments required by law, regulation or order (“Law”) or by Claim Administrator or the Association may be implemented by Claim Administrator upon sixty (60) calendar days’ prior notice to Employer","rationale":"Section 6.4 on page 12 opens by requiring mutual written agreement, then immediately allows amendments required by Law or by the Claim Administrator or the Association to be implemented on sixty days notice, with the Employer's only recourse an objection within thirty days followed by negotiation and dispute resolution. Economic terms can also move by notice elsewhere: Exhibit 2 Section 3.3 on page 22 lets the Claim Administrator change service charges on enrollment swings of ten percent, benefit variances, government cost increases or outdated projections; Exhibit 5 Section 1.3 on page 32 and Section 4.9 on page 40 deem the Employer to have approved modified PMPM payments and Inter-Plan fees if it does not respond; and Exhibit 7 Section 7(b) on page 45 converts AWP pricing to a benchmark chosen by Prime with deemed approval. The model bars any change to economic terms by notice or updated exhibit. This text permits several, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"TERM","verdict":"bad","confidence":0.7,"page_ref":"Page 22","evidence_quote":"Employer will Timely pay Claim Administrator the Termination Administrative Charge indicated in the Fee Schedule specifications of the most current ASO BPA.","rationale":"The Employer can leave, but not freely and not without loss. Section 6.1(a) on page 11 allows termination by either party only at the end of a month after the Fee Schedule Period ends, on ninety days notice, so there is no convenience exit during the fee period, and Exhibit 7 Section 9(a) on page 46 ties PBM exhibit termination to the end of a Guarantee Period. Exhibit 2 Section 3.4 on page 22 imposes a Termination Administrative Charge set in the missing ASO BPA, which the Claim Administrator may adjust if enrollment shifted ten percent. Section 9(f) on page 46 voids network discount and minimum Rebate guarantees for the Guarantee Period if the Employer terminates early, and pages 28 and 47 end Rebate Credits at termination. Only fraud, misrepresentation or material breach after cure supports for cause exit, with no regulatory integrity trigger. The model forbids penalties and forfeiture of earned amounts; this text imposes both, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"SPEC","verdict":"bad","confidence":0.85,"page_ref":"Page 49","evidence_quote":"The list of Specialty Drugs is determined by Prime or Claim Administrator and subject to change.","rationale":"Specialty is defined by vendor designation rather than function. The definition on page 49 describes typical characteristics but ends by making the list whatever Prime or the Claim Administrator determines, subject to change, and Specialty Pharmacy is a pharmacy designated by the Claim Administrator or PBM. Exhibit 7 Section 10(b) on page 46 says specialty claims are priced at the BPA Addendum specialty rates, separately from retail and mail pricing, and may be dispensed by Prime, an affiliate of Prime or another arranged pharmacy. Page 27 says Prime may keep a portion of the discounts it negotiates with the specialty pharmacy as its fee, and page 28 says the specialty pharmacy may be an affiliate of or partially owned by Prime. The model requires a functional definition, drug level rates that act as a ceiling in every channel and acquisition cost pricing at affiliates. This text allows the vendor to define the category, set the price in an omitted addendum and retain margin, so bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Claude Fable 5.1","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 7","evidence_quote":"Employer shall not use or disclose such Business Confidential Information, including this Agreement, to any third party without prior written consent of Claim Administrator.","rationale":"Section 3.4 on page 7 forbids the Employer from disclosing Business Confidential Information, expressly including the agreement itself, to any third party without the Claim Administrator's written consent, and requires advance notice of any legally required disclosure to a Covered Person, representative or governmental entity so the Claim Administrator can object and impose confidentiality protections. Section 7.3 on page 15 defines Business Confidential Information to include cost or pricing information such as provider discounts and rates and contracts. Section 3.3 on page 6 extends the restriction to the Employer's consultants, Section 2.10 on page 6 binds auditors, Exhibit 7 Section 6(c) on page 44 puts the MAC list behind a non disclosure agreement, and Section 4.11 on page 11 makes arbitration results confidential. The public records language only lets the vendor try to block a release, which under the rubric does not cure a gag clause. Nothing restricts pharmacies from discussing cheaper options, but the plan side restriction is enough for bad.","model_own_total":4.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FID","verdict":"partial","confidence":0.85,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"The agreement contains an express fiduciary undertaking, which is unusual for a pharmacy benefit manager, and section 5.4(b) on page 7 adds duties of utmost good faith, loyalty, candor and skill. The duty is framed around good faith performance of the contract rather than loyalty owed solely to the plan and its members. There is no requirement to disclose every form of direct and indirect compensation as part of that duty and no disgorgement remedy for value retained in breach. The model contract published by Mark Cuban and collaborators ties the fiduciary standard to sole loyalty and to giving back retained amounts, so this falls short of that standard.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 22","evidence_quote":"PBM warrants and represents that, if at any time after the Effective Date of the Contract, PBM discovers or is made aware of an actual or perceived conflict of interest, appearance of impropriety or Prohibited Communication","rationale":"Article 16 requires immediate written disclosure of actual or perceived conflicts of interest and prohibited communications, and section 4.1(a) on page 4 bars the vendor from taking any fee not accepted in writing by ERS. Section 4.1(e) on page 4 also directs manufacturer program fees to ERS rather than letting the vendor keep them. What is absent is any schedule of affiliate ownership touching plan claims, any disclosure of payments to consultants or brokers, and any quarterly or annual certification by a named officer that all direct and indirect compensation has been disclosed. Disclosure is therefore event driven rather than a standing certified accounting of revenue.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.7,"page_ref":"Page 10","evidence_quote":"Without contravening applicable law, PBM agrees to notify ERS¶ Executive Director immediately upon being able to lawfully make a public announcement of reaching any form of binding agreement in connection with and prior to any merger, acquisition, business reorganization, or other material change of PBM","rationale":"The contract requires immediate notice of any merger, acquisition or other change of ownership, management or control, and section 4.1(i) on page 4 names Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. as the affiliated specialty pharmacies. The insurance certificates at pages 55 to 58 list dozens of related entities, including MATRIX GPO, LLC and ECONDISC CONTRACTING SOLUTIONS, LLC, but that is an insurance schedule rather than a signed ownership exhibit and it is not tied to any refresh duty. There is no exhibit that identifies owners, parents, rebate aggregators and purchasing entities as such, and no obligation to update an ownership list when affiliates change. The disclosure that exists is partial and incidental rather than a complete affiliate map.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DEF","verdict":"partial","confidence":0.85,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The rebate definition is deliberately broad and reaches price protection dollars, price concessions, discounts and any other remuneration, and section 4.1(e) on page 4 folds manufacturer program and management fees into the same treatment. The definition is still limited to amounts received under a contract with a pharmaceutical manufacturer and related to formulary drug utilization, so revenue routed through a group purchasing entity or a supplier arrangement is not captured by function. Specialty is defined by which affiliate dispenses rather than by the economics of the drug, and there are no closing definitions for affiliate, generic or manufacturer revenue. Value can therefore still be relabeled outside the manufacturer contract channel.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.7,"page_ref":"Page 5","evidence_quote":"pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed to HealthSelect Medicare Rx PDP or HealthSelect PDP Participants. Such Rebates shall be paid to ERS by PBM promptly, but in no event later than on a quarterly basis until all such compensation has been received by ERS.","rationale":"The base text commits the vendor to pay all rebates and all federal subsidies to ERS on at least a quarterly basis, with best efforts to negotiate commercially reasonable rebate agreements. The share actually passed through is qualified by the phrase as set forth herein and in Exhibit D, and section 4.1(h) elsewhere refers to the applicable rate described in the fee schedule, so the text does not itself establish one hundred percent pass through. The quarterly timing is stated without the thirty day settlement deadline and without a closed list of excludable claims. Because the operative rate lives in the fee schedule while the base text does state a pass through duty, this is a genuine but incomplete protection.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NAC","verdict":"unclear","confidence":0.6,"page_ref":"Page 4","evidence_quote":null,"rationale":"The contract never uses the concept of net acquisition cost and never limits what an affiliated mail, retail or specialty pharmacy may retain on a plan claim. All reimbursement and channel pricing is committed to Exhibit D, the PBM Fee Schedule, by section 4.1(a) and the related pricing provisions on this page, and Exhibit D appears in the assembled document only as a cover sheet at page 39. The affiliated dispensing entities are named on page 4, so the parties clearly contemplated affiliate claims, but the pricing method for them is not in the text supplied. No conclusion is possible without the fee schedule.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"There is no benchmark ceiling anywhere in the base agreement, the amendments, the supplement or the service addendum. The only pricing reference point in the text is the average wholesale price source, which section 4.1(d) on page 4 fixes as Medi-span, and that is a benchmark for discount math rather than a cap. Nothing requires plan claim cost to stay at or below a published transparent cash price in any channel, and nothing provides a claim by claim check. The contract does not point to an appendix for such a ceiling, so this protection is simply absent.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CASH","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No provision protects a member from paying more than the pharmacy cash price, and the words cash price, usual and customary, accumulator and out of pocket maximum do not appear in the contractual text. Article 9 on page 12 compensates a participant for vendor error and the service addendum handles Medicare monthly payment plan invoicing, but neither addresses cheaper cash purchases or deductible credit. Plan design and cost share levels are handled by reference to the plan documents and the fee schedule without any member price ceiling. Nothing in the base agreement or the secondary documents reaches this subject.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MAC","verdict":"partial","confidence":0.85,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"Section 4.1(d) does constrain maximum allowable cost list changes to the ordinary course of business and adds a test protecting retail pharmacy participation, which is more than many agreements provide. It does not require a single list applying to both what the plan pays and what pharmacies are paid, does not require disclosure of the list to ERS or to pharmacies, and sets no update schedule. There is no pharmacy appeals path with defined timelines anywhere in the documents. Governance of the list therefore remains substantially with the vendor.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"unclear","confidence":0.65,"page_ref":"Page 4","evidence_quote":null,"rationale":"Nothing in the base agreement states whether ERS pays exactly what the network pharmacy is paid plus a disclosed administrative fee, and the word spread never appears. Section 4.1(a) and section 4.1(d) on this page commit the reimbursement schedule, discount terms and administrative fees to Exhibit D, the PBM Fee Schedule, which is present only as the cover sheet at page 39. Whether the arrangement is pass through or a guaranteed discount arrangement that lets the vendor retain a difference is determined entirely inside that fee schedule and the associated contract attachments. Section 15.6 audit rights refer to verifying costs and discounts on claims, which implies the plan can test pricing, but the pricing method itself cannot be read from the text supplied.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GPO","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"No document addresses purchase discounts, volume credits or supplier payments received by a group purchasing organization or other related purchasing entity. The rebate definition on pages 5 and 6 is limited to amounts received under contracts with pharmaceutical manufacturers, which leaves purchasing entity revenue outside the pass through duty by construction. The insurance schedule at pages 55 to 58 shows related entities that operate in this space, including MATRIX GPO, LLC, yet no clause requires their revenue to flow to the plan or to be allocated on disclosed drivers. The text does not defer this subject to an appendix, so it is absent rather than unreadable.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"Formulary control is meaningfully with the plan sponsor because changes require prior approval by authorized ERS representatives, and section 4.1(c) on page 4 separately requires written ERS approval of any material modification of plan design including the formulary. The clause openly acknowledges that manufacturer rebate arrangements are one driver of formulary changes without requiring that the plan be shown the economics behind a proposed change. There is no obligation to deliver a lowest net cost analysis with each change and no requirement to report utilization management outcomes by drug each quarter. Approval rights are strong, the supporting analytics the model contract expects are not present.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No provision imposes a lowest net cost standard on formulary decisions for this plan. There is no annual comparison of this plan against the vendor book of business and no requirement to disclose and justify a drug placed above a cheaper therapeutic equivalent. Section 4.1(h) on page 5 allows a formulary management program with cost containment initiatives subject to ERS review, which is a process right rather than a substantive net cost standard. Nothing in the amendments, the supplement or the service addendum supplies this standard.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NET","verdict":"partial","confidence":0.65,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"Two provisions give the plan some network leverage, this cooperation duty on alternate retail networks and the test in section 4.1(d) on page 4 that maximum allowable cost changes must not discourage retail pharmacy participation. The protections the model contract centres on are absent. There is no statement that claims are final when adjudicated and no bar on retroactive clawbacks or recoupment, no bar on conditioning reimbursement on volume, no anti steering restriction even though affiliated mail and specialty pharmacies are built into the design, and no any willing pharmacy right since network participation depends on vendor credentialing and a vendor contract. Members can be directed toward affiliated pharmacies without a contractual check.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"PBM warrants and represents that if, during the term of this Contract, PBM enters into any agreement with any other governmental customer or any commercial customer not affiliated with PBM, of a similar size or smaller (the Comparative Agreement), by which PBM agrees to perform, deliver or provide equivalent Services, coverages, benefits, supplies or products that PBM is providing in accordance with this Contract for more generous pricing terms","rationale":"Section 31.6 is a real most favoured pricing clause covering administrative fees, discounts, rebates and financial incentives, and it lets ERS elect to have the contract amended to give equivalent advantage. Its limits matter. The comparison is measured in the aggregate rather than line by line, it only reaches customers of similar size or smaller, and the vendor is the party that determines whether a comparative agreement exists and then notifies ERS. There is also no annual market check by an independent party with a meet, credit or release remedy, so the plan depends on vendor self reporting.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AUD","verdict":"good","confidence":0.8,"page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"Article 15 gives ERS an absolute audit right that expressly extends to the vendor arrangements and contracts with pharmaceutical manufacturers, uses auditors chosen by ERS, preserves State Auditor access under Texas Insurance Code section 1551.067, and states in section 15.13 that nothing in the vendor proposal limits these rights. Section 5.7 on page 9 gives ERS direct access to individual claim and group specific data on its own premises, and ad hoc reports must be produced at no additional charge. Section 15.9 on page 18 shifts audit costs to the vendor when errors exceed fifty thousand dollars, which makes the right practical rather than theoretical. Two limits keep this short of perfect, third party auditors must sign a non disclosure agreement with the vendor and rebate agreement audits are restricted to approved firms and to the portions the auditor deems necessary, and there is no pre adjudication claims access. Taken as a whole the audit and data access package is as strong as the model contract asks for.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 26","evidence_quote":"Upon termination or expiration of the Contract, or upon request by ERS or its designee, PBM shall promptly, in good faith, and with the standard of care required under the Contract, assign, transfer and/or deliver the ERS-related records and data in its possession to ERS","rationale":"Section 21.2 requires prompt return or transfer of plan records and data at no cost, section 21.3 requires a readable format that needs no specialized software, and section 13.6 on page 14 states that the designated confidential information is the exclusive property of ERS and the group benefits program. Article 17 on page 23 also bars use of participant data for solicitation or marketing. Against that, Article 14 on pages 15 and 16 reserves the vendor systems, methodologies and standard report formats to the vendor, the business associate agreement at page 45 lets the vendor de-identify protected health information and keep it indefinitely, and the service addendum permits use of participant data for outcomes and opportunity analyses and for other programs. Ownership of the underlying records is clear but the vendor retains meaningful reuse rights over derived data.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PERF","verdict":"unclear","confidence":0.6,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Performance guarantees are established by reference. Section 5.5 of the base agreement on page 7 points to Exhibit E, which appears in the assembled base document only as a cover sheet at page 40, and Amendment 2 replaces that exhibit effective January 1 2024 with First Amended and Restated Performance Guarantees. The page carrying those restated guarantees is fully redacted, so the measurement basis, frequency, cash reconciliation and whether shortfalls are paid dollar for dollar or capped cannot be read. Amendment 2 page 3 is the cover sheet for the same exhibit.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract, whichever ERS determines is appropriate.","rationale":"Article 9 gives ERS liquidated damages without having to prove actual damages, allows the amount to be deducted from money otherwise owed, and section 33.10 on page 32 lets ERS assess them immediately without notice for implementation failures. Termination for cause is immediate in the sole opinion of ERS, which is stronger than a two strikes exit. The weaknesses are that the remedy is discretionary and generally requires a notice of default and a cure period of at least five days, the amount is a ceiling rather than a set schedule, and the automatic credit mechanics for missed guarantees sit in the redacted performance guarantee exhibit. Enforcement is therefore real but not self executing.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 2","evidence_quote":"Amendments. The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"Section 2.6 permits change only by a written agreement executed by authorized representatives of both parties, and section 2.7 makes the article survive termination, renewal or amendment. Fee changes are subject to the same requirement, so economic terms cannot be moved by notice, portal update or a replacement exhibit issued unilaterally. The two amendments and the supplement in this record were in fact signed by both parties, which shows the mechanism operating as written. The service addendum accepts an email approval as an ERS signature, which is a form question rather than a loss of consent.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"TERM","verdict":"good","confidence":0.9,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"Section 2.4 gives ERS termination without cause on ninety days notice, immediate termination for cause, mutual termination, and a funding out if the board does not approve funds, with no termination fee anywhere in the document. Section 4.3 on page 6 requires a pro rata refund of prepaid fees within two business days of termination, and rebate and subsidy amounts continue to be paid until ERS has received all such compensation. Article 21 requires transition cooperation and delivery of records at no cost. Regulatory integrity events are covered because failures of the eligibility and conduct warranties in Article 31 allow immediate termination.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"unclear","confidence":0.6,"page_ref":"Page 4","evidence_quote":null,"rationale":"Specialty is treated as a channel rather than defined by function. Section 4.1(i) on this page defines the affiliated specialty pharmacies by naming Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. and any affiliate pharmacy that primarily dispenses specialty products, without defining specialty products themselves. Every drug level rate, channel ceiling and any acquisition cost treatment for affiliate specialty claims sits in Exhibit D, the PBM Fee Schedule, which is present only as the cover sheet at page 39. The specialty pricing controls cannot be assessed from the text supplied.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GAG","verdict":"good","confidence":0.8,"page_ref":"Page 15","evidence_quote":"PBM should assume that all reports created by it for ERS may be publicly available records, in accordance with Texas law, and may be subject to the PIA","rationale":"Article 13 runs in the plan direction rather than the vendor direction. Section 13.1 on page 13 confirms that ERS is subject to the Texas Public Information Act and must make contract information available to the public, section 13.11 states that ERS has no duty to designate vendor information as confidential and proprietary, and ERS auditors, advisors and consultants may use and retain the materials the vendor produces. Supplement 1 goes further by requiring the vendor to compile the gag clause prohibition compliance attestation information ERS must submit to federal regulators each compliance period. The one friction is that third party advisors and auditors must sign a non disclosure agreement with the vendor before receiving some material, and the service addendum is stamped as confidential information, but nothing bars ERS from sharing pricing, rebate or performance data with its advisors, members, the public or lawmakers.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"partial","confidence":0.97,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"The agreement expressly makes the PBM a fiduciary and separately requires loyalty, candor, skill, and good faith. It does not state that duties run solely to the plan and members, require disclosure of all direct and indirect compensation, or expressly provide disgorgement and participant enforcement.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.96,"page_ref":"Page 22","evidence_quote":"PBM warrants and represents that, if at any time after the Effective Date of the Contract, PBM discovers or is made aware of an actual or perceived conflict of interest, appearance of impropriety or Prohibited Communication that pre-existed the Contract¶s Effective Date or arose thereafter, PBM shall immediately disclose such interest, appearance or communication in writing to ERS.","rationale":"The PBM must immediately disclose actual or perceived conflicts and address mitigation with ERS. The clause does not require quarterly and annual officer certification of all compensation, affiliate ownership, broker payments, or prospective conflicts.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.94,"page_ref":"Page 10","evidence_quote":"PBM agrees to notify ERS¶ Executive Director immediately upon being able to lawfully make a public announcement of reaching any form of binding agreement in connection with and prior to any merger, acquisition, business reorganization, or other material change of PBM¶s management, ownership or business structure","rationale":"The agreement requires notice of material ownership and control changes, and its insurance schedule identifies many affiliates. It does not provide a signed current ownership exhibit covering pharmacies, GPOs, rebate aggregators, offshore entities, and administrators with a fixed thirty-day refresh duty.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"partial","confidence":0.96,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The rebate definition functionally captures several forms of manufacturer remuneration, including price protection and concessions. Its continuation limits the definition to manufacturer contracts tied to formulary drug utilization, and the agreement lacks equally complete functional definitions for manufacturer revenue, affiliates, generics, specialty, and pharmacy payments.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"partial","confidence":0.95,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed to HealthSelect Medicare Rx PDP or HealthSelect PDP Participants. Such Rebates shall be paid to ERS by PBM promptly, but in no event later than on a quarterly basis until all such compensation has been received by ERS.","rationale":"The PBM must remit all contract-defined rebates to ERS at least quarterly. The definition is narrower than all manufacturer revenue, does not clearly reach every affiliate or channel, and does not require remittance within thirty days after quarter end with invoice-level support and interest.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"unclear","confidence":0.97,"page_ref":"Page 4","evidence_quote":null,"rationale":"Page 4 places the compensation and reimbursement schedule in Exhibit D, while the incorporated Appendix A pricing attachments are not included in the available text. Those withheld pricing materials prevent a determination whether affiliate mail and specialty claims use acquisition cost plus a stated fee with no hidden margin.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the reimbursement, MAC, claim payment, fee, formulary, audit, and pricing provisions in the base agreement and all four secondary documents. None sets a lower-of benchmark and actual acquisition cost ceiling, provides cash-price protection, bans affiliate steering to evade a ceiling, or supplies an enforceable remedy for ceiling violations.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the claims, participant cost, reimbursement, pharmacy, and Medicare Prescription Payment Plan provisions in the base agreement and all secondary documents. None requires the participant to receive the lower of the negotiated amount or cash price, credit the full paid amount to deductible and out-of-pocket totals, or bar accumulator and maximizer programs.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.98,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"The clause affirmatively allows the PBM to modify MAC pricing under an ordinary-course standard. It does not require one disclosed list, fixed update timing, claim-level source support, rapid appeals, retroactive corrections, or access for ERS and pharmacies.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"unclear","confidence":0.96,"page_ref":"Page 4","evidence_quote":null,"rationale":"Page 4 states that compensation and reimbursement are governed by the Fee Schedule in Exhibit D, and the incorporated Appendix A pricing attachments are not in the available record. Without those financial terms, it is not possible to determine whether spread pricing and pharmacy payment retention are prohibited and reconciled.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the rebate provisions, PBM and agent definitions, affiliate insurance schedule, audit clauses, and all secondary documents, including references to procurement and group purchasing entities. No clause requires pass-through of GPO, purchasing, data, volume, credit, or other non-rebate payments, allocates shared payments, or provides ERS a make-whole right.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 5","evidence_quote":"As provided in the RFP, the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"ERS must approve formulary modifications before implementation, which provides meaningful sponsor control. The provision allows rebate arrangements to influence changes and does not require lowest-net-cost selection, approval of every tier and utilization-management change, conflict safeguards, or quarterly drug-level outcome reporting.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the formulary, rebate, fee, performance, audit, and reporting provisions in the base agreement and all secondary documents. None requires lowest-net-cost formulary selection, drug-level comparison of rebates and fees against lower-list-price alternatives, or an annual independent evaluation with a repayment remedy.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.91,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"ERS retains sole discretion to implement an alternate retail network and the PBM must cooperate in good faith. The agreement does not expressly ban affiliate steering and self-preference, require any willing pharmacy admission, prohibit clawbacks, or forbid volume guarantees to PBM-owned pharmacies.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"partial","confidence":0.97,"page_ref":"Page 29","evidence_quote":"for more generous pricing terms (lower administrative fees, lower compensation, more generous discounts, more generous rebates, and/or more generous financial incentives or terms), measured in the aggregate, then this Contract, at ERS¶ sole option, shall be amended to accord equivalent advantage to ERS.","rationale":"The agreement grants ERS an aggregate most-favored pricing adjustment when the PBM gives better terms to a comparable unaffiliated customer. The protection is limited by comparability and aggregate measurement, relies on PBM assessment, and lacks an annual independent market check and retroactive true-up mechanism.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.98,"page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"ERS receives broad audit rights over contract performance, ERS-related records, manufacturer arrangements, and affiliate pharmacy claims, with cost shifting after significant findings. Rebate audits are constrained by independence, insurance, nondisclosure, timing, and access limited to portions deemed necessary, and the agreement does not clearly provide live pre-adjudication claim access.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 45","evidence_quote":"de-identify PHI and maintain such de-identified health information indefinitely; provided that all identifiers are destroyed or returned in accordance with this Agreement.","rationale":"The agreement affirmatively permits the PBM to retain de-identified plan information indefinitely. Although ERS has ownership and access protections for plan records, indefinite reuse conflicts with the rubric requirement to prohibit retention and reuse except for narrow plan-serving purposes.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"unclear","confidence":0.99,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Amendment 2 replaces the performance guarantees with the First Amended and Restated Performance Guarantees, but page 4 containing those terms is fully redacted. That redaction prevents review of guarantee categories, denominators, exclusions, reporting, and amounts.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.97,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract, whichever ERS determines is appropriate.","rationale":"ERS may impose liquidated damages per default or per day and retains other remedies, creating a meaningful enforcement mechanism. The damages are discretionary rather than automatic routine credits, and the visible text lacks a two-strikes termination trigger tied to repeated performance-guarantee misses.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"Service addendum, page 2","evidence_quote":"ESI shall provide ERS with a minimum of thirty (30) calendar days written notice prior to effecting any material modifications or changes to the pricing structure of the M3P program.","rationale":"The service addendum affirmatively permits material pricing-structure changes through thirty days written notice rather than prior signed sponsor consent. This direct pricing exception defeats an otherwise strong written-amendment and no-oral-modification framework.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"good","confidence":0.99,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice;","rationale":"ERS has an express convenience-termination right on ninety days written notice, independent of breach. The agreement also requires return of prepaid amounts and transition cooperation without imposing an exit penalty.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"unclear","confidence":0.97,"page_ref":"Page 4","evidence_quote":null,"rationale":"Page 4 defines the PBM specialty pharmacy and places compensation and reimbursement in Exhibit D, while the incorporated Appendix A pricing attachments are unavailable. The visible documents therefore do not establish whether specialty pricing uses transparent acquisition cost plus a fee or instead uses a benchmark subject to a cost ceiling and periodic invoice reconciliation.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"partial","confidence":0.96,"page_ref":"Page 13","evidence_quote":"PBM agrees that it is required by Texas law to make any information pursuant to this Contract, and not otherwise excepted from disclosure under the PIA, available in a format that is accessible by the public at no additional charge to ERS.","rationale":"The agreement recognizes Texas public-records duties and allows legally required disclosure, which preserves a meaningful transparency route. It also permits confidentiality designations and requires nondisclosure agreements for auditors, while pricing in the service addendum is redacted, so sponsor, advisor, auditor, and public disclosure rights are not fully unconditional.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit\nG, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"The scope of services exhibit has the plan sponsor agree in advance that Express Scripts is not a fiduciary of the plan and has no discretionary authority, and the parties recite that they dealt at arm's length. The only fiduciary duty Express Scripts accepts is for its handling of an appeal. Express Scripts also reserves the right to stop serving any plan located in a state that would require a pharmacy benefit manager to be a fiduciary. The model contract published by Mark Cuban and collaborators does the opposite and puts a duty of loyalty to the plan and its members at the center, so this is the clearest contradiction in the document.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 115","evidence_quote":"ESI and\nESI’s wholly-owned subsidiaries or affiliates derive revenue in one or more of the ways as further described in the\nFinancial Disclosure to ESI PBM Clients set forth in the Proposal (“Financial Disclosure”), as updated by ESI from time\nto time.","rationale":"Compensation beyond the administrative fees is disclosed only by pointing to a generic Financial Disclosure to ESI PBM Clients that sits inside the proposal, a document that is on file with the A&M System rather than in the produced contract, and that Express Scripts may update on its own. There are no dollar amounts, no plan specific accounting of retained revenue, and no officer certification that everything has been disclosed and remitted. The subject is addressed, but far more weakly than the model contract published by Mark Cuban and collaborators requires.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.6,"page_ref":"Page 6","evidence_quote":"ESI agrees to provide the A&M System reasonable\nadvance notice prior to the effective date of any merger, acquisition, business reorganization, or other change\nof ESI management or ownership.","rationale":"There is no ownership or affiliate disclosure exhibit anywhere in the document. What exists is a promise of advance notice before a merger, acquisition, reorganization or change of ownership, and the A&M System agrees to keep that notice confidential. A few affiliates are named in passing, including Accredo Health Group and Express Scripts Specialty Distribution Services as specialty pharmacies on page 110 and Medco Containment Life Insurance Company as the Medicare plan sponsor on page 116, but there is no list of owners, group purchasing organizations or rebate aggregators and no duty to refresh a list when ownership changes.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DEF","verdict":"partial","confidence":0.7,"page_ref":"Page 110","evidence_quote":"“Brand/Generic Algorithm” or “BGA” means ESI’s standard and proprietary brand/generic algorithm, a copy of which\nmay be made available for review by Sponsor or its Auditor upon request.","rationale":"The definitions that survive redaction generally hand the labelling power to Express Scripts rather than tying terms to economic function. Whether a drug counts as brand or generic is decided by Express Scripts' own proprietary algorithm, the maximum allowable cost list is whatever Express Scripts develops or selects, and the specialty drug list is maintained and updated by Express Scripts. The central definitions of rebates, manufacturer administrative fees and specialty product are blacked out in the definition list on page 111, so the pass through language cannot be tested against them.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PASS","verdict":"bad","confidence":0.85,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial\ninterest in such fees and revenues described in the Financial Disclosure and, accordingly, A&M System acknowledges\nthat neither it, any Member, nor the Plan, has a right to receive, or possesses any beneficial interest in, any such fees\nor revenues;","rationale":"Instead of promising the plan one hundred percent of manufacturer revenue, the contract states that Express Scripts and its affiliates keep the beneficial interest in those revenues and that the A&M System has no right to receive them beyond the specific amounts written into the pricing exhibit. The rebate obligation on page 114 reads only that Express Scripts will pay the amounts set forth on Exhibit C, which is a guaranteed amount arrangement rather than a full pass through. The dollar figures in Exhibit C-3 are redacted, but the structure that leaves the surplus with the vendor is visible in the unredacted text.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NAC","verdict":"unclear","confidence":0.7,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Pricing for the Express Scripts owned mail and specialty pharmacies lives in Exhibit C-2 and in Exhibit D, Specialty Drugs Under the Mail Order Pharmacy Program. Exhibit D is blacked out in full across pages 54 to 106 and the mail pharmacy rate pages in Exhibit C-2 are blacked out as well. The only readable trace is the heading for ESI Mail Pharmacy ingredient cost and dispensing fee guarantees on page 25, which shows the affiliate channel is priced against guarantees rather than at documented acquisition cost, but the terms themselves cannot be read.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"unclear","confidence":0.65,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"A ceiling that caps plan cost at a published benchmark would appear in the general pricing terms and claims reimbursement rates of Exhibit C. Those pages are blacked out except for headings. The surviving headings on page 24 describe average aggregate annual ingredient cost and dispensing fee guarantees, which suggests testing on an annual average rather than claim by claim, but the actual text cannot be read so no verdict is possible.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CASH","verdict":"unclear","confidence":0.6,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"The usual and customary cash price is defined on page 112, which shows the concept is used in the pricing rules, but the pricing rules that would make the member pay the lesser of the cash price and the plan price sit in the blacked out general pricing terms of Exhibit C-1 and C-2. Nothing readable in the document addresses crediting a cash purchase toward the deductible or out of pocket maximum, or accumulator adjustments against manufacturer assistance. The redaction is the reason this cannot be decided.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.75,"page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules\ndeveloped or selected by ESI.","rationale":"The maximum allowable cost list is defined as whatever schedule Express Scripts develops or selects. Nothing in the readable text requires a single list to govern both what the plan pays and what pharmacies are paid, requires the list to be disclosed to the A&M System, sets an update schedule, or gives pharmacies an appeals route with deadlines. Vendor controlled pricing lists on both sides of the transaction are the classic route to spread pricing, which is what the model contract published by Mark Cuban and collaborators is written to block.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"a “bona fide dispute” means that, based on the results of an initial claims audit, there is a reasonably\nvalid basis for believing that ESI has billed the A&M System an amount other than the amount\nreimbursed to the pharmacy or has otherwise not passed through the pharmacy contracted rate.","rationale":"The agreement clearly contemplates that the A&M System is billed the rate paid to the retail pharmacy, and it gives the System a further audit right when a claims audit suggests Express Scripts billed something different. The audit protocol on page 127 backs this up but only for a sampling of claims and only if the System has a pass through arrangement for participating pharmacy claims. There is no across the board promise that the plan pays exactly what the pharmacy is paid in every channel, and the mail and specialty pricing that would show any retained margin is blacked out.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.7,"page_ref":"Page 115","evidence_quote":"In\nnegotiating any of the fees and revenues described in the Financial Disclosure or in this Contract, ESI and ESI’s wholly-\nowned subsidiaries and affiliates act on their own behalf, and not for the benefit of or as agents for A&M System,\nMembers or the Plan.","rationale":"There is no clause covering purchase discounts, volume credits or supplier payments collected by an affiliated purchasing entity, and no offshore group purchasing organization is named anywhere in the document. Worse than silence, the financial disclosure clause says Express Scripts and its affiliates negotiate that revenue on their own behalf and not for the plan, and keep it. That is the exact outcome the group purchasing pass through clause of the model contract published by Mark Cuban and collaborators exists to prevent.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 110","evidence_quote":"The drugs\nand supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but\nnot limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The formulary is built by the Express Scripts pharmacy and therapeutics committee, adopted by the sponsor, and then changed by Express Scripts over time for reasons that expressly include manufacturer rebate arrangements. Additions and deletions are treated as adopted by the sponsor automatically unless the A&M System affirmatively elects not to implement them through a set up form. The sponsor therefore has a veto but not the advance approval, lowest net cost analysis and quarterly utilization management reporting the model contract calls for.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the produced text sets a lowest net cost standard for formulary decisions or promises a comparison against the vendor's whole book of business. The formulary definition on page 110 and the formulary support clause on page 114 describe how the list is built and changed but say nothing about net cost to this plan, and no clause requires disclosure when a drug is placed above a cheaper equivalent. The phrase net cost does not appear anywhere in the document, and the only mention of book of business data on page 123 concerns Medicare reinsurance projections.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.8,"page_ref":"Page 112","evidence_quote":"Subject to Applicable Law, ESI will make Members aware of the ability to fill their\nprescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings, and provide\nsupporting services (e.g. pharmacist consultation) in connection with any prescription dispensed by the\nESI Mail Pharmacy.","rationale":"Express Scripts is expressly authorized to promote its own mail pharmacy to members, and it may move the plan between its networks and subnetworks as it chooses. Participating pharmacies are defined to exclude affiliated mail and specialty pharmacies, and Express Scripts disclaims any liability for them. There is no anti steering promise, no any willing pharmacy right, and no rule that a claim is final once adjudicated. Instead the retail audit clause on page 4 lets Express Scripts recover money from network pharmacies and keep fifteen percent of what it recovers, which is the opposite of the clawback protection in the model contract.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"There is no most favored pricing promise and no market check anywhere in the produced text. Page 2 fixes the Exhibit C pricing terms for the term of the contract unless both parties agree in writing, and page 115 allows repricing only if a change in law burdens Express Scripts, so the pricing can only move by agreement or by that trigger. Nothing entitles the A&M System to pricing at least as good as comparable clients or to a remedy of meet, credit or release after a benchmarking exercise. The words market check and most favored do not appear in the document.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 127","evidence_quote":"The Sponsor may select an initial number of manufacturer contracts to enable Sponsor to audit fifty percent (50%) of the total\nRebate payments due to Sponsor for two (2) calendar quarters during the twenty-four (24) month period immediately\npreceding the audit (the “Rebate Audit Scope and Timeframe”).","rationale":"The audit rights here are real but heavily fenced. The A&M System gets one claims audit a year at no cost over a rolling twenty four months, the State Auditor's authority is acknowledged, and rebate agreements can be reviewed, yet the auditor must be approved by Express Scripts, may not be a competitor or provide litigation services against Express Scripts, and a rebate audit reaches only half of the rebate payments for two quarters. Manufacturer and pharmacy contracts may be viewed on site only, with no copies and with Express Scripts entitled to inspect the auditor's notes. Routine claims level and financial data delivery on a schedule is not promised, and support for government audits carries Express Scripts' standard charges.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"All such records, including\nany research, reports, studies, data, or other documents that are specifically generated by ESI for the\nA&M System and are specific to its program under this Contract, shall be the property of the A&M\nSystem","rationale":"The A&M System owns the reports and studies Express Scripts generates specifically for its program, owns member identifiable health information and eligibility files, and Express Scripts may not sell member level data or take anything of value for it. That is narrower than sole ownership of every plan data set. The confidentiality clause on page 8 assigns anonymized claims data and the data of the Express Scripts mail and specialty pharmacies to Express Scripts, the business associate agreement on page 130 lets Express Scripts create and disclose de identified data, and nothing requires delivery in machine readable form on request.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PERF","verdict":"unclear","confidence":0.65,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Performance guarantees plainly exist, because the audit protocol on page 126 lists performance guarantees subsequent to true up as one of four auditable components and page 3 refers to performance standards obligations. The guarantees themselves, how often they are measured, whether they use plan specific data and whether shortfalls are paid in cash or as capped credits all sit in Exhibit C, which is blacked out apart from its headings. No verdict is possible on the strength of the remedies.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.7,"page_ref":"Page 127","evidence_quote":"To the\nextent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding\nadjustments to Sponsor through credits to a future invoice(s). If ESI is unable to reprocess claims and issue corresponding\ncredits to Sponsor through this process, ESI will make adjustments to Sponsor via a check or credit.","rationale":"Remedies here are not self executing. Money comes back only after both sides accept the audit results, and a new audit cannot begin until the previous one is closed by agreement. There are no liquidated damages, no automatic credits for missed guarantees or late reports, and no clause that lets the A&M System exit after a second material breach or a regulatory integrity failure. The System does have a general right to terminate for material breach after a forty five day cure period on page 5, which is why this is weaker than the model rather than absent.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AMD","verdict":"partial","confidence":0.75,"page_ref":"Page 117","evidence_quote":"the\nprogram pricing terms hereunder may be equitably modified by MCLIC to reflect the reduction or\nelimination of the number of Part D Eligible Retirees","rationale":"The base agreement is strong on this point: page 5 says any amendment must be in writing and signed by both parties, and page 2 freezes the Exhibit C pricing terms for the term unless both parties agree in writing. The Medicare addendum then carves out an exception that lets the Express Scripts affiliate equitably modify the program pricing terms on its own if the number of Part D eligible retirees falls materially. Express Scripts may also update the financial disclosure and the specialty drug list on its own, so a small amount of economic drift is possible without a signature.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"TERM","verdict":"good","confidence":0.75,"page_ref":"Page 5","evidence_quote":"the\nA&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written\nnotice.","rationale":"The A&M System may walk away for any reason on ninety days written notice, and no termination fee, penalty or wind down charge appears in the readable text. Either party may also terminate for uncured material breach, and there are separate exit rights if Express Scripts is acquired, fails the accessibility or cybersecurity requirements, or fails its public information duties, along with a loss of funding exit. The caution is that the conditions attached to rebate payments in Exhibit C-3 are blacked out, so whether earned rebates survive a termination cannot be confirmed, and the Medicare addendum lets the vendor delay final payments pending reconciliation.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"unclear","confidence":0.7,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Specialty drug economics are the single biggest hole in this release. Exhibit D, Specialty Drugs Under the Mail Order Pharmacy Program, is blacked out from page 54 through page 106, the specialty product pricing section of Exhibit C-2 on page 25 is blacked out, and the specialty rebate section of Exhibit C-3 is blacked out as well. The readable text does show that the specialty drug list is maintained and updated by Express Scripts and that its specialty pharmacies are affiliates, but the drug level rates and any acquisition cost discipline cannot be seen.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it\nto be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"Exhibit F designates the entire program pricing terms, the specialty and mail order exhibit and the clarifications as confidential and proprietary and claims they are exempt from the Texas Public Information Act, and Express Scripts reserves the right to designate still more. The confidentiality article on page 8 goes further and treats drug pricing information, rebate contracts and manufacturer administrative fee information as Express Scripts property. The A&M System still must obey the Public Information Act and must notify Express Scripts of requests so it can argue for an exemption, but that is only a right to fight disclosure, and the result is visible in this document: the prices taxpayers pay are blacked out.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"partial","confidence":0.9,"page_ref":"Page 34","evidence_quote":"Customer appoints United a named fiduciary under the Plan with respect to (i) performing initial benefit determinations and payment","rationale":"The contract appoints the vendor as a named fiduciary for initial benefit determinations and appeals, but does not impose broader duties of loyalty and care solely to the plan for pharmacy benefit pricing, nor does it require disgorgement of retained compensation.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not require full disclosure of PBM compensation, affiliate ownership, or payments to brokers. It also lacks any requirement for quarterly and annual certification by a named officer.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include an exhibit listing the PBM's owners, parents, subsidiaries, affiliates, or group purchasing organizations, and lacks any requirement to refresh such an exhibit upon a change in control.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool","rationale":"The definition of Rebate explicitly excludes manufacturer administrative fees, purchase discounts, and remuneration received by a group purchasing organization. This narrow definition allows the PBM to relabel and retain significant manufacturer revenue.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"The contract explicitly allows the PBM to retain discounts and purchase rebates received by its affiliated home delivery or specialty pharmacies, contradicting the requirement to pass through 100% of manufacturer revenue.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 64","evidence_quote":"Mail Order Brand, AWP less                            25.50%            25.50%           25.50%","rationale":"The contract does not price affiliate pharmacy claims at net acquisition cost. Instead, mail order and specialty claims are priced using an Average Wholesale Price (AWP) discount formula, which allows the PBM to retain margin.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a published benchmark ceiling, such as a transparent cash price (e.g., NADAC), to ensure the plan claim cost never exceeds a public benchmark on a claim-by-claim basis.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"partial","confidence":0.8,"page_ref":"Page 67","evidence_quote":"Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"The contract includes a 'lesser of' logic ensuring members do not pay more than the usual and customary charge. However, it does not guarantee that every cash purchase counts toward the deductible and out-of-pocket maximum, nor does it prohibit accumulator adjustments against member assistance.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"The contract explicitly permits the vendor to use multiple MAC lists and modify them at its sole discretion, enabling classic spread pricing.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"The contract explicitly permits spread pricing across retail, home delivery, and specialty channels by allowing the PBM to retain the difference between what the plan pays and what the pharmacy is paid.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer","rationale":"The contract explicitly excludes remuneration received by a group purchasing organization from the definition of rebates, permitting the PBM or its GPO to retain supplier payments rather than passing them through to the plan.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"bad","confidence":0.9,"page_ref":"Page 44","evidence_quote":"United makes the final classification of a Prescription Drug to a certain tier of the PDL by considering a number of factors","rationale":"Rather than allowing the plan sponsor to control the formulary and approve every change, the contract delegates final classification and tiering decisions to the vendor.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a lowest net cost standard for formulary decisions, nor does it require the PBM to provide an annual comparison against its book of business or disclose the reasoning for placing a drug above a cheaper equivalent.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish pharmacy network protections such as prohibiting retroactive clawbacks, preventing the PBM from steering claims to its own pharmacies, or ensuring any willing pharmacy may participate at the plan's terms.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 66","evidence_quote":"If the market check report validates an annualized savings of greater than three (3) percent between the median of the financial terms for such substantially similar customers and Customer’s financial terms for time period that is the subject of the market check, the parties will negotiate in good faith to revise the financial terms.","rationale":"The contract permits one market check during the term. However, the remedy is limited to negotiating in good faith to revise financial terms, rather than an automatic meet, credit, or release remedy.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"bad","confidence":0.95,"page_ref":"Page 46","evidence_quote":"Customer’s auditor may not copy (through handwritten notes or otherwise) or retain contracts or related documents provided by United during such audit.","rationale":"The contract severely restricts audit rights, requiring the PBM to agree to the auditor and the scope of the audit. It explicitly prohibits the plan's auditor from copying or retaining contracts during on-site rebate audits.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"Neither party may sell, license, or grant any other rights to the other Party’s Confidential Information, (b) use the other Party’s Confidential Information for the creation, operation or improvement of any product, service or database for external or commercial use","rationale":"The contract prohibits the sale, licensing, or commercial reuse of confidential information by either party. However, it does not explicitly designate the plan sponsor as the sole owner of all claims, eligibility, and derived data sets, nor does it guarantee delivery in machine-readable form upon request.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"bad","confidence":0.9,"page_ref":"Page 61","evidence_quote":"Fees at Risk         Total Dollars at Risk for this metric                                                              $11,000","rationale":"Performance guarantees are measured annually rather than quarterly, and shortfalls are paid as capped flat-dollar amounts against fees rather than dollar-for-dollar cash reconciliation.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include self-executing enforcement mechanisms like liquidated damages outside the annual performance guarantees, nor does it provide a two-strikes exit without penalty for repeat material breaches.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 65","evidence_quote":"United reserves the right to modify or eliminate any Rebate guarantees if there are any additional changes to Rebates received from pharmaceutical manufacturers.","rationale":"The contract permits the vendor to unilaterally modify or eliminate rebate guarantees based on market changes, and allows it to review and modify its multiple MAC lists at its sole discretion.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"bad","confidence":0.95,"page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination","rationale":"The contract explicitly penalizes the plan for terminating early by stating that the PBM will forfeit and retain any pending or future rebates owed to the plan as of the termination date.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"bad","confidence":0.95,"page_ref":"Page 68","evidence_quote":"Actual utilization, using Average Wholesale Price (AWP) in dollars, using our data, of listed specialty drugs","rationale":"Specialty drugs are not priced at acquisition cost. Instead, specialty claims in the network are priced using an Average Wholesale Price (AWP) discount formula.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 13","evidence_quote":"Confidential Information: Information disclosed or made available by a Party in connection with this Agreement, including without limitation the following, regardless of form or the manner in which it is furnished: (a) pricing, discounts, reimbursement terms, payment methodologies","rationale":"The contract defines pricing, discounts, and compensation arrangements as confidential trade secrets. While it acknowledges public records laws, it requires the plan to notify the vendor and cooperate in seeking a protective order to block release.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"partial","confidence":0.91,"page_ref":"Page 10","evidence_quote":"The Contractor warrants and represents that all services to be provided the City under the Contract will be performed using the care, skill, prudence and diligence under the circumstances then prevailing that a prudent claims administrator/fiduciary acting in a like capacity and familiar with such matters would use under similar circumstances","rationale":"The contract supplies a prudent claims administrator standard, and pharmacy claim determinations use the medical attachment's named fiduciary process. It does not impose loyalty solely to the City and members, require full conflict disclosure, or require disgorgement of compensation retained in breach. The duty is therefore materially narrower than the model clause published by Mark Cuban and collaborators.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.9,"page_ref":"Page 42","evidence_quote":"United maintains systems for processing pharmacy claims and may receive access fees and charges for marketing and administrative services as compensation for services United provides to Network Pharmacies.","rationale":"The pharmacy attachment acknowledges some compensation from network pharmacies, and the guarantee exhibit separately identifies a consultant fee. It does not disclose all compensation received by United and related entities, affiliate ownership affecting claims, or payments to all brokers and consultants. No named officer certifies complete disclosure and remittance quarterly or annually.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The pharmacy definitions and services on pages 40 through 47 identify affiliated home delivery and specialty pharmacies but do not list all owners, parents, subsidiaries, affiliates, purchasing entities, or rebate aggregators. The conflict questionnaire on pages 85 and 86 concerns local government officer conflicts rather than PBM ownership. No signed ownership exhibit or 30 day refresh duty appears anywhere in the agreement.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The Rebate definition expressly excludes direct purchase value and compensation received by United or a group purchasing organization for products, services, tools, and data analysis. Separate definitions and guarantee terms also let United control multiple MAC lists and specialty classifications. These exclusions allow manufacturer value to be relabeled outside the pass-through obligation, which is the precise loophole the model definition closes.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 45","evidence_quote":"United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"The fee exhibit states a 100 percent Rebate sharing percentage, but that promise applies only to the contract's narrowed definition. United expressly keeps affiliate pharmacy purchase discounts and purchase rebates and may pursue other manufacturer revenue. Payments also occur much later than 30 days after quarter end, so this is not full and prompt pass-through of all manufacturer revenue.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.99,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"United's definitions include affiliated pharmacies within home delivery and specialty channels. The contract then authorizes United to retain the difference between pharmacy reimbursement and the City's payment in those channels. It does not require affiliate claims to be invoiced at net acquisition cost plus a stated dispensing fee.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The pharmacy pricing guarantees on pages 64 through 68 use aggregate AWP discount targets by channel and drug category. The member lower-of rule on page 67 limits participant payment but does not cap the City's claim cost at a published cash benchmark. No claim-by-claim cheapest lawful option ceiling appears in the pricing, claims, or specialty provisions.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.97,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"The lower-of-three rule protects a member from paying more at the point of sale than the pharmacy's reported usual and customary cash charge. The agreement does not say an off-plan cash purchase counts toward the deductible and out-of-pocket maximum. It also lacks the model's written-election protection against accumulator adjustments for member assistance.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":1,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"The contract expressly permits multiple MAC lists and places their review and modification in United's sole discretion. It does not require the same list for City billing and pharmacy reimbursement, disclose the lists, establish a fixed update schedule, or state a pharmacy appeal process. This directly permits the structure that the model clause is designed to prevent.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"This is an express authorization for spread pricing. It applies to home delivery, retail, and specialty pharmacy services rather than limiting the City to pharmacy reimbursement plus a disclosed administrative fee. The guarantee exhibit repeats the same retained-spread rule.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.99,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The definition expressly removes remuneration received by a group purchasing organization for direct purchase and other products or services from Rebate. No other clause passes those purchasing entity payments through to the City or allocates them on disclosed drivers. The contract therefore preserves the exact GPO revenue channel addressed by the model clause.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"bad","confidence":0.97,"page_ref":"Page 44","evidence_quote":"United makes the final classification of a Prescription Drug to a certain tier of the PDL by considering a number of factors including, but not limited to, clinical and economic factors.","rationale":"The City selects and adopts a United formulary design, but United makes the final tier classification. United can also make changes and provides negative-change notices only at the City's request. This falls short of sponsor approval of the formulary and every change and leaves decisive formulary control with the PBM.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"bad","confidence":0.94,"page_ref":"Page 44","evidence_quote":"Economic factors may include, but are not limited to, the Prescription Drug's acquisition cost including, but not limited to, available Rebates, and assessments on the cost effectiveness of the Prescription Drug.","rationale":"United may make final tier decisions using available Rebates and general cost-effectiveness factors. The agreement does not require the lowest net cost for this City, an annual whole-book comparison, or disclosure when a drug is placed above a cheaper equivalent. The rebate guarantee also financially penalizes City-directed formulary deviations, increasing the risk of rebate-driven placement.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.86,"page_ref":"Page 42","evidence_quote":"United may add or remove Network Pharmacies from the pharmacy network. United will make a reasonable effort to provide Customer with advance notice of any material changes to the network.","rationale":"United maintains the network and promises reasonable efforts to notify the City of material changes. The agreement does not make adjudicated claims final, prohibit retroactive clawbacks or volume conditions, bar affiliate steering, or grant any willing pharmacy participation. United also controls membership in the network and operates affiliated home delivery and specialty pharmacies.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"partial","confidence":0.96,"page_ref":"Page 66","evidence_quote":"Customer may conduct one market check during the Pharmacy Pricing Term to confirm its financial terms are competitive with those currently available in the market for substantially similar customers.","rationale":"The City gets one market check during the three year pharmacy pricing term, not an annual check or automatic most-favored pricing. The comparison must clear a 3 percent median threshold and leads only to good-faith negotiation of a signed amendment. There is no mandatory match, credit, or release remedy if negotiations fail.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"bad","confidence":0.98,"page_ref":"Page 46","evidence_quote":"in the case of a Rebate audit, access to United’s top 5 Rebate agreements or Rebate agreements that account for at least 75% of the Customer’s total Rebate revenue generated per year, whichever is less.","rationale":"The City may conduct one pharmacy claims audit per year, but the auditor must be mutually agreeable and sign United's confidentiality agreement. Rebate review is limited to the lesser of five agreements or agreements covering 75 percent of annual rebate revenue, and documents cannot be copied. United also controls audit logistics, limits timing and lookback, and requires mutual settlement before payment, so the rights are materially contrary to full sponsor-directed access.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.97,"page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate’s own behalf.","rationale":"The agreement allows United to reuse and disclose de-identified plan information on its own behalf. It never makes the City sole owner of claims, eligibility, accumulator, rebate, and derived datasets. Transition delivery is limited to selected files in United's standard format, and post-runout plan information may be supplied at United's discretion for a fee.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"partial","confidence":0.9,"page_ref":"Page 64","evidence_quote":"The amount the combined actual Rebate amount is less than the combined guaranteed Rebate amount.","rationale":"The pharmacy pricing schedule measures customer-specific discount and rebate shortfalls annually and states a shortfall payment amount. However, the general guarantee terms use fee credits as exclusive financial remedies, and the pharmacy guarantees contain broad exclusions and revision rights. Measurement and payment are annual rather than quarterly, so the remedy is weaker than the model's quarterly cash reconciliation.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.92,"page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer’s Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"The guarantee exhibit provides fee credits without requiring the City to prove common-law damages, which is a useful self-executing feature. Those adjustments are the exclusive financial remedy for covered performance and are subject to exclusions and gradients. The contract has ordinary breach and cure rights but no defined two-strikes exit for repeated guarantee failures or regulatory integrity events.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.97,"page_ref":"Page 5","evidence_quote":"Any new Fee will be effective as of the date the change is applicable, even if that date is retroactive.","rationale":"A general clause says amendments must be signed by both parties, but the higher-priority special terms permit Contractor fee changes by notice and even allow retroactive effect. The guarantee exhibit also permits United to replace guarantees for a later period and reserves several rights to revise or revoke pharmacy arrangements. These economic change rights contradict the model's bilateral-signature rule.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"bad","confidence":1,"page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination of pharmacy benefit services and no reconciliation of minimum rebate guarantees will apply.","rationale":"The City has a general convenience termination right only after the initial term and on lengthy notice. More importantly, early pharmacy termination causes forfeiture of all pending and future rebates and eliminates minimum rebate reconciliation. That direct economic penalty contradicts termination without penalty and preservation of earned amounts.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"bad","confidence":0.99,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"Specialty is defined by functional criteria, but the contract lets United control the Specialty Drug List and includes affiliated specialty pharmacies. Specialty pricing is an annual composite AWP discount guarantee with exclusions, not a drug-level ceiling or acquisition-cost invoice rule. United may expressly retain specialty spread, including in its affiliate channel.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 13","evidence_quote":"Confidential Information: Information disclosed or made available by a Party in connection with this Agreement, including without limitation the following, regardless of form or the manner in which it is furnished: (a) pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"The agreement labels pricing, discounts, reimbursement, payment methods, and compensation as confidential and limits disclosure and use. It preserves disclosures legally required under public records law, but otherwise requires strict confidence, notice, and cooperation with efforts to narrow release. That legal-process carveout does not remove the restriction on voluntary sharing with members, the public, lawmakers, or other advisors.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 11","evidence_quote":"VENDOR and CITY acknowledge and agree that, except with respect to its fiduciary obligations as specifically delegated and accepted by VENDOR pursuant to this CONTRACT, VENDOR shall not be (i) the administrator of the Plan for any purpose; (ii) a named fiduciary with respect to the Plan for purposes of ERISA or any applicable state law;","rationale":"The vendor agrees to act as a fiduciary only for the narrow job of deciding claims and appeals, and then disclaims fiduciary status and discretionary authority for everything else. That leaves formulary placement, pricing lists and manufacturer money outside any duty of loyalty to the city. The model contract published by Mark Cuban and collaborators requires loyalty and care owed solely to the plan and its members across the whole relationship. Read together with the clause on page 10 that lets the vendor keep manufacturer fees, this is the opposite of the model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 10","evidence_quote":"may receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies, including, without limitation, administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost","rationale":"The contract does disclose that the vendor and its affiliates take manufacturer money, and it gives a range of one to four percent of wholesale acquisition cost. That is a book of business range, not the amounts actually earned on San Antonio claims, and nothing requires a named officer to certify quarterly or annually that everything has been disclosed and remitted. There is no schedule of consultant or broker payments either. The subject is addressed but far more weakly than the model contract published by Mark Cuban and collaborators.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.6,"page_ref":"Page 21","evidence_quote":"VENDOR agrees to notify CITY of any changes in VENDOR’S ownership interest greater than 50%, or control of its business entity, not less than sixty (60) days in advance of the effective date of such change, or as soon as permitted by applicable law if later.","rationale":"There is no signed exhibit listing the vendor's owners, parents, subsidiaries, affiliates, group purchasing organizations, mail pharmacies or specialty pharmacies. The only ownership disclosure is advance notice of a change of more than fifty percent ownership or control, plus the city ethics disclosure statement referenced on page 28. The contract repeatedly refers to affiliates and to vendor owned mail and specialty pharmacies without naming any of them, so the city cannot check affiliate pricing or steering against a known list.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"Rebates are defined on page 2 as formulary rebates, base and market share only, and page 10 then carves manufacturer fees, other compensation and purchase discounts out of the term entirely and assigns them to the vendor. Brand, generic and specialty drugs are all classified by the vendor using its chosen data source, and the MAC list is set by the vendor. This is exactly the relabeling problem the definitions section of the model contract published by Mark Cuban and collaborators is written to stop. Value that would be plan money under a functional definition stays with the vendor here.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"Page 9","evidence_quote":"Remittance of Rebates. VENDOR will remit to CITY the Rebates received by VENDOR with respect to CITY’s Claims during the prior calendar quarter pursuant to Exhibit B. CITY acknowledges and agrees that it shall not have a right to interest on, or the time value of, any Rebate payments received by VENDOR or monies payable under this CONTRACT.","rationale":"The contract promises only the Rebates as defined, on terms set out in Exhibit B, which is not part of the posted document, so the share and the timing cannot be read. What can be read is that manufacturer administrative fees and purchase discounts are excluded from Rebates and belong exclusively to the vendor, that the city gives up any interest or time value on rebate money, and that remittance can be delayed after termination. That is materially less than the one hundred percent of all manufacturer revenue the model contract requires. Even if Exhibit B promised a full share of Rebates, the definition would keep the fee streams out of it.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.85,"page_ref":"Page 10","evidence_quote":"In addition, VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"Nothing in the contract prices claims filled by CVS owned mail or specialty pharmacies at net acquisition cost plus a stated dispensing fee. Instead the text confirms that purchase discounts earned on drugs bought by vendor affiliated dispensing pharmacies stay with the vendor and its affiliates. The plan pays the discount off list price that the withheld pricing exhibit sets, while the vendor keeps whatever it buys the drug for below that. That is the retained affiliate margin the model contract published by Mark Cuban and collaborators is designed to remove.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.75,"page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be the lowest of the discounted rate, the Participating Pharmacy’s reported U&C price, if applicable, and the VENDOR MAC rate, if applicable), plus the applicable dispensing fee","rationale":"There is a lesser of test on each retail claim, so the plan should not pay more than the pharmacy's reported usual and customary price at a network pharmacy. That is a ceiling of sorts and it is applied claim by claim. It is not the model standard, though, because the benchmark is the pharmacy's own reported price rather than a published transparent cash price, it depends on the pharmacy self reporting, and mail and specialty channels run on rates in the withheld Exhibit B rather than on any stated ceiling.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"The VENDOR’S Participating Pharmacies will dispense prescriptions to CITY plan members according to the CITY’S plan, and shall collect from the Plan Member the lowest of the applicable co-payment, the discounted price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Members at a network pharmacy pay the lowest of the copayment, the discounted price, the vendor MAC rate or the pharmacy's usual and customary price, which stops the most obvious clawback of paying more than the shelf price at that pharmacy. The sentence continues onto page 5 with the usual and customary reference. What is absent is any promise that a cash purchase outside the benefit counts toward the deductible or out of pocket maximum, and there is no accumulator provision at all, so the member who finds a cheaper cash price gets no credit for it.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"partial","confidence":0.8,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR in maintaining its generic pricing program.","rationale":"The city does get the MAC list before signing and again on reasonable request, which is more disclosure than many contracts give. But the vendor sets the prices and may amend the list whenever it likes, there is no update schedule, and nothing requires the list used to bill the city to be the same list used to pay pharmacies. There is also no pharmacy appeal path with deadlines. The model contract published by Mark Cuban and collaborators requires a single disclosed list for both sides of the transaction.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.75,"page_ref":"Page 15","evidence_quote":"CITY acknowledges that, except as expressly set forth herein, it shall not be entitled to audit agreements with vendors, pharmaceutical companies, Participating Pharmacies or other providers of products or services to VENDOR as part of a Claims audit.","rationale":"Nothing in the contract says the city pays exactly what the pharmacy is paid plus a disclosed fee. The city is billed the adjudicated ingredient cost built from discount rates and vendor MAC prices, while pharmacies are paid under separate network agreements that the city is expressly barred from auditing. That combination is what allows a spread to exist and stay invisible, which is the harm the model contract published by Mark Cuban and collaborators is written to prevent. The discount rates themselves are in Exhibit B, which is not in the posting, but no language anywhere in the body prohibits retained spread.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 9","evidence_quote":"CITY’s Authorization. CITY authorizes VENDOR to contract with pharmaceutical companies for Rebates as a group purchasing organization for the Plan.","rationale":"The vendor negotiates with drug makers as the plan's group purchasing organization, so purchase side money runs through it. Page 10 then states that the fees, compensation and purchase discounts collected in that role belong exclusively to the vendor or its affiliates and are not Rebates. The city is separately barred from going around the vendor to negotiate rebates or discounts of its own. So the purchasing entity revenue the model contract sends to the plan is kept by the vendor here.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"bad","confidence":0.8,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"The city adopted the vendor's own drug list as the plan formulary, and the vendor creates, maintains and amends it. The city gets thirty days notice before a drug moves or is removed, and quarterly notice for the specialty list, but notice is not approval and there is no right to reject a change. The model contract published by Mark Cuban and collaborators puts formulary approval in the plan sponsor's hands with lowest net cost support for each change. Here the party that collects the rebates also decides which drugs are preferred.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The formulary sections on pages 8 and 9 list the reasons the vendor may change its drug list, including cost effectiveness, but they set no lowest net cost standard for this plan and require no analysis to be delivered. The performance standards article on pages 13 and 14 covers service metrics, and the audit article on pages 14 to 17 covers claims and rebates, neither of which addresses formulary economics. There is no annual comparison against the vendor's book of business and no requirement to explain why a drug sits above a cheaper equivalent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.7,"page_ref":"Page 5","evidence_quote":"VENDOR shall have the sole right to audit Participating Pharmacies.","rationale":"The vendor alone audits network pharmacies weekly and pursues recoveries from them, and the contract calls this its sole obligation on discrepancies, so retroactive recoupment against pharmacies is built in rather than barred. There is no any willing pharmacy clause, no bar on steering claims into the vendor's own mail and specialty pharmacies, and the scope of services routes mail and specialty volume to those affiliated pharmacies by design. Claims are also not final when adjudicated. This permits the steering and clawback pattern the model contract published by Mark Cuban and collaborators forbids.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the five year term gives the city pricing at least as good as comparable clients, and there is no market check. The consideration article on page 17 simply points to Exhibit B, the term article on pages 18 and 19 sets a five year term with a two year option and no repricing trigger, and the performance standards on page 13 may be adjusted no more than once a year by mutual agreement, which is not a market check with a meet, credit or release remedy. The city's only real lever is termination on notice.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 15","evidence_quote":"Such audit shall be limited to a review of up to ten (10) pharmaceutical company contracts directly related to CITY’s Rebates as selected by CITY.","rationale":"The city has real audit rights, including an annual claims audit, an annual rebate audit, a post termination audit and delivery of SOC 1 reports and audited financials. Those rights are then narrowed at every turn: one on site audit per plan year, an auditor who must be mutually acceptable and must sign the vendor's confidentiality agreement, no access to the vendor's agreements with pharmacies or drug makers, a ten contract cap on the rebate audit, vendor comment on the draft report, and claims data reissued at vendor cost. The city does get claims data through an online portal and standard reporting. This is narrower than the model, which gives the plan its own auditor, scheduled full claims and financial data, and no proprietary withholding.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"partial","confidence":0.85,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"The city owns information produced solely and exclusively for it, and page 29 says all files are city property and must be delivered at termination. Two carve outs weaken that. The vendor keeps its trade secret rights in material inside city information, and the vendor may use, adapt and even sell deidentified claims and eligibility data, including sharing it with data integration firms. There is also no promise to deliver plan data in machine readable form on request, and files given to a replacement vendor must be scrubbed of the vendor's confidential information.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 13","evidence_quote":"With respect to the aspects of VENDOR’S performance addressed in Exhibit A, these amounts at risk are CITY’S exclusive financial remedies. The Total Dollars at risk will be $175,000 as set forth in Exhibit A.","rationale":"Guarantees exist, they are measured on San Antonio claims only rather than book of business data, and shortfalls are taken out of amounts owed to the vendor within sixty days. But the total at risk is capped at $175,000, that money is the city's exclusive financial remedy for the guaranteed items, settlement happens once a year at reconciliation rather than quarterly, and the guarantee schedule itself sits in Exhibit A, which is not in the posting. Capped and annual is weaker than the dollar for dollar quarterly reconciliation the model contract calls for.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.7,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform as defined in Exhibit A Performance Guarantees (or after the close of any annual audit finding that the reported results were inaccurate).","rationale":"Penalties come off the vendor's invoice without the city having to prove damages, which is a self executing remedy, and misappropriated funds and processing overpayments must be repaid within thirty days. The weakness is that the trigger is the vendor's own reporting of its failure, the amounts are capped and exclusive, and late or missing reports carry no liquidated damages. There is no two strikes exit either: termination for cause requires a thirty day cure and there is no regulatory integrity trigger, while termination for convenience costs the city a pro rata repayment of credits.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"partial","confidence":0.75,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"The amendment clause itself is strong and matches the model: nothing binds unless it is written, dated and signed by both parties, and the entire agreement clause on page 34 repeats it. The problem is elsewhere in the text. The MAC definition on page 2 lets the vendor amend the pricing list that determines what the city pays whenever it chooses, and the formulary sections on pages 8 and 9 let the vendor change the drug list on notice. So economics can move without a signed amendment even though the contract language cannot.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"It is understood that in the event of Termination by Notice initiated by CITY, a pro rata share of any credits disbursed by VENDOR for the calendar year in which the termination occurred as well as a pro rata share of the actual implementation credit amount","rationale":"The city may cancel without cause on ninety to one hundred twenty days notice, and may also stop the contract if funds are not appropriated, which is a genuine exit. It is not penalty free. Leaving early means repaying a pro rata share of credits the vendor disbursed, including the implementation credit spread over the initial term, and the vendor may delay remitting rebates after termination. Record transfer is at the vendor's cost only if the city has completed three years of the term. There is also no regulatory integrity event listed as grounds for termination.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"partial","confidence":0.7,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease, including but not limited to, injectible, infused, or oral medication, or product that otherwise require special handling.","rationale":"Specialty is defined loosely by disease type and handling, and the definition leans on what the vendor uses rather than on a fixed functional test, so the vendor decides what counts as specialty. The plan runs on the vendor's Advance Control Specialty Formulary, specialty prescriptions are filled by the vendor's own specialty pharmacy, and specialty drugs are the one category exempted from the once a year limit on formulary removals. No drug level rate ceiling and no acquisition cost pricing appears in the body, and the specialty rates would sit in Exhibit B, which is not in the posting.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data, trade secrets","rationale":"Costs and pricing data are treated as confidential information, and the vendor asserts that some of the contract itself is confidential. Under the Public Information Act clause on page 36 the city must notify the vendor of any request, give it time to argue exemption to the Texas Attorney General or a court, agree not to oppose that effort, and release only the minimum if ordered. The rebate audit clause on page 15 goes further and says the terms of manufacturer contracts reviewed in an audit may not be revealed to any third party, including the city. The city may share data with its own consultants and auditors under separate confidentiality agreements, but for a taxpayer or a reporter this is a clause set that blocks disclosure of what the plan pays.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"The contract explicitly limits the PBM's fiduciary duties solely to initial claim adjudication and appeals, denying a broader duty of loyalty or care.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not require full disclosure of all compensation or conflicts, nor does it mandate an officer's certification of compliance. Although \"Exhibit B Administrative Fees\" is missing, the body text does not mention any comprehensive disclosure or officer certification.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include an exhibit listing the PBM's affiliates, mail order pharmacies, specialty pharmacies, or group purchasing organizations. There is no requirement to regularly update a disclosure of all related entities.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"bad","confidence":0.98,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"The contract explicitly excludes administrative fees (up to 4% of WAC) and purchase discounts from the definition of \"Rebates\", ensuring they are not passed through to the plan.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies, including, without limitation, administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost","rationale":"Because the contract lets the PBM or its affiliates retain administrative fees and concurrent or retrospective discounts on purchase prices, 100% of manufacturer revenue is not passed through to the plan sponsor.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not state that the PBM's mail or specialty pharmacies will invoice claims at their net acquisition cost. While there is an \"Administrative Fees\" exhibit (Exhibit B) that is withheld, the body text does not establish acquisition cost pricing as a standard.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The text defines \"Claim costs\" as the lowest of the discounted rate, U&C, and MAC, but this is a standard \"lesser of\" clause. It does not establish a published, transparent benchmark ceiling (like NADAC) checked claim by claim.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no clause guaranteeing that members can pay the cash price if it is lower than their copay, or that any such cash purchases will count toward their deductible and out-of-pocket maximum.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR","rationale":"The contract allows the PBM to set and amend the MAC list at its own discretion without guaranteeing a single list for both pharmacies and the plan. It also notes the plan's MAC list is specific to the plan, implying separate lists could exist.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not explicitly prohibit spread pricing or state that the plan will pay exactly what the pharmacy is paid plus a disclosed administrative fee. The definition of \"Claim costs\" only dictates what the plan pays, not that it perfectly matches pharmacy reimbursement.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"Instead of passing purchase discounts and supplier payments through to the plan, the contract explicitly states that discounts on products purchased by PBM-affiliated pharmacies belong exclusively to the PBM or its affiliates.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"bad","confidence":0.95,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"The PBM manages the formulary and can change it based on various considerations. The plan sponsor merely adopts the PBM's formulary, giving the PBM control over which drugs are covered and on which tiers.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no requirement for the PBM to make formulary decisions based on a lowest net cost standard, nor is there a provision for an annual book of business comparison to check pricing performance.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"VENDOR shall have the sole right to audit Participating Pharmacies.","rationale":"The contract gives the PBM the exclusive right to audit pharmacies, which is a tool often used to steer claims. There are no protections against retroactive clawbacks, volume-conditioned reimbursement, or steering to PBM-owned channels.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract contains no provision for a market check or a guarantee that the plan sponsor receives pricing at least as favorable as the PBM's comparable clients.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"bad","confidence":0.95,"page_ref":"Page 15","evidence_quote":"CITY acknowledges that, except as expressly set forth herein, it shall not be entitled to audit agreements with vendors, pharmaceutical companies, Participating Pharmacies or other providers of products or services to VENDOR as part of a Claims audit.","rationale":"The contract heavily restricts audit rights. The plan is limited to auditing once per year, the auditor must sign a PBM-approved confidentiality agreement, and the plan is explicitly denied access to the PBM's agreements with pharmaceutical companies and pharmacies.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"While the contract states the plan owns data produced solely for the plan, it permits the PBM to use, disclose, adapt, or sell de-identified claims and eligibility data for its own benchmarking and programs.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"unclear","confidence":0.95,"page_ref":"Page 32","evidence_quote":null,"rationale":"The specific performance guarantees, metrics, and whether shortfalls are paid dollar-for-dollar or as capped credits are located in \"Exhibit A - VENDOR’S Performance Guarantees\", which is listed on Page 32 but omitted from the provided document.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no provisions for automatic remedies or liquidated damages without proving damages, nor is there a two-strikes exit for repeat material breaches or regulatory integrity failures. Standard 30-day cure periods for default apply.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"partial","confidence":0.8,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"The contract nominally requires amendments to be in writing and signed by both parties. However, it allows the PBM to unilaterally alter economic terms like the MAC list and the formulary (PDL).","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"good","confidence":0.95,"page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause upon written notice, provided such notice specifies an effective date of termination, which shall be not less than 90 calendar days nor more than 120 calendar days after the date of receipt of the notice by the other party.","rationale":"The plan sponsor may terminate the contract without cause by providing 90 to 120 days' written notice. There are no apparent penalties for termination, only the requirement to repay a pro rata share of unearned implementation credits.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract defines \"Specialty Drugs\" but it does not establish drug-level rate ceilings, nor does it mandate that specialty claims at affiliate pharmacies be priced at net acquisition cost.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 34","evidence_quote":"costs and pricing data, trade secrets, know-how, processes, plans, designs and other information of or relating to either party’s business. VENDOR asserts that certain information contained in this Contract constitutes Confidential Information.","rationale":"The contract broadly defines pricing, MAC lists, and fee schedules as confidential trade secrets. Disclosures to the plan's own advisors or auditors require them to sign a PBM-approved confidentiality agreement, obstructing transparency.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"partial","confidence":0.85,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"The contract does use the word fiduciary, and Section 5.4(b) adds that the PBM will perform with utmost good faith, loyalty, candor and skill. But the model contract published by Mark Cuban and collaborators requires duties of loyalty and care owed solely to the plan and its members, disclosure of all direct and indirect compensation and conflicts, and disgorgement of anything retained in breach without the plan proving damages. None of those mechanics appear. What ERS got is a general good faith standard, not an enforceable loyalty duty with teeth.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"ERS and PBM agree that PBM shall not receive, charge or seek any administrative fees or any other costs, reimbursements, expenses or fees in connection with the Contract unless they are included in the administrative fees, if any, accepted in writing by ERS.","rationale":"Section 4.1 confines PBM compensation to a written fee schedule and requires manufacturer fees tied to certain management programs to be passed to ERS, which addresses the subject. But there is no named officer certifying quarterly or annually that all compensation has been disclosed and remitted, and no disclosure of payments to consultants or brokers. The audit article lets ERS examine manufacturer contracts, which is a verification right rather than a duty to disclose. The model contract's certification requirement is simply absent.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I looked for a signed exhibit listing every owner, parent, subsidiary, affiliate, group purchasing organization, rebate aggregator, mail order and specialty pharmacy tied to the PBM, and for a duty to refresh it within 30 days of any change. The contract has none. Article 8 only requires notice of mergers or changes of control, and Article 23 restricts assignment. The insurance declaration pages at Exhibit G (pages 55 to 58) happen to list many Express Scripts subsidiaries as named insureds, including Matrix GPO, LLC, but that is an insurance document, not a disclosure exhibit with an update obligation.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The rebate definition is broader than many contracts of its era: it sweeps in price protection dollars, price concessions and any other remuneration from a drug manufacturer, and Article 1.4 defines PBM to include its agents and subsidiaries. Two holes remain. First, the definition only reaches payments related to utilization of drugs on the PBM's own formulary, so value tied to non formulary drugs or other arrangements can escape. Second, value received through group purchasing organizations or other purchasing entities that are not the PBM contracting with the manufacturer is not plainly captured. Specialty Products is used without a functional definition in the base text, and there is no definition closing the relabeling loophole the way the model contract by Mark Cuban and collaborators does.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Federal subsidies, including direct subsidies, coverage gap subsidies and catastrophic re-insurance and all Rebates, as defined in this Contract, to ERS as set forth below and in Exhibit D and/or the Clarifications","rationale":"Section 4.1(h) commits the PBM to pay all Rebates, as defined, to ERS at least quarterly, along with federal subsidies, which is a real pass through promise. It falls short of 100 percent of manufacturer revenue of every kind in two ways: the rebate definition is limited to payments tied to formulary drug utilization received under manufacturer contracts, and the exact rates, exclusions and guarantees are set in Exhibit D and the Clarifications, which are not in the produced text. Whether administrative fees, data fees or other manufacturer revenue streams are retained cannot be verified from what was produced.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"unclear","confidence":0.85,"page_ref":"Page 4","evidence_quote":null,"rationale":"The base agreement defines PBM Mail Pharmacy and PBM Specialty Pharmacy as channels owned by the PBM or its affiliates (pages 3 and 4), so affiliate dispensing plainly exists under this contract. Whether claims at those affiliate pharmacies are invoiced at acquisition cost would be set in the Fee Schedule, which Section 4.1(a) on page 4 incorporates as Exhibit D and which lives in the contract attachment files that were not produced with this text. Because the base text gives no substantive pricing language itself, this item cannot be judged from the produced pages.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the base agreement caps a claim at a published benchmark or a transparent cash price, and nothing tests cost claim by claim. Article 4 on rates and payments discusses administrative fees, a Medi-Span AWP pricing source and MAC pricing limits but contains no ceiling language, and the model contract has no corresponding reference point in the produced exhibits. The subject is simply not addressed in the text available.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"I looked for language guaranteeing members never pay more than the pharmacy cash price, counting cash purchases toward deductibles and out of pocket maximums, and barring accumulator adjustment against member assistance. The base agreement has none of these. The Service addendum implements the Medicare Prescription Payment Plan, which lets Part D members spread cost sharing over monthly payments, but says nothing about cash price protection or deductible credit. The subject is absent from every document read.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"partial","confidence":0.85,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"Section 4.1(d) addresses maximum allowable cost pricing, limiting the PBM to ordinary course changes that would not discourage retail pharmacy participation. That is narrower than the model from Mark Cuban and collaborators, which requires one MAC list covering both what the plan pays and what pharmacies are paid, disclosure of the list, scheduled updates and a pharmacy appeals path with timelines. None of those elements appears, so the clause is a soft guardrail rather than real governance.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"unclear","confidence":0.85,"page_ref":"Page 5","evidence_quote":null,"rationale":"Section 4.1(f) on page 5 shows the claims flow: the PBM pays eligible claims first and is then reimbursed by ERS as provided in the RFP. Whether the reimbursement equals exactly what the pharmacy was paid, with the PBM retaining no difference, would be fixed by the reimbursement schedule in the RFP and the Exhibit D Fee Schedule, which are incorporated by reference and not in the produced text. The base agreement itself contains no statement barring or permitting spread pricing, so the item turns entirely on documents the reader cannot see.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.7,"page_ref":null,"evidence_quote":null,"rationale":"The contract never mentions group purchasing organizations, rebate aggregators, purchasing coalitions or offshore purchasing entities, and no clause routes purchase discounts or volume credits received by such entities to the plan. The rebate definition reaches remuneration received by PBM under a contract with a manufacturer, and although Article 1.4 folds subsidiaries and agents into the definition of PBM, it only covers those involved in performing services under this contract, which a separate purchasing entity generally is not. Notably, the insurance pages list Matrix GPO, LLC as an Express Scripts subsidiary, yet the agreement body is silent about it. Given the audit right reaches PBM arrangements with manufacturers, there is some indirect coverage, but the pass through of GPO value is not addressed.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"ERS holds an approval right over formulary modifications, both in Section 4.1(c) for material plan design changes and in Section 4.1(h) for the formulary itself, so the plan sponsor does control the formulary in a formal sense. The same clause openly names manufacturer rebate arrangements among the factors driving formulary placement, which is exactly the incentive the model contract published by Mark Cuban and collaborators tries to neutralize, and there is no requirement for lowest net cost analysis or quarterly utilization management outcomes by drug. Approval rights without a cost standard leave the rebate driven formulary problem intact.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I looked for a lowest net cost standard governing formulary decisions, an annual comparison of this plan's pricing against the PBM's whole book of business, and disclosure whenever a drug is placed above a cheaper equivalent. None appears in the base agreement, the amendments, the supplement or the service addendum. The Section 31.6 comparative pricing clause concerns aggregate contract pricing across customers, not formulary placement economics, so it does not fill the gap.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"missing","confidence":0.75,"page_ref":null,"evidence_quote":null,"rationale":"The contract contains no protection against retroactive claim clawbacks from pharmacies, no prohibition on steering participants to PBM owned mail or specialty pharmacies, and no any willing pharmacy participation right. The closest text is Section 4.1(d), which merely says MAC changes should not discourage retail pharmacy participation, and Section 5.4(d), where the PBM agrees to cooperate if ERS chooses an alternate retail network. The core network protections in the model contract are not addressed anywhere in the produced documents.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"then this Contract, at ERS¶ sole option, shall be amended to accord equivalent advantage to ERS.","rationale":"Section 31.6 is a genuine most favored pricing clause: if the PBM gives any government or commercial customer of similar size or smaller more generous aggregate pricing, ERS may require equivalent terms, and the PBM must notify ERS and document the determination. It is weaker than the model in two ways. The comparison is measured in the aggregate and made by the PBM itself, and there is no annual market check with a meet, credit or release remedy. Still, an automatic amendment right with a notification duty is more protection than most public contracts contain.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"good","confidence":0.85,"page_ref":"Page 18","evidence_quote":"ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract, and that all ERS-related records (and including, without limiting the foregoing, any arrangements, contracts, or related agreements that PBM has with any Pharmaceutical Manufacturers","rationale":"Article 15 gives ERS an absolute right to audit at times of its choosing, explicitly reaching the PBM's contracts with drug manufacturers and everything needed to check the most favored pricing clause, and Texas Insurance Code Section 1551.067 audit rights are layered on top. ERS gets claims data access through equipment on its own premises, the Texas State Auditor may audit, and Section 15.13 bars the Proposal or Clarifications from narrowing these rights. Two limits keep confidence short of total: audits of rebate agreements go through an approved independent auditor under a confidentiality agreement (Section 15.12), and ERS bears audit costs unless errors exceed $50,000. These are modest carve outs against an otherwise strong scheme.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"good","confidence":0.8,"page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program","rationale":"The confidentiality article makes ERS information, which the definition expressly says includes all records in the claims and membership records of participants, the exclusive property of ERS, and Article 17 bars the PBM from using, selling or disseminating participant data without written consent. On request or at termination the PBM must hand over all ERS related records and data at no cost in a format ERS can use without specialized software (Sections 21.2 and 21.3), and work product created for ERS belongs to ERS. The PBM does reserve ownership of its own systems, methodologies and report templates, so not every derived data set is unambiguously plan owned, but the core ownership, non reuse and portability promises of the model are present.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.9,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Performance guarantees exist under this contract but their content cannot be read. Section 5.5 incorporates them as Exhibit E, and Article 9 lets ERS invoke them alongside liquidated damages, but the exhibit pages in the base document are only a cover sheet. Amendment 2 replaced Exhibit E with the First Amended and Restated Performance Guarantees effective January 1, 2024, and page 4 of Amendment 2, where those guarantees appear, is fully redacted. Whether guarantees are measured quarterly on plan specific data or reconciled in cash is invisible in the produced text.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 12","evidence_quote":"shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform","rationale":"Article 9 gives ERS liquidated damages of up to $10,000.00 per default or per day without proving damages, Section 4.1(g) lets ERS offset sums owed against PBM compensation, and Article 11 makes all remedies cumulative. The weak spots are that assessment is discretionary with ERS rather than truly self executing, each default requires ERS action to collect, and there is no defined two strikes rule allowing penalty free termination after a second material breach or an integrity failure. Termination for cause exists under Section 2.4(a) but is a general remedy, not the model's automatic exit.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 2","evidence_quote":"The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"Section 2.6 requires a written agreement executed by both parties for any amendment, and Article 34 confirms the integrated list of contract documents controls. Section 4.1(b) lets ERS demand rate changes when more favorable pricing becomes available, which runs in the plan's favor rather than the vendor's. The service addendum permits an email response to count as an electronic signature, but that still requires affirmative ERS action. There is no unilateral amendment, portal update or notice based repricing right.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"good","confidence":0.9,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"Section 2.4 allows termination for cause immediately, without cause on 90 days notice, by mutual agreement, and on a funding out, with no termination penalty stated anywhere. Obligations to pay rebates, guarantees and damages survive termination, and prepaid fees must be refunded pro rata within two business days. The service addendum separately lets ERS exit the M3P program without cause by June 1 with year end effect. The one soft spot is that the contract does not expressly say earned rebate amounts are never forfeited, but nothing conditions them on continuation either.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"unclear","confidence":0.8,"page_ref":"Page 4","evidence_quote":null,"rationale":"The base agreement identifies the PBM specialty channel by name, defining PBM Specialty Pharmacy as Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc. and other affiliate pharmacies, but it defines Specialty Products only by reference to what those pharmacies dispense and sets no drug level pricing. Specialty rates and any acquisition cost terms would sit in the Exhibit D Fee Schedule referenced in Section 4.1(a) and in the contract attachments, which were not produced. The specialty pricing controls in the model contract therefore cannot be confirmed or denied from the available text.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"good","confidence":0.9,"page_ref":"Page 15","evidence_quote":"PBM should assume that all reports created by it for ERS may be publicly available records, in accordance with Texas law, and may be subject to the PIA","rationale":"The confidentiality obligations in this contract run one direction: the PBM must protect ERS data. Nothing restricts ERS from releasing pricing, rebate or performance information, and Section 13.11 tells the PBM to assume its reports are public records subject to the Texas Public Information Act, with the Attorney General, not the vendor, deciding what stays secret, and ERS expressly has no duty to advocate for the PBM's confidentiality claims. Supplement 1 has the PBM supporting the federal gag clause prohibition attestation under the Consolidated Appropriations Act, confirming the arrangement is meant to be gag free. No pharmacy gag clause appears in the produced text.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 4","evidence_quote":"Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client.","rationale":"The agreement owes IPM no duty of loyalty to the county or its members. Section 3.8 makes IPM an independent contractor and expressly not an agent of the county, and it disclaims any final discretionary authority, while nothing elsewhere requires IPM to act in the plan's interest or to give up money it keeps improperly. The model contract published by Mark Cuban and collaborators puts a duty of loyalty and care on the pharmacy benefit manager and requires disgorgement of retained amounts. This text does the opposite of that.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no compensation or conflict disclosure anywhere in the seventeen pages. Exhibit A on page 11 lists retail discounts and dispensing fees but no statement of what IPM earns from manufacturers, wholesalers or its own network, and no officer has to certify that everything has been disclosed. The word rebate appears only on page 4, where the county must tell members about rebates, and on page 10 in the tax clause. Nothing requires quarterly or annual disclosure of indirect revenue.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or schedule identifies IPM's owners, parents, subsidiaries, affiliated pharmacies, group purchasing organizations or rebate aggregators. Exhibit A is a one page fee sheet and Exhibit B is a HIPAA business associate agreement, so neither carries ownership information. The only affiliate reference is the cooperation language in the indemnity mechanics on page 8. The county therefore cannot tell which companies in the supply chain are related to its vendor.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.85,"page_ref":"Page 1","evidence_quote":"the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"The definitions article on pages 1 and 2 hands the vendor control of the terms that drive price. IPM picks the pricing benchmark in its sole discretion, decides what counts as a brand name drug, and determines generic status using a combination of data fields it does not have to disclose. There is no definition of rebate, manufacturer revenue, affiliate or specialty drug at all, so there is nothing to stop value from being relabeled. That is the reverse of the function based definitions in the model contract published by Mark Cuban and collaborators.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"PASS","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agreement contains no rebate or manufacturer revenue clause of any kind. Section 5 on pages 4 and 5 covers only what the county pays IPM, and Exhibit A on page 11 lists discounts off average wholesale price and dispensing fees with no rebate terms. Rebates surface only twice, on page 4 where the county must disclose rebates to members and on page 10 where taxes on rebate amounts are made the county's responsibility. Nothing entitles the county to any share of manufacturer money.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the text prices claims filled by IPM related pharmacies at acquisition cost. The recitals on page 1 say IPM has established a network of retail and mail order pharmacies, but Exhibit A sets only retail brand and generic rates and the word acquisition never appears. There is no definition of affiliate pharmacy and no documentation default if cost records are not produced. The county has no protection against retained margin in an IPM owned channel.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.6,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"The generic line in Exhibit A prices claims against usual and customary charge as one of the alternatives, which gives a limited ceiling at the pharmacy's own posted price for generic drugs. Brand drugs get only a discount off average wholesale price with no ceiling, and there is no reference to a published cash benchmark, no mail or specialty channel ceiling, and no claim by claim test. The model contract published by Mark Cuban and collaborators would cap plan cost at a transparent cash price in every channel. What is here is much narrower than that.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no cash price protection for members. Section 5.7 on page 5 stops pharmacies from billing members beyond copayments and deductibles, but that is balance billing protection, not a promise that the member pays no more than the shelf cash price. The word cash does not appear anywhere in the document, and nothing says a cash purchase counts toward the deductible or out of pocket maximum. Accumulator adjustment is not addressed either.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.7,"page_ref":"Page 11","evidence_quote":"Brand: AWP less 16% plus $2.00 dispensing fee Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"A generic maximum allowable cost list is used to price what the county pays, but the phrase Generic MAC appears only in this fee line and nowhere else in the agreement. The list is never defined, never disclosed, never put on an update schedule, and it is not tied to what network pharmacies are actually paid, since pharmacy payment sits in IPM's separate pharmacy agreements described in Section 5.8 on page 5. There is no pharmacy appeals path with timelines. That is exactly the arrangement that allows one list for the plan and another for pharmacies.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.85,"page_ref":"Page 5","evidence_quote":"Client understands that IPM ' s agreements w ith Network Pharmacies may allow etwork Pharmacies to review payments made by IPM related to the Covered Pharmacy Services.","rationale":"The county pays discounts off average wholesale price under Exhibit A while pharmacies are paid under separate IPM contracts the county never sees, and nothing requires the two amounts to match. Section 5.8 confirms that pharmacy payment terms live in IPM's own agreements, and it makes the county remit any additional payment a pharmacy later requests. There is no clause saying the county pays exactly what the pharmacy is paid plus a disclosed administrative fee, and no reconciliation of the difference. Retained spread is permitted in every channel.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No group purchasing organization, purchasing entity, volume credit or supplier payment is mentioned in the agreement. Section 5 on pages 4 and 5 addresses only invoices and payment timing, and Exhibit A on page 11 is limited to retail discounts and dispensing fees. Because there is no rebate clause at all, there is likewise nothing covering money that moves through an affiliated purchasing entity. The county has no claim on any of it.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans.","rationale":"The county keeps overall authority over its plan and supplies the benefit design and the description of coverage that IPM adjudicates against, which is a real measure of control. But the word formulary never appears, so there is no approval right over formulary placement or changes, no lowest net cost analysis, and no quarterly utilization management reporting by drug. Section 2.1 on page 2 also lets IPM change the Services from time to time on its own. The control the county has is over plan design, not over the drug list economics.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard appears anywhere in the text. There is no formulary article to attach such a standard to, no annual comparison against IPM's book of business, and no requirement to explain why a drug sits above a cheaper equivalent. The reporting clause in Section 2.7 on page 3 promises only standard IPM reports that IPM may amend at will. Nothing lets the county see the rebate versus net cost trade off.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.85,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"Network composition is entirely IPM's choice and IPM promises nothing about which pharmacies or how many will participate, so there is no any willing pharmacy right and no anti steering protection. Section 5.8 on page 5 goes further and requires the county to immediately remit additional payment whenever a network pharmacy asks for more after the fact, which is the opposite of claims being final when adjudicated. Reimbursement terms for pharmacies are not disclosed to the county at all. Members and independent pharmacies have no protection here.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement has no most favored pricing promise and no market check. Section 5.3 on page 4 addresses pricing changes only in the direction of IPM raising fees after the initial term, and Exhibit A fixes rates with no benchmarking mechanism. The phrase market check does not appear, and there is no meet, credit or release remedy. Because the term renews automatically every year, pricing can drift out of market with no test.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.75,"page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement.","rationale":"The only audit right in the file sits in the HIPAA business associate agreement at Exhibit B, and it covers compliance with that privacy agreement and records of protected health information uses, not claims pricing or vendor revenue. The main agreement gives the county no right to audit claims, no pre adjudication access, and only standard IPM reports that IPM may amend from time to time under Section 2.7 on page 3. Worse, Section 3.6 on page 3 deems reports and statements accurate if the county does not object within forty five days, and Section 5.5 on page 5 requires payment in full even while a charge is disputed. The county can audit privacy practices but not the money.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 6","evidence_quote":"the format of all reports, printouts, and copies thereof, and any prior and future versions thereof by any name, are the property ofIPM and are protected by copyright which shall be owned by !PM .","rationale":"Section 6.5 assigns IPM ownership of its databases, the compilations produced by its adjudication system and the format of all reports, which is the opposite of the county owning its own claims data. Section 7.1 on page 6 then lets IPM use, reproduce or adapt covered person information in any manner it deems appropriate, including product research and development, and Section 7.2 lets IPM use de identified data as it sees fit. Nothing requires delivery of claims data in machine readable form on request or at termination, and nothing bars resale. On this text the county would struggle to take its own data to a new vendor.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"PERF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There are no performance guarantees in the agreement. Exhibit A on page 11 states discounts and dispensing fees but sets no guaranteed discount to be reconciled, no service level standards, and no annual true up. The word guarantee does not appear anywhere in the seventeen pages. Nothing is measured quarterly on county specific data and nothing is settled in cash.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"ENF","verdict":"bad","confidence":0.9,"page_ref":"Page 7","evidence_quote":"!PM's maximum liability to Cl ient, regardless of the for m of action and whether for damages, indem nification or otherwise, shall not exceed the Administrative Fee paid by Cl ient over the previous six (6) months .","rationale":"Instead of automatic credits or liquidated damages, Section 9.6 caps everything IPM can ever owe the county at the administrative fee paid over the previous six months, and it bars claims raised more than ninety days after the county should have known of them. There are no self executing remedies for missed guarantees or late reports, because there are no guarantees or report deadlines. Termination for breach requires a thirty day cure and can be blocked if IPM merely starts a cure, and there is no two strikes exit or regulatory integrity trigger. A county pursuing money here would have to litigate for a capped amount.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.85,"page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"Section 18 on page 9 says amendments require mutual written consent, but Section 5.3 lets IPM change the fees or other pricing on its own after the first year, with only documentation delivered before the county budget cycle. Section 2.1 on page 2 also lets IPM change the Services from time to time, and the business associate agreement at Exhibit B provides that HIPAA related changes take effect without a signed amendment. The economics of the deal can therefore move without the county signing anything. That is the harm the model amendment clause exists to prevent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"TERM","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"The county can walk away for convenience on ninety days notice and no termination fee is stated, and the fiscal funding clause in Section 27 on page 12 lets the county stop when the commissioners court has not appropriated funds. The catch is that a convenience termination only takes effect at the end of the current term, so a late decision means another full year, and the exclusivity clause on page 8 blocks the county from lining up another manager in the meantime. There is no regulatory integrity trigger and no protection for earned amounts because no rebates or credits are ever owed. Useful but weaker than a clean exit on notice.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Specialty drugs are not addressed anywhere in the agreement. The word specialty does not appear, there is no specialty definition, no specialty rate sheet in Exhibit A on page 11, and no ceiling for specialty claims in any channel. Exhibit A prices only retail brand and generic fills for the indigent population. The largest and fastest growing part of drug spend is left entirely to the vendor.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"Section 6.1 defines confidential information to include pricing information and the agreement itself together with all exhibits, which sweeps in the Exhibit A fee schedule. Section 6.2 then bars either party from revealing that information without the other party's written consent, which may be withheld for any reason, and the only stated escape in Section 6.3 is a subpoena. There is no carve out for the Texas Public Information Act, for the county's own auditors or advisors, or for elected officials. On its face this clause is aimed at keeping what taxpayers pay out of public view.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 11","evidence_quote":"Claim Administrator is not the plan administrator of Employer’s employee benefit plan and is not a fiduciary of Employer, the plan administrator or of the Plan.","rationale":"Page 11 expressly disclaims fiduciary status and describes the claim administrator as a contract service provider. Page 43 adds that manufacturer contracting is on Prime's or the administrator's own behalf and for its own benefit. Pages 28 and 44 assign actual rebate and administrative fee interests away from the employer. The model term requires affirmative loyalty and care solely to the plan and members, conflict and compensation disclosure, and disgorgement without proof of damage. This draft takes the opposite position on fiduciary capacity and economic entitlement. Although page 4 keeps the administrator responsible for delegated services, that contractual responsibility is not an affirmative duty of loyalty to the city.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"DISC","verdict":"bad","confidence":0.97,"page_ref":"Page 28","evidence_quote":"Currently, none of these fees will be passed on to Employer as expenses, or accrue to the benefit of Employer, unless otherwise specifically set forth in the Agreement.","rationale":"Pages 27 and 28 describe pharmacy payments, Prime administrative fees from pharmacies and manufacturers, and amounts from third parties, but the quoted provision says those fees generally do not benefit the city. Page 44 states a disclosed maximum manufacturer administrative fee and says the administrator will notify the employer if that maximum changes. Page 12 offers an ownership-interest list on request at most annually, not a complete economic-conflicts exhibit. These are selected descriptions, not full disclosure of all direct and indirect compensation, related entities, broker payments, and plan-level allocations. No quarterly or annual named officer certification appears in the agreement or Exhibit 7. The omitted fee addendum may supply rates, but cannot cure the affirmative retention and limited disclosure structure visible here.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.96,"page_ref":"Page 12","evidence_quote":"Upon Employer request (not more than once per calendar year), Claim Administrator will provide a list of such entities to Employer.","rationale":"Page 12 acknowledges possible ownership interests in providers and vendors and offers a list upon request, limited to one request each calendar year. Pages 28 and 43 disclose significant equity ownership of Prime, and page 28 says the mail or specialty pharmacy operator may be an affiliate of, or partly owned by, Prime. That is meaningful but far weaker than a signed comprehensive exhibit of every owner, parent, subsidiary, affiliate, purchasing organization, rebate aggregator and related pharmacy. The text imposes no automatic update within 30 days of an ownership or control change. The page 12 list is discretionary to request, relates to the administrator's described entities, and does not establish a complete Prime ownership map.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 49","evidence_quote":"Rebates do not include Manufacturer Administration Fees or fees retained by a group purchasing organization for its role in securing Rebates and/or Manufacturer Administrative Fees.","rationale":"Page 49 defines rebates broadly at first but then excludes manufacturer administration fees and purchasing organization retention. Page 48 defines manufacturer administration fees as negotiated fees relating to rebate administration, so economic value can be classified separately from a rebate. Page 49 permits Prime or the administrator to determine and change the specialty drug list rather than fixing the category by economic function. Page 47 relies on a pricing source's brand designation, and page 48 similarly relies on it for generic drugs. The model requires definitions closing relabeling and affiliate loopholes. Here the explicit excluded categories and unilateral specialty designation create the opposite risk, even before reviewing the absent pricing addendum.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 28","evidence_quote":"Employer acknowledges that it has negotiated for the specific Rebate Credit included as part of this Agreement and that it and its Plan have no right to, or legal interest in, any portion of the rebates, payments, discounts and/or other allowances provided by the PBM or such manufacturers to Claim Administrator","rationale":"Page 28 says the PBM forwards collected rebates to the claim administrator, except interest and late fees, and purchasing organization fees may be deducted. The city receives only a negotiated rebate credit if one is provided, from the administrator's own assets regardless of actual manufacturer receipts. Pages 43 and 44 reiterate that Prime or the administrator retains actual rebate and manufacturer fee rights, with the city having no interest beyond applicable credits. Page 47 describes credits prospectively on monthly statements, ending at program or exhibit termination. This is not full manufacturer revenue pass-through within a fixed quarterly deadline. The omitted application and addendum conceal the credit amount, not the adverse allocation of actual receipts.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.96,"page_ref":"Page 27","evidence_quote":"For the administrative services that Prime provides as part of the mail order and specialty pharmacy program, Prime may keep as its fee a portion of the discounts and/or other allowances that it has negotiated with the mail-order and/or specialty pharmacy.","rationale":"Page 27 explicitly allows Prime to keep a portion of mail and specialty pharmacy discounts or allowances and excepts those channels from the pharmacy-negotiated amounts passed to the administrator. Page 28 notes a specialty or mail operator may be affiliated with or partly owned by Prime. Page 46 says specialty pricing follows a separate schedule and such drugs may be supplied by Prime or an affiliate. The draft never ties related pharmacy reimbursement or employer invoices to documented net acquisition cost plus a stated dispensing fee, and it supplies no documentation default. The omitted addendum means the precise specialty prices cannot be calculated, but the retained discount permission and channel carveout conflict with the model's no-margin standard.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.87,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the prescription drug Allowable Amount definition on page 14, the pharmacy pricing and rebate provisions on pages 27 and 28, and the whole pharmacy exhibit on pages 43 through 49. Participating pharmacy amounts and specialty drug prices are placed in the omitted PBM Fee Schedule Addendum, but the visible agreement does not state a published cash-price or other external benchmark ceiling applied claim by claim in every channel. The page 49 usual and customary cash-price definition is not an operative guarantee that the plan's claim cost is capped by that price. Because an actual claim rate is in the missing addendum, it cannot be measured here, but a benchmark-ceiling covenant is simply not addressed in the produced terms.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.91,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed pages 14 and 27 on deductibles and coinsurance, page 46 on pharmacy pricing and member cost share, and the usual and customary definition on page 49. That definition describes what a network pharmacy would charge a cash customer, including its discounts, but the produced text never makes the member's payment the lesser of the benefit price and cash or cheapest lawful price. It does not require out-of-plan cash purchases to count toward either a deductible or an out of pocket maximum, and it does not forbid an accumulator adjustment absent a written sponsor election. The missing benefit application could specify cost-sharing design, but no quoted term establishes these member protections in the produced contract.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.98,"page_ref":"Page 44","evidence_quote":"Prime’s MAC Lists applicable to this Exhibit will be available for viewing by authorized representatives of Employer after 30 days’ prior written request submitted by Employer to Claim Administrator, and subject to Employer’s execution of Prime’s non-disclosure agreement(s).","rationale":"Page 44 calls Prime's MAC lists proprietary and permits only limited viewing after notice and a nondisclosure agreement. It also restricts request frequency and location. Page 48 defines a MAC list of unit prices updated from time to time, but does not require a schedule, a single list governing both employer charges and pharmacy reimbursement, or pharmacy appeals with deadlines. Page 44 separately says Prime pays network participants under their network contracts, while employer pricing is in an omitted addendum. This framework does not establish the model's single-list transparency and appeal system. The access restrictions are affirmative contrary provisions, even though the exact relationship between lists and actual prices cannot be tested without the addendum and network contracts.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 44","evidence_quote":"Employer acknowledges that in negotiating the Agreement and this Exhibit, it has taken into consideration that Claim Administrator and/or Prime will keep all or a portion of the discounts and/or other allowances that Claims Administrator or its pharmacy benefits manager has negotiated with the Network Participant.","rationale":"Page 44 affirmatively permits retention of some or all pharmacy-negotiated discounts and allowances while Prime reimburses network participants according to separate network contracts. Pages 14 and 27 make the employer's participating claim amount the amount mutually agreed with the administrator, not the exact pharmacy remittance plus a disclosed fee. Page 27 also makes a mail and specialty exception to amounts passed from Prime to the administrator. These clauses permit economic differences instead of prohibiting spread in every channel. The absent PBM Fee Schedule Addendum holds the actual employer rates and may contain aggregate guarantees, but no visible provision compels claim-by-claim equivalence between employer invoice and pharmacy payment.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.99,"page_ref":"Page 28","evidence_quote":"PBM may contract with pharmaceutical manufacturers through a group purchasing organization and, in such case, rebates collected by PBM and paid to Claim Administrator will be net of any fee the group purchasing organization may retain for its role in securing rebates.","rationale":"Page 28 explicitly allows an intermediary purchasing organization's fee to be taken before collected rebates reach the administrator. Page 49 excludes such fees and manufacturer administration fees from the rebate definition. Pages 43 and 44 place manufacturer contracting and related revenue in Prime's or the administrator's own economic interest and deny the employer interest in actual manufacturer payments. No disclosed allocation drivers or duty to remit purchasing entity discounts, volume credits or supplier payments appears on pages 28, 43 through 49, or in the general financial terms. This is an affirmative GPO leakage permission, not merely a silent gap. The missing addendum would show any promised rebate credit, but not overturn the visible retention rights.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.93,"page_ref":"Page 43","evidence_quote":"Employer acknowledges and agrees that Claim Administrator may, in a manner consistent with the Benefit Plan, promote the dispensing of pharmaceuticals in a manner consistent with the designated Drug List selected by Employer.","rationale":"Page 43 gives the employer a selection of a designated drug list and binds promotion to the benefit plan, which is some sponsor control. The same page says the administrator uses its own list, Prime supports its development and maintenance, and Prime conducts exceptions under its contract with the administrator. The draft does not require city approval of every formulary change, presentation of lowest net cost alternatives, or quarterly drug-level utilization management outcomes. Page 48 defines the drug list primarily as coverage and tier information. This is materially weaker than the model's approval and analytic oversight requirements. The city controls benefit design generally on page 4, but that does not translate into the specific formulary-change veto.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the drug list and manufacturer contracting provisions on pages 43 and 44, the pharmacy network provision on page 44, and drug list and utilization management definitions on pages 48 and 49. Nothing makes lowest net cost to this city an enforceable formulary standard, requires an annual comparison to the administrator's or Prime's whole book, or mandates disclosure of each placement above a cheaper therapeutic equivalent with a reason. Page 44 even describes rebate arrangements based on formulary status or market share, without a countervailing net cost rule. The benefit application and fee addendum are absent, but the particular standard and comparative report are not addressed in the produced formulary provisions.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.86,"page_ref":"Page 44","evidence_quote":"Prime requires its Network Participants to not switch Covered Prescription Drug Products to a higher cost product unless requested to by the Member and/or the Member’s Physician.","rationale":"Page 44 contains a narrow member protection against a network participant switching to a higher cost product without a request. The same page assigns network construction and pharmacy reimbursement to Prime under separate contracts, and page 27 allows retained mail and specialty discounts. Pages 43 through 49 do not guarantee any willing pharmacy admission, bar plan or PBM steering toward related pharmacies, prevent retrospective pharmacy clawbacks, or prohibit volume-conditioned reimbursement. Page 8 describes offsets and overpayment recovery for providers generally, although that language is not a clear pharmacy-specific retroactive fee term. The single anti-switching constraint merits partial credit, but it does not provide the model's pharmacy choice, finality and anti-steering package.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the pharmacy exhibit on pages 43 through 49, the general fee provisions on pages 21 and 22, and termination provisions on pages 11 and 46. None promises the city terms as favorable as those of a comparable client, automatically improves its rates, or gives it an annual market check with a meet, credit or release mechanism. The agreement permits service charge changes for several events instead. The missing PBM Fee Schedule Addendum could disclose actual guarantees and their time periods, but a most favored client commitment and market-check procedure are not addressed anywhere in the produced text. Their absence is classified as missing, rather than unclear solely because the attachment is absent.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.98,"page_ref":"Page 5","evidence_quote":"Audit samples will be limited to no more than three hundred (300) Claims.","rationale":"Pages 5 and 6 permit employer or approved-agent claim payment audits, but require advance notice, a small sample, employer-paid costs, a separate audit agreement, restrictions on frequency and periods, and no reimbursement from extrapolated errors. Pages 44 and 45 add an indirect Prime inspection or audit route, with records withheld where Prime is legally or contractually prohibited and copying subject to approval. Page 19 offers standard reports, while customized reports can cost extra. These are real but constrained rights, so partial is more accurate than missing. They fall short of automatic comprehensive claims and financial feeds, unrestricted sponsor-selected auditors, pre-adjudication access and disclosure regardless of claimed proprietary status.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.96,"page_ref":"Page 7","evidence_quote":"excluding any and all of the Business Confidential Information of Claim Administrator, other Blue Cross and/or Blue Shield companies, or Claim Administrator’s subsidiaries, affiliates, and vendors, in the possession of Claim Administrator.","rationale":"Page 7 excludes broad business confidential information from claim determination records furnished on request after termination, imposes preparation costs and requires an agreed form. Page 15 includes pricing information, data and databases within the administrator's confidential information definition. Page 6 permits certain limited or de-identified data use for industry improvement, while prohibiting sale or use for financial profit in that stated category. These restrictions are not an outright sale right, but the city is never made sole owner of claim, eligibility, accumulator, rebate and derived data. Nor is unconditional machine-readable delivery promised. The administrator's explicit proprietary exclusion contradicts the model's comprehensive sponsor control and exit portability.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"PERF","verdict":"unclear","confidence":0.94,"page_ref":"Page 46","evidence_quote":"If Employer terminates this Exhibit under sections 9(a), 9(b), or 9(c) above, or by Claim Administrator under sections 9(d) or 9(e), prior to the end of the Guarantee Period, then applicable network discount and/or minimum Rebate guarantees set forth in the BPA Addendum will not be effective for such Guarantee Period.","rationale":"Page 46 confirms that network discount and minimum rebate guarantees exist in the absent BPA Addendum and sets a substantial forfeiture condition for early termination. Page 27 describes some Prime fees tied to processing and service standards, but that does not specify an employer remedy. The posted Exhibit 4 on page 31 has no application terms, and the referenced PBM pricing addendum is not attached. Consequently the actual targets, measurement unit, quarterly reconciliation, cash payment, credit caps and exclusions cannot be judged. The visible forfeiture provision is adverse, but the rubric asks whether guarantees have plan-specific measurement and real shortfall remedies. Those operative details belong to the explicitly omitted attachment, so unclear is narrower and more honest than assuming their contents.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"ENF","verdict":"bad","confidence":0.87,"page_ref":"Page 10","evidence_quote":"to allow the notified Party ninety (90) days in which to make necessary adjustments or corrections to satisfy the complaint or concern prior to taking any further action","rationale":"Page 10 imposes complaint notice and a lengthy adjustment opportunity before further action in the general case, followed by negotiation and confidential arbitration on pages 10 and 11. Page 11 permits termination for material breach only after notice and the cure period, and page 46 has a similar route for noncompliance with the pharmacy exhibit. There is no automatic credit or liquidated damages for a late report, no repeated-breach two-strikes termination right, and no specified regulatory integrity exit in the visible text. The missing addendum may contain performance guarantee reconciliation terms, but this draft's express general enforcement and exit architecture does not self-execute upon recurring material failure. The verdict addresses that visible adverse architecture, not an invented addendum remedy.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"Page 12","evidence_quote":"Notwithstanding the foregoing, any amendments required by law, regulation or order (“Law”) or by Claim Administrator or the Association may be implemented by Claim Administrator upon sixty (60) calendar days’ prior notice to Employer","rationale":"Page 12 starts with mutual written amendment but then expressly allows amendments required by the administrator or the Association on notice, with objection leading to negotiation and dispute resolution rather than a sponsor-signature condition. Page 22 separately allows service charge changes upon several triggers, including projection and enrollment changes. Page 40 deems employer approval of changed inter-plan fees if it does not respond or terminate, and page 45 allows automatic AWP-related adjustment and an alternative benchmark designated by Prime. These carveouts defeat the model rule that no economic amendment takes effect without both parties' signatures. The visible unilateral and deemed-approval powers are sufficient for bad, irrespective of missing rate details.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"TERM","verdict":"bad","confidence":0.98,"page_ref":"Page 28","evidence_quote":"Rebate Credits shall not continue after termination of the prescription drug program.","rationale":"Page 11 permits ordinary main-agreement termination only after the fee schedule period with notice, while page 46 permits ending the pharmacy exhibit after a guarantee period. Page 22 requires a termination administrative charge under the omitted application and allows repricing of that charge. Page 46 removes applicable network and minimum rebate guarantees for a guarantee period when specified early termination occurs, and page 28 ends rebate credits after program termination. This is not an unrestricted convenience exit without penalty or preservation of earned economic value. The size of the termination charge and guarantee period are unknown because their schedules are missing, but the affirmative charge, timing constraints and forfeiture language support a bad verdict. No independent regulatory integrity termination trigger appears.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"SPEC","verdict":"bad","confidence":0.97,"page_ref":"Page 49","evidence_quote":"The list of Specialty Drugs is determined by Prime or Claim Administrator and subject to change.","rationale":"Page 49 includes a functional description of specialty drugs, but lets Prime or the administrator decide and alter the operative list. Page 46 separates specialty claims from retail and mail pricing and puts their rates in the omitted addendum; it also allows supply by Prime, a Prime affiliate or another specialty pharmacy. Page 27 permits Prime to retain a portion of mail and specialty discounts as a fee. The produced text provides neither acquisition-cost pricing at affiliated specialty pharmacies nor claim-level drug rates as ceilings in every channel. The exact specialty prices cannot be examined because the addendum is absent, but the unilateral list and affirmative retained-margin permission conflict with the model protections.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"GPT 6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 7","evidence_quote":"Employer shall not use or disclose such Business Confidential Information, including this Agreement, to any third party without prior written consent of Claim Administrator.","rationale":"Page 7 expressly treats the agreement as business confidential information and requires administrator consent for third-party disclosure. It also requires notice if the city believes law requires disclosure, allowing objection and protective measures, and binds recipients against further disclosure. Page 15 defines confidential information to include cost or pricing information, provider discounts and rates, data and contracts. Pages 5 and 6 place audit agents under nondisclosure and a separate audit agreement, while page 44 conditions MAC viewing on Prime's nondisclosure agreement. The legal-release notice does not erase the direct sharing restriction. This meets the rubric's red flag definition even without proof of a separate pharmacy-to-patient gag clause.","model_own_total":10.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.97,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"The contract limits any fiduciary role to initial claim adjudication and appeals, and the same paragraph expressly states the vendor is not a named fiduciary, has no discretionary authority over the plan, and is not deemed a fiduciary under ERISA or any applicable state law. There is no duty of loyalty to the plan and its members, no requirement to disclose all direct and indirect compensation, and no disgorgement obligation. This is the opposite of what the model contract published by Mark Cuban and collaborators calls for.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"DISC","verdict":"bad","confidence":0.85,"page_ref":"Page 10","evidence_quote":"administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost (“WAC”) of the products dispensed across VENDOR’s book of business.","rationale":"The contract does disclose, in general terms, that the vendor and its affiliates may receive and retain manufacturer fees of one to four percent of WAC, and section 21.3 adds a warranty that no broker was paid a contingent fee to win this contract. But there is no complete disclosure of all compensation, no obligation to report what was actually received, and no officer certification that everything has been disclosed and remitted. The disclosure functions mainly to authorize retention rather than to let the city verify it.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or clause lists the vendor's owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, or mail and specialty pharmacies. Section 14.3 on page 21 requires only 60 days notice of a change in ownership interest greater than 50 percent, and section 21.2 on page 28 requires an ethics disclosure statement about city officers, not about the vendor's corporate family. The word affiliate appears in the compensation clause on page 10 and the assignment clause on page 21, but no ownership exhibit exists anywhere in the 37 pages.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 2","evidence_quote":"“Rebates” means the formulary rebates, including base and market share rebates, collected by VENDOR in its capacity as a group purchasing organization for the Plan","rationale":"Rebates are defined by label as formulary rebates only, and page 10 then carves manufacturer administrative fees, other compensation, and purchase price discounts out of the definition entirely, declaring they belong exclusively to the vendor or its affiliates. Generic Drug and Brand Drug are defined as whatever the vendor identifies using Medi-Span, and Maximum Allowable Cost is a unit price established and amended by the vendor alone. These definitions let value be relabeled to escape pass-through, which is exactly the loophole the model contract's functional definitions are meant to close.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"may receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies","rationale":"The vendor remits only 'Rebates' as narrowly defined, and the same section states that fees, compensation, and concurrent or retrospective discounts associated with purchase prices belong exclusively to the vendor or its affiliates. The city also waives any right to interest or the time value of rebate payments on page 9. This expressly permits the retention of manufacturer revenue, the harm the model contract's 100 percent pass-through clause exists to prevent. The remittance schedule itself is in Exhibit B, which is not in the posted PDF, but the retention language in the base text is decisive.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"NAC","verdict":"unclear","confidence":0.8,"page_ref":"Pages 4 and 17","evidence_quote":null,"rationale":"Page 4 says claim costs are the lowest of the discounted rate, the pharmacy's reported usual and customary price, and the vendor MAC rate, plus a dispensing fee, and page 17 points to Exhibit B for administrative fees, but Exhibit B is not in the posted PDF. Nothing in the base text requires claims dispensed by the vendor's own mail and specialty pharmacies to be invoiced at net acquisition cost with no retained margin. Because the rates that would answer this question live only in the withheld fee exhibit, the item cannot be decided from the readable text.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the 37 pages caps the city's claim cost at a published benchmark such as a transparent cash price, in any channel, checked claim by claim. The pricing language on page 4 only applies a lowest of logic among the discounted rate, the pharmacy's usual and customary price, and the vendor MAC rate, none of which is an external public benchmark. No market benchmark or ceiling provision appears anywhere in the contract.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"Pages 4 and 5 say the pharmacy collects from the member the lowest of the copayment, the discounted price, the vendor MAC rate, or the pharmacy's usual and customary price, which is a partial member level protection, but that is all. There is no provision crediting cash purchases toward deductibles or out of pocket maximums and no mention of accumulator adjustment programs anywhere in the text. Most of what this rubric item requires is simply not addressed in the produced pages.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"MAC","verdict":"bad","confidence":0.92,"page_ref":"Page 2","evidence_quote":"which list may be amended from time to time by VENDOR in maintaining its generic pricing program","rationale":"The MAC list is created and amended at the vendor's sole discretion, with no update schedule, no pharmacy appeals path, and no statement that the same MAC list governs what the plan pays and what pharmacies are paid. The list is provided to the city before execution and thereafter only on reasonable request. This is the classic single sided MAC structure the model contract's MAC governance clause is written against.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"SPRD","verdict":"unclear","confidence":0.75,"page_ref":"Pages 4 and 17","evidence_quote":null,"rationale":"The base text never states that the city pays exactly what the pharmacy is paid plus a disclosed administrative fee. Page 4 defines claim cost as the lowest of the discounted rate, usual and customary price, or MAC rate plus a dispensing fee, which is silent on whether the discounted rate equals the pharmacy's reimbursement, and page 17 sends all administrative fees to Exhibit B, which is not in the posted PDF. Whether spread exists cannot be verified from the readable text because the pricing exhibit is withheld.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"In addition, VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The vendor acts as the group purchasing organization for the plan, and the contract expressly allows the vendor and its affiliates to keep purchase related discounts and manufacturer fees rather than passing them through. There is no requirement that purchasing entity revenue of any kind flow to the plan; the same page states this money belongs exclusively to the vendor or its affiliates. That directly contradicts the model contract's GPO pass-through clause.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"FORM","verdict":"bad","confidence":0.95,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"The city's formulary is the vendor's own Performance Drug List, created, maintained and amended by the vendor and approved by the vendor's Pharmacy and Therapeutics Committee per the definition on page 2. The city receives 30 days notice of changes but has no approval right over the formulary or any change to it, and the specialty formulary works the same way with quarterly notice. This is PBM control of the formulary, the arrangement the model contract's plan approval clause exists to prevent.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard for this plan appears anywhere in the text, and there is no annual comparison of the city's drug costs against the vendor's book of business. Page 8 lists cost effectiveness as one of many factors the vendor may consider in formulary changes, but that is not an enforceable standard and no disclosure of above cost placements is required. The performance section on page 13 deals with service accuracy, not net cost.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"NET","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"The text contains no any willing pharmacy clause, no anti-steering language, and no prohibition on retroactive claim clawbacks. Page 5 gives the vendor the sole right to audit network pharmacies and authority to reconcile discrepancies, which implies recoupment power without any claim finality protection for pharmacies. Mail order appears in the plan design as a 90 day channel on page 4, but nothing governs steering into the vendor's own mail and specialty pharmacies.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the 37 pages gives the city pricing at least as good as comparable clients, and there is no annual market check with a meet, credit or release remedy. Searches of the full text for most favored and market check language return nothing. The five year term on page 18 runs without any mechanism to reprice to market.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"Pharmacy claims audits may be conduct at the discretion of CITY, but (i) are limited to one (1) on site audit per plan year and the audit must be completed within two years of the end of","rationale":"The city may audit claims annually and may audit rebates through review of up to ten pharmaceutical company contracts per year, which is a real right. But audits are limited to one per year, the auditor must be mutually acceptable and must sign the vendor's confidentiality agreement, rebate audit findings may not be revealed to any third party including the city, and the city may not audit the vendor's pharmacy or manufacturer agreements beyond that. Data access is through an online portal rather than scheduled delivery of full claims level files, so the rights are weaker than the model contract.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.78,"page_ref":"Page 19","evidence_quote":"VENDOR recognizes that CITY shall own any and all information in whatsoever form and character produced and/or maintained in accordance with this CONTRACT that is produced solely and exclusively for CITY","rationale":"The ownership clause is meaningful but narrow: it covers only information produced solely and exclusively for the city, and the vendor keeps the right to protect confidential trade secret information within it and may use and sell deidentified claims and eligibility data with data integration firms. Section 22.5 on page 29 adds that all files are the property of the city and must be delivered at termination, though scrubbed of the vendor's confidential information and at the vendor's cost only after three years. There is no machine readable delivery obligation on request and no blanket ban on reuse, so this is weaker than the model contract's data ownership clause.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.82,"page_ref":"Page 13","evidence_quote":null,"rationale":"The base text establishes that performance standards exist, that total dollars at risk will be $175,000 as set forth in Exhibit A, that only city claims are used for measurement, and that amounts at risk are adjusted within 60 days. But page 13 itself says the guarantees live in Exhibit A, which is not in the posted PDF, so whether the guarantees are quarterly, cash reconciled, and paid dollar for dollar cannot be determined. The $175,000 cap on total dollars at risk is visible and suggests limited remedies, but the substance is withheld with the exhibit.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform","rationale":"Missed performance standards produce an automatic adjustment against amounts due the vendor within 60 days without the city proving damages, which is a self executing remedy of the kind the model contract favors. However the amounts at risk are capped at $175,000 total per Exhibit A and are the city's exclusive financial remedies, and there is no liquidated damages clause for late reports and no two strikes termination right for repeated material breach. Termination for cause on page 29 requires only a single uncured default, so enforcement is present but limited.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"Amendments require a written document signed by both parties, and there is no clause letting the vendor change economic terms by notice, portal update, or updated exhibit. Section 31.1 on page 34 reinforces that no other agreements bind the parties unless in writing and duly executed. This matches the model contract's amendment clause.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"TERM","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause upon written notice, provided such notice specifies an effective date of termination, which shall be not less than 90 calendar days","rationale":"The city may cancel without cause on 90 to 120 days notice, which is a genuine convenience termination right. It is weakened by the requirement to repay a pro rata share of credits and the implementation credit disbursed by the vendor, by page 9's allowance that the vendor may delay rebate remittance on termination for final adjustments, and by the absence of a regulatory integrity event trigger. The record transfer at termination is at the vendor's cost only if the city completed at least three years of the initial term.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"SPEC","verdict":"partial","confidence":0.7,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease","rationale":"Specialty drugs are defined by function, though loosely and with the vendor doing the identifying, and the city adopts the vendor's Advance Control Specialty Formulary which the vendor may change from time to time with quarterly notice. There is no drug level rate ceiling and no acquisition cost pricing requirement for specialty claims at affiliate pharmacies in the base text; any specialty rates would sit in the withheld Exhibit B. What is visible addresses the definition and formulary notice only, so the item is addressed but far weaker than the model.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data, trade secrets","rationale":"Costs and pricing data are expressly classified as Confidential Information that neither party may disclose without the other's written consent, and the vendor asserts that information in this contract is confidential. The Public Information Act carve out on page 36 does not free the city to release pricing; it obligates the city to notify the vendor of any request, to give the vendor time to claim exemptions, and not to oppose the vendor's effort to block release through the Texas Attorney General or the courts. Audit confidentiality clauses on page 15 further bar disclosure of audited contract terms to any third party, including the city itself for rebate audit details. This is a gag structure on pricing and audit material, and the posted file's missing fee exhibits are consistent with it.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"partial","confidence":0.9,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall perform its obligations and duties under this Contract with utmost good faith, loyalty, candor and skill.","rationale":"The agreement states that the PBM will act as a fiduciary and perform its duties with good faith and loyalty. However, it does not mandate that these duties are owed solely to the plan and its members, nor does it include a provision for disgorgement of retained amounts.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include a requirement for a named officer to certify quarterly and annually that all compensation and conflicts have been fully disclosed and remitted.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The list of contract exhibits in Article 37 on page 34 covers the RFP, proposal, clarifications, fee schedule, performance guarantees, business associate agreement, insurance, data security, implementation plan, and incumbency certificate. There is no mention of an ownership and affiliate disclosure exhibit.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The contract defines Rebates broadly by economic function to include any manufacturer remuneration, which is strong. However, definitions for other key terms like generic or specialty are either missing or potentially located in the absent Exhibit D.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"good","confidence":0.9,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed","rationale":"The agreement requires the PBM to pay all manufacturer rebates to the plan on a quarterly basis. The broad definition of Rebates covers all types of manufacturer remuneration.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"Pricing terms are incorporated by reference from the Fee Schedule (Exhibit D). Because this exhibit is missing from the provided text, it is unclear whether affiliate pharmacies are priced at acquisition cost.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"The base agreement relies on the absent Exhibit D for the compensation and reimbursement schedule. Therefore, it is impossible to determine if a benchmark ceiling or cheapest lawful option requirement is present.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not contain any provisions addressing cash price protection, deductible credits for cash purchases, or accumulator adjustments. The text is completely silent on this subject.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"While the base agreement mentions on page 4 that the PBM may modify MAC pricing in the ordinary course of business, it does not mandate a single disclosed MAC list for both the plan and pharmacies or establish an appeals path with defined timelines.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"The contract indicates that the PBM's administrative fees and reimbursement schedule are exclusively governed by Exhibit D. Since this fee schedule is missing, the presence or absence of spread pricing cannot be evaluated.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not address group purchasing organizations (GPOs) or mandate the pass-through of purchase discounts, volume credits, or supplier payments received by related purchasing entities.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 4","evidence_quote":"ERS must approve in writing any material modification of the Plan design or program specifications, including the formulary in place for ERS, prior to any implementation thereof.","rationale":"The plan sponsor retains control by approving the formulary and any material modifications in writing. However, the contract does not require the PBM to deliver a lowest-net-cost analysis or utilization management outcomes each quarter.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a lowest net cost standard for formulary decisions. It also lacks any requirement for an annual comparison against the PBM's entire book of business.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no pharmacy network protections in the text. The agreement does not prohibit retroactive clawbacks, condition reimbursement on volume, prevent steering to PBM-owned pharmacies, or guarantee any willing pharmacy's right to participate.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 29","evidence_quote":"PBM warrants and represents that if, during the term of this Contract, PBM enters into any agreement with any other governmental customer or any commercial customer not affiliated with PBM, of a similar size or smaller (the Comparative Agreement), by which PBM agrees to perform, deliver or provide equivalent Services, coverages, benefits, supplies or products that PBM is providing in accordance with this Contract for more generous pricing terms","rationale":"The contract includes a robust most favored nation clause that requires the PBM to amend the contract if it offers better pricing to comparable clients. However, it lacks an annual market check with a distinct meet, credit, or release remedy.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract, and that all ERS-related records","rationale":"The plan sponsor has strong audit rights, including the ability to audit rebate agreements with pharmaceutical manufacturers using an independent representative. However, the clause does not grant pre-adjudication claims access or provide full claims-level data on a schedule without asking.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program (the ³GBP´) as applicable","rationale":"The contract designates confidential information (which includes participant and plan data) as the exclusive property of the plan sponsor. While this protects plan information, it does not explicitly declare ownership over every derived data set or rebate data in the manner of the model contract.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"unclear","confidence":0.9,"page_ref":"Page 40","evidence_quote":null,"rationale":"Performance guarantees are detailed in Exhibit E, which is referenced in the base agreement but not provided in the text. Thus, it cannot be determined if the guarantees are measured on plan-specific data or rely on capped credits.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"partial","confidence":0.9,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline","rationale":"The contract features strong self-executing enforcement mechanisms, allowing the plan to collect up to $10,000 per day in liquidated damages for default without proving actual damages. However, it does not establish a defined two-strikes exit for repeat material breaches.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 2","evidence_quote":"The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"The agreement strictly requires that any alterations or amendments be made through a written agreement signed by authorized representatives of both parties, preventing unilateral updates by the PBM.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"partial","confidence":0.9,"page_ref":"Page 2","evidence_quote":"In addition to and without restricting or waiving any other legal, contractual or equitable remedies otherwise available to ERS, ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"The plan sponsor has the right to terminate the contract for convenience without penalty by providing 90 days' written notice. However, the contract does not explicitly state that earned amounts are never forfeited upon termination.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"Because the pricing terms are incorporated from the absent Fee Schedule (Exhibit D), the contract's specialty drug pricing controls cannot be evaluated. The base agreement only defines a PBM Specialty Pharmacy.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"partial","confidence":0.8,"page_ref":"Page 15","evidence_quote":"ERS and, subject to a non-disclosure agreement with PBM, its auditors, advisors, consultants, and custodians, if applicable, are entitled to use and retain copies of all written materials generated by PBM under this Contract.","rationale":"The confidentiality provisions permit the plan sponsor to share materials with its auditors and advisors, provided an NDA is signed, and acknowledge that records may be subject to the Public Information Act. However, the PBM retains the right to label materials as proprietary to seek to block their public release.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FID","verdict":"partial","confidence":0.92,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"Express Scripts agrees to act as a fiduciary, and later warrants utmost good faith, loyalty, candor and skill. That is more than silence, but it is not the duty of loyalty and care owed solely to the plan and members in the model contract published by Mark Cuban and collaborators. There is no duty to disclose every economic conflict or to disgorge amounts retained in breach without ERS proving damages.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 4","evidence_quote":"PBM's administrative fees, if any, and the compensation and/or reimbursement schedule that PBM will in any way receive for or in connection with the Services, coverages, benefits, Equipment, supplies and products that PBM is required to perform, deliver or provide in connection with, arising out of or related to its performance of this Contract shall be only those specifically agreed to and accepted by ERS and that are reflected in the Fee Schedule attached hereto and fully incorporated herein as Exhibit D.","rationale":"Compensation is supposed to be only what Exhibit D lists, and manufacturer fees from extra management programs are pulled into the Rebate definition. Article 16 requires disclosure of procurement conflicts, not a full map of affiliate compensation. No named officer certifies quarterly or annually that everything has been disclosed and remitted. Exhibit D itself is only a title page in this file.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"OWN","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"PBM Specialty Pharmacy´ means Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc., or another pharmacy or home health agency owned or operated by PBM or its affiliates that primarily dispenses Specialty Products.","rationale":"The contract names Accredo and Express Scripts Specialty Distribution as owned specialty pharmacies and requires notice of merger, acquisition, or change of control. Exhibit G insurance pages list many subsidiaries, including MATRIX GPO, LLC and mail pharmacies. That is not a signed ownership exhibit that must be refreshed within 30 days of any ownership or control change, and it does not identify rebate aggregators as such.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"Rebate is defined more broadly than a label, covering price protection, concessions, discounts, and other manufacturer remuneration. Page 6 then limits that bag to amounts received under a pharmaceutical manufacturer contract and related to Formulary utilization by Participants. Affiliate, specialty, and generic are not defined by economic function, so value can still be moved into GPO, data, or non-formulary payments.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PASS","verdict":"partial","confidence":0.88,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Federal subsidies, including direct subsidies, coverage gap subsidies and catastrophic re-insurance and all Rebates, as defined in this Contract, to ERS as set forth below and in Exhibit D and/or the Clarifications for the Contract Term and any extension or renewal thereof.","rationale":"Express Scripts must pay all defined Rebates and listed federal subsidies to ERS, promptly and no later than quarterly. That is pass-through of Rebates as defined, not 100 percent of manufacturer revenue of every kind. The definition is limited to manufacturer contracts and Formulary utilization, timing is not within 30 days of quarter end, and the actual rates live in Exhibit D, which is not in this file.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Pages 3 to 4 define PBM Mail Pharmacy and PBM Specialty Pharmacy as owned or operated by Express Scripts or affiliates, so the contract knows those channels exist. Article 4 rates and payments, the Exhibit D cover, Amendment 2, and the Service addendum never require those pharmacies to invoice at net acquisition cost plus a stated dispensing fee. There is no documentation default if cost records are not produced.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Article 4 on rates, the Exhibit D fee schedule cover, Article 31.6 comparative pricing, and the Service addendum do not cap any claim at a published cash or other public benchmark. Nothing requires a claim by claim cheapest lawful option test.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Articles 3 through 5, the Business Associate Agreement, and the Service addendum have no cash price, usual and customary, deductible credit, or accumulator language. The Medicare Prescription Payment Plan addendum spreads Part D cost share over monthly invoices. It does not stop a member from paying more than the pharmacy cash price or make a cash purchase count toward the deductible.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MAC","verdict":"partial","confidence":0.9,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"MAC lists are acknowledged and cannot be changed in a way expected to drive retailers out of the network. There is no single MAC list for both plan cost and pharmacy pay, no disclosure schedule, and no pharmacy appeals path with timelines. Ordinary course updates can still move prices without a signed amendment.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPRD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Article 4 says Express Scripts pays claims and then seeks reimbursement from ERS, and that extra fees must sit in the administrative fee if they exist. Nowhere in Articles 4 or 15, the Exhibit D cover, or the Service addendum does the text say the plan pays exactly what the pharmacy is paid plus a disclosed fee. Spread is simply not addressed in the produced text.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"The Rebate definition on pages 5 to 6 covers manufacturer contract payments tied to Formulary use, not purchase discounts or supplier payments received by a related purchasing entity. Exhibit G insurance pages list MATRIX GPO, LLC among named insureds, but there is no pass-through of GPO or aggregator revenue and no allocation method.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 5","evidence_quote":"the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"ERS must approve formulary changes, and material plan design changes also need written ERS approval. The formulary is still described as the PBM's list, and manufacturer rebate arrangements are an express reason to change it. There is no lowest net cost analysis and no quarterly utilization management report by drug.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Formulary language on pages 4 to 5 requires ERS approval and even lists manufacturer rebate arrangements as a modification factor. Articles 4, 5, and 31 never impose a lowest net cost standard for this plan, never require an annual book of business comparison, and never require disclosure when a drug is placed above a cheaper equivalent.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NET","verdict":"partial","confidence":0.85,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"The contract defines a Network and lets ERS ask for an alternate retail network. Participating pharmacies are called independent contractors. There is no ban on steering to mail or specialty affiliates, no any willing pharmacy rule, no bar on volume conditioned reimbursement, and no statement that claims are final when adjudicated.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MFN","verdict":"partial","confidence":0.92,"page_ref":"Page 29","evidence_quote":"PBM shall determine whether the pricing terms offered under the Comparative Agreement are more generous in the aggregate than the pricing terms provided to ERS in this Contract","rationale":"If Express Scripts gives more generous aggregate pricing to a similar or smaller government or unaffiliated commercial customer, ERS may take equivalent terms. That is a most favored pricing clause, but it is not automatic, Express Scripts itself measures the comparison, and there is no annual market check with a meet, credit, or release remedy.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 18","evidence_quote":"ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"ERS may audit with its own representatives, may reach manufacturer contracts, and Texas Insurance Code 1551.067 gives an independent auditor access to facilities, records, and subcontractor agreements. Rebate audits can be narrowed to portions of confidential manufacturer agreements and require an NDA. Page 16 also lets Express Scripts withhold Third-Party IP that a supplier contract forbids sharing, so data is not fully un-withholdable as proprietary.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DATA","verdict":"partial","confidence":0.88,"page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program (the ³GBP´) as applicable","rationale":"Confidential information, including claims and membership records, is ERS and GBP property, Work Product is owned by ERS, and records must be delivered on termination in a usable format. The Business Associate Agreement still lets Express Scripts de-identify PHI and keep it indefinitely, and the data security exhibit treats further processing for historical, statistical or other business purposes as compatible. That is not sole ownership with a ban on reuse.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PERF","verdict":"unclear","confidence":0.9,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Article 5.5 on page 7 puts performance guarantees in Exhibit E. Amendment 2 replaces Exhibit E with a First Amended and Restated Performance Guarantees document, then Amendment 2 page 4 is fully redacted. The produced text does not show whether guarantees are measured quarterly on plan data, paid in cash, or capped as credits, so PERF cannot be scored from what is readable.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"ENF","verdict":"partial","confidence":0.88,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract","rationale":"Missed performance can draw liquidated damages after notice, and ERS may terminate for cause immediately in its sole opinion. Those are real remedies, but they are not self executing without ERS choosing to invoke them, and there is no two strikes exit for a second material breach or regulatory integrity failure. The detailed performance guarantee credits themselves are in the redacted Exhibit E replacement.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.86,"page_ref":"Service addendum, page 2","evidence_quote":"ESI shall provide ERS with a minimum of thirty (30) calendar days written notice prior to effecting any material modifications or changes to the pricing structure of the M3P program.","rationale":"Article 2.6 says the main contract may be amended only by written agreement of authorized representatives. The Service addendum still lets Express Scripts change M3P pricing structure on 30 days notice, and Article 4.1(d) lets MAC prices move in the ordinary course without a signed amendment. That is weaker than a rule that economic terms cannot change by notice or updated lists.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"TERM","verdict":"good","confidence":0.93,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"ERS may walk away without cause on 90 days written notice, may terminate for cause immediately, and may terminate if the Board does not approve funds. Prepaid fees must be refunded within two business days after a termination under section 2.5. No termination penalty or forfeiture of earned amounts appears in the produced text.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPEC","verdict":"partial","confidence":0.88,"page_ref":"Page 4","evidence_quote":"PBM Specialty Pharmacy´ means Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc., or another pharmacy or home health agency owned or operated by PBM or its affiliates that primarily dispenses Specialty Products.","rationale":"Owned specialty pharmacies are named, so the contract knows specialty is a distinct channel. Specialty Products is not defined by clinical or economic function, there is no drug level rate ceiling in every channel, and affiliate specialty claims are not priced at acquisition cost. Those controls, if they exist, would have to live in Exhibit D, which is not in this file.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GAG","verdict":"partial","confidence":0.85,"page_ref":"Page 15","evidence_quote":"If ERS receives a PIA request for information labeled as confidential and/or proprietary, ERS will notify PBM in accordance with the PIA of the PBM¶s right to submit written comments to the Office of the Attorney General as to why the information should not be released.","rationale":"ERS is subject to the Public Information Act, and advisors and auditors may see materials under a non-disclosure agreement. Express Scripts may still stamp materials confidential or proprietary and ask the Attorney General to block release, and the Service addendum is labeled Confidential Information. Nothing in the produced text stops pharmacies from telling patients about cheaper options. Supplement 1 is CAA gag clause attestation support, not a gag on ERS.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish any fiduciary duty or duty of loyalty. In Section 3.8 on page 4, the contract explicitly states that IPM operates as an independent contractor and has no final discretionary authority or responsibility for the administration of the plans.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The document does not require IPM to disclose all compensation, conflicts of interest, affiliate ownership, or broker payments. There is no requirement for quarterly or annual officer certifications regarding financial disclosures.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no signed exhibit or any other provision listing the PBM's owners, parents, subsidiaries, affiliates, or associated pharmacies. The contract does not mandate that the PBM refresh such an exhibit upon any change in ownership or control.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"bad","confidence":0.8,"page_ref":"Page 1","evidence_quote":"\"Generic Drug\" will mean a multisource generic drug as determined by IPM using a combination of data fields .","rationale":"Definitions for key terms like Generic Drug and Brand Name Drug are not based on objective economic functions. Instead, the contract allows IPM to determine these classifications in its sole discretion or using its own combination of data fields, which permits the PBM to relabel drugs to its advantage.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not require the pass-through of manufacturer revenue. In fact, rebates and manufacturer payments are not substantively addressed anywhere in the claims pricing terms or Exhibit A.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no requirement to price claims dispensed by PBM-owned or affiliated pharmacies at net acquisition cost. The contract does not address affiliate pharmacy pricing at all.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a published benchmark ceiling or require that plan claim costs never exceed the cheapest lawful cash price.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There are no cash price protections for members. The text does not guarantee that a member will pay the lesser of their copay or the cash price, nor does it mandate that cash purchases count toward the deductible.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Although Generic MAC is mentioned in the Exhibit A fee schedule, there are no governance provisions dictating a single MAC list, update schedules, or appeals processes for pharmacies.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not contain any language prohibiting spread pricing. Exhibit A sets the rates the plan pays to the PBM but does not stipulate that these rates must exactly match the reimbursement paid to pharmacies.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Group purchasing organizations and related entity purchasing agreements are not mentioned. There is no provision requiring GPO pass-through of discounts or supplier payments to the plan.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract lacks any language giving the plan sponsor control over formulary decisions, nor does it require the PBM to provide lowest-net-cost analysis or utilization management outcomes.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no lowest net cost standard for formulary design in this agreement, nor is there any requirement for an annual book of business comparison.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include pharmacy network protections. There are no clauses prohibiting retroactive clawbacks, preventing volume-conditioned reimbursement, or guaranteeing an any willing pharmacy policy.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not provide the plan with most favored pricing rights, and there are no provisions allowing for an annual market check.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The main agreement lacks any audit rights allowing the plan to inspect financial or claims-level data. The only audit provision is located in the Business Associate Agreement (Exhibit B) and is strictly limited to verifying HIPAA compliance.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"Instead of affirming that the plan sponsor solely owns all plan data, the contract explicitly grants the PBM the right to reproduce and adapt covered person information for its own product research and development. Additionally, Section 6.5 designates the databases containing this information as the PBM's copyrighted property.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no performance guarantees or service level agreements (SLAs) with measurable financial remedies outlined anywhere in the contract or exhibits.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not feature self-executing enforcement mechanisms, liquidated damages, or a two-strikes exit policy for repeat material breaches.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"bad","confidence":0.9,"page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"While the general amendments clause requires mutual written consent, Section 5.3 creates a major loophole by allowing the PBM to unilaterally change fees and pricing after the initial term merely by providing advance documentation.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"The contract allows either party to terminate with ninety days notice, but restricts this termination to only take effect at the end of the current one-year term. This effectively prevents the plan from terminating for convenience without penalty at any point during the year.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There are no specific pricing controls, transparent definitions, or acquisition cost requirements outlined for specialty drugs.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits","rationale":"The confidentiality provision explicitly defines pricing information and the agreement's exhibits as confidential. This restricts the government entity's ability to freely share pricing and contract terms with auditors, lawmakers, or the public.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"FID","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The definitions on pages 1 to 2, IPM duties on pages 2 to 3, Client duties including section 3.8 on page 4, the independent contractor clause in section 16 on page 9, and the ERISA sentence in section 19.1 on page 9 do not impose any duty of loyalty or care on IPM. Section 3.8 says IPM is an independent contractor with no final discretionary authority over the Plans, which is not a loyalty duty to the County or members. There is no conflict disclosure and no disgorgement remedy of the kind in the model contract published by Mark Cuban and collaborators.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"DISC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Compensation is limited to the fees in Exhibit A on page 11 and the billing article on pages 4 to 5. Nothing requires IPM to disclose affiliate ownership, related-entity compensation, or payments to consultants or brokers. There is no named officer certification quarterly or annually. Section 3.7 on pages 3 to 4 tells the County to disclose copays and rebates to members, which is not PBM compensation disclosure.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"No ownership exhibit appears in the 17-page file. Affiliates are mentioned only in the indemnity cooperation language on page 8. Section 20 on page 10 lets IPM assign the agreement to a wholly owned subsidiary without consent, but it does not list owners, parents, GPOs, mail order pharmacies, or specialty pharmacies, and it does not require a refresh within 30 days of a change in control.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 1","evidence_quote":"\"Brand Name Drug\" will mean a prescription drug specified as a single-source drug or multi-source brand name drug as determined by IPM.","rationale":"Pages 1 to 2 define Administrative Fee, AWP, Brand, Generic, Claims, Network, and PHI, so there is a definitions article. Brand and Generic are whatever IPM determines, and IPM picks the AWP source in its sole discretion. There is no definition of rebate, manufacturer revenue, affiliate, or specialty, so value can still be relabeled. That is weaker than the closed, function-based definitions in the model contract published by Mark Cuban and collaborators.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"PASS","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The word rebate appears in section 3.7 on page 4, where the County must disclose rebates or other discounts to members, and in section 24 on page 10, where taxes on rebate amounts are the County's cost. Neither clause requires 100 percent of manufacturer revenue to be paid to the plan. There is no rebate definition, no quarterly remittance, and no closed list of excludable claims.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"NAC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The recitals on page 1 mention a network of retail and mail order pharmacies. Exhibit A on page 11 prices only retail pharmacy claims at AWP discounts plus dispensing fees. Nothing prices PBM-owned or economically related pharmacies at net acquisition cost, and there is no documentation default if acquisition records are not produced.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 sets AWP discounts for retail brand and generic claims. Sections 5.1 to 5.8 on pages 4 to 5 describe invoicing and pharmacy payment. No clause caps any claim at a published cash or benchmark price, and there is no claim-by-claim test against the cheapest lawful option.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 uses U&C as one generic pricing option for what the County pays, not as a member cash-price cap. Section 5.7 on page 5 bars IPM and network pharmacies from balance billing members except for copays, deductibles, and non-covered services. Nothing says a member never pays more than the pharmacy cash price, nothing credits cash purchases to a deductible, and nothing addresses accumulator adjustment.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"MAC","verdict":"partial","confidence":0.86,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"Exhibit A prices generics at AWP less 80 percent, U&C or Generic MAC plus a $2.50 dispensing fee, so a MAC list is part of what the County pays. The contract never says one MAC list applies to both plan payment and pharmacy payment, never requires disclosure or a refresh schedule, and never gives pharmacies an appeals path with timelines. That is MAC as a pricing label without the governance the model requires.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.88,"page_ref":"Page 5","evidence_quote":"Furthermore, if in accordance with IPM's agreement with a Network Pharmacy there was an underpayment for Covered Pharmacy Services to a Covered Person, such etwork Pharmacy may seek reimbursement for such underpayment(s) .","rationale":"The County is billed at the AWP rates in Exhibit A on page 11, while IPM pays pharmacies under separate network agreements described in sections 5.2 and 5.8. Section 5.8 lets a pharmacy seek more money if IPM underpaid it relative to the pharmacy contract, and the County must remit that difference. Nothing requires the County to pay exactly what the pharmacy was paid plus a disclosed administrative fee, so IPM may keep a spread.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"No GPO, group purchasing organization, volume credit, or supplier-payment pass-through appears in the definitions on pages 1 to 2, the compensation article on pages 4 to 5, Exhibit A on page 11, or the remainder of the 17-page file.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.84,"page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans. Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client.","rationale":"Section 3.8 says the County has sole authority to control and administer its Plans and that IPM has no final discretionary authority over plan terms. Sections 3.1 and 3.2 on page 3 make the County furnish the benefit design that IPM uses to adjudicate claims. The word formulary never appears, and IPM need not deliver lowest-net-cost analysis or quarterly utilization management outcomes by drug.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Benefit design language on pages 3 to 4, reporting in section 2.7 on page 3, and Exhibit A on page 11 contain no lowest net cost standard for this plan, no annual comparison against IPM's book of business, and no duty to disclose when a drug is placed above a cheaper equivalent.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.91,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"Section 2.3 lets IPM add or drop network pharmacies in its sole discretion and makes no warranty that any specific pharmacy will remain. There is no any-willing-pharmacy right, no ban on steering claims into mail order or other IPM channels, and no rule that claims are final when adjudicated. Section 5.8 on page 5 even lets pharmacies reopen payment after the fact.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Pricing lives in Exhibit A on page 11 and in section 5.3 on page 4, which lets IPM change fees after the first year. Nothing grants the County pricing at least as good as any comparable client, and nothing creates an annual market check with a meet, credit, or release remedy.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 3","evidence_quote":"IPM wi ll provide Client records and reports, including standard !PM reports as amended from time to time, relating to Covered Persons. Client may request additional reports, which may be provided upon the mutual written agreement of the parties .","rationale":"Section 2.7 gives the County standard IPM reports as amended from time to time, and extra reports only by mutual written agreement. Section 3.6 on page 3 deems reports accurate if the County does not object within 45 days. Exhibit B section 7 on page 16 allows an audit after 10 business days, but only to verify HIPAA compliance, not claims-level financial data. There is no pre-adjudication feed and no rule that data cannot be withheld as proprietary.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"DATA","verdict":"bad","confidence":0.93,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development, except that each party and its agents, employees and contractors shall maintain the confidentiality of this information to the extent required by applicable Law","rationale":"Section 7.1 lets IPM use, reproduce, or adapt member information in any manner it deems appropriate, including product research and development. Section 6.5 on the same page says IPM owns the databases and the format of reports. Section 7.2 lets IPM de-identify PHI and use that information as it deems appropriate. The County is not the sole owner, and IPM may reuse plan data.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"PERF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"No performance guarantees, quarterly measurement on plan-specific data, cash reconciliation, or dollar-for-dollar shortfall payments appear in the services article on pages 2 to 3, Exhibit A on page 11, or the liability and termination sections on pages 4 and 7.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Section 4 on page 4 allows termination for an uncured material breach, but if the breach cannot be cured in 30 days the non-breaching party may not terminate if the other party has started a cure. Section 9.6 on page 7 caps IPM's liability at the Administrative Fee paid over the previous six months and bars consequential damages. There are no automatic credits, liquidated damages, or a two-strikes exit after a repeat failure.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.9,"page_ref":"Page 9","evidence_quote":"Except as otherwise set forth herein, this Agreement may be amended , modified , or supplemented on ly by mutual consent set forth in writing duly signed by the parties hereto .","rationale":"Section 18 requires mutual consent in a writing signed by both parties, except as otherwise set forth. Section 5.3 on page 4 lets IPM change fees and other pricing after the initial term by notice timed to the County budget cycle. Section 2.1 on page 2 lets IPM change services that do not materially alter the agreement. That is weaker than a hard ban on unilateral economic changes.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"TERM","verdict":"partial","confidence":0.92,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"Either party may give 90 days written notice, but termination is effective only at the end of the then expiring term, and the deal renews automatically for one-year periods. There is no mid-term termination for convenience and no regulatory integrity exit. No termination penalty or forfeiture of earned amounts is stated, and section 27 on page 12 adds a fiscal funding limit.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"SPEC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 lists only retail pharmacy fees. The recitals on page 1 mention mail order pharmacies. Specialty is never defined, and there is no drug-level specialty ceiling or acquisition-cost rule for affiliate specialty pharmacies anywhere in the 17 pages.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.94,"page_ref":"Page 5","evidence_quote":"pricing information, the Agreement and all exhibits, addenda and alterations hereto, Network Pharmacy coverage information, trade secrets and innovations","rationale":"Confidential Information includes pricing information and the Agreement and all exhibits. Neither party may reveal it without prior written consent, which may be withheld for any reason. The only extra-contract disclosure path is a bona fide subpoena with notice so the other party can object. There is no Texas public information carve-out, so this would stop the County from sharing pricing terms with the public or lawmakers.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 11","evidence_quote":"Claim Administrator is not the plan administrator of Employer's employee benefit plan and is not a fiduciary of Employer, the plan administrator or of the Plan.","rationale":"The model term requires duties of loyalty and care owed solely to the plan and its members, full disclosure of direct and indirect compensation, and disgorgement of anything retained in breach. This draft does the opposite. Section 5.2 on page 11 states the Claim Administrator is not a fiduciary of the Employer, the plan administrator or the Plan, and section 5.3 on the same page frames it as a service provider only. Section 4.6 on page 9 disclaims any fiduciary obligation for benefit design directions, and Exhibit 6 item 15 on page 42 disclaims fiduciary status in recovery litigation. There is no loyalty duty, no duty of care, and no disgorgement remedy anywhere in the 55 pages. Combined with the express retention of rebates on page 28, the vendor is contractually free to put its own revenue first. This is the inverse of the model term.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 28","evidence_quote":"the maximum that a PBM has disclosed to Claim Administrator that the PBM will receive from any pharmaceutical manufacturer for manufacturer administrative fees is five and a half percent (5.5%) of the Wholesale Acquisition Cost","rationale":"The draft contains more disclosure than many PBM contracts: page 28 caps disclosed manufacturer administrative fees at five and a half percent of WAC with a duty to advise the Employer if that maximum changes, pages 27 and 28 describe Prime's per claim fees, the rebate flow, and the equity stake the Claim Administrator holds in Prime, page 12 requires a once per year list of owned providers on request, and page 36 discloses that Host Blues may retain payments and allowances. But the model term requires disclosure of all direct and indirect compensation, affiliate ownership touching plan claims, and payments to consultants, certified by a named officer quarterly and annually. There is no certification mechanism anywhere, and the same disclosures that reveal the money also reserve the right to keep it. Disclosure without certification and paired with express retention is materially weaker than the model.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"OWN","verdict":"partial","confidence":0.75,"page_ref":"Page 12","evidence_quote":"Claim Administrator or its subsidiaries or affiliates may also have ownership interests in certain Providers who provide Covered Services to Covered Persons, and/or in vendors or other third parties","rationale":"The model term wants a signed exhibit listing every owner, parent, subsidiary, affiliate, group purchasing organization, rebate aggregator, mail order and specialty pharmacy tied to the PBM, refreshed within 30 days of any change. No such exhibit exists here. What exists instead is section 6.2 on page 12, which acknowledges the Claim Administrator or its affiliates may own stakes in providers and vendors and will furnish a list on request, but not more than once per calendar year, and pages 27, 28 and 43, which disclose the significant equity stake in Prime and that mail and specialty channels may be run by Prime affiliates or part-owned third parties. There is no signed ownership exhibit, no list of GPOs or rebate aggregators, and no refresh obligation on change of control. Some ownership information is reachable, but only on request and at most once a year, so this is present but materially weaker than the model.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 49","evidence_quote":"Rebates do not include Manufacturer Administration Fees or fees retained by a group purchasing organization for its role in securing Rebates and/or Manufacturer Administrative Fees","rationale":"The model term requires rebate, manufacturer revenue, affiliate, specialty, generic and pharmacy to be defined by economic function so value cannot be relabeled to escape pass-through. The main definitions section on pages 13 through 17 contains no definition of rebate or manufacturer revenue at all. The only rebate definition is in Exhibit 7 on page 49, and it is the loophole the model targets: manufacturer administrative fees and GPO-retained fees are expressly excluded from Rebates, so the two largest alternative revenue streams escape any pass-through or guarantee tied to that term. Brand and generic are defined by Medi-Span codes on pages 47 and 48, meaning a reclassification by the pricing source changes the economics, and specialty is whatever list Prime or the Claim Administrator maintains. The definitions here do not close loopholes; they create them.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 28","evidence_quote":"it and its Plan have no right to, or legal interest in, any portion of the rebates, payments, discounts and/or other allowances provided by the PBM or such manufacturers to Claim Administrator","rationale":"The model term requires 100 percent of manufacturer revenue of every kind paid to the plan quarterly, with only a closed list of exclusions. This draft does the opposite at every layer. On page 28 the Employer acknowledges it negotiated only a specific Rebate Credit, paid from the Claim Administrator's own assets regardless of actual rebate collections, and consents to retention of everything else. On the same page the PBM keeps interest and late fees earned on rebates, and GPO fees are netted out before money reaches the Claim Administrator. On page 27, Prime keeps a portion of mail and specialty discounts, and page 44 confirms the Employer has no right, title or interest in manufacturer administrative fees. Even the retail pass-through that does exist on page 27 runs only from Prime to the Claim Administrator, not to the plan. Nothing close to full pass-through exists.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"NAC","verdict":"bad","confidence":0.85,"page_ref":"Page 27","evidence_quote":"Prime may keep as its fee a portion of the discounts and/or other allowances that it has negotiated with the mail-order and/or specialty pharmacy","rationale":"The model term prices claims at PBM-owned or economically related pharmacies at net acquisition cost plus a stated dispensing fee with no retained margin. This draft permits retained margin in exactly those channels. Page 27 states Prime may keep a portion of the discounts and allowances it negotiates with the mail order and specialty pharmacy as its fee, page 28 says the mail order and specialty pharmacy may be operated through an affiliate of or entity partially owned by Prime, and page 46 confirms specialty drugs may be dispensed by Prime or a Prime affiliate at prices set in the omitted BPA Addendum. Because the Claim Administrator owns a significant portion of Prime's equity, margin retained by Prime is margin earned by an affiliate of the plan's own administrator. No acquisition cost pricing and no documentation default appear anywhere in the document.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"The model term caps plan claim cost at a published benchmark price in every channel, tested claim by claim. I looked through the Allowable Amount definitions on pages 13 through 15, the program pricing terms in Exhibit 7 on pages 45 through 47, and the Usual and Customary definition on page 49. The closest provision is on page 14: for non-network pharmacies the allowable amount is the lesser of the pharmacy's usual charge or the participating pharmacy amount minus twenty percent, but that is a benefit basis reduction for out of network claims, not a ceiling against a public cash price benchmark across all channels. The U&C definition on page 49 defines the cash price but is never used to cap what the plan or member pays. No claim level benchmark ceiling exists anywhere in the document, so this term is simply not addressed.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"The model term guarantees a member never pays more than the pharmacy cash price, credits cash purchases toward the deductible and out of pocket maximum, and bars accumulator adjustments absent written election. I looked at the Exhibit 7 pricing sections on pages 45 through 47, the copayment and deductible provisions on page 47, and the Usual and Customary definition on page 49. The only adjacent language is on page 46: the Employer is not charged when the member cost share covers 100 percent of the product, and zero balance logic is not employed, which protects the plan's invoice, not the member. There is no lesser of copay versus cash rule, no deductible credit for cash purchases, and no mention of accumulator adjustment programs anywhere in the 55 pages. The term is not addressed.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"MAC","verdict":"partial","confidence":0.8,"page_ref":"Page 44","evidence_quote":"Prime's MAC Lists applicable to this Exhibit will be available for viewing by authorized representatives of Employer after 30 days' prior written request submitted by Employer to Claim Administrator","rationale":"The model term wants a single MAC list governing both what the plan pays and what pharmacies are paid, disclosed, updated on a schedule, with a pharmacy appeals path. Exhibit 7 section 6(c) on page 44 does give the Employer access to Prime's MAC lists, but the access is nominal: 30 days advance written request, execution of Prime's non-disclosure agreements, no more than four requests per calendar year, and viewing only at Prime's headquarters or another secured location it designates. Definition 19 on page 48 says the list is maintained by Prime and updated from time to time, not on a disclosed schedule. Nothing states that the plan side and pharmacy side lists are the same, which leaves the classic two list spread mechanism open, and no pharmacy appeal process with timelines appears anywhere. A disclosed but caged list with no appeals and no single list rule is materially weaker than the model.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"SPRD","verdict":"bad","confidence":0.85,"page_ref":"Page 44","evidence_quote":"Claim Administrator and/or Prime will keep all or a portion of the discounts and/or other allowances that Claims Administrator or its pharmacy benefits manager has negotiated with the Network Participant","rationale":"The model term requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee, with no retained difference in any channel. The draft permits spread. Page 44 has the Employer acknowledging that the Claim Administrator or Prime will keep all or a portion of the network discounts and allowances. Page 27 requires pass-through of pharmacy negotiated discounts from Prime to the Claim Administrator for retail, but expressly excepts mail and specialty, and the pass-through stops at the Claim Administrator rather than the plan. Page 28 states none of Prime's per claim administrative fees accrue to the Employer's benefit, and page 36 lets Host Blues use estimated or average pricing that can differ from what the provider is actually paid. The document does not eliminate spread pricing; it reserves the right to retain it, subject only to whatever the omitted BPA Addendum says.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 28","evidence_quote":"rebates collected by PBM and paid to Claim Administrator will be net of any fee the group purchasing organization may retain for its role in securing rebates","rationale":"The model term requires purchase discounts, volume credits and supplier payments received by the PBM or any related purchasing entity, including offshore GPOs, to flow to the plan on disclosed allocation drivers. This draft builds the opposite into both the operative text and the definitions. Page 28 provides that when Prime contracts through a group purchasing organization, rebates are paid to the Claim Administrator net of whatever fee the GPO retains, with no cap and no disclosure of the amount. Page 44 states Prime may retain manufacturer administrative fees or pass them along in whole or in part at its discretion, and the definition of Rebates on page 49 expressly excludes fees retained by a group purchasing organization. GPO revenue is therefore carved out of pass-through by design rather than routed to the plan.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.7,"page_ref":"Page 43","evidence_quote":"promote the dispensing of pharmaceuticals in a manner consistent with the designated Drug List selected by Employer","rationale":"The model term gives the plan sponsor approval of the formulary and every change, plus lowest net cost analysis and quarterly utilization management outcomes by drug. What the draft offers is a selection right, not control. Page 43 says the Claim Administrator uses its own Drug List, with Prime supporting development, maintenance and updating and performing exception reviews under its agreement with the Claim Administrator; the Employer merely selects a designated Drug List, presumably from options the vendor offers. Nothing requires the Employer to approve subsequent changes, nothing requires lowest net cost analysis, and no quarterly utilization management outcome reporting to the Employer appears. Definition 13 on page 48 describes the Drug List as an informational list about tier status. The Employer picks a menu from the vendor's kitchen. That is present but materially weaker than sponsor control of the formulary.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The model term requires formulary decisions to meet a lowest net cost standard for this specific plan, an annual comparison against the vendor's whole book of business, and disclosure with reasons when a drug is placed above a cheaper equivalent. I looked at Exhibit 7 sections 3 and 4 on pages 43 and 44 covering Drug List services and rebate management, the Drug List definition on page 48, and the pricing terms on pages 45 and 46. Page 43 mentions only that the Claim Administrator may promote dispensing consistent with the selected Drug List, and page 44 acknowledges rebate arrangements are based on formulary status and market share, which points toward rebate driven placement rather than net cost. No lowest net cost standard, no book of business comparison, and no placement disclosure appears anywhere in the document.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.8,"page_ref":"Page 46","evidence_quote":"Specialty Drugs may be provided by Prime, an affiliate of Prime, or other Specialty Pharmacy that has a written arrangement with Prime or Claim Administrator","rationale":"The model term requires finality of adjudicated claims, no volume conditioned reimbursement, no steering into the vendor's own pharmacies, and any willing pharmacy participation. None of these protections appear, and the structure runs the other way. Page 46 permits specialty drugs to flow through Prime or a Prime affiliate, page 27 lets Prime keep margin on mail and specialty channels, and page 28 confirms those channels may be affiliate operated, which is the economics of steering rather than a ban on it. The pharmacy network is built and maintained by Prime under its contract with the Claim Administrator on page 44, with no any willing pharmacy clause, and section 6(f) authorizes pharmacy claims audits while pages 8 and 9 authorize post payment recovery processes against providers. The draft leaves the network and channel routing entirely in the vendor's hands.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The model term gives the plan pricing at least as good as any comparable client plus an annual market check with a meet, credit or release remedy. I searched the compensation provisions in Exhibit 2 on pages 21 through 24, the fee change provisions on pages 22 and 40, the AWP benchmark provisions on page 45, and the termination provisions on pages 11, 24, 25 and 46. What exists instead are repricing triggers running in the vendor's favor: section 3.3 of Exhibit 2 on page 22 lets the Claim Administrator change service charges on enrollment variance, benefit changes, or government cost increases, and page 40 lets Inter-Plan fees change on notice with deemed approval. No most favored client clause and no market check mechanism appears anywhere in the 55 pages, so this term is not addressed.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 5","evidence_quote":"Audit samples will be limited to no more than three hundred (300) Claims","rationale":"The model term gives the plan audits with its own auditor, full claims level and financial data delivered on a schedule without asking, pre-adjudication access, and nothing withheld as proprietary. Audit rights exist here but are heavily fenced. Section 2.10 on pages 5 and 6 requires 90 days notice, Claim Administrator approval of the Employer's auditor, samples capped at 300 claims, no extrapolation from samples, at most one audit per 12 months, only the current and prior agreement year, Employer paid costs, and a signed audit agreement indemnifying the Claim Administrator. Exhibit 7 section 6(g) on pages 44 and 45 routes any audit of Prime through the Claim Administrator, requires Prime's audit agreement, and bars copying or removal of materials without approval. Standard reports are available at no charge on page 19. The rights are real but materially weaker than the model.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"DATA","verdict":"bad","confidence":0.85,"page_ref":"Page 7","evidence_quote":"provide to Employer, a copy of all Claim determination records, excluding any and all of the Business Confidential Information of Claim Administrator","rationale":"The model term makes the plan sponsor sole owner of claims, eligibility, accumulator, rebate and derived data, delivered in machine readable form on request, with no vendor reuse or resale. Nothing in this draft assigns data ownership to the Employer. Section 3.7 on page 7 lets the Employer request copies of claim determination records for three years after termination, at the Employer's cost, excluding all Business Confidential Information, and retention is subject to the Claim Administrator's own changeable records policy. Section 3.8 permits the Claim Administrator to use and disclose de-identified data for industry improvement activities. Section 3.3 treats data flowing to the Employer's own vendors as the Claim Administrator's confidential information, gated by its sole discretion and its own data exchange agreement. Data here belongs to the administrator in practice, with the plan buying back access. That contradicts the model term.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.7,"page_ref":"Page 46","evidence_quote":"applicable network discount and/or minimum Rebate guarantees set forth in the BPA Addendum will not be effective for such Guarantee Period","rationale":"Performance guarantees clearly exist in this contract but their substance lives in an attachment that was not posted. Exhibit 7 is titled a guaranteed traditional aggregate pricing arrangement on page 43, page 46 references network discount and minimum rebate guarantees set forth in the BPA Addendum and Guarantee Periods, and page 27 notes that a portion of Prime's PBM fees are tied to performance standards including claims processing and customer service. What cannot be seen is everything that matters for the model term: the guarantee values, whether measurement is quarterly on plan specific data, and whether shortfalls are reconciled in cash or as capped credits. One visible warning sign is that the guarantees lapse entirely if the Employer terminates before the end of a Guarantee Period. Because the operative terms sit in the omitted PBM Fee Schedule Addendum, this item is unclear rather than missing.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"ENF","verdict":"bad","confidence":0.85,"page_ref":"Page 11","evidence_quote":"This provision precludes Employer from filing an action at law or in equity and from having any dispute covered by this Agreement heard by a judge or jury","rationale":"The model term makes remedies self executing: liquidated damages or automatic credits on missed guarantees and late reports, plus a penalty free exit after a second material breach. This draft moves enforcement in the opposite direction. There are no liquidated damages or automatic credits anywhere. Instead, section 4.9 on page 10 imposes a 90 day notice and cure window before any action, section 4.11 on pages 10 and 11 forces confidential binding AAA arbitration in Dallas and bars any judge or jury, section 4.10 caps the Claim Administrator's liability at the benefits that should have been paid, and a three year limitations period applies. The only breach exit is the generic termination for material breach after cure under section 6.1(c) on page 11. Meanwhile the Employer owes a 12 percent per annum late charge on page 24. Enforcement is slow, capped and secret for the plan, and automatic against it.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"AMD","verdict":"bad","confidence":0.8,"page_ref":"Page 12","evidence_quote":"any amendments required by law, regulation or order (\"Law\") or by Claim Administrator or the Association may be implemented by Claim Administrator upon sixty (60) calendar days' prior notice","rationale":"The model term requires every amendment to be signed by both parties, with no changes by notice, portal update or revised exhibit. The baseline in section 6.4 on page 12 does say the agreement may be amended only by mutual written agreement, but the very next sentence guts it: amendments required by law or by the Claim Administrator or the Association may be implemented unilaterally on 60 days notice, with objection routed only to negotiation and dispute resolution. Section 3.3 of Exhibit 2 on page 22 lets the Claim Administrator change service charges on stated triggers. Page 40 lets Inter-Plan fees change on 30 days notice with the Employer deemed to approve if it does not terminate. Page 45 converts AWP pricing to a new benchmark automatically if Medi-Span changes. Economic terms can in practice be rewritten by notice, so the draft permits the harm.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"TERM","verdict":"bad","confidence":0.8,"page_ref":"Page 22","evidence_quote":"Employer will Timely pay Claim Administrator the Termination Administrative Charge indicated in the Fee Schedule specifications of the most current ASO BPA","rationale":"The model term allows termination for convenience on reasonable notice without penalty, with earned amounts never forfeited. This draft attaches a price to exit at every step. Convenience termination is only available at the end of a month after the Fee Schedule Period ends, on 90 days notice, per section 6.1(a) on page 11. On termination the Employer owes a Termination Administrative Charge plus run off charges per pages 22 and 24 and 25, and even a partial termination of covered employees triggers the charge. Rebate Credits stop on termination per pages 28 and 47. Most pointedly, Exhibit 7 section 9(f) on page 46 voids the network discount and minimum rebate guarantees for the Guarantee Period if the Employer exits early, which forfeits earned value. Regulatory integrity events get no special exit right. Termination here is penalized, not free.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"SPEC","verdict":"bad","confidence":0.8,"page_ref":"Page 49","evidence_quote":"The list of Specialty Drugs is determined by Prime or Claim Administrator and subject to change","rationale":"The model term defines specialty by function, makes drug level rates a ceiling in every channel, and prices specialty claims at affiliate pharmacies at acquisition cost. This draft does none of that. Definition 33 on page 49 defines specialty drugs descriptively and leaves the list to Prime or the Claim Administrator, subject to change without Employer approval, so the vendor decides which drugs fall into the most expensive category. Page 46 says specialty pricing is set separately in the BPA Addendum rather than capped against retail or mail, specialty drugs may be dispensed by Prime or a Prime affiliate, and page 27 lets Prime keep a portion of specialty pharmacy discounts as its fee. Given that the Claim Administrator holds equity in Prime, the channel where most spend concentrates is priced by an affiliate with retained margin. The draft permits the harm the model term prevents.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 7","evidence_quote":"Employer shall not use or disclose such Business Confidential Information, including this Agreement, to any third party without prior written consent of Claim Administrator","rationale":"Section 3.4 on page 7 treats the entire agreement, including its cost and pricing information as defined on page 15, as Business Confidential Information the Employer may not disclose to any third party without the Claim Administrator's prior written consent, and it requires the Employer to give advance notice of any legally compelled disclosure so the vendor can object and seek protections. Per the briefing, a carve out that merely lets the vendor try to block a public records release does not cure the clause, and for a Texas municipality subject to public records law this is exactly that situation. The footer on every page brands the document proprietary and confidential. Audit confidentiality agreements on page 6 and vendor data gating in section 3.3 extend the same secrecy to the Employer's own advisors. This is a gag on pricing and performance information, which is the red flag the rubric measures.","model_own_total":12.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.85,"page_ref":"Page 4","evidence_quote":"Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client","rationale":"The model contract published by Mark Cuban and collaborators makes the PBM owe duties of loyalty and care to the plan and its members. This agreement does the opposite: it frames IPM as an arm's length independent contractor, states that IPM has no discretionary authority or responsibility for plan administration, and nowhere imposes any duty of loyalty, care, or disclosure of conflicts. IPM also disclaims liability for its drug utilization review and network pharmacy decisions. There is no fiduciary obligation of any kind in the text.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The compensation article (Section 5, pages 4 and 5) covers only the fees in Exhibit A and invoicing mechanics. Nothing requires IPM to disclose its full compensation, revenue from manufacturers or pharmacies, affiliate interests, or payments to brokers and consultants, and there is no officer certification of disclosure anywhere in the agreement or its exhibits. The only compensation visible is the Exhibit A fee schedule on page 11.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or clause lists IPM's owners, parents, subsidiaries, affiliates, group purchasing organizations, or owned pharmacies. The only exhibits are Exhibit A (fees, page 11) and Exhibit B (a HIPAA business associate agreement, pages 13 to 17). Section 20 on assignment (page 10) even contemplates affiliates and subsidiaries of IPM without ever identifying them, and there is no duty to refresh ownership information.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.88,"page_ref":"Page 1","evidence_quote":"\"Average Wholesale Price\" or \"A WP\" will mean the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"The definitions article (Section 1, pages 1 and 2) is short and vendor controlled. IPM picks the AWP pricing source in its sole discretion and decides unilaterally what counts as a brand or generic drug. There are no definitions of rebate, manufacturer revenue, affiliate, specialty drug, or MAC at all, so there is nothing to stop value from being relabeled or moved outside the county's view. The model contract from Mark Cuban and collaborators defines these terms by economic function precisely to close those loopholes.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The word rebate appears only twice in the entire document: Section 3.7 (page 3) requires the county to disclose rebates or other discounts to members as required by law, and Section 24 (page 10) makes the county responsible for taxes on the payment of rebate amounts. Neither clause passes any manufacturer revenue to the county. There is no rebate definition, no pass through percentage, no payment schedule, and no exclusion list, so the largest dollar item in most PBM contracts is simply not addressed.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the agreement acknowledges that IPM may own or be economically related to any pharmacy, and there is no acquisition cost pricing for any channel. The recitals mention that IPM has a network of retail and mail order pharmacies, but Exhibit A prices only retail claims on an AWP discount basis, and mail order pricing does not appear anywhere. Because no affiliate pharmacy pricing rule exists, the model requirement of net acquisition cost plus a dispensing fee is absent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No clause caps plan claim cost at a published benchmark or a transparent cash price, in any channel or for any drug. Exhibit A (page 11) sets AWP discount rates, which the agreement itself concedes do not represent a true wholesale price, and nothing tests any claim against an external ceiling. I checked the compensation article and both exhibits and found no ceiling of any kind.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"There is no cash price protection for members, no rule that a member never pays more than the pharmacy's cash price, and no provision crediting cash purchases toward deductibles or out of pocket maximums. The words accumulator, cash price, and usual and customary protections do not appear; the only member payment terms are co-payments and deductibles as defined in Section 1 and the balance billing protection in Section 5.7. The model's cash price and accumulator provisions are entirely absent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"partial","confidence":0.6,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee","rationale":"Exhibit A applies a Generic MAC to generic pricing, so a MAC list exists and affects what the county pays. But the agreement says nothing about how that list is built, whether the same list governs what pharmacies are paid, whether it is disclosed to the county, how often it is updated, or whether pharmacies have any appeal path. The subject is touched by the pricing exhibit but none of the governance the model contract requires is present.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Nothing states that the county pays what the pharmacy is paid plus a disclosed fee, and nothing prohibits IPM from retaining a difference between the two. Section 5.2 (page 4) has IPM paying network pharmacies only out of funds received from the county and says those funds are not an asset of the county's plan, which leaves the actual pharmacy reimbursement invisible to the county. Exhibit A prices claims on AWP discounts rather than pharmacy cost, a structure in which spread can live, but the contract never addresses it, so the item is not addressed rather than contradicted in words.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The agreement never mentions a group purchasing organization, rebate aggregator, purchasing entity, or any purchase discounts or volume credits received by IPM or its affiliates. With no rebate pass through and no affiliate disclosure, there is no mechanism for GPO derived revenue to reach the county. I searched the full text for these terms and they do not appear.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The word formulary does not appear anywhere in the 17 pages. There is no formulary approval right for the county, no lowest net cost analysis, and no utilization management reporting by drug. The county's only levers are the benefit design it furnishes under Section 3.1 and prior authorization criteria referenced in Section 2.5, neither of which is formulary control.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"Because the agreement contains no formulary provisions at all, it also contains no lowest net cost standard, no annual comparison of this plan against IPM's book of business, and no disclosure when a drug is placed above a cheaper equivalent. I confirmed there is no formulary, net cost, or book of business language anywhere in the document.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.88,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time","rationale":"Network composition is entirely in IPM's sole discretion with no any willing pharmacy right, no anti steering provision, and no promise that claims are final once adjudicated. Worse, Section 5.8 (page 5) obligates the county to immediately remit money to IPM whenever a network pharmacy claims it was underpaid, which passes retroactive pharmacy payment risk to the county, and Section 10 (page 8) makes IPM the county's exclusive PBM. The model contract from Mark Cuban and collaborators requires the opposite protections, so this contradicts the model.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"There is no most favored pricing clause and no annual market check with a meet, credit or release remedy. Pricing is fixed by Exhibit A for the initial term and thereafter IPM may change fees and other pricing under Section 5.3, so drift out of market is governed entirely by the vendor. I found no most favored or market check language anywhere in the text.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.75,"page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement","rationale":"The only audit right in the document is in Exhibit B, the HIPAA business associate agreement, and it covers compliance with privacy and security obligations, not claims pricing, rebates, or fees. The main agreement gives the county only IPM's standard reports as amended from time to time (Section 2.7, page 3), with additional reports requiring mutual written agreement, and Section 3.6 deems reports accurate if not disputed within 45 days. There is no claims level data schedule, no pre adjudication access, and no financial audit right, so the county can see very little of what it needs to verify.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"bad","confidence":0.92,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"The county is never named the owner of its claims, eligibility, or rebate data. Instead Section 7.1 lets IPM use Covered Person information however it deems appropriate, including product research and development, and Section 6.5 (page 6) states that IPM's databases, adjudication logic, and the format of all reports are IPM's property. De identified information may also be used and disclosed by IPM as it deems appropriate under Section 7.2. This contradicts the model contract requirement that the plan sponsor own all plan data and control its reuse.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The agreement contains no performance guarantees of any kind: no pricing or rebate guarantees, no service level standards with remedies, and no quarterly reconciliation. Exhibit A lists rates but guarantees nothing, and Section 9.3 expressly disclaims warranties and even the accuracy of the prices and reports IPM produces. The word guarantee does not appear in the document.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"There are no liquidated damages, automatic credits, or self executing remedies for missed obligations, and no two strikes exit. Enforcement runs entirely through the termination clause (Section 4, page 4), which requires 30 day cure periods, and litigation under Section 14, while Section 9.6 (page 7) caps IPM's total liability at six months of administrative fees and bars claims asserted more than twelve months after the event. Nothing triggers a remedy without the county proving its case.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"partial","confidence":0.8,"page_ref":"Page 9","evidence_quote":"this Agreement may be amended , modified , or supplemented on ly by mutual consent set forth in writing duly signed by the parties hereto","rationale":"Section 18 matches the model by requiring written, mutually signed amendments. But the protection is carved out in practice: Section 5.3 (page 4) lets IPM change the fees or other pricing after the initial term by giving documentation ahead of the county budget cycle, and Exhibit B (page 17) adopts HIPAA driven amendments automatically without a signed amendment. Economic terms can therefore move without the county's signature, which is exactly the risk the model clause exists to prevent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof","rationale":"The county can terminate without penalty on 90 days notice, and there are no termination fees or forfeiture of earned amounts in the text. However the termination only takes effect at the end of the then current term, and the agreement auto renews for successive one year periods, so the practical exit window is narrow. The fiscal funding clause (Section 27, page 12) gives the county an additional out if budget approval fails. This is weaker than the model's clean convenience termination but not punitive.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The word specialty does not appear anywhere in the document. Exhibit A prices only retail brand and generic claims, and there is no specialty definition, no drug level rate ceiling, and no channel pricing for specialty. Given that specialty drugs drive the majority of spend in most plans, this is a significant gap for the county.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"Section 6 treats pricing information, the agreement itself, and all exhibits as confidential information that neither party may reveal without the other's prior written consent, with only a subpoena carve out that requires notice so the other party can object. There is no carve out for the Texas Public Information Act, for the county's advisors or auditors, or for disclosure to lawmakers, and Section 6.6 backs the restriction with injunctive relief. For a Texas county this would position the vendor to resist public release of what taxpayers pay, which is exactly the harm this red flag item tracks.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment mentions Aetna acts as a fiduciary for ERISA claim determinations, but does not address broad fiduciary duties of care or loyalty for PBM services.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not address the disclosure of compensation, conflicts of interest, or require officer certifications.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not include an exhibit listing the PBM's owners, affiliates, or related entities.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment relies on the missing Prescription Drug Services Schedule for defined terms like rebate and specialty.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 47","evidence_quote":"Rebates for Specialty Products that are administered and paid through the Plan Participant’s medical benefit rather than the Plan Participant’s pharmacy benefit will be retained by Aetna as compensation","rationale":"The contract explicitly permits Aetna to retain manufacturer payments for certain specialty products and value-based rebate contracting arrangements, allowing the exact harm the model clause exists to prevent.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment includes pricing schedules for retail and mail order but does not price affiliate pharmacy claims at net acquisition cost.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"partial","confidence":0.9,"page_ref":"Page 39","evidence_quote":"Cost Share will be calculated on the basis of the rates charged to the Customer by Aetna for Covered Services, except for fixed copays or where required by law to be otherwise.","rationale":"The amendment addresses pricing logic but lacks a comprehensive benchmark ceiling for plan costs. It only specifies that member cost shares are based on negotiated rates or fixed copays.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"partial","confidence":0.9,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy’s Usual and Customary Charge","rationale":"The amendment provides cash price protection for the member at the point of sale. However, the base agreement is missing, and the amendment is silent on whether these cash purchases count toward the member's deductible.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment states that MAC pricing applies at mail order but does not establish governance rules, disclosure requirements, or an appeals process for the MAC list.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference","rationale":"The amendment explicitly defines a Traditional or Lock-In pricing arrangement that allows spread pricing, permitting Aetna to charge the plan sponsor more than it pays the pharmacy and keep the difference.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not mention pass-through of discounts or payments received by group purchasing organizations.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"The amendment gives the sponsor the authority to accept or reject the formulary. However, it does not require lowest-net-cost analysis or utilization management outcomes.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not contain a lowest net cost standard for formulary decisions or require an annual book of business comparison.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not address pharmacy network protections, anti-steering provisions, or any willing pharmacy requirements.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms","rationale":"The amendment allows for an annual market check. However, if savings are found, the parties are only obligated to discuss revisions in good faith, lacking a mandatory meet, credit, or release remedy.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"partial","confidence":0.95,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"Audit rights are addressed but severely restricted. The plan is explicitly limited to one annual rebate audit and one claim audit, falling short of the unrestricted access in the model.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not state that the plan sponsor solely owns all claims, eligibility, and rebate data, nor does it address data portability.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not outline comprehensive performance guarantees with dollar-for-dollar cash remedies.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not provide self-executing enforcement mechanisms or a two-strikes termination right for material breaches.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"The contract allows Aetna to unilaterally amend the agreement with just 30 days written notice, avoiding the model requirement for mutual written consent.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"bad","confidence":0.95,"page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna’s arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an “Early Termination”) Aetna shall retain any earned but unpaid rebates","rationale":"Although termination for convenience is mentioned elsewhere, terminating early triggers a massive penalty requiring the sponsor to forfeit all earned but unpaid rebates, contradicting the model.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"partial","confidence":0.9,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The amendment sets specific AWP discounts for specialty drugs but mandates the use of CVS Specialty Pharmacies, failing to price affiliate pharmacy claims at acquisition cost.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"Aetna and Contract Holder shall not disclose or make use of any Confidential Information except as permitted under this Group Agreement without the prior written consent of the non-disclosing party","rationale":"The amendment defines Confidential Information to include pricing data and strictly prohibits the plan sponsor from disclosing it without Aetna's prior written consent, restricting data sharing.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.93,"page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA. Aetna has complete authority to determine whether and to what extent eligible individuals and beneficiaries are entitled to coverage and to construe any disputed or doubtful terms under this Group Agreement.","rationale":"The attached Medicare Group Agreement names Aetna a fiduciary only for ERISA claims review and gives it complete coverage authority unless it acts arbitrarily and capriciously. The same packet says the parties are independent contractors, not agents of one another. That is the opposite of the loyalty and care duty to the plan and members in the model contract published by Mark Cuban and collaborators. The 2023 base agreement is not in the file, so no broader PBM fiduciary clause appears here either.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"The Pharmacy Service and Fee Schedule does tell the county that manufacturer administrative fees, other manufacturer payments, and pharmacy network transmission fees are kept by Aetna or CVS Caremark, and the rate exhibit says broker commissions are excluded. That is some compensation disclosure. There is no named-officer quarterly or annual certification that every related-entity payment has been disclosed and remitted. The 2023 base agreement is not in the file, so a fuller disclosure exhibit may exist there and is not available to score.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"OWN","verdict":"partial","confidence":0.86,"page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"The amendment names SilverScript as a CVS affiliate, CVS as parent of Aetna and SilverScript, CaremarkPCS Health L.L.C. as the affiliated PBM, and CVS Specialty and CVS Caremark Mail as the mail and specialty channels. That is useful affiliate identification, not a signed ownership exhibit listing every owner, GPO, rebate aggregator, and related pharmacy with a 30-day refresh. The 2023 base agreement is not in the file, so no such exhibit appears here.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"DEF","verdict":"bad","confidence":0.94,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"Rebate is defined by label, not by economic function. Administrative fees, other manufacturer payments, and network transmission fees are carved out of Rebates and stay with Aetna. The pricing charts even say capitalized terms are not defined except in the Prescription Drug Services Schedule, which is not attached. That is the loophole the model contract published by Mark Cuban and collaborators exists to close.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates. These payments are generally for one of two purposes: (i) to compensate Aetna for bona fide services it performs, such as the analysis or provision of aggregated data or (ii) to reimburse Aetna for the cost of various educational and other related programs","rationale":"The fee schedule advertises the greater of 100 percent or a per-brand-script dollar floor, but that 100 percent applies only to Rebates as narrowly defined. Manufacturer administrative fees, other manufacturer payments, medical-benefit specialty rebates, and value-based contracting payments are kept by Aetna. Rebate collections are paid 180 days after quarter end, not within 30 days. That is not 100 percent of manufacturer revenue of every kind.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Mail and specialty claims are priced at AWP discounts, not at net acquisition cost plus a stated dispensing fee. Mail order is CVS Caremark Mail Service and specialty is exclusive CVS Specialty, both affiliates, under Traditional lock-in pricing that lets Aetna keep a spread. There is no documentation default if acquisition-cost records are not produced. The 2023 base agreement is not in the file and does not change what this fee schedule actually prices.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The Pharmacy Service and Fee Schedule on pages 36 to 44 and the Caremark Cost Saver note on page 57 never cap plan claim cost at a published cash benchmark checked claim by claim. Lesser-of usual and customary language on page 39 governs what the member pays at a network pharmacy, not what the county may be charged. The 2023 base agreement is not in the file, so no ceiling clause from that agreement can be scored.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"CASH","verdict":"partial","confidence":0.84,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall give the Plan Participant the benefit of the lesser of (i) the Participating Pharmacy’s Usual and Customary Charge, (ii) MAC (where applicable) or (iii) discounted AWP cost.","rationale":"At participating pharmacies the member is supposed to pay the lesser of cost share, usual and customary, MAC, or discounted AWP, which is some cash-price protection inside the network. The text does not credit an out-of-plan cash purchase toward the deductible or out-of-pocket maximum. PrudentRx copay optimization is included as a savings program and requires exclusive specialty and a true accumulation design, which is narrower than the model cash and accumulator rules.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.9,"page_ref":"Page 40","evidence_quote":"MAC: Certain dosage forms and strengths may not be included on the MAC list and shall be priced at the Specialty Product default rate.","rationale":"MAC is used at mail and for some specialty products, but the county is on Traditional lock-in pricing, so the amount charged to the plan can differ from the amount paid to the pharmacy. That is the two-list problem. There is no single disclosed MAC list that applies to both sides, no update schedule, and no pharmacy appeals path with timelines in this amendment. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"The fee schedule states that Discounts and Dispensing Fees reflect a Traditional or Lock-In pricing arrangement and then defines that arrangement as Aetna keeping the difference between what the county and members are charged and what the pharmacy is paid. That is spread pricing in every network channel covered by those discounts. The model contract published by Mark Cuban and collaborators requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"GPO","verdict":"bad","confidence":0.92,"page_ref":"Page 47","evidence_quote":"Customer further agrees that the amounts described above belong exclusively to Aetna or it’s affiliate, CVS Caremark, and Customer has no right to, or legal interest in, any portion of the aforesaid amounts received by Aetna or CVS Caremark.","rationale":"The fee schedule does not name a GPO, but it does say other payments from drug manufacturers and other organizations, manufacturer administrative fees, and pharmacy network transmission fees are not Rebates and belong exclusively to Aetna or CVS Caremark. Those are the supplier and purchasing-entity dollars the model would pass through. The 2023 base agreement is not in the file, so no GPO pass-through from that agreement can be scored.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.87,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"The county is said to have sole discretion to accept or reject the formulary Aetna offers. Rebate guarantees require the Aetna Standard Formulary and Advanced Control Specialty Formulary, and Aetna may propose modifications based on market conditions, clinical information, cost, and rebates. The SilverScript summary also says the formulary may change at any time. That is weaker than plan approval of every change with lowest-net-cost analysis.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Formulary management on page 46 lists cost and rebates among reasons Aetna may propose changes, and a paid custom-formulary option on page 53 includes net cost analysis as an extra $100,000 service. Neither clause sets a lowest net cost standard for this plan, requires an annual book-of-business comparison, or requires disclosure when a higher-net-cost drug is placed above a cheaper equivalent. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.96,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Specialty is exclusive to CVS Specialty with no retail fills, and Aetna is the exclusive specialty provider except for the HIV class. The P1 preferred network charges higher member cost share at standard pharmacies, and Maintenance Choice and CVS Caremark Mail are core services. That is steering into affiliated pharmacies, not any-willing-pharmacy at the plan's terms. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"There is an annual market check against similar employers, which is more than silence. The trigger is a 2 percent net-cost gap, the remedy is a good-faith discussion, and any change needs a later amendment effective the following January 1. There is no automatic most-favored pricing and no meet, credit, or release right. That is weaker than the model.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"The county gets one annual rebate audit and one annual electronic claim audit, at its own expense unless otherwise agreed, and a small general allowance can be used for audit invoices. Audit terms live in the Prescription Drug Services Schedule, which is not attached. There is no right to full claims-level and financial data on a schedule without asking, no pre-adjudication access, and extra fees for older audit files. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"DATA","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Privacy language on page 10 is HIPAA only. Pages 15 to 16 and 27 grant a limited license to Aetna intellectual property in reporting systems and say nothing grants the county ownership of that IP. Historical claims, accumulator, and refill files are billed extras on pages 54 to 55. No clause makes the county the sole owner of claims, eligibility, rebate, or derived data or bars Aetna from reusing it. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.9,"page_ref":"Page 42","evidence_quote":"Rebate guarantees are measured individually by component and reconciled in the aggregate on an annual basis within 12 months following the end of the Plan year; a surplus in one or more component Rebate guarantees may be used to offset shortages in other component Rebate guarantees.","rationale":"Discount, dispensing-fee, and rebate guarantees exist and are reconciled, which is more than nothing. They are annual rather than quarterly, rebate components may offset each other, discount reporting is due 180 days after the period, and the PrudentRx savings guarantee is a future billing credit capped at 30 percent of program cost. That is not dollar-for-dollar quarterly cash on plan-specific results without caps.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Guarantee reconciliation on pages 39 to 42 is a performance true-up, not a self-executing penalty for missed reports or a second material breach. Early termination on page 47 imposes liquidated damages on the county, including retained rebates, rather than giving the county an automatic exit. The Medicare Group Agreement termination article on pages 8 to 9 has no two-strikes clause. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"The Medicare Group Agreement lets Aetna amend on 30 days written notice and says all amendments, other than automatic mandate changes, must be approved and executed by Aetna. The Pharmacy Service and Fee Schedule also lets Aetna make Equitable Adjustments to financial terms and amend individual specialty drug discounts to manage its guarantee. That is unilateral change of economic terms, which the model forbids.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"TERM","verdict":"bad","confidence":0.93,"page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna’s arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an “Early Termination”) Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein.","rationale":"The Medicare Group Agreement allows either party to end that group agreement without cause on 90 days notice. The pharmacy fee schedule, which runs through December 31, 2028, treats an earlier exit as Early Termination: Aetna keeps earned unpaid rebates, pharmacy guarantees become void, and allowances must be refunded, labeled liquidated damages. Earned amounts are forfeited, which is how plans get trapped. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"SPEC","verdict":"bad","confidence":0.95,"page_ref":"Page 40","evidence_quote":"Aetna may amend the individual Specialty Drug discounts to manage the financial guarantee.","rationale":"Specialty is defined by Aetna's product list and exclusive CVS Specialty network, priced at AWP minus 22.75 percent in 2026 on the blended guarantee and at drug-level AWP discounts, including some at 0.00 percent, not at acquisition cost. Aetna may change individual specialty discounts to manage its guarantee, and medical-benefit specialty rebates are retained. That is not a claim-level acquisition-cost ceiling in every channel.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.96,"page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna’s prior written consent.","rationale":"Confidential Information includes the Group Agreement and costs and pricing data. The financial conditions bar Harris County from releasing the proposal to any third party without Aetna's prior written consent. The public records clause on page 22 only requires the county to warn Aetna and not oppose Aetna's effort to block release, which does not cure a gag. Nothing in this amendment frees pharmacies to tell members about cheaper options.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"Section 4.2 of Exhibit G is an express fiduciary disclaimer negotiated in what the contract calls an arm's length fashion, and the same page reserves ESI's right to stop services in any state that would require a PBM to act as a fiduciary. The only fiduciary acceptance anywhere is ESI's narrow agreement, for appeals work only, to accept fiduciary status with respect to the performance of an appeal. The model contract from Mark Cuban and collaborators instead asks the PBM to owe loyalty and care solely to the plan and to disgorge anything retained in breach. This contract is an explicit statement of the opposite posture.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries or affiliates derive revenue in one or more of the ways as further described in the Financial Disclosure to ESI PBM Clients set forth in the Proposal (“Financial Disclosure”), as updated by ESI from time to time","rationale":"Section 4.3 of Exhibit G does disclose that ESI and its affiliates earn revenue beyond the administrative fees, and it points to a Financial Disclosure document in the Proposal, which is itself incorporated into the contract. That is more disclosure than silence. But the same section declares those revenues are not compensation from the plan, says ESI acts on its own behalf in negotiating them, and states the plan has no right to or beneficial interest in any of them, and the actual Financial Disclosure is not in the posted text and can be updated by ESI at will. There is no named officer certifying completeness of disclosures quarterly or annually, so the clause falls well short of the model's certified full disclosure.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I looked in the exhibit list on page 17, the subcontracting clause on page 14 and the definitions in Exhibit G. There is no signed exhibit listing ESI's owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, mail order pharmacies or specialty pharmacies, and no duty to refresh any such list on a change in control. The text names Accredo, Express Scripts Specialty Distribution Services and Medco Containment Life Insurance Company only inside operational definitions, and acknowledges affiliates perform mail and specialty services, without any ownership or affiliate inventory. The change of ownership clause on page 6 only requires advance notice of a merger and gives A&M a termination election.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"unclear","confidence":0.8,"page_ref":"Pages 110 to 112","evidence_quote":null,"rationale":"Whether the definitions close labeling loopholes cannot be decided because the decisive definitions are individually blacked out. The Exhibit G definition list on pages 110 to 112 skips items 1.4, 1.15, 1.17, 1.18, 1.22, 1.26 and 1.29, rendered only as black-bar artifacts in the OCR. Alphabetically, item 1.26 sits exactly where Rebate belongs, between Prescription Drug Claim and Set-Up Forms, and items 1.17 and 1.18 sit where Manufacturer Administrative Fee belongs. The definitions that survive, such as Formulary and MAC List, are vendor friendly, but the core pass-through definitions are unreadable, so redaction, not ambiguity, is the reason this cannot be settled.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"unclear","confidence":0.8,"page_ref":"Pages 35 to 37","evidence_quote":null,"rationale":"The rebate exhibit, Exhibit C-3 on pages 35 to 37, is where pass-through percentages and payment terms live, and it is blacked except for headings and one surviving clause on page 38 noting that Rebate and Manufacturer Administrative Fee amounts paid to A&M are intended to be treated as discounts under the federal anti-kickback statute. The readable text cuts both ways: page 114 says only that ESI will pay the amounts set forth on Exhibit C, and section 4.3 on page 115 says ESI and its affiliates keep all other manufacturer related revenue, which would contradict the model's 100 percent pass-through, but the actual contractual share owed to A&M is behind the black bars. Because the exhibit that decides this is redacted, the read is redaction blocked rather than missing.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"unclear","confidence":0.85,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Pricing for ESI's own mail order and specialty pharmacies is exactly what the fully blacked Exhibit D and the blacked ESI Mail Pharmacy guarantee section on page 25 contain. Definitions on pages 110 and 111 confirm ESI Mail Pharmacy and ESI Specialty Pharmacy are ESI or affiliate owned, and section 4.3 reserves affiliate revenue to ESI, so nothing readable promises acquisition cost pricing with no retained margin. In the readable text there is no net acquisition cost commitment at all; the phrase acquisition cost appears nowhere. The standard cannot be judged because the pages where it would live are blacked.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"unclear","confidence":0.75,"page_ref":"Pages 27 to 29","evidence_quote":null,"rationale":"A benchmark ceiling or cheapest lawful option commitment would have to appear in the general pricing terms of Exhibit C-2, section 5, on pages 27 to 29, and those are essentially fully blacked. What little is readable shows guarantees framed as average aggregate annual guarantees on page 24, not claim level ceilings, so the visible architecture leans against the model, which asks that no claim ever exceed a published benchmark. Because the actual ceiling terms, if any, sit behind the redaction, I treat this as redaction blocked rather than missing.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"unclear","confidence":0.75,"page_ref":"Pages 27 to 29","evidence_quote":null,"rationale":"Nothing readable anywhere in the contract addresses a member paying no more than the cash price, crediting cash purchases toward the deductible, or accumulator adjustment programs; the word accumulator does not appear and cash price does not appear outside the usual and customary definition. Such protections could in principle sit inside the blacked general pricing terms of Exhibit C-2 on pages 27 to 29, since that section is said to apply to all pricing in the contract. Because I cannot rule out that the subject is addressed behind the black bars, redaction rather than absence is the reason I cannot decide.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"unclear","confidence":0.8,"page_ref":"Pages 27 to 29","evidence_quote":null,"rationale":"The surviving definition on page 111 lets ESI develop or select the MAC list, which is vendor discretion, not shared governance. Whether one list applies to both plan and pharmacy sides, whether the list is disclosed, and whether pharmacies have an appeal path would be set out in the general pricing terms of Exhibit C-2, and those pages are blacked. Some sections even within that blacked run, such as the vaccine claim pricing on page 29, remain partially visible, so I cannot confirm the subject is simply absent. Redaction is the reason this cannot be settled.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"unclear","confidence":0.8,"page_ref":"Pages 24 to 33","evidence_quote":null,"rationale":"The readable text hints at a pass-through retail arrangement: page 4 defines a billing dispute as A&M being billed other than the amount reimbursed to the pharmacy, and the audit protocol on page 127 describes verifying an existing Pass-Through pricing arrangement for participating pharmacy claims. But the claims reimbursement rates on pages 24 to 33 are blacked, and the mail and specialty pricing in Exhibit D is fully blacked, so I cannot confirm whether the plan pays exactly what the pharmacy is paid plus a disclosed fee in any channel. Because the pages that decide spread pricing are withheld, this is redaction blocked rather than a finding that spread pricing exists.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"unclear","confidence":0.8,"page_ref":"Pages 35 to 37","evidence_quote":null,"rationale":"No readable passage anywhere mentions a group purchasing organization, a rebate aggregator, or purchase discounts received by a related purchasing entity, and section 4.3 on page 115 broadly reserves affiliate revenue to ESI. If rebate aggregation economics are addressed at all, it would be in the rebate exhibit on pages 35 to 37 or in the individually blacked definitions on pages 110 to 112, both of which ESI has designated proprietary. Since the pages where a GPO pass-through would live are redacted, I treat this as redaction blocked, noting that the visible retention language points against the model.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 110","evidence_quote":"“Formulary” means the list of FDA-approved prescription drugs and supplies developed by ESI’s Pharmacy and Therapeutics Committee and/or customized by Sponsor, and which is selected and/or adopted by Sponsor","rationale":"The sponsor selects or adopts the formulary, but it is developed by ESI's pharmacy and therapeutics committee and ESI modifies it from time to time with additions and deletions automatically adopted unless the sponsor opts out through Set-Up Forms. That is opt-out control rather than the model's standard that the sponsor approve every change. Nothing readable requires a lowest net cost analysis or quarterly utilization management outcomes by drug. The EGWP formulary on page 120 is even further from sponsor control since Medicare rules restrict changes.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"bad","confidence":0.8,"page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The formulary definition states on its face that manufacturer rebate arrangements are a reason ESI moves drugs on and off the formulary, which is the rebate driven placement the model's lowest net cost standard exists to prevent. The phrases lowest net cost and book of business appear nowhere in the produced text, so there is no stated lowest net cost standard, no annual comparison against ESI's whole book of business, and no duty to disclose drugs placed above cheaper equivalents. Because the contract affirmatively elevates rebate arrangements as a formulary factor, this contradicts the model rather than merely falling short of it.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"partial","confidence":0.8,"page_ref":"Page 112","evidence_quote":"ESI maintains multiple networks and subnetworks, and periodically consolidates networks or migrates clients to other networks and subnetworks","rationale":"The network clause lets ESI consolidate networks and migrate the plan between networks, and the mail pharmacy clause has ESI marketing its own mail channel to members with cost savings messaging, plus the right to suspend a member's mail service over an unpaid copay, all of which sits uneasily with the model's anti-steering and any willing pharmacy principles. On the protective side, page 4 commits ESI to return pharmacy audit overpayments to A&M, keeping only 15 percent for running the audit program, and nothing readable mentions retroactive claim clawbacks or volume conditioned reimbursement. The protections are narrower than the model's, so this is addressed but weaker.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"unclear","confidence":0.7,"page_ref":"Pages 21 to 29","evidence_quote":null,"rationale":"The phrases most favored and market check appear nowhere in the readable text, and no annual market check with a meet, credit or release remedy is described in the base agreement or the audit protocol. A pricing adjustment of that kind could conceivably sit in the blacked billing and general pricing terms of Exhibit C-1 and C-2 on pages 21 to 29, where section 5 states terms applicable to all pricing. Since I cannot exclude the subject living behind the black bars, redaction is the reason I cannot decide, though the visible text gives no hint the protection exists.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"bad","confidence":0.9,"page_ref":"Page 3","evidence_quote":"Auditing representatives selected by the A&M System (the “Auditor’) and approved by ESI, whose approval shall not be unreasonably withheld, shall be allowed access to A&M System specific records","rationale":"The audit right is fenced in on every side: one audit a year, a rolling 24 months of data, an auditor ESI must approve, a six month ban on the auditor later working for anyone in proceedings against ESI, and extra audits at ESI's standard cost. The rebate audit in Exhibit I is on site only, restricted to a mutually agreed CPA firm, covers only fifty percent of rebate payments for two quarters, and ESI may review the auditor's notes. The bright spots, State Auditor access under Texas law and a right to audit rebate agreements for Exhibit C compliance, do not offset the fact that the plan cannot freely choose its auditor or take away copies. This is the classic restricted audit the model clause exists to prevent.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.85,"page_ref":"Page 8","evidence_quote":"anonymized claims data (de-identified in accordance with HIPAA); ESI Specialty Pharmacy and ESI Mail Pharmacy data","rationale":"The plan gets real but incomplete data rights: page 4 makes A&M specific records and reports the property of the A&M System with delivery on request at termination, page 12 bars ESI from selling member identifiable data, and page 130 bars PHI sales under Texas law. But the confidentiality clause on page 8 lists anonymized claims data and specialty and mail pharmacy data as ESI property, and the business associate agreement lets ESI use and disclose de-identified data. There is no clause making the plan sole owner of claims, rebate and derived data sets, no machine readable delivery duty, and no ban on ESI reusing anonymized plan data, so the subject is addressed but materially weaker than the model.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.75,"page_ref":"Pages 39 to 51","evidence_quote":null,"rationale":"Performance guarantees and their reconciliation mechanics would be set with the pricing in Exhibit C, and pages 39 to 51 covering administrative services fees and EGWP administrative fees are blacked, as are the guarantee values on pages 24 to 25. The readable headings show the guarantees are average aggregate annual ingredient cost and dispensing fee guarantees, which already leans toward book averaging rather than the model's quarterly, plan specific, cash reconciled standard. Because the measurement and remedy terms themselves are behind the redaction, this is redaction blocked.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 127","evidence_quote":"To the extent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding adjustments to Sponsor through credits to a future invoice(s).","rationale":"Enforcement is not self executing: audit corrections arrive as credits against future invoices, and only after both parties accept the audit results, with no liquidated damages, interest, or automatic credit for missed guarantees or late reports anywhere in the readable text. A second material breach carries no special consequence beyond the ordinary 45 day cure and termination right on page 5. The stronger pieces are statutory: page 9 allows termination if ESI knowingly violates the contracting information duties of Subchapter J of the Texas Public Information Act, and page 6 lets A&M terminate immediately on an ESI change of control. That is meaningful but short of the model's automatic remedies and two strikes exit.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The amendment clause is clean and bilateral, and it is reinforced by page 2, where ESI agrees not to revise the Exhibit C pricing terms during the term except as required by law or by written agreement of the parties. Nothing readable gives ESI a right to change economic terms by notice, portal update or updated exhibit. The one caution is section 4.3 of Exhibit G, which lets ESI update its Financial Disclosure document from time to time without an amendment, but that document discloses revenue rather than setting plan pricing. This meets the model's requirement.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"good","confidence":0.85,"page_ref":"Page 5","evidence_quote":"the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice","rationale":"The plan holds a straightforward 90 day convenience termination with no stated penalty, plus loss of funding termination on page 12, immediate termination on an ESI merger or acquisition on page 6, and EGWP auto-termination if CMS ends MCLIC's Part D contract. The caveats that keep confidence below full are on pages 123 to 125 of the EGWP addendum, where MCLIC may delay final rebate and CMS reimbursement payments to allow for final reconciliation, and on page 4 where A&M specific records are delivered only on written request. The core model requirement, convenience exit without penalty and without express forfeiture, is present.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"unclear","confidence":0.85,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Specialty pricing is the single most blacked out subject in the contract: the Specialty Product Pricing heading on page 25 has no surviving text, the specialty rebate amounts on page 35 are blacked, and the entire fifty three page Exhibit D on specialty drugs under the mail order pharmacy program is fully blacked. The specialty definition itself appears to sit at item 1.29 of the Exhibit G definitions, which is also individually blacked. Whether specialty is defined by function, whether drug level rates act as ceilings, and whether affiliate specialty claims price at acquisition cost simply cannot be seen.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 109","evidence_quote":"The Contract, Exhibit C (Program Pricing Terms), Exhibit D (Specialty Drugs Under the Mail Specialty Drugs Under the Mail Order Pharmacy Program), and Exhibit E (Clarifications)","rationale":"Exhibit F is ESI's designation of what it considers confidential and proprietary, and it sweeps in the entire pricing exhibit, the entire specialty exhibit and the clarifications, while page 8 separately lists rebate contracts, manufacturer administrative fees and drug pricing information as ESI confidential property. The Public Information Act clause then obliges A&M to notify ESI of requests so ESI can advocate that the information be withheld, and the blacked out pages in this very posting are the practical result of that machinery. The contract does acknowledge Texas public records law, under which ESI can only seek to block release, but treating all pricing and rebate material as proprietary trade secret material is exactly the gag the model flags. No pharmacy gag clause appears in the readable text, but the pricing confidentiality is enough.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"FID","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"Guarantees will be calculated as described in this Addendum and the PBM Exlstill t to the Administrative Services Agreement Unless\n\n otherwise specified In this Addendum, capitalized terms used, n th, s Ad endum shall have the meanings set forth the Admi+Istrative Services\n Agreement or the PBM Exhib t,\n as applicable","rationale":"The incorporated ASA and PBM Exhibit are not in this 38-page packet. An optional limited-fiduciary-services label on page 8 does not establish an elected, comprehensive PBM loyalty covenant. The underlying delegation cannot be determined here.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"DISC","verdict":"partial","confidence":0.93,"page_ref":"p. 13","evidence_quote":"Claim Administrator may pay the Employer' s POR a commission and/ or other compensation in connection with such\n services under the Administrative Services Agreement. If the Employer desires additional information regarding\n commissions and/ or other compensation paid to the POR by the Claim Administrator in connection with services\n under the Administrative Services Agreement, the Employer should contact its POR.","rationale":"The packet discloses possible producer commissions and other compensation and directs the employer to the producer for more information. It does not establish complete PBM/affiliate compensation disclosure or recurring officer certification; the page-10 rebate reservation and page-30 actual-rebate true-up must also be read together.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"Unless\n\n otherwise specified In this Addendum, capitalized terms used, n th, s Ad endum shall have the meanings set forth the Admi+Istrative Services\n Agreement or the PBM Exhib t,\n as applicable","rationale":"No comprehensive PBM ownership/affiliate schedule is supplied. Employer-affiliate questions in the application are not disclosure of PBM affiliates. Incorporated but unavailable ASA/PBM terms prevent an absence conclusion about the whole agreement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"DEF","verdict":"partial","confidence":0.93,"page_ref":"p. 29","evidence_quote":"For discount and dispensing fees, Brand drugs are defined as drugs that have a Medi-Span multlsource code field equal to' M\",' N', or' O'\n For it scount and dispensing fees, Generic drugs are defined as drugs available in sufficient supply that have a Medi- Span multisource code field\n equal to' Y'","rationale":"Brand/generic classifications and a separate specialty-pricing-file definition are supplied. Classification rules include supply qualifications and exclusions; they do not establish economic-function definitions for all manufacturer value, affiliates or rebates. The controlling capitalized definitions also point to an unavailable ASA/PBM Exhibit.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"PASS","verdict":"partial","confidence":0.93,"page_ref":"p. 30","evidence_quote":"Rebates will be trued up annually to the greater of the PEPM rebate credits, per brand Rx rebate guarantees. and actual rebatr.","rationale":"The specific pharmacy addendum promises annual true-up to the greatest of PEPM credits, per-brand-Rx guarantees and actual rebates, a meaningful protection. Page 10 nevertheless reserves legal interest in actual rebates to the administrator, and page 30 excludes many claim types from guarantees. The packet does not resolve all scope/priority questions or require 100% of every manufacturer revenue category within 30 days. Do not describe this as simple excess-rebate retention without acknowledging the addendum.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 29","evidence_quote":"Aggregate Spec airy discount guarantees do not include Imlted distribution drugs ( LDDs) nor any new specialty drugs brought to market and\n added to the specialty list dur ng the term of each contract year","rationale":"An aggregate specialty benchmark guarantee with exclusions is not evidence of affiliate net-acquisition-cost invoicing. The packet does not provide affiliated-pharmacy purchase costs or the incorporated PBM Exhibit needed to establish the relationship.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"CEIL","verdict":"partial","confidence":0.93,"page_ref":"p. 29","evidence_quote":"For the purpose of reconciliation at contract year end, discount and dispensing fee guarantees are reconciled in aggregate, as long as the\n contract remains in effect.","rationale":"The schedule provides aggregate annual discount/dispensing-fee guarantees, not a claim-level ceiling against an independently published cash benchmark. This is a narrower price protection; it cannot prove each plan claim was at or below the cheapest lawful option.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"CASH","verdict":"partial","confidence":0.93,"page_ref":"p. 31","evidence_quote":"Members will pay the lower of the contracted rate, UBC, or their applicable copayment. Zero balance logic is not employed.","rationale":"The lesser-of contracted rate, U&C and copay is real member price protection; U&C is OCR-rendered UBC in the bound text and was checked visually. No corresponding promise in this packet credits every independently purchased cash prescription to deductibles/out-of-pocket accumulators.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"Guarantees will be calculated as described in this Addendum and the PBM Exlstill t to the Administrative Services Agreement Unless\n\n otherwise specified In this Addendum, capitalized terms used, n th, s Ad endum shall have the meanings set forth the Admi+Istrative Services\n Agreement or the PBM Exhib t,\n as applicable","rationale":"The unavailable incorporated PBM Exhibit/ASA may contain MAC rules. This packet does not establish a single shared MAC list, update deadlines or pharmacy appeals procedures; the pass-through heading alone does not establish those protections.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"SPRD","verdict":"unclear","confidence":null,"page_ref":"p. 29","evidence_quote":"Discounts are based on the actual NDC- 11 dispensed on the fill date.","rationale":"The schedule is visually labeled custom pass-through pricing, but supplies benchmark discounts rather than an explicit all-channel equality between employer payment and pharmacy reimbursement plus a disclosed fee. It does not prove spread is permitted, absent or actually earned. The underlying ASA/PBM Exhibit and claims/remittance data are needed.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 30","evidence_quote":"Rebates will be trued up annually to the greater of the PEPM rebate credits, per brand Rx rebate guarantees. and actual rebatr.","rationale":"A true-up to actual rebates does not establish pass-through of every affiliated purchasing entity's discounts, fees and supplier revenue. The packet lacks the definitions/allocation terms needed to assess this wider requirement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"FORM","verdict":"partial","confidence":0.93,"page_ref":"p. 31","evidence_quote":"Guarantees are based on adoption and adherence of an above BCBS TX drug 119, Including associated utilization management\n and clinical programs.","rationale":"The application identifies a drug list and the addendum conditions guarantees on adherence to the administrator's list and associated utilization/clinical programs. That provides a defined offering, but not a sponsor veto over each change or quarterly lowest-net-cost analysis.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"Guarantees are based on adoption and adherence of an above BCBS TX drug 119, Including associated utilization management\n and clinical programs.","rationale":"List/clinical-program adherence is not a lowest-net-cost mandate. The supplied packet does not establish plan-specific annual book-of-business comparisons or a duty to justify placing a drug above a cheaper equivalent; no conclusion about absent incorporated terms is warranted.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"NET","verdict":"partial","confidence":0.93,"page_ref":"p. 19","evidence_quote":"Geographic Access Network Members will have access to Network Participants for 90%- 10000 0\n covered prescription drug services. Measured at the Blue Plan book of business level. 890 0 or less 2, 000\n Geographic Access means the Claims Administrator guarantees that a Network Participant\n will be within two ( 2) miles of a Member in an urban area 90°•0 of the time.\n Note These networks do not apply to limited networks, only broad networks.","rationale":"The exhibit offers broad-network geographic access guarantees, but measured at Blue Plan book-of-business level with a limited-network exclusion. Page 29 assumes an exclusive specialty network. Neither an any-willing-pharmacy right nor broad anti-steering/clawback protection is established by these provisions.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"BCBS TX reserves the right to equitably adjust the guarantees In the event the number of covered members or p^ armacy dal ms volume\n materially changes over the course of the contract.","rationale":"This administrator adjustment provision is not a sponsor most-favored-price or annual market-check right. The supplied application/addenda do not establish such rights, and the separate governing ASA/PBM Exhibit is unavailable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"AUD","verdict":"partial","confidence":0.93,"page_ref":"p. 16","evidence_quote":"The Claim Administrator will measure Performance Guarantees and report the\n measurement results to Employer, and any refund amounts due in accordance with this","rationale":"There is a performance-reporting obligation, completed on page 17 with a 120-day deadline after measurement periods close. Provider self-measurement and sample audits in the exhibits are not a plan-appointed auditor's full claims/financial access, nor pre-adjudication access. Those broader rights are not established here.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"Unless\n\n otherwise specified In this Addendum, capitalized terms used, n th, s Ad endum shall have the meanings set forth the Admi+Istrative Services\n Agreement or the PBM Exhib t,\n as applicable","rationale":"No ownership and export/reuse prohibition for claims, eligibility, accumulators, rebate data and derived datasets is established in this packet. Access for administering enrollment is not ownership. The incorporated ASA must be obtained before a complete-contract finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"PERF","verdict":"partial","confidence":0.93,"page_ref":"p. 18","evidence_quote":"Performance Guarantees are measured annually unless otherwise noted. Performance Guarantees are reported and settled on an annual basis\n only.","rationale":"A signed pharmacy service-guarantee exhibit lists quantified remedies (total PDP $34,000 visually verified on page 21), mixed employer-specific and book-of-business measurements, annual settlement and qualifications. This is not uncapped, quarterly, plan-specific dollar-for-dollar reimbursement of all financial loss.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"ENF","verdict":"bad","confidence":0.93,"page_ref":"p. 17","evidence_quote":"If for any reason the Agreement is terminated prior to the end of any Settlement Period,\n the Performance Guarantees will not be measured and Employer will not receive any\n refund, based on that part of the Settlement Period in which the Administrative Services\n Agreement was in effect.","rationale":"The supplied performance remedy disappears for an unfinished settlement period on termination. Other page-17 conditions suspend measurement/refunds for documentation, payment and change issues. This undermines the rubric's automatic enforceability and repeat-breach exit protection; it does not establish those broader rights in the underlying ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"AMD","verdict":"bad","confidence":0.93,"page_ref":"p. 31","evidence_quote":"BCBS TX reserves the right to equitably adjust guarantees for the following: changes In any law or regulation,\n changes In interpretation of a law or regulation, changes within PBM marketplace which lead to a significant deviation from the current\n economic environment, unexpected market events, unexpected generic launches, authorized generic launches, blosimilar launches, products\n launched at risk, products under patent litigation, new lower cost NDCs priced net of rebates from the Innovator, products with AWP decreases,\n implementation of new clinical programs, removal of existing clinical programs. changes in pharmacy benefit pan desigrk or drug zst changes.","rationale":"The addendum expressly reserves broad economic adjustment grounds, including market events, generic/biosimilar launches, programs and drug-list changes. The rubric requires bilateral signed amendments for economic changes. Whether a specific attempted adjustment is legally enforceable is not determined here.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"TERM","verdict":"bad","confidence":0.93,"page_ref":"p. 13","evidence_quote":"Upon Termination, the run- off administration fee will be multiplied times the total of all certificates actually exposed during\n each of the three months immediately preceding contract termination and the result will be the obligation of the Employer.\n The Run- off Administration amount is due and payable whether or not BCBSTX processes the run- off claims","rationale":"The run-off administration amount is payable even when BCBSTX processes no run-off claims. Page 10 ends rebate credits on program termination and page 17 eliminates unfinished-period performance refunds. These are concrete exit costs/forfeiture mechanisms, although complete convenience-termination rights require the separate ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"SPEC","verdict":"partial","confidence":0.93,"page_ref":"p. 29","evidence_quote":"Guarantees are based upon a exclusive specialty network arrangement\n Aggregate Spec airy discount guarantees do not include Imlted distribution drugs ( LDDs) nor any new specialty drugs brought to market and\n added to the specialty list dur ng the term of each contract year","rationale":"A visually verified 24% aggregate specialty discount appears for 2023–2025, but limited-distribution and new specialty drugs are excluded from that aggregate guarantee and specialty follows a proprietary file. This is narrower than universal drug-level ceilings and affiliate acquisition-cost pricing. No present-day price is asserted.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"GPT 6 Astra","rubric_key":"GAG","verdict":"bad","confidence":0.93,"page_ref":"p. 2","evidence_quote":"Not for use or disclosure outside Claim Administrator, Employer, their respective affiliated companies and third -party representatives, except\n with written permission of Claim Administrator.","rationale":"The packet labels terms proprietary/confidential and conditions disclosure beyond the stated parties/representatives on written permission. That conflicts with the rubric's open sharing standard. This is analysis of the words, not a finding that Texas public-records disclosure is legally barred; the city actually published the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:20:39.764667+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"partial","confidence":0.95,"page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA.","rationale":"Aetna accepts fiduciary status only for ERISA claim determinations. The clause does not impose loyalty and care solely to the plan and members, require conflict disclosure, or require disgorgement. It also grants Aetna broad interpretive discretion, so it is substantially narrower than the model protection.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.94,"page_ref":"Page 47","evidence_quote":"Rebates for Specialty Products that are administered and paid through the Plan Participant’s medical benefit rather than the Plan Participant’s pharmacy benefit will be retained by Aetna as compensation","rationale":"The exhibits disclose several retained revenue categories, including medical-benefit specialty rebates, value-based rebate payments, administrative fees, and network fees. That is useful conflict information, but the amendment does not require disclosure of all direct and indirect compensation, consultant payments, or affiliate ownership. No named officer must certify completeness quarterly or annually.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.97,"page_ref":"Page 72","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"The rate exhibit identifies CVS as parent of Aetna and SilverScript, and other pages identify CVS Caremark and Aetna Rx Home Delivery. There is no signed exhibit listing every owner, subsidiary, affiliate, purchasing entity, rebate aggregator, mail pharmacy, and specialty pharmacy. The amendment also lacks a duty to refresh the disclosure within 30 days after a change.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers","rationale":"The rebate definition expressly excludes manufacturer administrative fees. The same section excludes other manufacturer payments, data-related payments, educational payments, and network transmission fees from rebate sharing. These labels create the precise loophole that the model's economic-function definitions are intended to close.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 46","evidence_quote":"These payments are not considered Rebates and are not included in Rebate sharing arrangements with Customers.","rationale":"The schedule promises minimum rebate guarantees but excludes multiple streams of manufacturer and other organization revenue from sharing. It also allows Aetna to retain medical-benefit specialty rebates and value-based rebate payments. Payments occur 180 days after quarter end, much later than the model's 30-day standard.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.98,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The contract requires use of CVS-owned specialty pharmacies but prices specialty drugs through AWP discount schedules. It does not invoice affiliate claims at documented net acquisition cost plus a stated dispensing fee. The traditional pricing disclosure also allows Aetna to retain a spread, directly contradicting the model's affiliate cost rule.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"partial","confidence":0.9,"page_ref":"Page 57","evidence_quote":"If the price is lower through a non-Aetna contracted network (including an administrative fee paid to the third-party that contracts the network), the Claim will be processed through that network.","rationale":"Caremark Cost Saver compares an Aetna network price with an available non-Aetna network price and uses the lower option. That is a limited claim-price comparison, but it is not a ceiling tied to a published cash benchmark. It does not apply to every drug and channel or guarantee the cheapest lawful option claim by claim.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.94,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy’s Usual and Customary Charge, (iii) MAC (where applicable) or (iv) discounted AWP cost.","rationale":"The member receives a useful lesser-of protection against the pharmacy's usual and customary charge, MAC, and discounted AWP. The amendment does not say that an outside cash purchase counts toward the deductible and out-of-pocket maximum. It also conditions the PrudentRx guarantee on a true accumulation design without requiring a written sponsor election for accumulator treatment.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"partial","confidence":0.88,"page_ref":"Page 39","evidence_quote":"MAC Pricing applies at Mail Order.","rationale":"The pricing terms use MAC at mail order and in the member lesser-of calculation, and the service list mentions third-party pharmacy appeals. The amendment does not require one disclosed MAC list for both plan billing and pharmacy reimbursement. It also omits update schedules and defined appeal timelines, while the base agreement is not in the file.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference","rationale":"The schedule expressly defines traditional or lock-in pricing to permit different plan and pharmacy amounts. Aetna keeps the difference in addition to other fees. This is spread pricing and directly contradicts the model.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.93,"page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates.","rationale":"The schedule permits Aetna to receive payments from manufacturers and other organizations outside rebate sharing. It contains no requirement that a related purchasing entity or rebate aggregator pass purchase discounts, volume credits, or supplier payments to the plan. Because the base agreement is not in the file, there is no broader related-entity pass-through provision to cure this exclusion.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"Harris County may accept or reject the formulary, which provides some sponsor control. Aetna determines which formulary options are available and may propose modifications based on cost, rebates, and other factors. The amendment does not require sponsor approval of every change, lowest-net-cost analysis, or quarterly drug-level utilization management outcomes.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The formulary terms on pages 40 and 46 do not require decisions based on lowest net cost for Harris County or an annual comparison with Aetna's whole book of business. Page 53 lists net cost analysis only as part of an optional custom formulary service, not as a governing standard. The underlying base agreement is not in the file, so any broader formulary standard that might be there cannot be scored.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"bad","confidence":1,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The amendment mandates CVS Specialty and prohibits retail fills for the Specialty Performance Network. It also conditions pricing on Aetna being the exclusive specialty provider, with only a stated HIV exception. This is direct affiliate steering and contradicts the model's network protections.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"partial","confidence":0.98,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs","rationale":"The schedule allows an annual market check against comparable employers. It does not automatically give Harris County the best comparable pricing, and a qualifying result only leads to good-faith discussion. There is no mandatory meet, credit, or release remedy if Aetna declines a revision.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.97,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"The amendment grants one annual rebate audit and an annual electronic claim audit at the customer's expense. Both rights are subject to terms in the Prescription Drug Services Schedule, which is not in this file. Reporting tools and quarterly aggregate reports are offered, but there is no full scheduled financial data, pre-adjudication access, or unrestricted sponsor-selected auditor right.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.98,"page_ref":"Page 54","evidence_quote":"Accumulator files                                      $1,000                  Per file\n\n             Historical claims data                                 $1,000                  Per file","rationale":"The service schedule charges separate per-file fees for accumulator and historical claims data, as well as other transition files. The amendment never grants Harris County sole ownership of claims, eligibility, accumulator, rebate, and derived data or prohibits Aetna from reusing it. Charging for core plan data creates the switching and audit barrier the model provision is designed to prevent.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"bad","confidence":0.98,"page_ref":"Page 43","evidence_quote":"CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"The PrudentRx savings remedy is an annual future billing credit capped at 30 percent of program cost. Discount guarantees are also annual and may take 180 days to reconcile, while rebate guarantee components may offset one another. These are capped or delayed credits rather than quarterly plan-specific cash remedies.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.91,"page_ref":"Page 43","evidence_quote":"CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"The PrudentRx provision supplies a defined credit without requiring proof of damages, which is a limited self-executing remedy. The credit is delayed, capped, and usable only against future billing. The amendment has no automatic damages for late reports and no penalty-free two-strikes termination right for repeated breach or integrity failure.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":1,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"The Medicare Group Agreement lets Aetna amend the agreement unilaterally on 30 days' notice. It also allows automatic amendments for mandates. The unilateral notice right directly contradicts the model requirement that both parties sign every amendment.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"bad","confidence":0.99,"page_ref":"Page 47","evidence_quote":"Aetna shall retain any earned but unpaid rebates as of the Early Termination date","rationale":"Although the Medicare Group Agreement permits termination without cause on 90 days' notice, the pharmacy schedule penalizes termination before December 31, 2028. Aetna keeps earned but unpaid rebates, voids plan-year pharmacy guarantees, and may recover prorated allowances as an Early Termination Fee. Forfeiting earned rebates and imposing termination costs contradict the model.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"bad","confidence":0.99,"page_ref":"Page 40","evidence_quote":"Aetna being the exclusive provider of Specialty Services with the exception of the HIV class","rationale":"The contract includes drug-level specialty AWP discounts but makes Aetna the exclusive specialty provider except for the HIV class. It does not price CVS affiliate specialty claims at net acquisition cost. The mandatory affiliate channel and AWP methodology contradict the model's core specialty pricing control.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":1,"page_ref":"Page 14","evidence_quote":"The term “Confidential Information” includes, but is not limited to, this Group Agreement or any information of either Contract Holder or Aetna","rationale":"The confidentiality clause covers the agreement, costs, and pricing data and restricts disclosure without consent. Pricing exhibits are repeatedly marked proprietary, confidential, and not for further distribution. A public-records clause requires notice to Aetna and an opportunity to seek protection, so it does not remove the gag on voluntary public disclosure.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 10","evidence_quote":"The relationship between the Parties is a contractual relationship between independent contractors. Neither Party is an agent or employee of the other in performing its obligations pursuant to this Group Agreement.","rationale":"The Group Agreement expressly frames Aetna as an independent contractor, not a fiduciary to the County or its retirees. The only fiduciary statement anywhere in the file is that Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA for claims decisions, with an abuse of discretion standard, which is the narrow claims administrator role and nothing like the duty of loyalty over formularies, networks and pricing that the model contract published by Mark Cuban and collaborators requires. The base agreement, where a broader duty might theoretically sit, is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"To its credit, the fee schedule affirmatively discloses several revenue streams Aetna keeps, including manufacturer administrative fees, data and education payments, and network transmission fees. But it discloses them only to retain them, not to remit them, and there is no officer certification, quarterly or annual, that all compensation has been disclosed and remitted as the model contract of Mark Cuban and collaborators contemplates. Broker compensation disclosure on page 29 says only that rates exclude broker commissions.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"OWN","verdict":"partial","confidence":0.8,"page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"There is no signed ownership exhibit, but the documents do disclose the corporate chain in plain text: SilverScript Insurance Company issues the drug plan, CVS Caremark administers the pharmacy benefit, CVS Specialty fills the specialty drugs, and CVS is the parent of Aetna and SilverScript. That is more than silence, but it is a narrative disclosure with no completeness duty and no obligation to refresh it within 30 days of an ownership change, which is what the model exhibit requires.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.85,"page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates. These payments are generally for one of two purposes: (i) to compensate Aetna for bona fide services it performs, such as the analysis or provision of aggregated data or (ii) to reimburse Aetna for the cost of various educational and other related programs","rationale":"The definitions in this text open loopholes rather than close them. Rebates are defined elsewhere, in the Prescription Drug Services Schedule that is not in the file, and this document then excludes manufacturer administrative fees, data and education payments, network transmission fees, and medical benefit specialty rebates from that definition of Rebates, letting value be relabeled as fees to escape the 100 percent pass through. Specialty is defined by Aetna's own Specialty Product List, that is, by label rather than economic function.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.85,"page_ref":"Page 37","evidence_quote":"Customer will receive the following minimum rebate guarantees: 01/01/2026 01/01/2027 01/01/2028 Greater of 100%or Greater of 100%or Greater of 100%or Retail $406.62 Per Brand $406.62 Per Brand $406.62 Per Brand Script Script Script","rationale":"The rebate numbers look strong: the County receives the greater of 100 percent of rebates or fixed per brand script minimums, paid quarterly. But the definition of Rebates excludes manufacturer administrative fees and several other payment streams, which stay with Aetna or CVS Caremark, and payment comes 180 days after quarter end rather than within 30 days as the model contract of Mark Cuban and collaborators requires. Guarantees are also reconciled in the aggregate annually, letting surpluses on one component offset shortfalls on another. One hundred percent of a shrunken definition is not 100 percent of everything.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"NAC","verdict":"bad","confidence":0.88,"page_ref":"Page 36","evidence_quote":"Brand Discount AWP - 19.50% AWP - 19.50% AWP - 19.50% Generic Discount AWP - 92.00% AWP - 92.20% AWP - 92.40% Dispensing Fee $0.00 per Script $0.00 per Script $0.00 per Script","rationale":"The mail order channel is run by CVS Caremark Mail Service Pharmacy and the specialty channel by CVS Specialty, both affiliates of the vendor. Claims through these owned pharmacies are priced at AWP discounts, for example brand drugs at AWP minus 19.50 percent at mail, not at net acquisition cost plus a dispensing fee, and under traditional pricing the vendor can retain margin on those channels. That leaves the incentive to route retirees into the vendor's own pharmacies fully intact.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the produced text caps what the plan pays at a published benchmark on a claim by claim basis. The lesser of language on page 39 limits only what the pharmacy collects from the member at the counter, the lesser of cost share, usual and customary charge, MAC or discounted AWP, not what the plan itself is charged. A plan level benchmark ceiling would live in the pricing articles of the base agreement, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I searched the amendment body, the Group Agreement, the fee schedule and the Summary of Benefits for any promise that a member never pays more than the pharmacy cash price, that cash purchases count toward the deductible and out of pocket maximum, or any language on accumulator adjustment. None exists. This kind of member protection would ordinarily sit in the base agreement or plan documents, which are not in the file. The file does mention the PrudentRx copay optimization program and true accumulation as a plan design assumption, but that is a vendor program condition, not a member cash price right.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"MAC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The text references MAC pricing in passing: page 39 says MAC Pricing applies at Mail Order and retail guarantees exclude claims priced at usual and customary rates, and some specialty drugs are priced at MAC in the list on pages 59 to 71. But there is no MAC list governance: no disclosure obligation, no update schedule, no single list for plan and pharmacy sides, and no pharmacy appeal path with timelines. The only appeal related item is a pass through fee per review for retail network pharmacy third party appeals on page 52. MAC governance would live in the Prescription Drug Services Schedule, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"SPRD","verdict":"bad","confidence":0.96,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"This is a written admission of spread pricing. The County chose a Traditional pricing arrangement under which what the plan is charged for a claim can exceed what the pharmacy is paid, and Aetna keeps the difference as compensation. The model contract published by Mark Cuban and collaborators exists to eliminate exactly this undisclosed markup.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"Group purchasing organizations and rebate aggregators are never mentioned in the 87 pages. The closest language is page 47, where the County agrees that payments Aetna receives from manufacturers for aggregated data and book of business activities belong exclusively to Aetna or CVS Caremark, which is precisely the kind of purchasing entity revenue a GPO clause should capture but does not. If a GPO pass through clause exists, it would be in the base agreement or the Prescription Drug Services Schedule, neither of which is in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan. Customer further understands and agrees that from time to time Aetna may propose modifications to the drugs and supplies included on the Formulary as a result of factors, including but not limited to, market conditions, clinical information, cost, rebates and other factors.","rationale":"The County formally retains sole discretion to accept or reject the formulary, which is the right starting point. But the pricing is conditioned on adopting the Aetna Standard Formulary, the Choose Generics program and the Advanced Control Specialty Formulary, and the Financial Conditions document reserves the right to restructure the plan design or formulary in response to regulatory events, so the County's control is exercised within guardrails set by the vendor's economics. There is no right to receive lowest net cost analysis or quarterly utilization management outcomes by drug.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard for this plan appears anywhere in the file, and no annual comparison of the County's formulary results against Aetna's whole book of business is promised. Page 46 says formulary modifications may be driven by market conditions, clinical information, cost, rebates and other factors, which names rebates as a placement factor without any offsetting net cost test. Such a standard might be in the base agreement, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The network design steers specialty patients into the vendor's own channel: retirees must use CVS Specialty pharmacies and retail fills are not allowed, with only the HIV class excepted, and specialty retail leakage of 10 percent or more lets Aetna amend pricing. Nothing in the text protects pharmacies from retroactive clawbacks, promises any willing pharmacy access, or bars steering into affiliate pharmacies. Mail order is likewise run by CVS Caremark Mail Service Pharmacy.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"MFN","verdict":"partial","confidence":0.88,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"There is an annual market check in the second quarter of each contract year, which is a real protection many contracts lack. But there is no most favored pricing promise that the County automatically receives pricing as good as comparable clients, and even when the check shows savings of 2 percent or more the only remedy is a good faith discussion, with any revision effective the following January 1. The model's meet, credit or release remedy is absent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule. Customer is entitled to an annual electronic claim audit subject to standard pharmacy benefit audit practices and audit terms and conditions outlined in the Prescription Drug Services Schedule. Pharmacy audits shall be conducted at the Customer's own expense unless otherwise agreed to between the Customer and Aetna.","rationale":"Audit rights exist but are thin: one rebate audit and one electronic claim audit per year, run at the County's own expense, and governed by the Prescription Drug Services Schedule that is not in the file, so the actual limits on scope, auditor independence and records access cannot be verified. Data access is also paywalled: page 54 charges the County per file fees for audit claim files over 24 months old and for its own historical claims data. Pre-adjudication claims access and a guarantee that no data is withheld as proprietary are absent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"DATA","verdict":"bad","confidence":0.82,"page_ref":"Page 54","evidence_quote":"Refill Transfers upon termination $4,500 Per file Precertification history $3,500 Per file Accumulator files $1,000 Per file Historical claims data $1,000 Per file","rationale":"The text never says the County owns its claims, eligibility, accumulator or rebate data, and the fee schedule prices the County's own data back to it: accumulator files at $1,000 per file, historical claims data at $1,000 per file, and termination files for open refills at $5,200. A vendor that can charge a public body for its own accumulated claims data at termination can effectively hold that data at transition, which is the opposite of the model contract's ownership rule.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.82,"page_ref":"Page 43","evidence_quote":"If CVS Health fails to achieve the applicable savings target in any contract year, within ninety (90) days after the end of such contract year, CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"There are real guarantees: discount, dispensing fee and rebate guarantees reconciled annually, a PrudentRx first year savings target of $106.85 per member per year, and a Drug Savings Review return on investment guarantee. But measurement is annual rather than quarterly, rebate components are reconciled in the aggregate so surpluses offset shortfalls, and remedies are capped credits against future billing, such as the 30 percent cap above, rather than dollar for dollar cash payments. The Drug Savings Review remedy is capped at fees paid.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"ENF","verdict":"missing","confidence":0.82,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the text gives the County liquidated damages or automatic credits when reports are late or when the discount and rebate guarantees are reconciled short, and there is no two strikes or repeat breach termination right. The only self executing remedies run against the County: a 12 percent annual late payment charge on page 48 and the early termination fee on page 47. No automatic enforcement mechanism appears, and if one existed it would sit in the base agreement, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"AMD","verdict":"bad","confidence":0.9,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder. The Parties agree that an amendment does not require the consent of any Member or other person. Except for automatic amendments to comply with Mandates, all amendments to this Group Agreement must be approved and executed by Aetna.","rationale":"The Group Agreement incorporated by this amendment can be amended by Aetna alone on 30 days written notice, and is deemed automatically amended to conform with regulatory mandates. The First Amendment itself was signed by both parties, but the documents it attaches hand the vendor a unilateral amendment right, which is exactly what the model contract's written amendment rule exists to prevent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna's arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an \"Early Termination\") Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein.","rationale":"The Group Agreement does let either party terminate without cause on 90 days notice, which is decent, but the pharmacy fee schedule takes the value back: if the County exits before December 31, 2028 it forfeits earned but unpaid rebates, all pharmacy guarantees become null and void for the plan year, and the County must refund allowances for the unfulfilled term on a prorated basis. The document itself labels this an Early Termination Fee, which is precisely the trap the model contract's termination clause exists to remove.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"SPEC","verdict":"bad","confidence":0.85,"page_ref":"Page 40","evidence_quote":"Aetna Specialty Performance Network – Reconciled OEDThe Overall Effective Discount (OED) offer is conditioned on Plan Participants using the Aetna Specialty Performance Network with Aetna being the exclusive provider of Specialty Services with the exception of the HIV class","rationale":"Specialty is defined by the Aetna Specialty Product List, a label set by the vendor rather than by economic function, and the discount guarantee is measured in the aggregate across all specialty drugs, with Aetna free to amend individual specialty discounts to manage the guarantee. The channel is exclusive to CVS Specialty pharmacies except for HIV drugs, and claims there are priced at AWP discounts ranging widely by drug on pages 59 to 71, not at acquisition cost, with new to market products at only AWP minus 16 percent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna's prior written consent.","rationale":"Pricing is wrapped in confidentiality. Section 9.20 of the Group Agreement defines confidential information to include costs and pricing data and the agreement itself, permits compelled disclosure only under a non-appealable court order, and obliges the County to help Aetna seek protective orders. The Public Records Acts clause on page 22 acknowledges the County is subject to state disclosure law, but requires notice to Aetna, time to claim exemptions, and a promise not to oppose Aetna's court action to block release, and every pricing exhibit is footer marked as trade secrets not for distribution. That combination treats what taxpayers pay as the vendor's secret.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"Exhibit G section 4.2 says the parties negotiated in an arm's length fashion and that A&M does not intend ESI to be a fiduciary under ERISA or state law, except for a narrow appeals role. ESI also reserves the right to stop serving any plan in a state that would require a PBM to be a fiduciary. The model contract from Mark Cuban and collaborators requires a duty of loyalty and care solely to the plan and its members. This clause is written to prevent that duty.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DISC","verdict":"bad","confidence":0.9,"page_ref":"Page 115","evidence_quote":"Unlike the Administrative Fees, the revenues described in the Financial Disclosure are not direct or indirect compensation to ESI from A&M System for services rendered to A&M System or the Plan under this Contract.","rationale":"Section 4.3 points to a Financial Disclosure in the Proposal that ESI may update from time to time. Those extra revenues are labeled as not compensation, ESI and its affiliates keep them, and the plan is told it has no beneficial interest except amounts expressly set in the contract. There is no named officer who certifies quarterly or annually that every dollar has been disclosed and remitted. The Proposal itself is not in this file, so even the listed streams cannot be checked here.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The exhibit list on page 17 runs from Exhibit A through K and has no ownership or affiliate disclosure exhibit. Exhibit G names Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. as ESI specialty pharmacies, and section XI.b allows affiliates to perform services, but that is not a signed list of owners, parents, subsidiaries, GPOs, rebate aggregators, and related pharmacies with a 30 day refresh duty.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DEF","verdict":"partial","confidence":0.75,"page_ref":"Page 110","evidence_quote":"“Brand/Generic Algorithm” or “BGA” means ESI’s standard and proprietary brand/generic algorithm, a copy of which may be made available for review by Sponsor or its Auditor upon request.","rationale":"Exhibit G defines AWP, a proprietary brand and generic algorithm, MAC as a list ESI develops or selects, and a Specialty Product List that ESI updates on its own. Several numbered definitions on pages 110 to 112 are blacked out, which is where rebate, manufacturer fee, brand, generic, and specialty product definitions would usually sit. The definitions that can be read leave coding and list placement with ESI rather than closing relabeling loopholes by economic function.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure","rationale":"ESI will pay only the rebate amounts set forth in Exhibit C, and Exhibit C-3 is blacked out so the share cannot be read. Section 4.3 separately lets ESI and its affiliates keep Financial Disclosure revenues and says the plan has no right to them. That is not 100 percent of manufacturer revenue of every kind. Page 38 notes that rebate and manufacturer administrative fee amounts paid to A&M are treated as discounts, which shows some money moves, but the keep-the-rest language is the opposite of a closed pass through.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.8,"page_ref":"Page 24","evidence_quote":"PARTICIPATING PHARMACY _AND_ESI_Mait_ PHARMACY _AVERAGE_AGGREGATE_ANNUAL_INGREDIENT_ COST _AND_DISPENSING FEE Guarantees (Does NoT APPLY TO SPECIALTY PRODUCTS).","rationale":"ESI Mail is an ESI owned pharmacy, yet Exhibit C-2 prices it on average aggregate annual ingredient cost guarantees rather than net acquisition cost plus a stated dispensing fee. Aggregate guarantees leave room for retained margin on individual claims. Specialty is carved out of those guarantees and Exhibit D is blacked out, but the mail channel already contradicts acquisition cost invoicing.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit C-2 on pages 24 to 27 shows average aggregate ingredient cost guarantees, not a claim by claim ceiling against a published cash benchmark. Exhibit G defines usual and customary price on page 112 but never says plan cost cannot exceed that price or any other public benchmark. No other readable article imposes a cheapest lawful option test.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Copayment is defined on page 110 as the member's share, and a Member Submitted Claim on page 111 is only a paper claim for a drug the member already paid cash for, processed for a fee if A&M elects it. Usual and customary price is defined on page 112 as a pharmacy reported cash amount, not as a cap on what the member pays through the plan. Nothing in Exhibit G, the billing article on page 2, or the readable pricing pages credits a cash purchase toward the deductible or bars accumulator adjustment.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.92,"page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules developed or selected by ESI.","rationale":"The only MAC clause gives ESI the power to develop or select the list. There is no requirement that the same list govern what the plan pays and what pharmacies are paid, no disclosure or update schedule, and no pharmacy appeal path with timelines. Vendor controlled MAC lists are how spread is built. Several nearby definitions on the same pages are blacked out, but this definition is readable and is enough.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPRD","verdict":"unclear","confidence":0.7,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Whether the plan pays exactly what the pharmacy is paid is a claims reimbursement term, and Exhibit C-2 on those pages is blacked out. A bona fide dispute definition on page 4 assumes the plan should receive the pharmacy contracted rate, but Exhibit I on page 127 treats a pass through arrangement as something the sponsor might or might not have. The 15 percent ESI keeps on pharmacy audit recoveries is a retained difference, yet it does not prove spread on every claim. The rate exhibit is the place this would be decided.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"The word GPO, group purchasing, and purchasing entity never appear in the 140 pages. Exhibit C-3 headings on pages 35 to 38 cover rebate amounts and manufacturer administrative fees, not a purchasing organization pass through. Section 4.3 on page 115 talks about other ESI revenues in general terms and does not allocate supplier or GPO payments to the plan.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The formulary is developed by ESI's pharmacy and therapeutics committee and is selected or adopted by A&M. ESI may change it for rebate arrangements, and those changes are automatically adopted unless A&M elects not to implement them through a Set-Up Form. That is an opt out, not prior approval of every change, and there is no lowest net cost analysis delivered with each change. The EGWP formulary on page 120 is even tighter because Medicare rules limit sponsor edits.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Formulary section 1.14 on pages 110 to 111 and formulary support section 2.6 on page 114 never state a lowest net cost standard for this plan. There is no annual comparison against ESI's book of business and no duty to disclose a drug placed above a cheaper equivalent. Rebate arrangements are an express reason ESI may change the list, which is the opposite of a net cost test.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.92,"page_ref":"Page 112","evidence_quote":"ESI will make Members aware of the ability to fill their prescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings, and provide supporting services","rationale":"ESI Mail is owned by ESI, and this clause requires ESI to steer members there and to advertise savings. ESI also maintains multiple networks and may consolidate or migrate clients among them. There is no any willing pharmacy term, no ban on retroactive clawbacks, and no bar on conditioning reimbursement on volume. Exclusive and limited distribution products are defined so specialty can be restricted to selected pharmacies.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The main agreement, Exhibit C headings, Exhibit G, and the EGWP addendum contain no most favored pricing clause and no annual market check with a meet, credit, or release remedy. Pricing is locked to Exhibit C for the term unless the parties sign a change or a change in law applies, which is not a market check.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 3","evidence_quote":"Audit by the A&M System may be conducted once annually during the Term of this Contract and the four year period following termination of this Contract.","rationale":"A&M may audit claims, rebates, and performance, and the State Auditor has a statutory right. The A&M auditor must be approved by ESI, may not be a competitor, may not provide litigation services against ESI, and must sit out that work for six months after the audit. One claims audit of 24 months is free each year, rebate contract review is limited to the pieces needed for Exhibit C, Exhibit I caps follow up at 300 claims, and manufacturer contracts may be viewed on site but not copied. Data can be withheld as ESI confidential under those rules.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DATA","verdict":"partial","confidence":0.88,"page_ref":"Page 8","evidence_quote":"anonymized claims data (de-identified in accordance with HIPAA); ESI Specialty Pharmacy and ESI Mail Pharmacy data; information and contracts relating to Rebates and Manufacturer Administrative Fees, prescription drug evaluation criteria, drug pricing information, and Participating Pharmacy agreements","rationale":"Page 4 says research, reports, studies, and data that ESI specifically generates for A&M and that are specific to this program are A&M property and must be delivered on request at the end of the contract. Page 8 then assigns anonymized claims, mail and specialty data, rebate contracts, and drug pricing to ESI. The business associate agreement on page 130 also allows ESI to create de-identified information. A&M does not solely own every derived data set, and ESI may reuse de-identified claims.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PERF","verdict":"unclear","confidence":0.72,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Exhibit I on page 126 lists performance guarantees as something A&M may audit after a true up, so some guarantees exist. The actual measures, whether they are plan specific, whether shortfalls are paid in cash dollar for dollar, and any caps would sit in Exhibit C, which is blacked out on these pages. Without that schedule it is not possible to say whether the remedies are real.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Section VII.b on page 5 allows termination for material breach after a 45 day cure, and section XI.f on page 8 says remedies are cumulative. Exhibit I on page 127 credits claims errors only after both parties accept the audit, through a future invoice. None of those clauses create liquidated damages or automatic credits when a guarantee is missed, and there is no two strikes exit for a second material breach or a regulatory integrity failure.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AMD","verdict":"good","confidence":0.88,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The amendment article requires a writing signed by both parties. Page 2 separately says ESI will not revise Exhibit C program pricing during the term unless required by law or by written agreement. A change in law on page 115 can reopen fees and rebates, but if the parties cannot agree either may terminate rather than ESI rewriting terms by notice. That is as protective as the model on economic amendments.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"TERM","verdict":"good","confidence":0.9,"page_ref":"Page 5","evidence_quote":"the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"A&M may end the contract without cause on ninety days written notice, with no termination fee stated. Either party may also terminate for uncured material breach after 45 days. Loss of legislative funding on page 12 is a further exit. ESI may delay final rebate and CMS amounts for reconciliation at termination, which is not a forfeiture of earned amounts.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPEC","verdict":"unclear","confidence":0.8,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Exhibit D is titled Specialty Drugs Under the Mail Order Pharmacy Program and is fully blacked out on these pages. Page 25's specialty product pricing section is also redacted. Readable text names Accredo as an ESI specialty pharmacy and lets ESI update the Specialty Product List, but the drug level rates, channel ceiling, and whether affiliate specialty claims are billed at acquisition cost would live in Exhibit D.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it to be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"Exhibit F tells A&M to treat the Proposal and Exhibits C, D, and E as confidential and proprietary so they can be withheld from public information requests. Section XI.h on page 8 also treats rebate contracts, manufacturer fees, drug pricing, and pharmacy agreements as ESI property. Page 9 lets ESI advocate for an exemption and seek a protective order. A Public Information Act carve out of that kind does not make the gag a good clause, and it is why the posted contract is blacked out.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"FID","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"I looked through the two pharmacy memoranda on pages 8 to 11, the agenda request on pages 1 to 3 and the consultant recommendation on pages 16 to 18 and found no statement that Envision owes any duty of loyalty or care to the county or its members. The packet describes a transparent business model and a fee only compensation promise, but a business model is not a fiduciary obligation and there is no disgorgement remedy. The executed pharmacy benefit management agreement is not part of this backup, so any fiduciary language it might contain cannot be seen here.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.72,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"The consultant records a promise that Envision will take only its per employee per month fee and no other money connected to the county's drug spend, which is a real statement about compensation. It is well short of what the model contract published by Mark Cuban and collaborators asks for, because there is no schedule of direct and indirect compensation, no disclosure of payments to consultants or brokers, and no officer certification on any cycle. The promise is also described as something Envision will put in writing rather than language the packet actually contains.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no ownership or affiliate exhibit anywhere in the 18 pages. The only corporate relationships named are Envision's mail and specialty partnership with Costco on page 10 and the fact that the outgoing pharmacy benefit manager, OptumRx, is a United Healthcare subsidiary, noted on pages 4 and 8. Neither is a signed disclosure of owners, parents, subsidiaries, group purchasing organizations or rebate aggregators, and nothing requires Envision to refresh such a list when ownership changes.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"DEF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The packet contains no definitions article. Terms that carry the most money in a pharmacy benefit contract, including rebate, manufacturer revenue, affiliate, generic and specialty, are used in the pricing summary on pages 10 and 11 and in the narrative on page 2 without being defined anywhere. Because the executed agreement is not in the backup, there is no way to tell whether the pass through promise reaches administrative fees, data fees or other manufacturer payments.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.75,"page_ref":"Page 2","evidence_quote":"has agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The agenda request states that Envision has agreed to pass through 100 percent of all monies received or earned from county utilization, and the table on page 11 shows retail and mail order rebates as 100 percent pass through with stated minimums of $17.35 per Brand Rx and $66.60 per Brand Rx. That is a broad promise on its face, but the backup gives no definition of the money covered, no payment schedule, no closed list of excluded claims and no audit right to verify the amount. Because the operative contract is not in this packet, the promise cannot be read as the enforceable clause the model contract published by Mark Cuban and collaborators requires.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the packet prices claims dispensed by a pharmacy related to the pharmacy benefit manager at net acquisition cost plus a stated dispensing fee. Mail order and specialty are described on page 10 as a partnership with Costco, and the mail order rates on page 11 are discounts off average wholesale price rather than cost based pricing. There is no documentation default and no rule against retained margin in any owned or related channel.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The pricing summary on pages 10 and 11 sets discount rates off average wholesale price but never caps what the plan pays against any external published benchmark such as a transparent cash price. There is no claim by claim test and no statement that the county will never pay more than a publicly available price. The subject does not appear in the memoranda, the consultant notes on page 17 or anywhere else in the packet.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the packet protects a member from paying more through the plan than the pharmacy cash price, and nothing addresses whether a cash purchase counts toward the deductible or out of pocket maximum. The closest item is the point of sale rebate design described on pages 10 and 17, which lowers member cost at the counter but is not a cash price ceiling and says nothing about accumulators. Member cost sharing rules would live in the plan document and the executed agreement, neither of which is in this backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"MAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Maximum allowable cost appears in the tables on pages 10 and 11 only as the label for the current pricing arrangement with OptumRx, while the proposed Envision generic rates are stated as discounts off average wholesale price. There is no statement that a single list governs both what the county pays and what pharmacies are paid, no disclosure requirement, no update schedule and no pharmacy appeals path with timelines. Whether any list governance exists would have to be read in the executed agreement, which is not part of the packet.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"partial","confidence":0.75,"page_ref":"Page 10","evidence_quote":"which includes no spread pricing on retail, mail or specialty pharmacy","rationale":"The pharmacy award memorandum states that Envision agreed to a complete pass through of pharmacy discounts with no spread pricing in the retail, mail or specialty channels, and page 11 shows a separate administrative fee of $3.50 per employee per month, which is the shape the model contract published by Mark Cuban and collaborators asks for. What is absent is the operative language that would make it enforceable, including a definition of the amount paid to the pharmacy, a reconciliation duty and an audit right. Guaranteed discount rates off average wholesale price, without a stated tie to the pharmacy's actual payment, can still leave room for a difference, so this reads as a strong promise rather than a proven no spread contract.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"GPO","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No group purchasing organization, rebate aggregator or other purchasing entity is named or addressed anywhere in the packet. Page 10 states that Envision contracts directly with pharmacies rather than using rental networks, which speaks to network fees rather than to purchase discounts or supplier payments collected by a related purchasing entity. The broad pass through sentence on page 2 might be argued to reach such money, but the packet contains no clause allocating purchasing entity revenue to the county.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"FORM","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"The packet never says who approves the formulary or its changes. Page 10 describes Envision's flexibility through formulary management to meet the county's needs, which is a statement about vendor capability, not a grant of approval rights to the plan sponsor. There is no lowest net cost analysis requirement and no quarterly reporting of utilization management outcomes by drug, and the agreement that would carry those terms is not in the backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"There is no lowest net cost standard for formulary decisions and no annual comparison against Envision's whole book of business anywhere in the 18 pages. The consultant notes on page 17 discuss claim repricing done during the bid evaluation, which is a one time procurement exercise rather than an ongoing contractual standard. Nothing requires disclosure when a drug is placed above a cheaper equivalent.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"NET","verdict":"partial","confidence":0.6,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"The memorandum notes that members may fill 90 day prescriptions at retail rather than being pushed into mail order, and the packet prices a 90 day retail network on pages 10 and 11, which is a mild protection against steering into a single channel. Page 10 also describes a network of more than 67,000 retail pharmacies contracted directly rather than rented. None of the other network protections in the model contract are present, including finality of adjudicated claims, a bar on retroactive clawbacks, a rule against conditioning reimbursement on volume and an any willing pharmacy right.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The packet contains no most favored pricing promise and no market check. Pricing is fixed in the summary tables on pages 10 and 11 with no mechanism to test it against what comparable clients receive during the term. There is no meet, credit or release remedy, and the executed agreement that could contain one is not in this backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"AUD","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No audit right appears anywhere in the packet, and there is no schedule for delivering claims level or financial data to the county. Reporting appears only as an evaluation criterion for the bid on page 9, listing standard, custom and ad hoc reports, and page 10 describes integrating pharmacy data with medical data for case management. Those are descriptions of capability during scoring, not contractual rights to audit with the county's own auditor or to receive data without asking.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"DATA","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Ownership of claims, eligibility, accumulator and rebate data is never addressed. The only data language is on page 10, where Envision and United Healthcare commit to integrating pharmacy data with medical data for case and disease management, which describes a use of data rather than who owns it. Nothing requires machine readable delivery on request and nothing bars the vendor from reusing or licensing county data.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"Page 2","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan. In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"The agenda request and the pharmacy memorandum both record service performance guarantee money and a 9.5 percent spend reduction guarantee, and page 11 adds rebate minimums per brand prescription, so guarantees clearly exist. The packet does not say how often they are measured, whether they are measured on Travis County data, whether shortfalls are paid in cash or as credits, or whether payouts are capped. Those mechanics would sit in a performance guarantee exhibit that is not part of this agenda backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"ENF","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the packet makes a missed guarantee or a late report trigger an automatic credit or liquidated damages. There is no two strikes exit, no regulatory integrity trigger and no statement that the county can recover without proving damages. Enforcement terms would live in the executed agreement, which was not filed with this agenda item.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"AMD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"The packet has no clause requiring amendments to be signed by both parties and no bar on changing economic terms by notice or updated exhibit. Page 3 labels the contract type as annual and unilateral and page 16 says the three year term runs unless changed by Travis County, but neither line is an amendment procedure. Without the executed agreement there is no way to see how pricing could be changed mid term.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"TERM","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no termination provision in the backup, for convenience or for cause. Page 3 gives a contract period of October 1, 2014 through September 30, 2015 and page 16 gives a three year term ending in 2017, but neither states notice requirements, penalties or what happens to earned rebates and guarantee amounts on exit. A reader cannot tell from this packet whether the county can leave without cost.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"partial","confidence":0.6,"page_ref":"Page 10","evidence_quote":"no spread pricing on retail, mail or specialty pharmacy","rationale":"Specialty pricing is touched only by the statement that there is no spread pricing in the specialty channel and by the note that mail and specialty run through a partnership with Costco. The rate tables on pages 10 and 11 cover retail, 90 day retail and mail order and contain no specialty discounts, dispensing fees or drug level ceilings, and specialty is never defined. There is also no acquisition cost standard for specialty claims, so the single no spread sentence is the only control a reader can see.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"GAG","verdict":"good","confidence":0.7,"page_ref":"Page 11","evidence_quote":"Retail Rebate Minimum                                      $17.35 per Brand Rx","rationale":"Nothing in the packet treats pricing, rebates or fees as confidential or proprietary, and the discount rates, dispensing fees, rebate minimums and administrative fee are printed in a public Commissioners Court agenda record that any resident can read. No language restricts pharmacies from telling members about cheaper options. The caution is that the executed agreement is not in the backup, so a confidentiality article in that document would not be visible here.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"FID","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the 18 pages imposes a duty of loyalty or care on Envision or addresses conflicts of interest. Pages 8 through 11 are the PBM backup memo and they cover pricing, rebates and network design only. A fiduciary clause would live in the executed services agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"The consultant records Envision's commitment to take only its per employee per month fee and no other monies from the drug spend, which is a strong compensation transparency statement. But the backup contains no officer certification, no schedule of affiliate or consultant payments, and no periodic disclosure obligation. How this commitment is defined and enforced sits in the executed agreement, which is not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or passage lists Envision's owners, parents, subsidiaries or affiliates. The only affiliation mentioned is the Costco partnership for mail and specialty pharmacy on page 10, and it is not described as an ownership relationship. There is no obligation to refresh ownership information during the term.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"DEF","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The document is agenda backup and contains no definitions at all. Rebate, manufacturer revenue, affiliate, specialty and generic are never defined, so the pass-through commitment on page 10 cannot be tested against relabeling. The definitions article of the executed agreement is not in the file, and this item's score depends on that missing language.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"PASS","verdict":"good","confidence":0.85,"page_ref":"Page 11","evidence_quote":"Retail Rebate Minimum $17.35 per Brand Rx","rationale":"The backup states on page 10 that Envision agreed to pass through 100% of all monies received or earned through the utilization of the County and its members, and page 11 shows 100% pass-through on both retail and mail rebates with per-brand-claim minimums of $17.35 retail and $66.60 mail, which is stronger than a bare promise. The confidence is capped because the exclusions, definitions and payment timing would live in the executed agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"NAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 notes a partnership with Costco for mail and specialty and page 11 gives AWP discount rates for mail and retail, but nothing prices any related pharmacy at net acquisition cost with a stated dispensing fee. Whether related-entity pricing rules exist depends on the executed agreement, which is not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page sets a claim-level ceiling tied to a published benchmark or cash price. The rate tables on pages 10 and 11 are AWP discount guarantees only. A benchmark ceiling is not mentioned anywhere in the 18 pages.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Nothing addresses member cost sharing relative to pharmacy cash prices, deductible credit for cash purchases, or accumulator adjustments. Member cost sharing is outside the scope of the pricing tables on pages 10 and 11 and is not discussed elsewhere. This would be contract language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"MAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"The letters MAC appear on pages 10 and 11 only in the current UHC column, where generic pricing is listed as MAC or MAC Pricing, while the proposed Envision pricing is stated as AWP discounts (AWP-74.5% retail, AWP-79.00% mail). There is no mention of a MAC list for the new contract, no disclosure or update schedule, and no pharmacy appeals process.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"SPRD","verdict":"good","confidence":0.85,"page_ref":"Page 10","evidence_quote":"which includes no spread pricing on retail, mail or specialty pharmacy","rationale":"The memo states Envision agreed to a complete pass-through of all pharmacy discounts with no spread pricing in any channel, and page 11 discloses the PBM's fixed compensation as a $3.50 per employee per month administrative fee. That matches the model contract's structure of pass-through pricing plus a disclosed admin fee. Confidence is held below 0.9 because the executed agreement's definitions and any network-level exceptions are not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No page mentions a group purchasing organization, rebate aggregator, or purchase discounts or volume credits received through a related purchasing entity. The 100% pass-through language on page 10 is broad but the file never addresses GPO revenue by name. Any such term would be in the executed agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"FORM","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 says Envision has flexibility through formulary management to meet the County's needs, and page 9 lists a covered PDL as an evaluation criterion, but nothing states that the County approves the formulary or its changes or receives utilization management outcomes. Formulary control terms would be in the executed agreement and the formulary exhibit, neither of which is in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page states a lowest net cost standard for formulary decisions, an annual comparison against the PBM's book of business, or disclosure when a drug is placed above a cheaper equivalent. The entire subject is absent from the backup and would live in the executed agreement.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"NET","verdict":"partial","confidence":0.8,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"The 90-day retail fill option is an affirmative protection against steering members into mail order, and page 10 notes Envision contracts directly with pharmacies rather than using rental networks. But the backup says nothing about final adjudication, retroactive clawbacks, volume-conditioned reimbursement, or any willing pharmacy participation. Those network terms would be in the executed agreement or the network manual, which are not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page grants most favored client pricing or an annual market check with a meet, credit or release remedy. The three year term on page 16 has no companion market check provision in this file. Such a clause would be contract language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.75,"page_ref":"Page 9","evidence_quote":"Ability to provide Rx repricing down to the actual claim and pharmacy level","rationale":"The County built claim-level repricing into its evaluation criteria on page 9, and the PBM criteria also list standard, custom and ad hoc reporting, which shows data visibility mattered in scoring. But the backup contains no audit clause: no right to use the plan's own auditor, no audit frequency, no financial data delivery schedule and no pre-adjudication access. Audit and data rights are provisions of the executed agreement, which the backup does not contain, so this can only score partial on what the backup states.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"DATA","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing addresses ownership of claims, eligibility or rebate data, machine readable delivery, or limits on the PBM reusing or selling plan data. Page 7 mentions integration of prescription data from the outside PBM into TPA reports, but that is a service description, not an ownership clause. Data ownership would be defined in the executed agreement, which is not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.82,"page_ref":"Page 10","evidence_quote":"In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"The backup states Envision proposed substantial performance guarantee monies, a 9.5% spend reduction guarantee, and page 11 adds rebate minimums of $17.35 per retail brand claim and $66.60 per mail brand claim. What is missing is the machinery the model requires: measurement on plan-specific data, quarterly reconciliation and dollar-for-dollar cash payment of shortfalls. Whether the guarantees pay out in cash depends on guarantee language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"ENF","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page provides liquidated damages, automatic credits for late reports or missed guarantees, or a two strikes termination right. Enforcement mechanics would be in the executed agreement's guarantee and default articles, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"AMD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"There is no amendment clause anywhere in the 18 pages, so the file cannot show whether changes require mutual signature. Page 3 describes the contract type as annual and unilateral but says nothing about how the agreement may be amended. Amendment terms would be in the executed agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"TERM","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"No termination for convenience provision, notice period, penalty clause or treatment of earned rebates appears in the file. The term itself is described inconsistently, with page 3 stating an annual period ending September 30, 2015 and page 16 stating a three year term ending in 2017 unless changed by Travis County. Termination rights would be contract language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"SPEC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Specialty is mentioned on pages 8, 9 and 10, including the Costco partnership for mail and specialty and the no-spread commitment covering specialty, but the backup gives no specialty definition and no specialty rate table, ceiling or acquisition cost pricing. Specialty pricing terms would sit in the executed agreement and its rate exhibits, which are not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"GAG","verdict":"good","confidence":0.85,"page_ref":"Page 17","evidence_quote":"we agree with the committee that Envision is an excellent choice for the pharmacy spend that will be totally transparent in pricing","rationale":"Reading all 18 pages, there is no confidentiality clause at all: nothing treats pricing, rebates or audit material as proprietary and nothing restricts pharmacies from telling patients about cheaper options. For an agenda backup that is the expected and protective state, and consultant Gallagher describes the pricing as totally transparent. Whether the executed agreement adds a confidentiality article cannot be seen from this file, which is why confidence is not higher.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FID","verdict":"partial","confidence":0.96,"page_ref":"p. 13","evidence_quote":"Customer appoints United a named fiduciary under the Plan with respect to (i) performing initial \nbenefit determinations and payment, (ii) performing the fair and impartial review of first level internal appeals and \n(iii) performing the fair and impartial review of second level internal appeals.","rationale":"A real but function-specific claims and appeals fiduciary delegation appears in the posted text. It is not the rubric's across-the-board PBM loyalty, compensation-disclosure and disgorgement covenant; Section 2.1 also reserves other plan responsibilities to Customer.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DISC","verdict":"partial","confidence":0.96,"page_ref":"p. 34","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to Honest Rx (“Consultant”).  The Consultant Fees are \nincluded in Customer’s pharmacy financial terms.  United shall provide Consultant with a one time Procurement Fee in the amount of \n$25,000, Annual Audit Fees in the amount of $20,000 and monthly payment for all Consultant Fees collected in the amount of $4.00 \nPMPM.","rationale":"The packet discloses a named consultant and distinct one-time, annual and per-member-per-month compensation, plus retained spread/rebates elsewhere. This is useful specific disclosure, not a complete officer-certified inventory of all related-entity revenue. No annualized consultant cost is inferred.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 8","evidence_quote":"United can use its affiliates or subcontractors to perform United’s services under this \nAgreement. United will be responsible for those services to the same extent that United would have been had it \nperformed those services without the use of an affiliate or subcontractor.","rationale":"Scope anchor only: generic affiliate/subcontractor language is not an ownership inventory. All supplied pages were read, but no signed ownership exhibit or refresh obligation can be established from this unsigned packet and the separate incorporated materials were not supplied. This is not an adverse absence finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DEF","verdict":"bad","confidence":0.98,"page_ref":"p. 15","evidence_quote":"Rebate: Any discount, manufacturer administration fees, price concession or other remuneration United receives \nfrom a drug manufacturer under a rebate agreement that is contingent upon and related directly to Participant use \nof a Prescription Drug under the Plan's pharmacy benefit or the medical benefit during the Term. Rebate does not \ninclude any discount, price concession or other direct or indirect remuneration United receives from a drug \nmanufacturer for direct purchase of a Prescription Drug.","rationale":"Although manufacturer administration fees are included, the definition ties receipts to a rebate agreement and participant use and expressly excludes direct-purchase remuneration. That is narrower than the rubric's economic-function definition capturing all manufacturer value.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"p. 33","evidence_quote":"United will pay Fixed Rebates consistent with the Agreement.  To the extent Rebates paid to United exceed the Fixed Rebate amount, We \nwill retain the excess, including any Rebates United may earn on prescription drug products in any tiers not included in this arrangement and \nany related interest.","rationale":"The express excess-retention right contradicts 100% manufacturer-revenue pass-through. Fixed amounts are per eligible brand script by channel, subject to the listed exclusions and PDL conditions; page 17 allows payment within 120 days after quarter-end. Medical-benefit rebates separately use an 80% share on page 12.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NAC","verdict":"bad","confidence":0.97,"page_ref":"p. 34","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United will retain the difference \nbetween what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"The ASA expressly includes affiliated mail/specialty dispensers within Network Pharmacy on page 15, yet permits a retained billing difference in those channels. It therefore does not impose the rubric's net-acquisition-cost-plus-fee/no-margin model. Actual acquisition cost and margin amounts are not established.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CEIL","verdict":"partial","confidence":0.93,"page_ref":"p. 32","evidence_quote":"Discounts calculated based on AWP less the ingredient cost; discount percentages are the discounts divided by the AWP.  Discounts for \nretail and mail order generic prescriptions represent the average AWP based on savings off Maximum Allowable Cost (MAC) pricing for \nMAC generics and percentage discount savings off AWP for non-MAC generics.  All other discounts represent the percentage discount \nsavings off of AWP.","rationale":"AWP-based aggregate discount guarantees provide limited benchmark protection. The denominator is AWP and the numerator is AWP less ingredient cost, not a cash-price or acquisition-cost comparison. Annual combined reconciliation and exclusions do not create a claim-by-claim cheapest-lawful-price ceiling.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CASH","verdict":"partial","confidence":0.98,"page_ref":"p. 34","evidence_quote":"The lessor of three logic (non-ZBL) will apply to Participant payments.  Participants pay the lessor of the discounted price, the usual and \ncustomary charge or the cost share amount.","rationale":"This expressly limits participant payment to the least of three stated amounts. It does not establish automatic deductible/out-of-pocket credit for every outside-plan cash purchase or a sponsor-election requirement for assistance accumulators. Usual-and-customary is not assumed to equal every available discount-card or cash price.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MAC","verdict":"bad","confidence":0.99,"page_ref":"p. 14","evidence_quote":"MAC:  The maximum allowable cost of a Prescription Drug as specified on a list established by United. United \nmay have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole \ndiscretion.","rationale":"Multiple lists and unilateral modification are expressly permitted, opposite to the rubric's single disclosed plan/pharmacy list. This identifies a contractual permission; it does not assert that a particular claim actually used two different MAC prices.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPRD","verdict":"bad","confidence":0.99,"page_ref":"p. 34","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United will retain the difference \nbetween what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"This is an express permission to retain spread across the named channels, including dispensing fees. No amount of actual spread or recoverable overpayment can be calculated from the contract text alone.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 15","evidence_quote":"Rebate does not \ninclude any discount, price concession or other direct or indirect remuneration United receives from a drug \nmanufacturer for direct purchase of a Prescription Drug.","rationale":"The quoted exclusion warrants investigating purchase economics, but does not identify a GPO, establish its revenue, or show its allocation duties. GPO-specific pass-through is not assessable from this unsigned packet and unsupplied purchasing arrangements; no missing-term or actual GPO-retention finding is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FORM","verdict":"partial","confidence":0.94,"page_ref":"p. 15","evidence_quote":"While Customer is the ultimate decision-maker on selecting the design of Customer’s PDL(s), Customer has requested \nthat United supply and assist Customer with, certain PDL development and management functions including but not \nlimited to drug tiering decisions.  United’s intent is to provide Customer with the same PDL and management strategies \nthat United develops and employs in the management of United’s fully insured business.","rationale":"Sponsor design selection is recognized, but the same section gives United final tier classification and permits periodic changes without prior notice; pages 16 and 33 add notice/opt-out procedures and rebate conditions. This is materially weaker than sponsor approval of every change with plan-specific lowest-net-cost analysis.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 15","evidence_quote":"Economic factors may \ninclude, but are not limited to, the Prescription Drug product's acquisition cost including, but not limited to, available \nRebates, and assessments on the cost effectiveness of the Prescription Drug product.","rationale":"Permissible consideration of economic factors is not a mandatory plan-specific lowest-net-cost standard or annual whole-book comparison. Those protections cannot be established in the supplied packet. The illustrative net-cost guarantee concerns a different medical/pharmacy spending measure and is not proof of this formulary standard.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NET","verdict":"bad","confidence":0.94,"page_ref":"p. 34","evidence_quote":"All pricing guarantees require the selection of United as the exclusive mail provider. \n  \nUnited will have no financial guarantee obligation under the Agreement for any partial Guarantee Period if Customer terminates prior to the \nend of the Pharmacy Pricing Term.","rationale":"Pricing protection is conditioned on exclusive United mail service, which page 15 expressly supplies through an affiliate. That creates a documented affiliate-channel restriction inconsistent with the rubric's anti-steering protection. It does not prove actual patient steering, retail exclusion, or pharmacy clawbacks.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 28","evidence_quote":"Prior to the end of the Guarantee Period, and on the condition that this Agreement remains in force, United may specify \nto Customer in writing new performance guarantees for the subsequent Guarantee Period.","rationale":"A provider's ability to set subsequent guarantees is not a sponsor's most-favored-client entitlement or annual market-check remedy. Neither a comparable-client benchmark nor meet/credit/release mechanism is established by the supplied unsigned packet. This is a scope-limited nonassessment, not proof of absence from every related instrument.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AUD","verdict":"partial","confidence":0.99,"page_ref":"p. 16","evidence_quote":"Rebate audits \nare to be conducted separate from claims audits, must be conducted on site at United, and are limited to five (5) Rebate \nagreements.","rationale":"The ASA grants pharmacy/rebate audit rights, but limits rebate review to five agreements on site and ordinarily a qualifying Big Four firm. The same page imposes mutually agreeable auditor/scope, calendar restrictions, confidentiality, and a 300-claim additional-research limit. These are genuine but narrower rights than unrestricted sponsor-selected audits and full scheduled financial data.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DATA","verdict":"bad","confidence":0.96,"page_ref":"p. 45","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the \nPrivacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and \nmay be used and disclosed on Business Associate’s own behalf.","rationale":"Express own-behalf use/disclosure of de-identified derived information is inconsistent with the rubric's absolute no-reuse rule for every derived dataset. This is an editorial commercial comparison, not a conclusion of unlawful PHI use. Pages 5 and 24 provide some confidentiality and transition-file protections, not sole ownership of every dataset.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PERF","verdict":"partial","confidence":0.98,"page_ref":"p. 32","evidence_quote":"Level \nCustomer Specific \nPeriod \nAnnually \nPayment \nPeriod \nAnnually \nPayment \nAmount \n-- \nDiscounts \nThe amount the actual discounts are less than the combined guaranteed Retail, Mail, and Specialty discount amount.","rationale":"Customer-specific pharmacy shortfall formulas are meaningful protection and must not be confused with site/office-level medical service metrics. Pharmacy measurement/payment is annual, combines channels and is subject to exclusions, revision rights and partial-period forfeiture; the exhibit generally uses exclusive fee-credit remedies. The illustrative net-cost table is not an earned payout.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"ENF","verdict":"partial","confidence":0.92,"page_ref":"p. 28","evidence_quote":"With respect to the aspects of \nUnited’s performance addressed in this exhibit, these fee adjustments are Customer’s exclusive financial remedies.","rationale":"Predefined guarantee adjustments give limited enforcement without ordinary damages proof, but are exclusive financial remedies for the specified performance. The base text separately permits termination for uncured material breach after 30-day notice; it does not establish the rubric's automatic late-report relief and penalty-free second-strike mechanism.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"p. 4","evidence_quote":"United will provide Customer with thirty (30) days prior written notice of the revised fees for \nsubsequent Renewal Terms. Any such fee change will become effective on the later of the first day of the new Renewal \nTerm or thirty (30) days after United provides Customer with written notice of the new fees.","rationale":"The general signed-writing provision on page 8 expressly yields to other provisions. Page 4 permits effective fee revisions by notice, and pharmacy provisions also reserve revision/revocation rights. The right to terminate after a fee change is not the same as requiring mutual signed consent before the change.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"TERM","verdict":"bad","confidence":0.99,"page_ref":"p. 33","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to 12/31/2024, United will retain any and all pending or future Rebates \npayable under the Agreement as of the effective date of the termination of pharmacy benefit services.","rationale":"This pharmacy-pricing condition expressly permits loss of pending/future rebates before the stated pricing-term end. Page 26 separately addresses pharmacy-only non-cause termination, and page 33 requires proportional credit repayment and forfeits unpaid credits. The base's post-initial-term 30-day exit does not establish an economically penalty-free exit.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPEC","verdict":"partial","confidence":0.97,"page_ref":"p. 35","evidence_quote":"Actual utilization, using Average Wholesale Price (AWP) in dollars, using our data, of listed specialty drugs through Our specialty \nPharmacy Network will be multiplied against the discount target of 19.0% to determine the overall discount target dollars. \n  \nThe overall discount target dollars may be adjusted based on utilization of unlisted drugs to which the separate 14.0% discount \napplies.","rationale":"The listed/unlisted AWP targets and complete included-drug schedule give a limited pricing control. They are utilization-weighted annual composite targets within United's specialty network, not individual-drug ceilings in every channel or acquisition-cost pricing. Express exclusions, reclassification, revision rights and spread retention substantially narrow protection.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GAG","verdict":"bad","confidence":0.98,"page_ref":"p. 5","evidence_quote":"Neither Party may disclose the other's Confidential Information to \nany person or entity other than to the receiving Party's employees and Business Associates needing access to such \ninformation to administer the Plan, to perform under this Agreement, or as otherwise permitted under this Agreement.","rationale":"Page 2 expressly includes pricing, discounts, reimbursement and compensation in Confidential Information, while page 5 limits recipients and use. Legal-disclosure/public-records and required participant/provider sharing exceptions must be preserved in reporting. This is a rubric transparency red flag, not a legal conclusion that the provision violates a gag-clause law or defeats public-records duties.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FID","verdict":"bad","confidence":0.85,"page_ref":"p. 3","evidence_quote":"United is not the Plan Administrator of the Plan. Any references in this \nAgreement to United “administering the Plan” are descriptive only and do not confer upon United anything beyond \ncertain agreed upon claim administration duties.","rationale":"The full ASA text disclaims any plan-administrator role for United (p. 3). The only fiduciary appointment is narrow: 'Customer appoints United a named fiduciary under the Plan with respect to (i) performing initial benefit determinations' and appeals (p. 13). No clause imposes a duty of loyalty for pharmacy pricing, rebate negotiation or formulary decisions; instead United expressly retains spread (p. 16, p. 34), excess Rebates (p. 33) and 20% of medical drug rebates (p. 12). Scope: posted unsigned ASA text only.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DISC","verdict":"partial","confidence":0.7,"page_ref":"p. 16","evidence_quote":"United maintains systems for \nprocessing pharmacy claims and may receive access fees as compensation for services United provides to Network \nPharmacies. ","rationale":"The document does disclose several compensation streams in general terms: pharmacy access fees (p. 16), retained spread (p. 16, p. 34), retention of excess Rebates and manufacturer administrative fees (p. 33), 20% of medical-benefit drug rebates (p. 12), affiliate payment-services transaction fees 'e.g., 1% to 3% of the total transaction amount' (p. 27), the Honest Rx consultant fee administered through pharmacy terms (p. 34), and the statement that retained rebates 'are used to lower the medical administration fee' (p. 33). It does not quantify amounts retained, does not require periodic compensation reports, and contains no officer certification of completeness. Categorical disclosure without amounts supports 'partial'.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"OWN","verdict":"missing","confidence":0.7,"page_ref":"p. 15","evidence_quote":"An affiliate of United, in its capacity as a Mail Order Pharmacy or Specialty \nPharmacy is a Network Pharmacy of the Customer. ","rationale":"The complete posted ASA (46 pp., Exhibits A-C and BAA) contains no ownership or affiliate-disclosure exhibit and no refresh obligation. Affiliation is acknowledged only in passing (mail order and specialty pharmacies 'that are affiliates of United', p. 15) and in the affiliate payment-services paragraph (p. 27). Because the whole agreement is supplied and no exhibit of this type exists, 'missing' rather than 'unclear'.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DEF","verdict":"partial","confidence":0.7,"page_ref":"p. 15","evidence_quote":"Rebate: Any discount, manufacturer administration fees, price concession or other remuneration United receives \nfrom a drug manufacturer under a rebate agreement that is contingent upon and related directly to Participant use \nof a Prescription Drug under the Plan's pharmacy benefit or the medical benefit during the Term. Rebate does not \ninclude any discount, price concession or other direct or indirect remuneration United receives from a drug \nmanufacturer for direct purchase of a Prescription Drug. ","rationale":"A definitions section exists (pp. 14-15). 'Rebate' is broad enough to reach manufacturer administrative fees and price concessions, which is positive, but it carves out remuneration for 'direct purchase' of drugs and is limited to amounts 'under a rebate agreement'. 'Specialty Drugs' are defined by availability at United's own Specialty Pharmacy (p. 15), and 'MAC' is a list United sets 'in its sole discretion' (p. 14). Definitions are present but not drafted to close economic loopholes.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"p. 33","evidence_quote":"United will pay Fixed Rebates consistent with the Agreement.  To the extent Rebates paid to United exceed the Fixed Rebate amount, We \nwill retain the excess, including any Rebates United may earn on prescription drug products in any tiers not included in this arrangement and \nany related interest. ","rationale":"The pharmacy arrangement is a fixed per-script Rebate guarantee (p. 17, p. 31-32), not a pass-through. United keeps any excess over the guarantee and related interest (p. 33); 'Rebate Administration fees are included in the guaranteed rebate arrangement' (p. 33); payment is quarterly but only 'within 120 days after the end of the quarter' (p. 17); medical-benefit rebates are shared 80/20 (p. 12). Note the guaranteed dollar figures are quoted clause values (e.g., Retail 30 $60.63/$61.73/$64.86, p. 31), not calculated savings.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NAC","verdict":"bad","confidence":0.8,"page_ref":"p. 16","evidence_quote":"On mail order and retail pharmacy services, United will retain the difference between what United reimburses the \nNetwork Pharmacy and Customer payment for a Prescription Drug product or service.  ","rationale":"Mail order and specialty pharmacies are United affiliates and are treated as Network Pharmacies (p. 15). Rather than acquisition-cost pricing, the agreement prices affiliate mail order at AWP-discount guarantees (p. 31) and expressly lets United retain the difference between reimbursement and Customer payment (p. 16; expanded to specialty on p. 34). Affiliate reimbursement rates are disclosed only 'Upon request' (p. 15).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CEIL","verdict":"bad","confidence":0.75,"page_ref":"p. 32","evidence_quote":"Discounts \nThe amount the actual discounts are less than the combined guaranteed Retail, Mail, and Specialty discount amount. ","rationale":"Pricing protection is an annual, aggregate AWP-discount guarantee measured as a combined Retail/Mail/Specialty amount (p. 32), with shortfalls settled after the year. There is no claim-by-claim benchmark ceiling, no cheapest-lawful-option requirement, and United may change specialty designations (p. 34). Positive nuance: a shortfall payment mechanism exists.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CASH","verdict":"partial","confidence":0.6,"page_ref":"p. 34","evidence_quote":"• The lessor of three logic (non-ZBL) will apply to Participant payments.  Participants pay the lessor of the discounted price, the usual and \ncustomary charge or the cost share amount. ","rationale":"Participants pay the lesser of discounted price, U&C or cost share (p. 34), which is a form of cash-price protection at the point of sale. The agreement does not address deductible credit for cash purchases outside the plan, and U&C-priced claims are excluded from the guarantees (p. 32-34).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MAC","verdict":"bad","confidence":0.85,"page_ref":"p. 14","evidence_quote":"MAC:  The maximum allowable cost of a Prescription Drug as specified on a list established by United. United \nmay have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole \ndiscretion. ","rationale":"The ASA permits multiple MAC lists modified in United's 'sole discretion' (p. 14) and generic guarantees are 'based on MAC pricing' (p. 32). No MAC disclosure, single-list requirement, update methodology or appeals process appears anywhere in the 46 pages.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"p. 16","evidence_quote":"On mail order and retail pharmacy services, United will retain the difference between what United reimburses the \nNetwork Pharmacy and Customer payment for a Prescription Drug product or service.  ","rationale":"Spread pricing is expressly authorized in the Statement of Work (p. 16) and again in Exhibit C, extended to specialty drugs and dispensing fees (p. 34: 'On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United will retain the difference'). This is a direct contradiction of the no-spread standard.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GPO","verdict":"bad","confidence":0.65,"page_ref":"p. 15","evidence_quote":"Rebate does not \ninclude any discount, price concession or other direct or indirect remuneration United receives from a drug \nmanufacturer for direct purchase of a Prescription Drug. ","rationale":"No GPO or purchasing-entity pass-through language exists in the complete ASA. The Rebate definition affirmatively excludes remuneration for 'direct purchase' of drugs (p. 15), which leaves purchasing-side manufacturer revenue outside the shared/guaranteed pool. Verdict 'bad' rests on this carve-out; confidence moderated because the document never uses the term GPO.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FORM","verdict":"partial","confidence":0.55,"page_ref":"p. 15","evidence_quote":"United makes the final classification of an FDA-approved Prescription Drug product to a certain tier of the PDL by \nconsidering a number of factors including, but not limited to, clinical and economic factors. ","rationale":"Customer is called 'the ultimate decision-maker on selecting the design of Customer's PDL(s)' and may decline an exclusion or clinical change with 60 days' notice (p. 15-16), but United 'makes the final classification' of drugs to tiers, changes may occur 'without prior notice to Customer' (p. 15), and rebate guarantees are 'contingent upon Customer's adoption, without deviation, of United's PDL' (p. 33). Nominal sponsor control with an economic penalty for exercising it.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"LNC","verdict":"bad","confidence":0.65,"page_ref":"p. 15","evidence_quote":"Economic factors may \ninclude, but are not limited to, the Prescription Drug product's acquisition cost including, but not limited to, available \nRebates, and assessments on the cost effectiveness of the Prescription Drug product. ","rationale":"Tiering considers acquisition cost 'including ... available Rebates' (p. 15) and United's stated intent is to mirror its fully insured PDL (p. 15). There is no lowest-net-cost commitment to the Customer and no book-of-business comparison obligation. The illustrative Net Cost Guarantee pages (pp. 41-43) are a separate, illustrative product description, not a binding lowest-net-cost standard.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NET","verdict":"bad","confidence":0.7,"page_ref":"p. 34","evidence_quote":"• All pricing guarantees require the selection of United as the exclusive mail provider. ","rationale":"United alone 'will determine which pharmacies are Network Pharmacies' (p. 15); all pricing guarantees require United as exclusive mail provider (p. 34); United may revoke guarantees if Customer 'utilizes a vendor, that facilitates steering members to different drugs or pharmacies' (p. 34); Customer must 'encourage Customer Participants to use a Network Pharmacy' (p. 17). No any-willing-pharmacy, no anti-clawback (DIR) protection for pharmacies appears.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MFN","verdict":"missing","confidence":0.8,"page_ref":"p. 8","evidence_quote":"Section 9.4 Entire Agreement. This Agreement, with its exhibits, constitutes the entire agreement between the parties \ngoverning the subject matter of this Agreement.","rationale":"The complete ASA with exhibits (p. 8 entire-agreement clause) contains no most-favored-pricing, market-check or re-benchmarking right for Customer. Fee changes run one way (United may change fees at each Renewal Term, p. 4). Verdict 'missing' because the whole agreement is supplied.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AUD","verdict":"bad","confidence":0.9,"page_ref":"p. 16","evidence_quote":"Without limiting the foregoing, with respect to audits regarding the payment of Rebates by pharmaceutical \nmanufacturers, the audit must be conducted solely by a “big four” public accounting firm that maintains a separate \nand stand-alone audit department and is not providing support in conjunction with any litigation pending against \nUnited or United’s affiliates.","rationale":"Audit rights exist but are heavily constrained: auditor must be 'mutually agreeable' (p. 5, p. 16); no contingency-fee auditors (p. 5, p. 16); once per year, not in December/January, sample capped at 300 pharmacy claims (p. 16) and 400 transactions (p. 5); information beyond claim accuracy 'may be provided at United's reasonable discretion' (p. 16); rebate audits limited to big-four firms, on-site, five Rebate agreements (p. 16). This is the opposite of 'own auditor, full data, no proprietary withholding'.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DATA","verdict":"bad","confidence":0.7,"page_ref":"p. 45","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the \nPrivacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and \nmay be used and disclosed on Business Associate’s own behalf.  ","rationale":"No clause states that the Customer/Plan owns claims or plan data. United retains all rights in its Systems (p. 13), and the BAA authorizes United to de-identify PHI and use it 'on Business Associate's own behalf' and to provide Data Aggregation services (p. 45). Post-termination transition files are limited to open refills, prior authorizations and 'non-financial claims history' (p. 24).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"p. 32","evidence_quote":"Rebates \nThe amount the combined actual Rebate amount is less than the combined guaranteed Rebate amount. ","rationale":"Pharmacy discount, dispensing-fee and Rebate guarantees are customer-specific with dollar shortfall payments (p. 32), which is dollar-for-dollar in form, but measured annually rather than quarterly, subject to numerous exclusions and enrollment/PDL conditions (pp. 33-34), and medical performance guarantees are capped fee credits (p. 28-30).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"ENF","verdict":"bad","confidence":0.75,"page_ref":"p. 28","evidence_quote":"With respect to the aspects of \nUnited’s performance addressed in this exhibit, these fee adjustments are Customer’s exclusive financial remedies.  ","rationale":"Guarantee credits are the 'exclusive financial remedies' (p. 28); disputes go to confidential AAA arbitration after escalation (p. 7); United may unilaterally 'revise, reprice or revoke' pharmacy terms in listed events (p. 34). No self-executing remedy or two-strikes exit right exists.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AMD","verdict":"partial","confidence":0.7,"page_ref":"p. 8","evidence_quote":"Section 9.5 Amendment. Except as may otherwise be specified in this Agreement, the Agreement may be amended \nonly by both parties agreeing to the amendment in writing, executed by a duly authorized person of each party. ","rationale":"Signed-writing amendment clause is present (p. 8), but it is expressly subject to exceptions elsewhere: United may replace Exhibit B fees at each Renewal Term on 30 days' notice (p. 4) and may 'provide Customer with a new Exhibit that will replace this Exhibit' for guarantees (p. 28). The posted copy itself is unsigned by both parties (p. 1).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"TERM","verdict":"bad","confidence":0.7,"page_ref":"p. 26","evidence_quote":"Pharmacy Benefit Rebates - Termination \n \nPursuant to the termination section of this Agreement, if \nCustomer terminates the Pharmacy Benefit Services portion \nof this Agreement only during the Term of the Agreement \nand termination is for any reason other than for cause, United \nmay retain all Rebates that have not been remitted to \nCustomer as of the effective date of such termination. ","rationale":"Either party may terminate on 30 days' notice after the Initial Term (p. 7) and Customer may exit on a fee change (p. 4), but exit carries forfeiture: United may retain unremitted Rebates (p. 26), 'will retain any and all pending or future Rebates' if pharmacy services end before 12/31/2024 (p. 33), owes no guarantee for a partial period (p. 34), and credits/allowances are repayable pro rata (p. 27, p. 33).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPEC","verdict":"bad","confidence":0.75,"page_ref":"p. 34","evidence_quote":"Specialty drug discount level based on actual specialty drug utilization for the specialty drugs dispensed through United's specialty \nPharmacy Network.  United reserves the right to change the designation of a drug from specialty to non-specialty based on market \nconditions. ","rationale":"Specialty is defined by what United's own Specialty Pharmacy dispenses (p. 15); United may re-designate drugs (p. 34); the specialty guarantee is a 19.0% composite with 14.0% for unlisted drugs (p. 34) and spread is retained on specialty (p. 34). The list on pp. 35-40 shows every drug 'Included' but provides no per-drug pricing. No acquisition-cost or open-network specialty control.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0036","contract_slug":"city-of-round-rock-uhc-2022-posted-unsigned-asa","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GAG","verdict":"bad","confidence":0.8,"page_ref":"p. 2","evidence_quote":"Confidential Information:  Information disclosed or made available by a Party in connection with this Agreement, \nincluding without limitation the following, regardless of form or the manner in which it is furnished:  (a) pricing, \ndiscounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements and any \nsimilar commercial information","rationale":"Pricing, discounts, reimbursement terms and compensation arrangements are defined as Confidential Information (p. 2); neither party may 'sell, license, or grant any other rights' to it (p. 5); under a public-records request Customer may furnish 'only that portion ... that is legally required' (p. 5); audits require a signed confidentiality agreement (p. 16) and arbitration is confidential (p. 7). A gag-type restriction on pricing information is present (red flag; zero weight in scoring).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:56:42+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FID","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2023 Financial Renewal under the Administrative Services Agreement (“ASA”) \nbetween United HealthCare Services, Inc. and City of Round Rock","rationale":"Scope anchor only: this financial renewal refers to a separate ASA. It does not permit a determination of PBM-wide loyalty, care, conflict disclosure or disgorgement duties. Do not infer their absence or import the 2022 posted ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DISC","verdict":"partial","confidence":0.97,"page_ref":"p. 11","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to HonestRX (“Consultant”).  \nThe Consultant Fees are included in Customer’s pharmacy financial terms.  United shall provide Consultant with \nan annual audit credit of $20,000 and monthly payment for all Consultant Fees collected in the amount of  $4.00 \npmpm.","rationale":"The renewal names the consultant and discloses the annual audit credit and per-member-per-month payment mechanism as included in pharmacy financial terms. Page 5 separately discloses affiliate payment-service compensation. These limited disclosures do not establish complete PBM/related-entity compensation, ownership and officer certifications. No annual total is calculated from unverified membership.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2023 Financial Renewal under the Administrative Services Agreement (“ASA”) \nbetween United HealthCare Services, Inc. and City of Round Rock","rationale":"The supplied renewal is not a complete set of ASA exhibits. A signed ownership/GPO/affiliate exhibit and its change-notice obligations cannot be assessed; no absence finding is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DEF","verdict":"bad","confidence":0.94,"page_ref":"p. 10","evidence_quote":"The Rebate Credit is calculated as the difference in \npharmaceutical manufacturer revenue between what United would have invoiced pharmaceutical manufacturers if \nthe Customer continued to prefer the originator brand product and the actual pharmaceutical manufacturer revenue \nreceived after favoring the new product (e.g. biosimilar, an authorized brand alternative, reduction of wholesale \nacquisition cost (WAC) on a Brand Drug subject to Rebates, launch of a lower cost non-Generic Drug alternative).","rationale":"The defined Rebate Credit counts a counterfactual manufacturer-revenue difference toward guaranteed rebates and/or the fee credit, rather than requiring that credited value be manufacturer cash received and remitted. This is an explicit economic-definition exception to strict pass-through, not a finding that lower-rebate alternatives are undesirable or that the unprovided ASA contains no other definitions. The clause excludes post-patent generic launches from this credit.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"p. 10","evidence_quote":"United will pay Fixed Rebates consistent with the Agreement.  To the extent Rebates paid to United exceed the \nFixed Rebate amount, We will retain the excess, including any Rebates United may earn on prescription drug \nproducts in any tiers not included in this arrangement and any related interest.","rationale":"Express retention of excess fixed rebates and interest is incompatible with the rubric's 100% all-manufacturer-revenue remittance. The guarantee is per eligible Brand script under the Traditional PDL, with enumerated exclusions and adjustments; it is not a percentage of gross drug spend. Administrative fees being included in the guaranteed arrangement does not convert fixed rebates to full pass-through.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service.","rationale":"The quoted all-channel spread permission is assessed under SPRD. This renewal does not identify which dispensing entities are owned or economically related, their net acquisition costs, or an affiliate-specific pricing/documentation regime. The full affiliate-acquisition-cost item is therefore not assessable rather than deemed absent.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CEIL","verdict":"partial","confidence":0.98,"page_ref":"p. 9","evidence_quote":"Discounts are based on actual Network Pharmacy brand and generic usage of retail and mail order drugs.  The \nguaranteed discount amount will be determined by multiplying the AWP by the contracted discount rate off AWP \nby component.","rationale":"An AWP benchmark constrains aggregate guarantee dollars, but page 9 tests combined Retail, Mail and Specialty discount shortfalls annually. Discounts are AWP less ingredient cost, divided by AWP. This is not a claim-by-claim cheapest-lawful-price ceiling across all drugs/channels; excluded claims and no-AWP items limit coverage.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CASH","verdict":"partial","confidence":0.98,"page_ref":"p. 11","evidence_quote":"The lessor of three logic (non-ZBL) will apply to Participant payments.  Participants pay the lessor of the \ndiscounted price, the usual and customary charge or the cost share amount.","rationale":"The participant payment comparison is an affirmative but limited cash-price protection. It does not establish that every outside cash purchase receives deductible/OOP credit or that assistance accumulators require a written sponsor election. Those broader benefit-administration terms are not assessable from this renewal.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 9","evidence_quote":"Discounts for retail and mail order generic prescriptions represent the average AWP based on savings \noff Maximum Allowable Cost (MAC) pricing for MAC generics and percentage discount savings off AWP for \nnon-MAC generics.","rationale":"This defines the guarantee's generic discount measurement, not MAC-list governance. The renewal does not establish whether identical plan/pharmacy lists, disclosure, update schedules or timed pharmacy appeals apply under the base or network agreements.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"p. 11","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service.","rationale":"The renewal expressly permits retaining the plan-payment/pharmacy-reimbursement difference in retail, mail and specialty, including dispensing fees. This directly conflicts with no-spread pricing; it does not quantify any actual retained margin.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"Rebate Administrative Fee:  United maintains systems and processes necessary for managing and administering \nRebate programs.  As consideration for these efforts, pharmaceutical manufacturers pay United administrative fees \nin addition to Rebates.  Rebate Administration fees are included in the guaranteed rebate arrangement.","rationale":"Manufacturer administrative fees are addressed, but this is not a definition or disclosed allocation of all related purchasing-entity discounts, volume credits and supplier payments. GPO agreements, ownership and allocation terms are not supplied; no inference of missing GPO obligations is drawn.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FORM","verdict":"partial","confidence":0.93,"page_ref":"p. 10","evidence_quote":"Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in \nchanges to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliation.","rationale":"Customer-directed deviations are expressly contemplated, providing some sponsor choice, but with financial consequences against a Traditional PDL assumption. The packet does not establish sponsor approval of every PBM-initiated change, lowest-net-cost analyses, or quarterly drug-level UM outcomes.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and United's \nother ASO customers, result in significant reductions to the Rebate level","rationale":"Lower net drug cost is described as a purpose of a change that permits modifying the rebate arrangement, not an enforceable plan-specific lowest-net-cost standard or an annual whole-book comparison. Neither the existence nor absence of those broader obligations can be resolved from the renewal.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NET","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"All pricing guarantees require the selection of United as the exclusive mail provider. \n  \nUnited will have no financial guarantee obligation under the Agreement for any partial Guarantee Period if \nCustomer terminates prior to the end of the Pharmacy Pricing Term.","rationale":"Exclusive-mail selection conditions the quoted guarantees. It is not sufficient evidence of dispensing-entity ownership, member steering, retroactive pharmacy clawbacks, volume-conditioned reimbursement or any-willing-pharmacy rights. Those network protections remain unassessable; exclusivity is not converted into an unsupported affiliate-steering finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2023 Financial Renewal under the Administrative Services Agreement (“ASA”) \nbetween United HealthCare Services, Inc. and City of Round Rock","rationale":"This scope anchor identifies a renewal rather than the full ASA. Scheduled multi-year financial terms are not evidence for or against automatic comparable-client pricing or an annual market-check remedy in unprovided terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to HonestRX (“Consultant”).  \nThe Consultant Fees are included in Customer’s pharmacy financial terms.  United shall provide Consultant with \nan annual audit credit of $20,000 and monthly payment for all Consultant Fees collected in the amount of  $4.00 \npmpm.","rationale":"Funding a named consultant's audit credit does not grant unrestricted audit authority, claims-level financial records or pre-adjudication access. CAA/TiC service descriptions elsewhere likewise do not resolve PBM audit scope. The underlying audit provisions must be obtained.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2023 Financial Renewal under the Administrative Services Agreement (“ASA”) \nbetween United HealthCare Services, Inc. and City of Round Rock","rationale":"The full ASA and data-use terms are outside this renewal. Reporting and transparency services do not determine sole ownership of claims, accumulators, rebates or derived data, nor restrictions on reuse, sale or licensing.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PERF","verdict":"partial","confidence":0.99,"page_ref":"p. 9","evidence_quote":"Level \nCustomer Specific \nPeriod \nAnnually \nPayment Period \nAnnually \nPayment \nAmount \n-- \nDiscounts \nThe amount the actual discounts are less than the combined guaranteed Retail, Mail, and Specialty discount \namount.","rationale":"The pharmacy guarantee is customer-specific and states a dollar shortfall remedy, but is annual rather than quarterly and combines Retail, Mail and Specialty discount dollars. Dispensing and rebate tests are also combined within their categories. The medical service metrics on pages 6–7 are not mischaracterized as pharmacy guarantees. Actual payouts require claims and reconciliation evidence.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"ENF","verdict":"partial","confidence":0.93,"page_ref":"p. 6","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to its fees in accordance with \nthe performance guarantees set forth below unless otherwise defined in the guarantee.","rationale":"The renewal provides predetermined fee adjustments for the health-benefit guarantees and separately specifies pharmacy shortfall payment amounts. This is limited affirmative enforcement evidence, not proof of automatic cash settlement, late-report damages or penalty-free repeat-breach/regulatory-integrity exit. The latter rights cannot be resolved without the ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"p. 11","evidence_quote":"Pricing and guarantees assume enrollment of 903 Employees and 2,053 Participants; pricing and guarantees may \nbe revised or withdrawn if actual enrollment varies by 10% or more from assumptions.","rationale":"Express revision/withdrawal rights for a defined enrollment deviation are inconsistent with an unconditional both-party-signed-only economic amendment standard. The same page includes other revise/revoke grounds and page 10 rebate modifications. This finding is limited to reserved rights in the renewal; it does not establish that any repricing occurred.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"TERM","verdict":"bad","confidence":0.99,"page_ref":"p. 10","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, \nUnited will retain any and all pending or future Rebates payable under the Agreement as of the effective date of \nthe termination of pharmacy benefit services.","rationale":"The pharmacy-specific clause permits forfeiture of pending/future rebates on termination before the stated January 2023–December 2024 pricing-term end. Page 11 also removes partial-period guarantees and claws back a prorated management allowance. Page 5's pharmacy-only termination provision separately excepts cause; the broader ASA's complete termination rights are not established.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPEC","verdict":"partial","confidence":0.97,"page_ref":"p. 12","evidence_quote":"Actual utilization, using Average Wholesale Price (AWP) in dollars, using our data, of listed \nspecialty drugs through Our specialty Pharmacy Network will be multiplied against the \ndiscount target  to determine the overall discount target dollars.","rationale":"The listed-drug composite target is 19% of AWP for each stated year, with 14% for unlisted drugs dispensed in the specialty network. The target is utilization-weighted and shortfalls are combined with retail/mail; it is not a drug-level ceiling in every channel. Outside-network/no-AWP and medical-benefit specialty exclusions, and reclassification rights, further limit it. Affiliate acquisition-cost terms are not resolved.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GAG","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2023 Financial Renewal under the Administrative Services Agreement (“ASA”) \nbetween United HealthCare Services, Inc. and City of Round Rock","rationale":"The renewal's proprietary footer does not itself establish an operative gag clause. The CAA service offering to support an anti-gag attestation is also not proof of unrestricted disclosure rights or legal compliance. Without the underlying confidentiality/data provisions, this red-flag item remains unknown.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"FID","verdict":"partial","confidence":0.95,"page_ref":"Page 16","evidence_quote":"Client will not identify or represent RIGHTWAY as a Plan Administrator or a named fiduciary of Client's Plan as those terms are used in state or federal Law, except as related to claims and appeals administration as provided in this Agreement.","rationale":"The agreement expressly disclaims general fiduciary status for Rightway, while reserving fiduciary responsibility for claims and appeals administration. That is materially weaker than a loyalty and care duty owed solely to the plan and its members. The cited language does not impose disgorgement, a sole-interest standard, or a broad duty to disclose economic conflicts. Section 5.1 requires written disclosure of existing or potential conflicts, but it does not create a fiduciary remedy. Pages 2, 15 and 16 support this partial verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"DISC","verdict":"partial","confidence":0.9,"page_ref":"Page 2","evidence_quote":"Vendor hereby warrants to City that Vendor has made full disclosure in writing of any existing or potential conflicts of interest related to Vendor's Services under this Agreement. In the event that any conflicts of interest arise after the Effective Date of this Agreement, Vendor hereby agrees immediately to make full disclosure to City in writing.","rationale":"Section 5.1 requires full written disclosure of existing or potential conflicts and prompt disclosure of later conflicts. That is a meaningful disclosure promise, but it does not enumerate all compensation streams, affiliate ownership, broker or consultant payments, or require named officer certification on a quarterly or annual schedule. The contract therefore falls short of the model's comprehensive disclosure and certification architecture. The evidence is on Page 2, with related transparency language on Page 26.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I found no produced page containing a signed ownership and affiliate exhibit listing every parent, subsidiary, owner, GPO, rebate aggregator, mail order pharmacy, and specialty pharmacy, or requiring a thirty-day refresh after ownership changes. Page 10 requires notice of a company name or ownership change for City records, but that is not an ownership disclosure exhibit and does not identify economic affiliates. Pages 1, 10, 26, 31 and 52 were reviewed for this item, so the correct verdict is missing.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 52","evidence_quote":"The amount RIGHTWAY receives for Rebates from Manufacturers, Rebate Aggregators and/or intermediaries may be different from the amount such Rebate Aggregators and/or intermediaries receive through their own Manufacturer or intermediary agreements, which such difference may be retained by the Rebate Aggregator and/or intermediary as its compensation","rationale":"The agreement defines Manufacturer Derived Revenue and Rebates broadly in the definitions, but then permits intermediary compensation to remain outside the rebate amount delivered to the City. That carve out allows value to be relabeled or retained as aggregator compensation rather than passed through. The contract also leaves specialty classification subject to Rightway's changing list. These economic exceptions make the definitions weaker than an economic-function standard that captures every manufacturer and purchasing payment. Pages 31, 32, 33 and 52 support the verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"PASS","verdict":"partial","confidence":0.98,"page_ref":"Page 51","evidence_quote":"Client will receive 100% of the Rebates earned and collected on a pass -through basis. RIGHTWAY will calculate and report the Client's Manufacturer Derived Revenue allocations quarterly. Additionally, RIGHTWAY is required to pay Minimum Rebate Guarantee within ninety (90) days following each calendar quarter close.","rationale":"The contract states that the City receives one hundred percent of rebates earned and collected and identifies Manufacturer Derived Revenue categories. However, payment is limited to amounts actually earned and collected, while aggregator or intermediary compensation can be retained outside the defined rebate. Rebate guarantees also contain numerous exclusions, and the agreement waives claims against upstream failures. Thus the promise is strong on collected rebates but weaker than one hundred percent of every manufacturer-derived payment. Pages 31, 51 and 52 support this partial verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"NAC","verdict":"partial","confidence":0.85,"page_ref":"Page 49","evidence_quote":"Under the RIGHTWAY transparent, full Pass -Through model, Client pays the actual reimbursement rate (discounts and dispense fees) paid by RIGHTWAY to the Participating Pharmacy from which the Claim originates, less the Eligible Person Cost -Sharing Amount.","rationale":"The pass-through provision requires the City to pay the actual reimbursement rate Rightway pays the participating pharmacy, which is favorable for network claims. The text does not establish acquisition-cost-plus-dispensing-fee pricing for Rightway-owned or economically related pharmacies, does not prohibit retained affiliate margin, and does not create a documentation default if records are withheld. Specialty and mail pharmacies remain preferred Rightway channels. The evidence on Page 49 supports a partial rather than good verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"CEIL","verdict":"partial","confidence":0.85,"page_ref":"Page 50","evidence_quote":"All Claims will adjudicate at and Client will pay RIGHTWAY \n(except as stated in (c) below) the lower of (i) U&C (if applicable); (ii) AWP minus the Participating \nPharmacy's discount rate plus Dispensing Fee; (iii) MAC (if applicable) plus Dispensing Fee; or (iv) the \nParticipating Pharmacy's submitted amount plus Dispensing Fee","rationale":"The pricing logic selects the lower of U&C, an AWP discount formula, MAC, or the pharmacy submitted amount, which creates a useful claim-level ceiling among the listed measures. It is not a published universal benchmark for every drug and channel, and third-party discount pricing has separate treatment. The agreement also contains many guarantee exclusions. Because the formula is protective but not the model's unconditional benchmark ceiling, the verdict is partial. Page 50 is the primary evidence.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"CASH","verdict":"partial","confidence":0.9,"page_ref":"Page 50","evidence_quote":"All Claims will adjudicate at and Eligible Person will pay \nParticipating Pharmacies (except as stated in (c) below) the lower of (i) U&C (if applicable); (ii) AWP \nminus the Participating Pharmacy's discount rate plus Dispensing Fee; (iii) MAC (if applicable) plus \nDispensing Fee; (iv) the Participating Pharmacy's submitted amount plus Dispensing Fee","rationale":"The member pricing rule generally uses the lower of U&C, AWP, MAC, submitted amount, or the cost-sharing amount, and third-party discount pricing can lower the claim further. The document does not say every cash purchase counts toward deductible and out-of-pocket maximum, and it does not address accumulator adjustment restrictions for assistance. The rule therefore protects point-of-sale price in part but omits the model's complete member protections. Page 50 supplies the evidence.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"MAC","verdict":"partial","confidence":0.9,"page_ref":"Page 31","evidence_quote":"Maximum Allowable Cost (\"MAC\") means the maximum allowable cost determined by RIGHTWAY \nand updated at least quarterly, or more frequently as required by Law, based upon review and analysis of \ncurrent pricing in the marketplace.","rationale":"The MAC definition requires quarterly or more frequent updates and makes the mail and retail MAC lists identical, which addresses a central spread-pricing concern. The agreement does not disclose the list itself, provide a pharmacy appeal procedure, or establish defined response timelines for appeals. It also leaves MAC determination with Rightway. Those omissions make the clause materially weaker than a disclosed, governed MAC regime. Pages 31 and 44 support this partial verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"SPRD","verdict":"good","confidence":0.98,"page_ref":"Page 49","evidence_quote":"100% of the Participating Pharmacy negotiated pricing will be passed through to Client from RIGHTWAY on a Claim by Claim basis even if a Claim is excluded from an AWP Discount Guarantee or Dispensing Fee Guarantee hereunder.","rationale":"The contract expressly requires one hundred percent of participating pharmacy negotiated pricing to pass through to the City on a claim-by-claim basis, including claims excluded from AWP or dispensing fee guarantees. It also defines pass-through as the amount Rightway pays the pharmacy equaling the amount invoiced to the City. The cited language directly addresses the model's no-spread requirement across network channels, although upstream aggregator compensation remains a separate concern. Pages 31 and 49 support this good verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 52","evidence_quote":"The amount RIGHTWAY receives for Rebates from Manufacturers, Rebate Aggregators and/or intermediaries may be different from the amount such Rebate Aggregators and/or intermediaries receive through their own Manufacturer or intermediary agreements, which such difference may be retained by the Rebate Aggregator and/or intermediary as its compensation","rationale":"The contract expressly allows the rebate aggregator or intermediary to retain the difference between its manufacturer receipts and the amount Rightway receives. That is a direct economic carve out for a purchasing or rebate intermediary and is not allocated to the plan. The agreement does not require disclosure of every related purchasing entity or allocate those retained amounts using disclosed drivers. The provision therefore permits precisely the intermediary revenue leakage the model term is designed to prevent. Page 52 is decisive.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"FORM","verdict":"bad","confidence":0.98,"page_ref":"Page 21","evidence_quote":"RIGHTWAY shall provide a recommended drug Formulary to Client and Client hereby adopts, as part of the Plan design and as Client's formulary, such Formulary (as amended from time to time). Client agrees to implement, administer, and cooperate with RIGHTWAY and to facilitate Eligible Persons' utilization of the Formulary.","rationale":"The agreement makes Rightway's recommended formulary the City's formulary and permits amendment over time, while requiring the City to implement and facilitate utilization. That is the opposite of sponsor approval of every formulary change. The text does not require the sponsor to receive lowest-net-cost analysis or quarterly drug-level utilization management outcomes before changes become effective. The cited Page 21 language therefore supports a bad verdict, reinforced by the Rightway-controlled formulary definition on Page 30.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"LNC","verdict":"partial","confidence":0.85,"page_ref":"Page 30","evidence_quote":"Formulary means the list of FDA -approved Covered Products developed by RIGHTWAY's Pharmacy and Therapeutics Committee, approved and adopted by Client and subject to Client's Plan Documents and coverage decisions. The Formulary is based on drug safety, drug efficacy, and drug cost/lowest net cost analysis.","rationale":"The definition says the formulary is based on safety, efficacy, and cost or lowest-net-cost analysis, which is a useful substantive criterion. However, the agreement does not require a plan-specific lowest-net-cost standard, annual whole-book comparison, or disclosure of every drug placed above a cheaper equivalent with reasons. Moreover, Rightway develops the formulary and the City adopts it as amended. The clause is therefore partial. Page 30 is the primary evidence, with Page 21 showing control.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"NET","verdict":"bad","confidence":0.95,"page_ref":"Page 53","evidence_quote":"Guarantees and PMPM Target assumes RIGHTWAY's preferred network of Mail Order Pharmacy and Specialty Pharmacies as exclusive fulfillment partners.","rationale":"The agreement conditions guarantees and PMPM targets on Rightway's preferred mail order and specialty pharmacies being exclusive fulfillment partners. It also grants Rightway exclusive service status and permits pricing changes after a client breach of exclusivity. These terms do not provide the model's anti-steering protections, willing-pharmacy participation, or final adjudication without retroactive clawbacks. The contract therefore supports steering into preferred channels and earns a bad verdict. Pages 16, 18, 49, 50 and 53 support the conclusion.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"MFN","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"I found no produced clause granting automatic most-favored pricing against comparable clients, no annual market check, and no meet, credit, or release remedy. The cooperative purchasing sentence on Page 1 permits possible use by other governmental entities but expressly reserves the right to modify fees, pricing, and financial terms based on claims detail. Pages 1, 38, 48 through 54 were reviewed for market-check or comparable-client protections. The document does not address this rubric item, so the verdict is missing.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"AUD","verdict":"partial","confidence":0.96,"page_ref":"Page 4","evidence_quote":"For the avoidance of doubt, Auditor shall not be entitled to audit Vendor's vendors, Manufacturers, Rebate Aggregator, pharmacies, or other providers of Services hereunder, however, Auditor will be provided access to relevant business records (e.g. rate sheets, contract provision excerpts, policies and procedures, invoices, etc.) reasonably necessary to conduct the audit.","rationale":"The City receives one annual audit right during the term and for one year afterward, with access to directly pertinent records and relevant business records. Claims files and financial components are also delivered on a schedule. However, the auditor cannot audit Rightway's vendors, manufacturers, rebate aggregator, pharmacies, or other providers, must sign Rightway's nondisclosure agreement, and is subject to Rightway's audit policy. These limitations materially weaken the model's full data and independent audit access. Pages 3, 4 and 20 support the partial verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"DATA","verdict":"bad","confidence":0.98,"page_ref":"Page 3","evidence_quote":"During and after the Term of this Agreement, Vendor may use, reproduce, disclose, and/or adapt information obtained, generated, or derived in connection with this Agreement, including Claims data information, eligibility information, medical data, and other health data, in a de -identified and/or aggregated format for research, profiling, benchmarking","rationale":"The agreement gives Rightway continuing rights during and after the term to use, reproduce, disclose, and adapt claims, eligibility, medical, and other health data in de-identified or aggregated form for research, profiling, benchmarking, and business purposes. It expressly states that Rightway retains full ownership of resultant data. Although the City receives claims files and certain disclosures, the vendor's reuse and ownership rights contradict sole sponsor ownership and a no-license or no-sale rule. Page 3 is decisive.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"PERF","verdict":"partial","confidence":0.98,"page_ref":"Page 34","evidence_quote":"In no event will the sum of the amounts owed to Client, as a result of RIGHTWAY's failure to meet the performance guarantees exceed the total dollars stated at risk for any given calendar year. Performance guarantees shall be void if the Agreement is terminated before completion of Year One.","rationale":"The contract contains measurable performance guarantees and dollar credits, but the remedies are capped at the dollars placed at risk, credits are applied to future invoices, and guarantees are void if the contract ends before Year One or during a partial year. Many guarantees are measured across Rightway's book of business rather than plan-specific data. These limits are materially weaker than uncapped dollar-for-dollar cash reconciliation on plan data. Pages 27, 34, 35, 36 and 37 support the partial verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"ENF","verdict":"bad","confidence":0.98,"page_ref":"Page 27","evidence_quote":"The parties agree that any financial penalties determined under this Agreement payable by RIGHTWAY for failure to meet the performance standards shall be payable solely on the account of a failure to satisfy the standards. The failure to meet a performance standard shall not, in and of itself, constitute a Material Breach of the Agreement.","rationale":"The agreement provides limited performance credits, but expressly says a missed performance standard is not itself a material breach. It does not create liquidated damages for late reporting, automatic credits for every late report, or a two-strikes exit for repeat failures or regulatory integrity events. The plan must also reconcile through procedures and capped amounts. Because enforcement lacks the model's self-executing exit and broad automatic remedies, the verdict is bad. Page 27 supplies the clearest evidence.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"AMD","verdict":"partial","confidence":0.96,"page_ref":"Page 9","evidence_quote":"No amendment, modification, or extension of this Agreement will be binding upon a party hereto unless set forth in a written instrument, which is executed by an authorized representative of each party.","rationale":"The body of the agreement requires amendments, modifications, and extensions to be in a written instrument executed by authorized representatives of both parties. That is strong protection against ordinary unilateral changes. However, the agreement separately allows Rightway to modify regulatory addenda by written notice for legal compliance and to change pricing under listed conditions. Those carve outs prevent an unqualified good verdict under the model's economic-term standard. Pages 8, 9, 53 and 54 support partial.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"TERM","verdict":"good","confidence":0.98,"page_ref":"Page 2","evidence_quote":"City may terminate this Agreement at any time and for any reason by providing Vendor with 90 days' written notice of termination without penalty or termination fees. Vendor may terminate this Agreement at any time and for any reason by providing City with 180 days' written notice of termination.","rationale":"The City has a clear convenience termination right on ninety days written notice without penalty or termination fees. The agreement also provides payment for services rendered through termination, transition files, and payment or credit of amounts owed in ordinary termination circumstances. The principal limitation is that rebate obligations can be withheld or offset after a City material breach. On the model item, the express no-penalty convenience right and regulatory change termination support a good verdict. Pages 2 and 24 through 25 support this finding.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"SPEC","verdict":"partial","confidence":0.95,"page_ref":"Page 33","evidence_quote":"A then -current list of Specialty Pharmaceuticals may be obtained at any time by contacting RIGHTWAY. RIGHTWAY reserves the right to modify the Specialty Drug list from time to time. Specialty Drugs are not devices, supplies, medical foods, or durable medical equipment.","rationale":"Specialty drugs are defined functionally to include biotech and complex products requiring monitoring, management, special handling, or administration. The agreement also provides specialty-specific rates and guarantees, including a drug-level high-cost schedule. However, Rightway controls and may modify the specialty list, and the contract does not establish a universal drug-level ceiling in every channel or require acquisition-cost pricing for affiliate specialty pharmacies. The result is partial. Pages 33, 49, 50 and 55 support the verdict.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Gemini 3.8 Flash","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 26","evidence_quote":"RIGHTWAY will share with Client: (a) sources of revenue as they relate to the Client's contract, and (b) the pricing structure for pharmacy benefit management Services including rebate structure and administrative fees; provided Client acknowledges and agrees that information shared with Client pursuant to this section is RIGHTWAY's Confidential Information.","rationale":"The agreement labels sources of revenue, pricing structure, rebate structure, and administrative fees shared with the City as Rightway confidential information. Other provisions restrict disclosure of City Information and require auditors to sign Rightway's nondisclosure agreement, while the public-records clause merely gives Rightway an opportunity to object to release. The contract does not provide a clean unconditional right to share pricing and performance data with the public, lawmakers, members, and advisors. This is a bad red-flag result. Pages 3, 4 and 26 support it.","model_own_total":41.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"FID","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The eighteen page agenda backup never states that Envision owes duties of loyalty or care solely to Travis County or its members, must disclose conflicts, or must disgorge amounts retained in breach. Pages 8 through 11 and 16 through 17 describe the award, AWP rates, rebates, and a PEPM fee, not a fiduciary standard. Because the executed agreement is not in this file, a loyalty duty cannot be scored from contract text.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"DISC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Pages 10 and 11 list proposed AWP discounts, dispensing fees, rebate minimums, and a $3.50 PEPM administrative fee, and page 17 says Envision will accept only that PEPM fee. There is no covenant requiring disclosure of all related-entity compensation, affiliate ownership, or broker payments, and no named officer certification quarterly or annually. The backup also says additional fees are in the Contract that is not attached. Full compensation and conflict disclosure as required by the model contract of Mark Cuban and collaborators is not in this packet.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No signed ownership exhibit appears in the eighteen pages. Page 10 mentions a Costco partnership for mail and specialty but does not list owners, parents, subsidiaries, affiliates, group purchasing organizations, or rebate aggregators, and does not require a refresh within 30 days after a change in control. The award memos and Gallagher notes on pages 8 through 11 and 16 through 18 do not fill that gap.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"DEF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The backup has no definitions article. Pages 10 and 11 use rebates, 100% Pass-Through, MAC, and Brand as table labels without defining manufacturer revenue, affiliate, specialty, or generic by economic function. Staff language on page 10 about all monies received or earned is a narrative claim, not a closed definition. Verdict depends on the missing agreement.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"PASS","verdict":"partial","confidence":0.84,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"HRMD on page 10 says Envision has agreed in contracts to pass through 100% of all monies received or earned through Travis County utilization, and Gallagher on page 17 says Envision will put in writing that it will accept only its PEPM fee. Page 11 labels retail and mail rebate management as 100% Pass-Through and states brand rebate minimums of $17.35 and $66.60. That is weaker than the model because this is agenda backup rather than the executed agreement, payment timing and a closed exclusion list are not stated, and additional fees are said to live in the unattached Contract.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing on pages 8 through 11 prices Envision-related or Costco mail or specialty claims at net acquisition cost plus a stated dispensing fee. The Costco partnership and no-spread sentence on page 10 address discounts, not acquisition-cost invoicing or a documentation default if records are not produced. Affiliate acquisition-cost terms are not in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The rate tables on pages 10 and 11 are AWP discounts and dispensing fees. There is no claim-by-claim ceiling against a published cash price or other public benchmark. Pages 1 through 18 do not mention a cheapest lawful option test.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Member cash price, deductible credit for cash purchases, and accumulator treatment of manufacturer assistance are not discussed on any page. The PBM recommendation on pages 8 through 11 and the Gallagher notes on pages 16 through 17 address plan cost and rebates, not what a member pays at the counter versus cash. Those protections would have to appear in the missing agreement.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"MAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 shows current generic pricing as MAC and proposed generic pricing as AWP-74.5%, and page 11 shows mail generic moving from MAC Pricing to AWP-79.00%. That is a change in the pricing index, not MAC list governance. There is no single list for plan and pharmacy, no disclosure schedule, and no pharmacy appeals path in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"SPRD","verdict":"partial","confidence":0.83,"page_ref":"Page 10","evidence_quote":"no spread pricing on retail, mail or specialty pharmacy.","rationale":"Page 10 states Envision agreed to a complete pass through of all pharmacy discounts, including no spread pricing on retail, mail or specialty, and page 17 says Envision will accept only the PEPM fee. Those terms move toward the model, but the same pages present AWP guarantee tables as the cost structure and warn that additional fees are included in the Contract that is not attached. Without executed adjudication language that the County pays exactly what pharmacies are paid, spread cannot be ruled out.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Group purchasing organizations, offshore aggregators, volume credits, and supplier payments to related purchasing entities are not named on any page. Pages 10, 11, and 17 discuss rebates and all monies in general terms, which is not a GPO pass-through clause. The missing agreement would have to supply that.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"FORM","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Pages 2 and 10 praise Envision flexibility through formulary management to meet County needs. That is PBM-side flexibility, not a rule that Travis County approves the formulary and every change or receives lowest-net-cost analysis and quarterly utilization management outcomes. No formulary control clause appears in the backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No lowest-net-cost standard, book of business comparison, or disclosure of drugs placed above a cheaper equivalent appears on pages 8 through 11 or 16 through 18. Formulary is mentioned only as Envision flexibility on pages 2 and 10. The executed agreement is not in the file.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"NET","verdict":"partial","confidence":0.8,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"Page 10 says Envision has over 67,000 retail pharmacies, contracts directly rather than using rental networks, and lets members fill 90-day prescriptions at retail instead of requiring mail order. Those are network access points, but the backup has no claims-final rule, no ban on retroactive clawbacks, and no any-willing-pharmacy term. It also does not forbid steering to a preferred mail or specialty pharmacy such as the Costco partnership described on that page.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Pages 8 through 11 and 16 through 18 contain no most favored customer, comparable client, or annual market check with a meet, credit, or release remedy. The 9.5% spend reduction guarantee on pages 2 and 10 is a savings promise, not an MFN. Market-check rights are not in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"AUD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 9 lists reporting and claim-level repricing as RFP evaluation criteria, and page 10 says Envision completed a one-time re-pricing of prior year claims. That is the procurement process, not a continuing right for the County to audit with its own auditor, receive claims-level financial data on a schedule, or obtain pre-adjudication access. No audit article is in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"DATA","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 says Envision and UHC will integrate Rx data with medical data for case management. That is data sharing, not County ownership of claims, eligibility, accumulator, rebate, or derived data, and it does not bar Envision from reusing or selling the data. Ownership language is not in the packet.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.82,"page_ref":"Page 10","evidence_quote":"In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"Pages 2 and 10 state that Envision included substantial performance guarantee monies and is proposing a 9.5% spend reduction guarantee over current pharmacy costs. Page 11 adds retail and mail brand rebate minimums of $17.35 and $66.60 per Brand Rx. The backup does not say guarantees are measured quarterly on plan-specific data, paid in cash, or uncapped dollar for dollar, and the guarantee exhibit is not attached.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No liquidated damages, automatic credits, two-strikes exit, or termination for a second material breach or integrity failure appears in the eighteen pages. Pages 3 and 16 state term length only. Self-executing enforcement is not in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"AMD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 3 labels the award Annual, Unilateral, but that is a purchasing classification, not a clause that amendments are effective only if signed by both parties. Nothing on pages 8 through 18 stops midterm economic changes by notice or exhibit. The executed amendment article is not here.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"TERM","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Page 16 states a three year term from October 1, 2014 ending 12:00 a.m. on September 31, 2017, unless changed by Travis County. Page 3 separately lists a one year period through September 30, 2015. Neither passage grants termination for convenience without penalty, preservation of earned amounts, or a regulatory integrity exit.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"SPEC","verdict":"partial","confidence":0.8,"page_ref":"Page 10","evidence_quote":"partnership with Costco for mail and specialty pharmacy","rationale":"Page 10 includes specialty in the no-spread promise and names a Costco partnership for mail and specialty pharmacy. The rate tables on pages 10 and 11 have retail, 90-day retail, and mail rows but no specialty drug-level rates, no functional definition of specialty, and no acquisition-cost rule for affiliated specialty pharmacies. Specialty is addressed only at that high level in this backup, not in an executed specialty exhibit.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"GAG","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The eighteen pages are open agenda backup with no confidentiality, trade secret, or pharmacy gag clause. Because this is not the executed agreement, whether the contract restricts the County from sharing pricing or rebate data, or restricts pharmacies from telling members about cheaper options, cannot be determined from this file. Nothing here is redacted. The verdict depends on contract language the backup does not contain.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FID","verdict":"unclear","confidence":null,"page_ref":"p. 2","evidence_quote":"Customer acknowledges that Fees paid for administrative services \nare reasonable.","rationale":"Only the fee acknowledgement (p. 2) touches on duties; no fiduciary or loyalty language is in the renewal exhibits. This record is a financial renewal (cover letter plus replacement Exhibit B Fees and Exhibit C Performance Standards, 1/1/2023-12/31/2024). The base ASA governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is not an adverse finding and does not imply redaction.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DISC","verdict":"partial","confidence":0.5,"page_ref":"p. 5","evidence_quote":"Some options are \navailable to medical providers for a fee and may result in the receipt of transaction fees or other compensation (e.g., \n1% to 3% of the total transaction amount) by a United affiliate.","rationale":"Within the renewal's own scope it discloses several revenue streams: affiliate payment-services fees (p. 5), retention of spread (p. 11, p. 12), retention of Rebates above the fixed guarantee and inclusion of manufacturer administrative fees in the guarantee (p. 10), retained rebates lowering the medical fee (p. 10), and the HonestRX consultant fee (p. 11). Amounts retained are not quantified and no certification is present. Disclosure obligations of the base ASA are not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 5","evidence_quote":"Some options are \navailable to medical providers for a fee and may result in the receipt of transaction fees or other compensation (e.g., \n1% to 3% of the total transaction amount) by a United affiliate.","rationale":"The only affiliate reference is the payment-services disclosure (p. 5). No ownership exhibit is expected in a financial renewal. This record is a financial renewal (cover letter plus replacement Exhibit B Fees and Exhibit C Performance Standards, 1/1/2023-12/31/2024). The base ASA governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is not an adverse finding and does not imply redaction.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DEF","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"Rebate Credit” is a credit towards the achievement of the guaranteed Rebate amount, and/or Rebate Fee Credit.  \nThe Rebate Credit is applied in the event of a change impacting the level of Rebates expected as a result of the \navailability of clinically comparable lower Rebate drugs.","rationale":"The renewal defines only guarantee-mechanics terms such as 'Rebate Credit' (p. 10); it does not define Rebate, Brand, Generic, Specialty or MAC. Those definitions live in the base ASA, which is not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PASS","verdict":"bad","confidence":0.85,"page_ref":"p. 10","evidence_quote":"• United will pay Fixed Rebates consistent with the Agreement.  To the extent Rebates paid to United exceed the \nFixed Rebate amount, We will retain the excess, including any Rebates United may earn on prescription drug \nproducts in any tiers not included in this arrangement and any related interest. ","rationale":"The 2023-2024 pharmacy financials are a 'Fixed Rebate Guarantee (Traditional PDL)' per brand script (Retail 30 $61.73/$64.86; Retail 90 $181.00/$182.77; Mail $144.18/$135.29; Specialty $328.03/$338.82, p. 9). United retains excess Rebates and interest (p. 10), 'Rebate Administration fees are included in the guaranteed rebate arrangement' (p. 10), and retained rebates fund a $40 PEPM fee credit (p. 2, p. 10). This is directly assessable from the renewal and is not a 100% pass-through. Figures are quoted clause values, not calculated savings.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service. ","rationale":"The renewal prices mail and specialty on AWP-discount guarantees (p. 8) and authorizes United to retain the difference on mail order and specialty drugs (p. 11, p. 12). Whether the mail/specialty pharmacies are United affiliates is not stated in this document, so acquisition-cost pricing for affiliates cannot be assessed here; the retained-difference clause is noted as relevant context.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CEIL","verdict":"bad","confidence":0.7,"page_ref":"p. 9","evidence_quote":"Discounts \nThe amount the actual discounts are less than the combined guaranteed Retail, Mail, and Specialty discount \namount. ","rationale":"Discount protection is an annual, combined Retail/Mail/Specialty guarantee (p. 9) with a shortfall payment; there is no claim-by-claim benchmark ceiling and U&C-priced claims and other categories are excluded (p. 9-10). Assessable directly from Exhibit C.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CASH","verdict":"partial","confidence":0.6,"page_ref":"p. 11","evidence_quote":"The lessor of three logic (non-ZBL) will apply to Participant payments.  Participants pay the lessor of the \ndiscounted price, the usual and customary charge or the cost share amount. ","rationale":"Lesser-of-three participant pricing is stated (p. 11), a point-of-sale cash-price protection. No deductible-credit provision for outside-plan cash purchases appears in the renewal.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 9","evidence_quote":"order generic prescriptions represent the average AWP based on savings \noff Maximum Allowable Cost (MAC) pricing for MAC generics and percentage discount savings off AWP for \nnon-MAC generics.","rationale":"MAC is referenced only as the basis for generic effective-discount measurement (p. 9). MAC list governance (single list, disclosure, appeals) is a base-ASA topic not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"p. 11","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service. ","rationale":"Exhibit C expressly authorizes spread on mail, specialty, retail and dispensing fees (p. 11) and repeats it for specialty (p. 12). Directly assessable; contradicts the no-spread standard.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"Rebate Administrative Fee:  United maintains systems and processes necessary for managing and administering \nRebate programs.  As consideration for these efforts, pharmaceutical manufacturers pay United administrative fees \nin addition to Rebates.","rationale":"No GPO or purchasing-entity language appears in the renewal; manufacturer administrative fees are described (p. 10) but purchasing-side revenue is not. This record is a financial renewal (cover letter plus replacement Exhibit B Fees and Exhibit C Performance Standards, 1/1/2023-12/31/2024). The base ASA governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is not an adverse finding and does not imply redaction.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FORM","verdict":"partial","confidence":0.5,"page_ref":"p. 10","evidence_quote":"• Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in \nchanges to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliation.","rationale":"Guarantees assume United's Traditional PDL (p. 10) and client-directed deviations trigger repricing (p. 10), and United may modify or eliminate the arrangement on PDL-driven rebate changes (p. 10). The sponsor's underlying formulary authority is in the base ASA (not in packet); the renewal shows sponsor deviation is permitted but economically penalized.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"• if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and United's \nother ASO customers, result in significant reductions to the Rebate level","rationale":"The renewal acknowledges PDL changes 'for the purpose of achieving a lower net drug cost' as a trigger for United to modify the rebate arrangement (p. 10) and includes a Rebate Credit mechanism for lower-rebate comparable drugs (p. 10), but contains no lowest-net-cost commitment or book-of-business comparison. Cannot be assessed as a standard from this document.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NET","verdict":"bad","confidence":0.6,"page_ref":"p. 11","evidence_quote":"g) Customer utilizes a vendor, that facilitates steering members to different drugs or \npharmacies to the extent these services impact the financial guarantees under this Agreement. ","rationale":"All pricing guarantees require United as 'the exclusive mail provider' (p. 11) and United may revise, reprice or revoke guarantees if Customer uses a steering vendor (p. 11). These are directly assessable anti-choice terms. Any-willing-pharmacy and pharmacy clawback protections are base-ASA topics not in the packet, so the verdict is scoped to the exclusivity and steering-vendor terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"United reserves the right to modify or eliminate this arrangement as follows based upon changes in Rebates: ","rationale":"No most-favored-pricing or market-check right appears in the renewal; United holds one-way modification rights (p. 10). This record is a financial renewal (cover letter plus replacement Exhibit B Fees and Exhibit C Performance Standards, 1/1/2023-12/31/2024). The base ASA governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is not an adverse finding and does not imply redaction.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"United shall provide Consultant with \nan annual audit credit of $20,000 and monthly payment for all Consultant Fees collected in the amount of  $4.00 \npmpm.","rationale":"The renewal funds a $20,000 annual audit credit paid to the consultant HonestRX (p. 9, p. 11), which supports audit activity, but the audit rights themselves (auditor selection, data access, sampling limits) are base-ASA terms not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 4","evidence_quote":"Prepare and file pharmacy benefits and drug cost reports. ","rationale":"The renewal lists CAA/transparency reporting support (pp. 3-4) but says nothing about ownership of plan data. This record is a financial renewal (cover letter plus replacement Exhibit B Fees and Exhibit C Performance Standards, 1/1/2023-12/31/2024). The base ASA governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is not an adverse finding and does not imply redaction.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"p. 9","evidence_quote":"Rebates \nThe amount the combined actual Rebate amount is less than the combined guaranteed Rebate amount. ","rationale":"Customer-specific pharmacy guarantees with dollar shortfall payments for discounts, dispensing fees and Rebates (p. 9) are dollar-for-dollar in form but annual, heavily conditioned (pp. 9-11) and, for medical standards, capped fee credits of $14,286 each (pp. 6-8). Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"ENF","verdict":"bad","confidence":0.7,"page_ref":"p. 6","evidence_quote":"With respect to the aspects of United’s performance addressed in this \nexhibit, these fee adjustments are Customer’s exclusive financial remedies.  ","rationale":"Fee adjustments are the 'exclusive financial remedies' (p. 6); United may unilaterally modify or eliminate the rebate arrangement (p. 10) and revise, reprice or revoke pricing (p. 11). No self-executing or two-strikes remedy for the sponsor. Directly assessable from Exhibit C.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AMD","verdict":"bad","confidence":0.6,"page_ref":"p. 6","evidence_quote":"United may specify to \nCustomer in writing new performance guarantees for the subsequent Guarantee Period.  If United specifies new \nperformance guarantees, United will also provide Customer with a new Exhibit that will replace this Exhibit for that \nsubsequent Guarantee Period. ","rationale":"The renewal is delivered by a one-way confirmation letter with no signature blocks for either party (p. 1) and Exhibit C lets United replace the exhibit by written notice (p. 6). The base ASA amendment clause is not in the packet; verdict scoped to the mechanism shown in this document.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"TERM","verdict":"bad","confidence":0.75,"page_ref":"p. 10","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, \nUnited will retain any and all pending or future Rebates payable under the Agreement as of the effective date of \nthe termination of pharmacy benefit services. ","rationale":"Early exit forfeits pending and future Rebates (p. 5, p. 10), voids guarantees for any partial period (p. 11), and requires prorated repayment of the Pharmacy Management Allowance and the $30,000 wellness allowance (p. 5, p. 11). Directly assessable termination-penalty terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPEC","verdict":"bad","confidence":0.7,"page_ref":"p. 12","evidence_quote":"United reserves the right to change \nthe designation of a drug from specialty to non-specialty based on market conditions. ","rationale":"Specialty guarantee is a 19.0% composite for drugs through United's specialty network with 14.0% for unlisted drugs (p. 12); United may re-designate drugs (p. 12); specialty spread is retained (p. 12); the list on pp. 12-18 marks every drug 'Included' without per-drug pricing. Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0037","contract_slug":"city-of-round-rock-uhc-2023-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GAG","verdict":"unclear","confidence":null,"page_ref":"p. 4","evidence_quote":"Provide language to support Customer’s anti-gag clause \nattestation requirement. ","rationale":"No confidentiality or gag clause appears in the renewal; it offers support for the Customer's anti-gag attestation (p. 4) and pages carry a 'Proprietary Information of UnitedHealth Group' footer. Confidentiality terms are in the base ASA, not in the packet. No legal-compliance determination is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:58:40+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FID","verdict":"partial","confidence":0.91,"page_ref":"p. 2","evidence_quote":"The following financial terms are effective for the period January 1, 2024 through December 31, 2024, unless \notherwise specified. \n \nFinal Claims Fiduciary:  United \nPrescription Drug List:  Traditional","rationale":"The medical-fee exhibit expressly identifies United as final claims fiduciary. That limited designation is not a PBM-wide duty of loyalty and care over formularies, affiliate compensation or pricing, and does not establish disgorgement or comprehensive conflict duties. The omitted ASA is needed to determine its full scope.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DISC","verdict":"partial","confidence":0.97,"page_ref":"p. 12","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to HonestRX \n(“Consultant”).  The Consultant Fees are included in Customer’s pharmacy financial terms.  United shall \nprovide Consultant with an annual audit credit of $20,000 and monthly payment for all Consultant Fees \ncollected in the amount(s) of $4.00 pmpm.","rationale":"The named consultant and annual audit-credit/per-member-per-month fee mechanism are disclosed as included in pharmacy financial terms. Page 6 separately describes affiliate medical payment-service compensation. Neither provision establishes a complete PBM/related-entity compensation inventory or quarterly/annual officer certification. No unsupported annual dollar extrapolation is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2024 Financial Renewal under the Administrative Services Agreement (“ASA”) between United \nHealthCare Services, Inc. and City of Round Rock","rationale":"The cover identifies a financial renewal with Exhibits B and C, not the complete ASA exhibit set. A signed ownership/affiliate/GPO inventory and 30-day change obligations are not assessable. This is not an absence finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DEF","verdict":"partial","confidence":0.93,"page_ref":"p. 12","evidence_quote":"Generic Drug:  An FDA approved drug, or a drug that is designated by FDA a DESI (Drug Efficacy Study \nImplementation) drug, or product, that is therapeutically equivalent to other pharmaceutically equivalent \nproducts, as set forth in Medi-Span’s National Drug Data File as a generic drug identified by all products \nmeeting at least one of the following criteria: \n-   Medi-Span Multi-Source Code (\"MSC\") is equal to Y.","rationale":"Explicit Medi-Span generic and companion brand criteria improve classification specificity for reconciliation. They do not establish economic-function definitions of all manufacturer revenue, affiliates, pharmacies and specialty. Page 11's lower-rebate adjustment and page 12's specialty reclassification reservation remain material limitations. The complete ASA definition regime is not supplied.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"p. 11","evidence_quote":"United will pay Fixed Rebates consistent with the Agreement.  To the extent Rebates paid to United exceed \nthe Fixed Rebate amount, We will retain the excess, including any Rebates United may earn on prescription \ndrug products in any tiers not included in this arrangement and any related interest.","rationale":"Express retention of excess rebates and interest contradicts all-manufacturer-revenue pass-through. Page 10 fixes dollars per eligible Brand script under the Traditional PDL; exclusions, lower-rebate adjustments and the AMP-cap reservation qualify those amounts. Medical-benefit rebates separately use an 80%-of-received denominator on page 4, not an all-pharmacy-revenue share.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 12","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service.","rationale":"The packet establishes permission for network spread, assessed under SPRD, but not dispensing-entity ownership, affiliate net acquisition cost, or an affiliate-specific pricing/documentation regime. That narrower ownership-and-cost question is unknown rather than deemed absent from the complete relationship.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CEIL","verdict":"partial","confidence":0.98,"page_ref":"p. 10","evidence_quote":"Discounts are based on actual Network Pharmacy brand and generic usage of retail and mail order drugs.  The \nguaranteed discount amount will be determined by multiplying the AWP by the contracted discount rate off \nAWP by component.","rationale":"The AWP-based target provides a benchmark, but the remedy uses combined annual Retail/Mail/Specialty discount dollars rather than individual-claim ceilings. The discount percentage is AWP less ingredient cost divided by AWP. No-AWP items and other listed claims are excluded; a cheapest-lawful-price ceiling across all channels is not established.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CASH","verdict":"partial","confidence":0.98,"page_ref":"p. 12","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments.  Participants pay the lesser of the \ndiscounted price, the usual and customary charge or the cost share amount.","rationale":"This affirmatively limits participant payments to the stated comparison. It does not establish deductible/OOP credit for outside cash purchases or a written sponsor election for assistance accumulators. Those benefit terms remain unknown from the renewal.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"Discounts for retail and mail order generic prescriptions represent the average AWP based on \nsavings off Maximum Allowable Cost (MAC) pricing for MAC generics and percentage discount savings off \nAWP for non-MAC generics.","rationale":"The quotation concerns aggregate discount measurement, not whether a single disclosed MAC list binds both plan billing and pharmacy payment, with scheduled updates and appeals. Those governance terms require the ASA and network documents.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"p. 12","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service.","rationale":"The renewal expressly permits retention of the network-pharmacy reimbursement/customer-payment difference across retail, mail and specialty, including dispensing fees. This is direct adverse evidence against no-spread terms, not a calculation of actual retained revenue.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"Rebate Administrative Fee:  United maintains systems and processes necessary for managing and \nadministering Rebate programs.  As consideration for these efforts, pharmaceutical manufacturers pay United \nadministrative fees in addition to Rebates.  Rebate Administration fees are included in the guaranteed rebate \narrangement.","rationale":"Inclusion of manufacturer administrative fees in a guaranteed arrangement is not a complete related-purchasing-entity revenue definition or allocation provision. Without the base definitions, ownership and purchasing agreements, pass-through of GPO discounts, supplier payments and volume credits cannot be resolved.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FORM","verdict":"partial","confidence":0.93,"page_ref":"p. 10","evidence_quote":"Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in \nchanges to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliation.","rationale":"The clause recognizes customer-directed changes but ties them to possible pricing/guarantee changes under the Traditional PDL arrangement. The renewal does not establish approval of every PBM-initiated formulary change, drug-level quarterly UM reporting or lowest-net-cost analyses.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and \nUnited's other ASO customers, result in significant reductions to the Rebate level","rationale":"This states a purpose of PDL changes that can trigger modification of rebates. It does not establish an enforceable lowest-net-cost standard for this plan, an annual whole-book comparison, or exception explanations; their status under omitted documents remains unknown.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NET","verdict":"unclear","confidence":null,"page_ref":"p. 12","evidence_quote":"All pricing guarantees require the selection of United as the exclusive mail provider. \n  \nUnited will have no financial guarantee obligation under the Agreement for any partial Guarantee Period if \nCustomer terminates with an effective date prior to the end of the Pharmacy Pricing Term.","rationale":"The quoted exclusivity is a guarantee condition, not sufficient evidence of affiliate ownership or actual member steering. Network finality, volume conditions and any-willing-pharmacy protections are not assessable without the network/ASA terms; no adverse missing-terms inference is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2024 Financial Renewal under the Administrative Services Agreement (“ASA”) between United \nHealthCare Services, Inc. and City of Round Rock","rationale":"A financial-renewal letter and scheduled fees do not resolve comparable-client pricing rights or an annual market-check meet/credit/release remedy in the omitted ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 12","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to HonestRX \n(“Consultant”).  The Consultant Fees are included in Customer’s pharmacy financial terms.  United shall \nprovide Consultant with an annual audit credit of $20,000 and monthly payment for all Consultant Fees \ncollected in the amount(s) of $4.00 pmpm.","rationale":"An audit credit is funding, not a grant of unrestricted audit authority or pre-adjudication/full financial data access. The CAA/TiC service descriptions elsewhere do not establish the complete PBM audit/data regime.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2024 Financial Renewal under the Administrative Services Agreement (“ASA”) between United \nHealthCare Services, Inc. and City of Round Rock","rationale":"The omitted ASA and data-use documents, not this financial-renewal scope anchor, would establish ownership of plan and derived data and restrictions on reuse, sale or licensing. Unknown is not absent.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PERF","verdict":"partial","confidence":0.99,"page_ref":"p. 10","evidence_quote":"Level \nCustomer Specific \nPeriod \nAnnually \nPayment Period \nAnnually \nPayment \nAmount \n-- \nDiscounts \nThe amount the actual discounts are less than the combined guaranteed Retail, Mail, and Specialty discount \namount.","rationale":"Customer-specific dollar shortfall guarantees provide meaningful financial remedies, but annual combined discount measurement is weaker than quarterly claim/plan-specific cash reconciliation. Dispensing and rebate guarantees have their own combined tests. Medical site/office service metrics are not treated as pharmacy metrics. No actual reconciliation or payout is supplied.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"ENF","verdict":"partial","confidence":0.93,"page_ref":"p. 7","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer’s fees in \naccordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"The exhibit prescribes fee adjustments and the pharmacy section specifies dollar shortfalls, providing limited predetermined-remedy protection. The exhibit also calls the adjustments exclusive financial remedies. The renewal does not resolve late-report damages or penalty-free repeat-breach/regulatory-integrity termination under the base ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"p. 11","evidence_quote":"The Rebate guarantees and any Administrative Fee Credits funded by retained Rebates set forth herein do not \nincorporate the impact of the elimination of the Average Manufacturer’s Price (AMP) Cap pursuant to the \nAmerican Rescue Plan Act of 2021.  United reserves the right to modify or eliminate any Rebate guarantees and \nAdministrative Fee Credits once it has been able to determine that impact and the resulting changes to Rebates \nreceived from pharmaceutical manufacturers.","rationale":"The express right to modify/eliminate both rebates and rebate-funded administration credits after United determines the stated impact is inconsistent with unconditional bilateral signed-only economic changes. Page 12 also reserves enrollment/benchmark/benefit-related revision rights. This reviews the reservation, not legal effect, actual use, or the realized impact of the cited statute.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"TERM","verdict":"bad","confidence":0.99,"page_ref":"p. 11","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, \nUnited will retain any and all pending or future Rebates payable under the Agreement as of the effective date of \nthe termination of pharmacy benefit services.","rationale":"Pending/future rebates may be forfeited on early termination of the stated 2024 pharmacy pricing term. The same page adds prorated management-allowance repayment/unpaid-credit forfeiture; page 12 denies partial-period guarantees. Page 4's separate pharmacy-only provision excepts cause, but the complete ASA exit regime is not available. No clawback amount is calculated.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPEC","verdict":"partial","confidence":0.97,"page_ref":"p. 12","evidence_quote":"Actual utilization, using Average Wholesale Price (AWP) in dollars, using our data, of listed \nspecialty drugs through Our specialty Pharmacy Network will be multiplied against the discount \ntarget  to determine the overall discount target dollars.","rationale":"The specialty schedule provides listed/unlisted AWP targets of 19%/14%, both marked All Include LDD. These are utilization-weighted network-only annual targets, with a combined retail/mail/specialty shortfall remedy on page 13, not all-channel drug-level ceilings. Reclassification, no-AWP and medical-specialty exclusions limit protection; affiliate acquisition-cost rules are not assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GAG","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"January 1, 2024 Financial Renewal under the Administrative Services Agreement (“ASA”) between United \nHealthCare Services, Inc. and City of Round Rock","rationale":"The confidential footer is not itself an operative prohibition on disclosure. Page 5's anti-gag-attestation support service is not proof of unrestricted rights or compliance. Underlying confidentiality, advisor access and pharmacy patient-disclosure provisions are unprovided, leaving this red flag unresolved.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FID","verdict":"unclear","confidence":null,"page_ref":"p. 2","evidence_quote":"Final Claims Fiduciary:  United \nPrescription Drug List:  Traditional ","rationale":"Exhibit B records United as 'Final Claims Fiduciary' (p. 2), a claims-adjudication role only; nothing in the renewal addresses a duty of loyalty for pricing or rebate decisions. This record is a financial renewal (cover letter dated Aug 30, 2023 plus replacement Exhibit B Fees for 2024-2026 and Exhibit C Performance Standards for 2024). The base ASA (Agreement No. 66492.3) governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DISC","verdict":"partial","confidence":0.5,"page_ref":"p. 4","evidence_quote":"Medical Benefit Drug Rebate Compensation \n80% to Customer, the balance is retained by United as \ncompensation for the services. ","rationale":"Within its scope the renewal discloses: the 80/20 medical-benefit drug rebate split (p. 4), retention of gene-therapy rebates when stop loss is bought through United (p. 4), affiliate payment-services fees of 1%-3% or up to $10 per transaction (p. 6), spread retention (p. 12, p. 13), retention of excess Rebates and inclusion of manufacturer administrative fees in the guarantee (p. 11), retained Rebates funding the administrative fee credit (p. 11), and the HonestRX consultant fee (p. 12). Amounts retained are not quantified; no certification. Base-ASA disclosure duties not in packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 4","evidence_quote":"If Customer purchases gene therapy stop loss though United \nor an affiliate, United will retain rebates for gene therapy ","rationale":"Affiliates are referenced (p. 4, p. 6) but not identified; no ownership exhibit is expected in a financial renewal. This record is a financial renewal (cover letter dated Aug 30, 2023 plus replacement Exhibit B Fees for 2024-2026 and Exhibit C Performance Standards for 2024). The base ASA (Agreement No. 66492.3) governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DEF","verdict":"partial","confidence":0.5,"page_ref":"p. 12","evidence_quote":"Brand Drug:  An FDA approved drug, or a drug that is designated by FDA a DESI (Drug Efficacy Study \nImplementation) drug, or product, which is manufactured and distributed by an innovator drug company, or its \nlicensee , set forth in Medi-Span’s National Drug Data File as a brand drug identified by all of the products \nmeeting at least one of the following criteria: ","rationale":"Unlike the 2023 renewal, this renewal includes Medi-Span MSC-based Brand and Generic definitions (p. 12) and an explicit LDD indicator in the specialty list (pp. 13-22), which are objective, loophole-closing definitions for guarantee measurement. Rebate, MAC and Specialty definitions remain in the base ASA (not in packet). Verdict limited to the definitions actually present.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PASS","verdict":"bad","confidence":0.85,"page_ref":"p. 11","evidence_quote":"To the extent Rebates paid to United exceed \nthe Fixed Rebate amount, We will retain the excess, including any Rebates United may earn on prescription \ndrug products in any tiers not included in this arrangement and any related interest. ","rationale":"2024 pharmacy financials remain a 'Fixed Rebate Guarantee (Traditional PDL)' per brand script (Retail 30 $64.86; Retail 90 $182.77; Mail $135.29; Specialty $338.82, p. 10) with a $40.00 PEPM Administrative Fee Credit. United retains excess Rebates and interest (p. 11), 'Rebate Administration fees are included in the guaranteed rebate arrangement' (p. 11), retained Rebates 'are used to lower the medical administration fee' (p. 11), and United reserves the right to modify or eliminate Rebate guarantees and credits after assessing the AMP-cap change (p. 11). Not a 100% pass-through. Figures are quoted clause values.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 12","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service. ","rationale":"Mail and specialty are priced on AWP-discount guarantees (p. 9-10) with United retaining the difference (p. 12, p. 13). The renewal does not state whether those pharmacies are United affiliates, so affiliate acquisition-cost pricing cannot be assessed here; the clause is noted as relevant context.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CEIL","verdict":"bad","confidence":0.7,"page_ref":"p. 10","evidence_quote":"Discounts \nThe amount the actual discounts are less than the combined guaranteed Retail, Mail, and Specialty discount \namount. ","rationale":"Combined annual Retail/Mail/Specialty discount guarantee (p. 10) with shortfall payment; no claim-by-claim ceiling; U&C and other claim categories excluded (p. 10-11). Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CASH","verdict":"partial","confidence":0.6,"page_ref":"p. 12","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments.  Participants pay the lesser of the \ndiscounted price, the usual and customary charge or the cost share amount. ","rationale":"Lesser-of-three participant pricing is stated (p. 12). No deductible-credit protection for cash purchases outside the plan appears in the renewal.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"order generic prescriptions represent the average AWP based on \nsavings off Maximum Allowable Cost (MAC) pricing for MAC generics and percentage discount savings off \nAWP for non-MAC generics.","rationale":"MAC appears only as the measurement basis for generic effective discounts (p. 10). MAC list governance is a base-ASA topic not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"p. 12","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service. ","rationale":"Exhibit C authorizes United to retain the difference between pharmacy reimbursement and Customer payment on mail, specialty, retail and dispensing fees (p. 12) and repeats the clause for specialty (p. 13). Directly assessable; contradicts the no-spread standard.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"Rebate Administration fees are included in the guaranteed rebate \narrangement. ","rationale":"Manufacturer administrative fees are addressed (p. 11) but no GPO or purchasing-entity revenue language appears. This record is a financial renewal (cover letter dated Aug 30, 2023 plus replacement Exhibit B Fees for 2024-2026 and Exhibit C Performance Standards for 2024). The base ASA (Agreement No. 66492.3) governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FORM","verdict":"partial","confidence":0.5,"page_ref":"p. 10","evidence_quote":"• Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in \nchanges to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliation.","rationale":"Exhibit B fixes the Prescription Drug List as 'Traditional' (p. 2); guarantees assume that PDL and client-directed deviations trigger repricing (p. 10); United may modify or eliminate the arrangement on PDL-driven rebate changes (p. 11). Sponsor deviation is permitted but economically penalized; underlying formulary authority is in the base ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"• if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and \nUnited's other ASO customers, result in significant reductions to the Rebate level","rationale":"The renewal references PDL changes made 'for the purpose of achieving a lower net drug cost' only as a trigger for United to modify the rebate arrangement (p. 11) and offers a Rebate Credit for lower-rebate comparable drugs (p. 11). No lowest-net-cost commitment or book-of-business comparison; not assessable as a standard from this document.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NET","verdict":"bad","confidence":0.6,"page_ref":"p. 12","evidence_quote":"g) Customer utilizes a vendor, that facilitates steering members to different \ndrugs or pharmacies to the extent these services impact the financial guarantees under this Agree","rationale":"Guarantees require United as 'the exclusive mail provider' (p. 12) and may be revised, repriced or revoked if Customer uses a steering vendor (p. 12). Any-willing-pharmacy and pharmacy clawback protections are base-ASA topics not in the packet; verdict scoped to the exclusivity and steering-vendor terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 11","evidence_quote":"United reserves the right to modify or eliminate any Rebate guarantees and \nAdministrative Fee Credits once it has been able to determine that impact and the resulting changes to Rebates \nreceived from pharmaceutical manufacturers.  ","rationale":"No most-favored-pricing or market-check right for the Customer appears; United holds one-way modification rights (p. 11). This record is a financial renewal (cover letter dated Aug 30, 2023 plus replacement Exhibit B Fees for 2024-2026 and Exhibit C Performance Standards for 2024). The base ASA (Agreement No. 66492.3) governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 12","evidence_quote":"United shall \nprovide Consultant with an annual audit credit of $20,000 and monthly payment for all Consultant Fees \ncollected in the amount(s) of $4.00 pmpm.","rationale":"A $20,000 annual audit credit to the consultant HonestRX (p. 10, p. 12) funds audit work, but the audit rights themselves are base-ASA terms not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 5","evidence_quote":"Prepare and file pharmacy benefits and drug cost \nreports. \n• \nPrepare and file air ambulance claims reports. ","rationale":"CAA/transparency reporting support is listed (p. 5) but nothing addresses ownership of plan data. This record is a financial renewal (cover letter dated Aug 30, 2023 plus replacement Exhibit B Fees for 2024-2026 and Exhibit C Performance Standards for 2024). The base ASA (Agreement No. 66492.3) governing this topic is not part of the supplied packet, so the topic cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"p. 10","evidence_quote":"Rebates \nThe amount the combined actual Rebate amount is less than the combined guaranteed Rebate amount. ","rationale":"Customer-specific pharmacy guarantees with dollar shortfall payments (p. 10) are dollar-for-dollar in form but annual and heavily conditioned (pp. 10-12); medical standards are capped fee credits of $15,408 each (pp. 7-9). Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"ENF","verdict":"bad","confidence":0.7,"page_ref":"p. 7","evidence_quote":"With respect to the aspects of United’s performance addressed in this exhibit, these fee adjustments are \nCustomer’s exclusive financial remedies.  ","rationale":"Fee adjustments are the 'exclusive financial remedies' (p. 7); United may 'revise, reprice or revoke this arrangement' if terms conflict with law (p. 7) and may modify or eliminate rebate terms (p. 11) or revoke pricing (p. 12). No self-executing or two-strikes remedy for the sponsor.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AMD","verdict":"bad","confidence":0.6,"page_ref":"p. 7","evidence_quote":"United may specify \nto Customer in writing new guarantees for the subsequent Guarantee Period.  If United specifies new guarantees, \nUnited will also provide Customer with a new Exhibit that will replace this Exhibit for that subsequent Guarantee \nPeriod. ","rationale":"Delivered as a one-way confirmation letter with no signature blocks (p. 1); Exhibit C allows United to replace the exhibit by written notice (p. 7). Base-ASA amendment clause not in packet; verdict scoped to the mechanism shown.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"TERM","verdict":"bad","confidence":0.75,"page_ref":"p. 11","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, \nUnited will retain any and all pending or future Rebates payable under the Agreement as of the effective date of \nthe termination of pharmacy b","rationale":"Early exit forfeits unremitted and future Rebates (p. 4, p. 11), voids guarantees for a partial period (p. 12), and the $5,000 communication credit and $25,000 wellness allowance are repayable pro rata if the Customer terminates before 12/31/2026 (p. 2-3). Directly assessable termination-penalty terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPEC","verdict":"partial","confidence":0.5,"page_ref":"p. 13","evidence_quote":"• Limited Distribution (LDD) status is subject to change based on manufacturer decision. ","rationale":"Improved transparency versus 2023: the specialty list carries an LDD indicator per drug (pp. 13-22) and the 19.00%/14.00% targets are stated to 'All Include LDD' (p. 12). But United may still re-designate specialty drugs (p. 12), specialty spread is retained (p. 13), guarantees apply only through United's specialty network, and no per-drug pricing is given. Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0038","contract_slug":"city-of-round-rock-uhc-2024-posted-financial-renewal","entity":"City of Round Rock","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GAG","verdict":"unclear","confidence":null,"page_ref":"p. 5","evidence_quote":"anti-gag \nclause attestation requirement. ","rationale":"No confidentiality clause appears in the renewal; it lists support for the Customer's anti-gag attestation (p. 5) and pages carry a 'Confidential Information of UnitedHealth Group' footer. Confidentiality terms are in the base ASA, not in packet. No legal-compliance determination is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:01:04+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FID","verdict":"partial","confidence":0.91,"page_ref":"p. 3","evidence_quote":"The following financial terms are effective for the period January 1, 2025 through December 31, 2027, unless \notherwise specified. \nFinal Claims Fiduciary: United","rationale":"The medical-fee exhibit identifies United as final claims fiduciary, a limited positive designation. It does not establish a PBM-wide loyalty/care duty over formulary and economic decisions or disgorgement of conflicted compensation. Base ASA definitions and scope remain unprovided; the separate FSA fiduciary designation is not conflated with this one.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DISC","verdict":"partial","confidence":0.91,"page_ref":"p. 8","evidence_quote":"Some options are available to medical \nproviders for a fee and may result in the receipt of transaction fees or other compensation (e.g., 1% to 3% of the total transaction \namount, or at the election of the provider a per transaction fee of up to $10) by a United affiliate. This has no impact on the Fees \npaid by Customer under this Agreement.","rationale":"The amendment discloses one affiliate medical payment-service compensation stream and page 16 identifies manufacturer administrative fees paid to a PBM affiliate. These are limited affirmative disclosures, not a complete PBM/related-entity compensation, ownership or officer-certification regime. The percentages apply to transactions in the disclosed service, not to drug spend.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"Any capitalized terms used in this Amendment have the meanings shown in the Agreement. These terms may or may \nnot have been capitalized in prior contractual documents between the parties but will have the same meaning as if \ncapitalized.","rationale":"The instrument imports an unprovided base agreement and does not purport to supply all exhibits. A signed owner/affiliate/GPO inventory and 30-day updates cannot be assessed from FRAT8 plus FRAT7; no absence finding is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"p. 15","evidence_quote":"The retail and mail order generic discounts exclude any generic drug that has two or fewer generic manufacturers; \nthe retail and mail order brand discounts include any generic drug that has two or fewer generic manufacturers.","rationale":"An explicit manufacturer-count exception moves actual generic drugs into brand-discount calculations, weakening functional generic classification for guarantees. Page 17's general Medi-Span brand/generic definitions do not erase this express exception. This does not establish how such claims count for rebates or quantify its realized economic effect.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PASS","verdict":"partial","confidence":0.97,"page_ref":"p. 14","evidence_quote":"Minimum Rebate Guarantee (Advantage PDL) \n \nRebate Sharing Percentage \n100.0% \n100.0% \n \nBasis, per script \nBrand \nBrand \n \nRetail - 30 and 90 Day \n$411.52 \n$463.16 \n \nMail Order \n$665.06 \n$701.55","rationale":"The 2024/2025 columns state 100% rebate sharing within an Advantage-PDL minimum-rebate arrangement, with eligible Brand-script minimums and specialty rebates included in retail. Page 16 includes manufacturer administrative fees in that arrangement and reconciles annually after payments are substantially complete. This is not evidence of 100% of every manufacturer/GPO revenue type or quarterly remittance within 30 days: the imported definitions, exclusions, adjustments and termination terms matter. Medical-benefit rebates have a separate 80% statement on page 6.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service.","rationale":"The express spread permission is assessed under SPRD. These amendments do not identify ownership of dispensing pharmacies, their net acquisition costs, or an affiliate-specific cost-plus/documentation regime. Those terms remain unassessable rather than presumed absent from the base agreement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CEIL","verdict":"partial","confidence":0.98,"page_ref":"p. 14","evidence_quote":"The Guaranteed Discount amount will be determined by multiplying the AWP by the guaranteed discount off AWP \nby each component.","rationale":"The component-level AWP target is a benchmark protection, and component-specific shortfalls avoid the Round Rock-style cross-component combined discount test. It remains an annual aggregate target, not a cheapest-lawful-price ceiling for every claim/channel. Discounts are AWP less ingredient cost divided by AWP; no-AWP and listed claim exclusions apply.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"CASH","verdict":"partial","confidence":0.98,"page_ref":"p. 16","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the \ndiscounted price, the usual and customary charge or the cost share amount.","rationale":"The stated participant comparison is a limited affirmative cash-price protection. It does not establish outside cash-purchase deductible/OOP credit or a written sponsor election for assistance accumulators. The Variable Copay program fee on page 14 alone does not establish how assistance is treated.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 14","evidence_quote":"Discounts for retail and mail order generic prescriptions represent the average AWP based on savings \noff Maximum Allowable Cost (MAC) pricing for MAC generics and percentage discount savings off AWP for \nnon-MAC generics.","rationale":"This describes generic guarantee measurement, not the identity, disclosure, updates or appeals governance of MAC lists used for plan billing and pharmacy reimbursement. Full network and ASA terms are needed to assess the rubric.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"p. 16","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service.","rationale":"The amendment explicitly permits retained spread across retail, mail and specialty, including dispensing fees. A 100% rebate-sharing label addresses a different revenue stream and does not make this a no-spread arrangement. No actual margin is calculated.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"Manufacturer Administrative Fees are the administrative fees paid by drug manufacturers to United’s PBM \naffiliate as consideration for maintaining systems and processes necessary for managing and administering Rebate \nprograms. Manufacturer Administrative Fees are included in the guaranteed rebate arrangement.","rationale":"This expressly addresses one PBM-affiliate fee category, not all purchase discounts, volume credits, supplier payments or GPO allocations. The amendments do not establish the complete purchasing-entity revenue definitions or ownership, so all-GPO pass-through remains unknown.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"FORM","verdict":"partial","confidence":0.93,"page_ref":"p. 15","evidence_quote":"Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in \nchanges to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliation.","rationale":"Client-directed deviations are recognized, but the Advantage-PDL-based economics may change as a result. The amendments do not establish sponsor approval of every formulary change, lowest-net-cost analysis or quarterly drug-level utilization-management results.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 15","evidence_quote":"if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and United's \nother ASO customers, result in significant reductions to the Rebate level","rationale":"Lower net drug cost is a stated purpose of changes that can permit modifying the rebate arrangement, not an established mandatory plan-specific lowest-net-cost standard or annual whole-book comparison. Their status in the unprovided ASA is unknown.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"NET","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"All pricing guarantees require the selection of United’s PBM as exclusive provider of pharmacy benefit services, \nincluding but not limited to retail, mail order, and specialty networks.","rationale":"An exclusive PBM-administration/network condition is not proof that members must use owned pharmacies or of actual steering. These amendments do not resolve pharmacy claim finality, volume-linked reimbursement or any-willing participation. Page 2's Customer Specific Provider terms concern medical providers, not affirmative PBM network protections.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"Nothing shown in this Amendment alters, varies or affects any of the terms, provisions or conditions of the agreements \nother than as stated herein.","rationale":"The amendment preserves unstated base terms. Scheduled AWP discounts and rebate minimums do not determine automatic comparable-client pricing or annual market-check remedies in those terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"Nothing shown in this Amendment alters, varies or affects any of the terms, provisions or conditions of the agreements \nother than as stated herein.","rationale":"The medical-services table's included Data Extracts and Expanded eCR Reporting do not define unrestricted PBM audit authority, full financial data or pre-adjudication access. FRAT7's fee/headcount reconciliation is also not a PBM audit grant. Those rights require the base agreement and data exhibits.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"Nothing shown in this Amendment alters, varies or affects any of the terms, provisions or conditions of the agreements \nother than as stated herein.","rationale":"Neither reporting-service inclusion nor fee reconciliation determines sole ownership of claims, eligibility, accumulators, rebates and derived data or restrictions on PBM reuse/sale. The amendments leave the underlying data regime unassessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"PERF","verdict":"partial","confidence":0.99,"page_ref":"p. 14","evidence_quote":"Level \nCustomer Specific \nPeriod \nAnnually \nPayment Period \nAnnually \nPayment \nAmount \nDiscounts \n-- \nThe amount the actual discounts are less than the guaranteed discount amount for each individual component.","rationale":"Customer-specific component discount shortfalls provide a meaningful dollar remedy; dispensing and rebates have separate combined tests. Measurement/payment remain annual, not quarterly. Specialty shortfalls aggregate individual drug targets under page 18. Medical operational metrics are not presented as pharmacy metrics, and actual cash reconciliations/payouts are not evidenced.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"ENF","verdict":"partial","confidence":0.93,"page_ref":"p. 11","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer’s Fees in \naccordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"Predetermined fee adjustments and pharmacy dollar-shortfall definitions provide limited self-executing-remedy support. The exhibit calls fee adjustments exclusive financial remedies. The amendments do not establish late-report damages or penalty-free repeat-breach/regulatory-integrity exit. FRAT7's separate reconciliation machinery concerns fees/headcounts, not quarterly pharmacy performance.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"p. 16","evidence_quote":"Pricing and guarantees assume enrollment of 1,643 Employees and 3,439 Participants; pricing and guarantees \nmay be revised or withdrawn if actual enrollment varies by 10% or more from assumptions.","rationale":"Express pharmacy repricing/withdrawal rights tied to a defined enrollment deviation depart from unconditional bilateral signed-only changes. Other revise/revoke rights and the AMP-cap reservation reinforce the limitation. The older FRAT7 deemed-execution provision is separately described, not used to declare FRAT8 executed.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"TERM","verdict":"bad","confidence":0.99,"page_ref":"p. 16","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, \nUnited will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the \ntermination of pharmacy benefit services.","rationale":"The amendment permits rebate forfeiture on pharmacy termination before the stated December 2025 pricing-term end and denies partial-period guarantees. Page 6 separately claws back a prorated credit paid in the termination year before December 2027, expressly excluding prior-year credits. FRAT7 describes a different legacy credit; stacking, supersession and complete base-ASA exit rights are unresolved.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"SPEC","verdict":"partial","confidence":0.98,"page_ref":"p. 18","evidence_quote":"Actual utilization, using Average Wholesale Price (AWP) in dollars, using our data, of specialty drugs \nthrough our specialty Pharmacy Network will be multiplied against the discount targets for the individual \ndrugs to determine the overall discount target dollars. This total will be compared to actual discounts \nachieved for these drugs during the Guarantee Period.","rationale":"Drug-specific targets and a 14% AWP discount for unlisted specialty drugs are affirmative controls, but they produce an aggregate annual specialty-dollar target, not individual-drug/claim ceilings across all channels. Outside-network/no-AWP and medical-specialty exclusions, reclassification and retained specialty spread limit protection. An affiliate acquisition-cost regime is not established.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"GPT 6 Astra","rubric_key":"GAG","verdict":"unclear","confidence":null,"page_ref":"p. 1","evidence_quote":"Nothing shown in this Amendment alters, varies or affects any of the terms, provisions or conditions of the agreements \nother than as stated herein.","rationale":"The confidential/proprietary footers alone are not operative gag provisions. Full ASA confidentiality, advisor/public disclosure and pharmacy patient-communication rights are outside these amendments, so this red flag cannot responsibly be marked present or absent.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T21:46:26.86328+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FID","verdict":"unclear","confidence":null,"page_ref":"p. 6","evidence_quote":"This quotation assumes UnitedHealthcare will retain claim fiduciary responsibility ","rationale":"Exhibit B names United 'Final Claims Fiduciary' (p. 3) and the pricing assumes United retains 'claim fiduciary responsibility' (p. 6); that is a claims-adjudication role. Nothing in the amendment addresses a duty of loyalty for pricing or rebate decisions. This record is Financial Renewal and Terms Amendment No. 8 (Agreement No. 00032072.8) to a base Administrative Services Agreement that is not in the supplied packet. The topic is governed by the base ASA and cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DISC","verdict":"partial","confidence":0.5,"page_ref":"p. 16","evidence_quote":"Manufacturer Administrative Fees are the administrative fees paid by drug manufacturers to United’s PBM \naffiliate as consideration for maintaining systems and processes necessary for managing and administering Rebate \nprograms. Manufacturer Administrative Fees are included in the guaranteed rebate arrangement. ","rationale":"Within its scope the amendment discloses: manufacturer administrative fees paid to United's PBM affiliate (p. 16), spread retention (p. 16, p. 18), the 80.0% medical-benefit rebate share (p. 6), affiliate payment-services fees of 1%-3% or up to $10 per transaction (p. 8), retention of the 2% COBRA administration fee (p. 10), exclusion of commissions (p. 6), and third-party UHC Hub vendor relationships (p. 6). Amounts retained are not quantified and no officer certification is included. Base-ASA disclosure duties are not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"Manufacturer Administrative Fees are the administrative fees paid by drug manufacturers to United’s PBM \naffiliate as consideration for maintaining systems and processes necessary for managing and administering Rebate \nprograms.","rationale":"The amendment refers to 'United's PBM affiliate' (p. 16) and to a 'United affiliate' receiving payment-services fees (p. 8) without naming them; no ownership exhibit is expected in a renewal amendment. This record is Financial Renewal and Terms Amendment No. 8 (Agreement No. 00032072.8) to a base Administrative Services Agreement that is not in the supplied packet. The topic is governed by the base ASA and cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DEF","verdict":"partial","confidence":0.5,"page_ref":"p. 17","evidence_quote":"Brand Drug: An FDA approved drug, or a drug that is designated by FDA a DESI (Drug Efficacy Study \nImplementation) drug, or product, which is manufactured and distributed by an innovator drug company, or its \nl","rationale":"The amendment adds a 'Customer Specific Provider' definition (p. 2), supplies Medi-Span MSC-based Brand and Generic definitions (p. 17) and defines 'Manufacturer Administrative Fees' (p. 16); these are objective definitions for guarantee measurement. Rebate, MAC and Specialty definitions remain in the base ASA (not in packet). Verdict limited to definitions present.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PASS","verdict":"partial","confidence":0.55,"page_ref":"p. 14","evidence_quote":"Minimum Rebate Guarantee (Advantage PDL) \n \nRebate Sharing Percentage \n100.0% \n100.0% ","rationale":"Positive: the 2024/2025 pharmacy financials state a 'Rebate Sharing Percentage' of 100.0% with a Minimum Rebate Guarantee (Retail 30/90 $411.52/$463.16; Mail $665.06/$701.55 per brand script; specialty 'Included In Retail', p. 14), a structural improvement over a fixed guarantee. Limits: 'Manufacturer Administrative Fees are included in the guaranteed rebate arrangement' (p. 16), which does not clearly pass them through; reconciliation is annual and only 'when Rebate payments are substantially complete' (p. 16) rather than quarterly within 30 days; Customer receives Rebates only 'to the extent that Rebates are actually received by United' and United may 'increase the percentage of Rebate dollars retained by United' on industry changes (p. 5); medical-benefit rebates are shared at 80.0% (p. 6); AMP-cap reservation to modify guarantees (p. 15). Figures are quoted clause values, not calculated savings.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service. ","rationale":"Mail and specialty are priced on AWP-discount guarantees (p. 14, p. 18) with United retaining the difference (p. 16, p. 18) and guarantees require United's PBM as exclusive provider of mail and specialty networks (p. 16). The amendment does not state whether those pharmacies are United affiliates, so affiliate acquisition-cost pricing cannot be assessed; clause noted as relevant context.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CEIL","verdict":"partial","confidence":0.6,"page_ref":"p. 14","evidence_quote":"The amount the actual discounts are less than the guaranteed discount amount for each individual component. ","rationale":"Discount guarantees are component-level (retail brand, retail 90, retail generic, mail brand, mail generic) with a shortfall payment 'for each individual component' (p. 14) and specialty targets are set per drug (pp. 18-29), which is tighter than a combined guarantee. Still an annual aggregate reconciliation rather than a claim-by-claim benchmark ceiling, with excluded claim categories (p. 15) and re-designation rights (p. 18).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"CASH","verdict":"partial","confidence":0.6,"page_ref":"p. 16","evidence_quote":"lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the \ndiscounted price, the usual and customary charge or the cost share amount. ","rationale":"Lesser-of-three participant pricing is stated (p. 16). No deductible-credit provision for outside-plan cash purchases appears in the amendment.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 14","evidence_quote":"Component Discount Guarantee - Broad Network \nRetail Brand, Average Wholesale Price (AWP) less \n21.90% \n21.90% \n \nRetail Brand -- 90 Day Supply, AWP less \n24.90% \n24.90% \nRetail Generic - 30 and 90 Day Supply, AWP less \n84.00% \n","rationale":"Generic pricing is expressed as an effective AWP discount guarantee (p. 14); the amendment does not describe MAC list governance (single list, disclosure, appeals), which is a base-ASA topic not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"p. 16","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United \nwill retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a \nprescription drug product or service. ","rationale":"Exhibit C authorizes United to retain the difference between pharmacy reimbursement and Customer payment on mail, specialty, retail and dispensing fees (p. 16) and repeats it for specialty (p. 18). Directly assessable; contradicts the no-spread standard.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"Manufacturer Administrative Fees are included in the guaranteed rebate arrangement. ","rationale":"Manufacturer administrative fees to the PBM affiliate are addressed (p. 16); no GPO or purchasing-entity revenue language appears. This record is Financial Renewal and Terms Amendment No. 8 (Agreement No. 00032072.8) to a base Administrative Services Agreement that is not in the supplied packet. The topic is governed by the base ASA and cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"FORM","verdict":"partial","confidence":0.5,"page_ref":"p. 15","evidence_quote":"Assumes implementation of United's Advantage PDL \n \n• Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in \nchanges to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliatio","rationale":"Rebate guarantees assume United's Advantage PDL and client-directed deviations trigger repricing (p. 15); United may modify or eliminate the arrangement on PDL-driven rebate changes (p. 15). Sponsor deviation is permitted but economically penalized; the sponsor's underlying formulary authority is in the base ASA.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 15","evidence_quote":"• if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and United's \nother ASO customers, result in significant reductions to the Rebate level ","rationale":"PDL changes 'for the purpose of achieving a lower net drug cost' appear only as a trigger for United to modify the rebate arrangement (p. 15). No lowest-net-cost commitment or book-of-business comparison is present; not assessable as a standard from this document.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"NET","verdict":"bad","confidence":0.6,"page_ref":"p. 16","evidence_quote":"• All pricing guarantees require the selection of United’s PBM as exclusive provider of pharmacy benefit services, \nincluding but not limited to retail, mail order, and specialty networks. ","rationale":"Guarantees require United's PBM as exclusive provider of retail, mail and specialty networks (p. 16); ASO fees and credits are 'subject to change' if pharmacy is carved out (p. 4); United may revise, reprice or revoke guarantees if Customer uses a steering vendor (p. 16). Any-willing-pharmacy and clawback protections are base-ASA topics not in the packet; verdict scoped to the exclusivity and steering-vendor terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 15","evidence_quote":"United reserves the right to \nmodify or eliminate any Rebate guarantees once it has been able to determine that impact and the resulting changes","rationale":"No most-favored-pricing or market-check right for the County appears; United holds one-way modification rights (p. 5, p. 15). This record is Financial Renewal and Terms Amendment No. 8 (Agreement No. 00032072.8) to a base Administrative Services Agreement that is not in the supplied packet. The topic is governed by the base ASA and cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"United will pay Rebates consistent with the Agreement. A reconciliation of the Rebate amounts will occur after \nthe end of each annual contract period and when Rebate payments are substantially complete.","rationale":"The amendment describes an annual rebate reconciliation (p. 16) but contains no audit-rights terms (auditor selection, data access, sampling); those are base-ASA topics not in the packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 3","evidence_quote":"Data Extracts \nIncluded \nIncluded \nIncluded \nIncluded ","rationale":"Exhibit B lists 'Data Extracts' as included in the ASO fee for all years (p. 3), a practical data-access positive, but nothing addresses ownership of plan data. This record is Financial Renewal and Terms Amendment No. 8 (Agreement No. 00032072.8) to a base Administrative Services Agreement that is not in the supplied packet. The topic is governed by the base ASA and cannot be assessed here; 'unclear' is a scope limitation, not an adverse finding.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"p. 14","evidence_quote":"The amount the actual discounts are less than the guaranteed discount amount for each individual component. ","rationale":"Customer-specific pharmacy guarantees with component-level dollar shortfall payments (p. 14) are dollar-for-dollar in form but annual and conditioned (pp. 15-16); medical standards are capped fee credits of $23,143 each (pp. 11-13) and United 'shall not be required to meet any of the guarantees' where failure is due to Customer actions or force majeure (p. 11). Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"ENF","verdict":"bad","confidence":0.7,"page_ref":"p. 11","evidence_quote":"With respect to the aspects of United’s performance addressed in this exhibit, these Fee adjustments are \nCustomer’s exclusive financial remedies. ","rationale":"Fee adjustments are the 'exclusive financial remedies' (p. 11); United may 'revise, reprice or revoke this arrangement' if terms conflict with law (p. 14) and may modify or eliminate rebate terms (p. 5, p. 15). No self-executing or two-strikes remedy for the sponsor.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"AMD","verdict":"partial","confidence":0.6,"page_ref":"p. 1","evidence_quote":"The parties, by signing below, agree to amend the agreements as contained herein. \nWilliamson County \nBy \nAuthorized Signature \nPrint Name \nPrint Title \nDate \nUnited HealthCare Services, Inc. \nSara Minnis \nBy Sara Minnis (12/04/2024 12:35 EST) ","rationale":"Positive: the amendment is structured as a mutual signed writing with signature blocks for both parties (p. 1). Limits: in the posted copy only United has signed (Sara Minnis, 12/04/2024); the County block is blank, so execution by the County is not shown in this packet. Exhibit C also lets United replace the exhibit by written notice (p. 11). Base-ASA amendment clause not in packet.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"TERM","verdict":"bad","confidence":0.7,"page_ref":"p. 16","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, \nUnited will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the \ntermination of ","rationale":"Early exit forfeits pending and future Rebates (p. 16) and voids guarantees for a partial period (p. 16); Wellness and Administrative Credits are forfeited if unused by 01/01/2026 and repayable pro rata if the County terminates before 12/31/2027 (p. 6). The appended p. 30 and the FRAT7 supplement show an Early Termination Penalty schedule (100%/75%/50% of the Renewal Credit) for the 2023-2025 term. Directly assessable termination-penalty terms.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"SPEC","verdict":"partial","confidence":0.5,"page_ref":"p. 18","evidence_quote":"Discount targets for individual drugs dispensed through United's specialty Pharmacy Network. See chart \nbelow. \nSpecialty drugs not included on the list below and dispensed through United's specialty Pharmacy Network \nwill be guaranteed at a discount of 14.0%. ","rationale":"Positive: per-drug specialty discount targets with LDD indicator are disclosed for the listed drugs (pp. 18-29), more transparent than a composite. Limits: unlisted specialty drugs default to 14.0% (p. 18); United may re-designate drugs (p. 18); LDD status changes with manufacturer decisions (p. 18); specialty spread is retained (p. 18); specialty rebates are folded into retail per-script guarantees (p. 16); guarantees apply only through United's specialty network. Directly assessable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0039","contract_slug":"williamson-county-uhc-2025-one-side-signed-frat8","entity":"Williamson County","vendor":"United HealthCare Services, Inc.","model":"Claude Fable 5.1","rubric_key":"GAG","verdict":"unclear","confidence":null,"page_ref":"p. 3","evidence_quote":"Data Extracts \nIncluded \nIncluded \nIncluded \nIncluded ","rationale":"No confidentiality or gag clause appears in the amendment; pages carry a 'Confidential Information of UnitedHealth Group' footer. Confidentiality terms are in the base ASA, not in packet. No legal-compliance determination is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T22:03:53+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"FID","verdict":"bad","confidence":0.93,"page_ref":"Page 15","evidence_quote":"Nothing in this Agreement is intended by the parties, or shall be construed, to confer upon RIGHTWAY the status of a fiduciary of Client or any benefit plan maintained by Client","rationale":"The agreement refuses the loyalty duty required by the model contract published by Mark Cuban and collaborators. On pages 15 and 16 the parties agree that nothing in the agreement confers on Rightway the status of a fiduciary of the City or any benefit plan, except for claims and appeals administration, and the City must not identify Rightway as a named fiduciary outside that exception. Page 4 states that Rightway is an independent contractor, not an agent, and that the agreement does not create a partnership or joint enterprise. There is no duty of loyalty and care owed solely to the plan and its members, no fiduciary duty to disclose every direct and indirect compensation stream, and no duty to disgorge amounts retained in breach without the plan proving damages. The claims and appeals delegation on page 19 is a narrow administrative grant, not a plan wide loyalty obligation. The Texas addendum on page 82 uses fiduciary language only for return premium, if any. Because the contract expressly disclaims the duty, the verdict is bad.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"DISC","verdict":"partial","confidence":0.86,"page_ref":"Page 2","evidence_quote":"Vendor hereby warrants to City that Vendor has made full disclosure in writing of any existing or potential conflicts of interest related to Vendor's Services under this Agreement.","rationale":"Page 2 contains a warranty that Rightway has disclosed existing or potential conflicts related to the services, and a promise to disclose conflicts that arise later. Page 26 adds that, on request, Rightway will share sources of revenue related to this contract and the pricing and rebate structure, but it labels that information Rightway confidential information. That is narrower than the model term. There is no disclosure of all related entity compensation, no listing of affiliate ownership touching plan claims, and no disclosure of payments to consultants or brokers. Page 41 mentions consultant fees only to exclude them from the core administrative fee, without an amount or a payee. Pages 32 and 52 allow a rebate aggregator to retain formulary management fees and the difference between manufacturer payments and amounts remitted to Rightway, and that difference is excluded from the defined rebate. No named officer certifies quarterly or annually that everything has been disclosed and remitted. I looked through the signature pages, exhibits, and definitions and did not find that certification. The disclosure that exists is real, so this is partial rather than missing.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"OWN","verdict":"partial","confidence":0.78,"page_ref":"Page 6","evidence_quote":"Upon request, Vendor will provide City with a list of its subcontractors and give City access to subcontractor agreements pursuant to City's audit rights under Section 6 of this Agreement.","rationale":"There is no signed exhibit listing every owner, parent, subsidiary, affiliate, group purchasing organization, rebate aggregator, mail pharmacy, and specialty pharmacy, and no duty to refresh such an exhibit promptly after a change in ownership or control. What the text does provide is weaker. Page 6 says Rightway may use affiliates and subcontractors and, upon request, will provide a list of subcontractors and access to subcontractor agreements under the audit clause. Pages 10 and 11 require notice to the purchasing manager of a company name, ownership, or address change, with supporting documents, so City vendor records can be updated. That notice is not a full affiliate map and does not cover pharmacies or purchasing entities on a set refresh cycle. Page 52 states that rebate aggregators contracted by Rightway are subcontractors and are not affiliates. A plan cannot police affiliate pricing, steering, or purchasing entity pass through without knowing which companies are related. The limited list on request and the ownership change notice make this partial, not missing.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"DEF","verdict":"partial","confidence":0.87,"page_ref":"Page 32","evidence_quote":"Client acknowledges that reasonable formulary management fees and costs may be retained by the Rebate Aggregator.","rationale":"Definitions are present and some are broad, but they do not close the relabeling loophole the model targets. On page 31, manufacturer derived revenue covers monies received by Rightway or the rebate aggregator from manufacturers and tied to the City's claims, including rebates, manufacturer administrative fees, access rebates, incentive rebates, market share rebates, price protection, and value based rebates. The rebate definition on the same page says rebates include manufacturer derived revenue. Page 32 then lets the rebate aggregator retain reasonable formulary management fees and costs. Page 52 goes further and excludes from the defined term rebate the difference between what an aggregator or intermediary receives and what it remits to Rightway, and says that difference belongs to the intermediary. Specialty on page 33 is whatever Rightway identifies as specialty, and Rightway may change the list. Generic status follows a pricing source indicator and selected dispense as written codes, not economic function alone. Affiliate is used on page 30 and is not defined. These carve outs are why the verdict is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"PASS","verdict":"partial","confidence":0.91,"page_ref":"Page 51","evidence_quote":"Client will receive 100% of the Rebates earned and collected on a pass -through basis.","rationale":"Page 51 states that the City will receive 100 percent of the rebates earned and collected on a pass through basis, and that Rightway will report manufacturer derived revenue allocations quarterly. That is a real pass through of collected rebates, but it is not every kind of manufacturer revenue, paid on a short cycle after quarter end, with only a closed exclusion list. The same page requires the minimum rebate guarantee within ninety days after quarter close, and a year to date settlement one hundred twenty days after quarter close equal to the greater of collected rebates or the amount needed to meet the minimum. Page 52 excludes aggregator and intermediary compensation from the defined rebate. Page 51 waives City losses if a manufacturer or aggregator fails to pay, limits Rightway to commercially reasonable collection efforts, and excludes a long list from the minimum guarantee, including over the counter products, vaccines, generics, 340B claims, insulins, authorized generics, limited distribution drugs, cash cards, non formulary biosimilars, and COVID-19 antivirals. Page 52 also drops the minimum rebate guarantee if the per member per month target is met. Timing, the collection condition, and retained intermediary money make this partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I looked for affiliate or related pharmacy pricing at net acquisition cost in the definitions on pages 28 through 33, the pharmacy network section on pages 17 and 18, and the pricing attachment on pages 48 through 54, including the high cost drug schedule that follows through page 75. Wholesale acquisition cost is defined on page 33 as a published data point. It is not used as the invoice price for mail, specialty, or retail claims, and no clause prices claims from a Rightway owned or economically related pharmacy at net acquisition cost plus a stated dispensing fee. There is no documentation default if acquisition records are not produced. Mail and specialty guarantees on pages 48 and 49 are average wholesale price discounts and dispensing fees, reconciled in aggregate. Because the pricing exhibits are included and simply do not contain this term, the verdict is missing rather than unclear.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"CEIL","verdict":"partial","confidence":0.76,"page_ref":"Page 50","evidence_quote":"All Claims will adjudicate at and Client will pay RIGHTWAY (except as stated in (c) below) the lower of (i) U&C (if applicable)","rationale":"Page 50 sets claim level adjudication at the lower of usual and customary price, average wholesale price minus the pharmacy discount plus dispensing fee, maximum allowable cost plus dispensing fee, or the pharmacy submitted amount plus dispensing fee, less member cost sharing. That is a claim level lesser of rule, and it includes the dispensing pharmacy's cash price. It is not the model ceiling. Nothing ties plan cost, in every channel and for every drug, to a published benchmark such as a transparent cash price at an independent benchmark site. Page 49 states that Rightway will try to achieve the discount and dispensing fee guarantees on an aggregated basis, not claim by claim, and that actual pharmacy rates may be higher or lower than those guarantees. A favorable average can therefore hide an individual claim priced above any external cash benchmark. The lesser of rule is a real but weaker ceiling, so the verdict is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"CASH","verdict":"partial","confidence":0.8,"page_ref":"Page 50","evidence_quote":"All Claims will adjudicate at and Eligible Person will pay Participating Pharmacies (except as stated in (c) below) the lower of (i) U&C (if applicable)","rationale":"Page 50 requires the member to pay the lower of usual and customary price, the contracted rate, maximum allowable cost, the submitted amount, or the plan cost sharing amount. The cost sharing definition on page 29 also says certain pharmacies collect the lesser of cost sharing and usual and customary price. A member using a participating pharmacy should not pay more than that pharmacy's cash price on an adjudicated claim. That is only part of the model term. I found no clause stating that a cash purchase outside the claim counts toward the deductible and out of pocket maximum. The accumulator file on page 20 moves deductible and out of pocket data to one service provider. It does not credit off claim cash purchases. I also found no rule that an accumulator adjustment against member assistance applies only if the City elects it in writing. Page 50's third party pricing path can adjudicate at a vendor discount with the member paying the full claim cost. The point of sale lesser of rule makes this partial, not missing.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"MAC","verdict":"partial","confidence":0.84,"page_ref":"Page 31","evidence_quote":"The list of drugs with a MAC offered at Mail Order will be identical to the list of drugs with a MAC offered at Retail Pharmacies.","rationale":"Page 31 defines maximum allowable cost as an amount determined by Rightway, updated at least quarterly or more often if law requires, based on marketplace pricing. The same definition says the list of drugs with a maximum allowable cost at mail will be identical to the list at retail. Page 32 requires one pricing source for invoicing the City and paying pharmacies. Combined with the pass through definition on page 31, the City is invoiced what the pharmacy is paid, which reduces the classic two list spread. The model also requires the list to be disclosed and a pharmacy appeals path with defined timelines. I did not find either. Page 44 lists maximum allowable cost program administration as included in the administrative fee, without a disclosure or appeal duty. Pharmacies have no stated appeal clock. The identical drug list and quarterly update are real governance, but without disclosure and appeals the term is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"SPRD","verdict":"partial","confidence":0.8,"page_ref":"Page 49","evidence_quote":"Under the RIGHTWAY transparent, full Pass -Through model, Client pays the actual reimbursement rate (discounts and dispense fees) paid by RIGHTWAY to the Participating Pharmacy from which the Claim originates","rationale":"The pass through is stated in strong terms. Page 31 defines pass through pricing as equality between the price Rightway pays the participating pharmacy and the amount invoiced to the City, and says Rightway does not retain rebates or other direct financial benefits from manufacturers or pharmacies. Page 38 says Rightway invoices claims at the amount it pays for those claims. Page 49 says 100 percent of participating pharmacy negotiated pricing is passed through claim by claim, and that the City pays the actual reimbursement rate paid to the pharmacy, less member cost sharing, with a separate administrative fee on page 41. That matches the core of the model. It is not quite as strong, because page 50 allows Rightway's vendor to assess and retain transaction fees from participating pharmacies. That is an express retention from the pharmacy side in the pricing attachment. Guarantees are aggregate, but the invoice rule is claim by claim, so the aggregate point is not itself spread. The vendor fee carve out is why this is partial rather than good.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"GPO","verdict":"bad","confidence":0.92,"page_ref":"Page 52","evidence_quote":"the term \"Rebate\" as used in this Agreement does not include this compensation, which belongs exclusively to the Rebate Aggregator or intermediary.","rationale":"The contract permits the purchasing intermediary to keep manufacturer value instead of passing it through. Page 32 defines a rebate aggregator as any party engaged by Rightway to obtain rebates and states that reasonable formulary management fees and costs may be retained by the aggregator. Page 52 states that the amount Rightway receives may differ from the amount the aggregator or intermediary receives from manufacturers, that the difference may be retained as the intermediary's compensation, and that the defined term rebate does not include that compensation, which belongs exclusively to the aggregator or intermediary. The same page says those aggregators are subcontractors and are not affiliates, which keeps them outside any affiliate pass through concept. I found no clause moving purchase discounts, volume credits, or supplier payments received by a related purchasing entity, including an offshore group purchasing organization, to the City on disclosed allocation drivers. This is the opposite of the model term, so the verdict is bad.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"FORM","verdict":"partial","confidence":0.88,"page_ref":"Page 21","evidence_quote":"RIGHTWAY shall provide a recommended drug Formulary to Client and Client hereby adopts, as part of the Plan design and as Client's formulary, such Formulary (as amended from time to time).","rationale":"Page 21 says Rightway will provide a recommended formulary and that the City hereby adopts it as the plan formulary, as amended from time to time. The City authorizes Rightway to implement prior authorization, step therapy, and quantity limits. Page 30 defines the formulary as developed by Rightway's pharmacy and therapeutics committee, approved and adopted by the City, and based in part on lowest net cost analysis. That is adoption, not ongoing sponsor control of every change. Page 53 conditions guarantees and the per member per month target on complete adoption of Rightway's Comprehensive Value Formulary, including exclusions and clinical edits. Page 45 prices a custom formulary as an hourly clinical service, and page 46 says formulary management in the administrative fee does not include client custom formularies. I found no duty to deliver utilization management outcomes by drug each quarter. The City keeps plan design authority on pages 15 and 16, and plan changes require agreement, but Rightway need not implement a change it says it cannot administer. Sponsor control is present and weaker than the model, so this is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"LNC","verdict":"partial","confidence":0.8,"page_ref":"Page 30","evidence_quote":"The Formulary is based on drug safety, drug efficacy, and drug cost/lowest net cost analysis.","rationale":"Page 30 says the formulary is based on drug safety, drug efficacy, and drug cost and lowest net cost analysis. That names the standard the model wants, but it does not bind formulary decisions to lowest net cost for this plan, does not require an annual comparison against Rightway's whole book of business, and does not require disclosure, with a reason, when a drug is placed above a cheaper equivalent. Page 51 gives a rebate credit for low wholesale acquisition cost biosimilar claims only if the City elects the low wholesale acquisition cost formulary strategy. That is a pricing adjustment, not a book of business comparison. Page 27 uses book of business measurement for operational performance standards, which is a different and less protective use of the phrase. I looked through the clinical services section on pages 20 through 22 and the pricing attachment and did not find the annual comparison or the placement disclosure. The named analysis makes this partial rather than missing.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"NET","verdict":"bad","confidence":0.83,"page_ref":"Page 18","evidence_quote":"RIGHTWAY may refuse to add pharmacies to its network if they do not meet RIGHTWAY's minimum credentialing criteria or are owned by, or under common control with, a direct competitor of RIGHTWAY.","rationale":"The network terms permit the harms the model prohibits. Page 18 lets Rightway refuse to add a pharmacy that fails its credentialing criteria or that is owned by, or under common control with, a direct competitor. That is the opposite of any willing pharmacy participation at the plan's terms. The same page allows Rightway to collect audit discrepancies from participating pharmacies and to offset collection costs, so adjudicated pharmacy payments are not final. I found no clause barring Rightway from steering claims into a pharmacy it owns or is economically tied to. Page 23 includes site of service optimization and therapy optimization as navigation services, and page 22 allows drug interchange programs. Page 30 notes that limited distribution drugs may be dispensed by pharmacies owned by or affiliated with Rightway, without a steering ban. Reimbursement is not stated to be independent of volume. Client requested custom exclusions on page 18 are a City tool, not an anti steering duty. Because the contract permits a closed network and post adjudication recovery, the verdict is bad.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"MFN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"I looked for most favored pricing and a market check in the term clause on page 1, the renewal language on page 1, the payment schedule on pages 38 through 40, and the financial conditions on pages 52 through 54. Nothing says the City automatically receives pricing at least as good as any comparable client. Nothing gives the City an annual market check with a meet, credit, or release remedy. Page 1 allows the City to renew for up to two one year terms, but renewal fees and financial terms must be agreed by both parties. That is a renegotiation at the option point, not a market check during the term. Page 1 also lets Rightway modify fees for another governmental purchaser under a cooperative arrangement, which is the opposite of a most favored commitment to this City. The pricing exhibits are present and do not contain the term, so this is missing rather than unclear.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 4","evidence_quote":"Auditor shall not be entitled to audit Vendor's vendors, Manufacturers, Rebate Aggregator, pharmacies, or other providers of Services hereunder","rationale":"Pages 3 and 4 give the City one audit each contract year during the term and for one year after termination, at reasonable times outside a Rightway blackout period, on thirty days' notice, at no additional cost, covering transactions in the prior three years. The City designates an independent auditor, which is closer to the model than a vendor chosen auditor. The right is materially limited. The auditor must not be prohibited by Rightway, must sign Rightway's standard nondisclosure agreement, and may not audit Rightway's vendors, manufacturers, the rebate aggregator, pharmacies, or other service providers, though relevant records such as rate sheets and invoices are to be provided. Page 4 deems the City to have accepted Rightway's objection if the City does not dispute it within thirty days. Standard reports are due within thirty days of month or quarter end on page 20, and claim files go to the City and up to six service providers. I found no pre adjudication claims access, and confidential information can be withheld behind the nondisclosure agreement. Audit rights exist and are weaker than the model, so this is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"DATA","verdict":"bad","confidence":0.87,"page_ref":"Page 3","evidence_quote":"Vendor shall retain full ownership rights over all resultant data.","rationale":"Page 3 allows Rightway, during and after the term, to use, reproduce, disclose, and adapt claims, eligibility, medical, and other health data in de identified or aggregated form for research, benchmarking, and business purposes for this City and other customers, and it states that Rightway retains full ownership of all resultant data. Rightway will not sell protected health information. That is the opposite of the model, which gives the sponsor sole ownership of claims, eligibility, accumulator, rebate, and every derived data set and bars reuse, license, or sale. Page 10 gives the City ownership of work product, but page 26 says Rightway is not providing work product as part of these services, so that clause does not vest claims data in the City. Pages 20 and 25 require delivery of claim and accumulator files in Rightway's standard format to named service providers, which is access, not ownership. Post termination files on page 25 are scrubbed of Rightway confidential information. Because the contract assigns derived data to Rightway and permits reuse, the verdict is bad.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"PERF","verdict":"partial","confidence":0.88,"page_ref":"Page 34","evidence_quote":"placing up to $20 per Eligible Person at risk for implementation performance guarantees in Year One and $20 per Eligible Person at risk for ongoing performance guarantees","rationale":"Attachment A-2 on pages 34 and 35 puts up to $20 per eligible person at risk for implementation guarantees in year one and $20 per eligible person at risk for ongoing guarantees each year, allocated by the City with a cap of 20 percent on any one ongoing guarantee. Amounts are credited against what the City owes, not paid in cash, and the sum cannot exceed the dollars at risk. Page 27 measures performance standards across Rightway's book of business unless otherwise stated, and says a miss is not itself a material breach. Page 35 makes those amounts the City's sole monetary remedy aside from correction of payment or billing errors. Several operational measures on pages 36 and 37 are book of business, not plan specific, and measurement is annual, not quarterly. Separate discount, dispensing fee, and rebate guarantees on pages 48 and 51 are reconciled dollar for dollar, which is stronger, but they are annual credits, can be voided for a partial year, and fall away if the per member per month target on page 52 is met. Capped credits on book of business data make the performance guarantee term partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"ENF","verdict":"partial","confidence":0.84,"page_ref":"Page 27","evidence_quote":"The failure to meet a performance standard shall not, in and of itself, constitute a Material Breach of the Agreement.","rationale":"Some remedies run without a damages proof, and there is no two strike exit. Page 34 credits amounts owed for a missed performance guarantee within forty five days after the City receives the annual report. The City does not have to prove damages to receive that credit. Page 27 says those amounts are payable solely for failure to meet the standard, and that a miss is not, by itself, a material breach. Page 35 calls the credit the sole monetary remedy for those misses. Page 2 allows either party to terminate if a material breach is not cured within thirty days, and the City may terminate for convenience without a penalty. I found no clause that a second material breach, or a regulatory integrity failure, lets the City terminate without penalty as an automatic consequence. Late reports are not given their own liquidated damage. The audit objection rule on page 4 can deem findings accepted if the City is silent for thirty days, which cuts against self executing enforcement. Automatic credits exist, but the two strike exit does not, so this is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"AMD","verdict":"partial","confidence":0.86,"page_ref":"Page 53","evidence_quote":"RIGHTWAY can change the pricing (e.g., Administrative Fees, Additional Fees, Ancillary Service Fees, PMPM Targets, AWP Discount Guarantees and Dispensing Fee Guarantees, Minimum","rationale":"Page 9 states that no amendment, modification, or extension is binding unless set out in a written instrument signed by an authorized representative of each party. That is the model rule, and it is not the whole contract. Page 1 gives schedules and attachments precedence over the body. Pages 53 and 54 say Rightway can change administrative fees, ancillary fees, per member per month targets, discount guarantees, dispensing fee guarantees, and minimum rebate guarantees by the minimum amount necessary if listed conditions occur, including plan design changes, law changes, a shift in eligible persons, a change in claims mix, discontinued manufacturer concessions, or a specialty carve out. Page 8 lets Rightway modify the regulatory addenda on written notice for legal compliance. Page 33 lets Rightway modify the specialty list, and page 55 lets Rightway change the high cost drug listing for new products and line extensions. Page 16 allows non material service changes. The signed amendment rule is real, and the economic carve outs are material, so this is partial rather than bad.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"TERM","verdict":"partial","confidence":0.89,"page_ref":"Page 2","evidence_quote":"City may terminate this Agreement at any time and for any reason by providing Vendor with 90 days' written notice of termination without penalty or termination fees.","rationale":"Page 2 lets the City terminate at any time and for any reason on 90 days' written notice without penalty or termination fees. Vendor termination for convenience requires 180 days' notice. Non appropriation on page 2 also ends the agreement without penalty to the City. Page 24 says that if the agreement ends other than by Rightway for the City's breach, Rightway will pay or credit rebates, performance standards, and financial reconciliations under the payment terms. Those are the strengths. They are not the full model term. Page 54 voids discount, dispensing fee, rebate, and per member per month guarantees for any contract year that is not completed, so a mid year City exit forfeits that year's guarantee reconciliation. Page 24 lets Rightway keep rebates and other amounts if it terminates for the City's material breach, and use pre termination amounts to offset damages. I found no regulatory integrity event as a stated ground for termination. Convenience termination without a fee is present, and earned guarantee amounts can be forfeited, so this is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"SPEC","verdict":"partial","confidence":0.85,"page_ref":"Page 33","evidence_quote":"Specialty Pharmaceuticals or Specialty Drug means those biotech, biological, and other Covered Products identified by RIGHTWAY as specialty pharmaceuticals from time to time","rationale":"Specialty is not defined by function alone. Page 33 defines specialty pharmaceuticals as products Rightway identifies as specialty from time to time, typically biotech or biological products with special handling, and Rightway may modify the list. A current list is available on request and is not attached. Page 49 sets aggregate average wholesale price discount guarantees for specialty brand, specialty generic, and limited distribution drugs, with a dispensing fee guarantee of $0.00, and says those guarantees are not claim by claim. Page 55 sets separate annual discount guarantees by product code for rare high cost drugs, reconciled independently and paid dollar for dollar if the aggregate discount misses, and Rightway may add new to market drugs and line extensions. Those are useful controls. They are not a claim level ceiling in every channel, and nothing prices specialty claims at an affiliated pharmacy at acquisition cost. Page 51 also excludes limited distribution drugs and several other categories from the minimum rebate guarantee even while saying limited distribution drugs are included unless another exclusion applies. The controls are real and weaker than the model, so this is partial.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Grok 4.7","rubric_key":"GAG","verdict":"bad","confidence":0.91,"page_ref":"Page 26","evidence_quote":"information shared with Client pursuant to this section is RIGHTWAY's Confidential Information.","rationale":"Page 26 requires the City to treat sources of revenue, the pricing structure, the rebate structure, and administrative fees shared under the transparency section as Rightway's confidential information. That is a confidentiality clause covering pricing and rebate data. Page 4 requires the City's auditor to sign Rightway's standard nondisclosure agreement before any confidential information is disclosed, and bars the auditor from the rebate aggregator. Pages 25 and 26 allow disclosure to the City's consultants and auditors only after Rightway and that provider sign a separate confidentiality agreement. Page 3 gives Rightway a chance to mark requested vendor information confidential or proprietary and to object to disclosure under the Texas Public Information Act, with the attorney general or a court deciding. That is not a clean, unconditional public records carve out. A process that lets the vendor try to block release does not free the City to share pricing with advisors, members, the public, or lawmakers. I did not find a clause barring pharmacies from telling patients about cheaper options. The pricing confidentiality and the sharing limits are enough for a bad verdict.","model_own_total":35,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"FID","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"have agreed to the Rebate Credit and Employer agrees that it and its group health plan have no\n right to, or legal interest in, any portion of the rebates, either under the pharmacy benefit or the medical benefit, actually\n provided by the Pharmacy Benefit Manager (\" PBM\") or a pharmaceutical manufacturer to Claim Administrator and\nconsents to Claim Administrator' s retention of all such rebates.","rationale":"Not assessable on this record. Fiduciary status, duty of loyalty and standard of care for an ASO arrangement are set by the governing Administrative Services Agreement, which is incorporated by reference (p. 12) but not part of these 38 pages, so no verdict on the arrangement's fiduciary framework can be reached here. Scope-specific observations only: the one loyalty-relevant term that does appear in this document runs against the plan, in that the Employer disclaims any right or legal interest in pharmacy or medical rebates and consents to the Claim Administrator's retention of them (p. 10); and Limited Fiduciary Services for Claims and Appeals appears as an available service line on the Medical Plan Services page (p. 8) with its Fee Schedule row left blank (p. 9), which shows the concept exists in the product but not what was agreed. A rebate-ownership term alone does not establish the absence of fiduciary duties, and no adverse inference is drawn from the omitted agreement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"DISC","verdict":"bad","confidence":0.7,"page_ref":"p. 13","evidence_quote":"the Employer should contact its POR","rationale":"Producer compensation is deflected rather than disclosed: the Claim Administrator may pay the Employer's Producer of Record a commission or other compensation, and for the amount the Employer is told to ask its own broker. Marsh & McLennan Agency is named as Producer of Record (p. 3) but every commission field on that page (PCPM, flat, percentage of stop loss, monthly cap, split) is left blank. On the Fee Schedule itself, Rebate Credit values for 2024 and 2025 are entered as TBD (p. 9); the PBM Fee Schedule Addendum does supply figures for those years, stating per-brand rebate guarantees by channel and per-employee-per-month rebate amounts for each of 2023, 2024 and 2025 together with a $4.57 per employee per month administrative fee (pp. 29-31), so the guaranteed amounts are disclosed even where the application form leaves them open. What remains undisclosed is a separate question the record does not answer: how much manufacturer and vendor revenue is actually retained, since actual rebates received are not reported to the Employer anywhere in these pages and, on p. 10, the plan disclaims any legal interest in them while p. 30 promises a true-up to the greater of guarantees or actual rebates. The verdict here rests on the producer-compensation deflection and the blank commission fields, which are in-document facts, not on the rebate ambiguity.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 35","evidence_quote":"Prescription Drug Claims with: Prime ( Preferred PBM)","rationale":"Not assessable on this record: an ownership or affiliate disclosure exhibit, if one exists, would be an attachment to the Administrative Services Agreement or PBM Exhibit, neither of which is supplied, so its absence from this application packet is not evidence that no such disclosure was made. The pharmacy benefit manager is identified only as \"Prime (Preferred PBM)\" on the stop loss application, and the performance guarantee exhibit names Prime, ESI Mail Pharmacy and Accredo Specialty Pharmacy as the operating vendors (pp. 18-21) without stating any ownership relationship between Health Care Service Corporation, Prime Therapeutics or those pharmacies. Within this document the relationships are simply not described; no adverse inference is drawn from the omitted governing documents.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"DEF","verdict":"unclear","confidence":null,"page_ref":"p. 29","evidence_quote":"For discount and dispensing fees, Brand drugs are defined as drugs that have a Medi-Span multlsource code field equal to' M\",' N', or' O'\n For it scount and dispensing fees, Generic drugs are defined as drugs available in sufficient supply that have a Medi- Span multisource code field\n equal to' Y'","rationale":"The document defines eligibility terms (Eligible Person, Full-Time Employee, disabled dependent, limiting age, pp. 3-6) in detail, but the pharmacy economics rest on definitions controlled by third parties or by the Claim Administrator: brand and generic turn on the Medi-Span multisource code, and specialty is \"defined by the BCBS TX specialty drug pricing file\" (p. 29), a file that is not attached. Definitions such as AWP, Rebate, Administrative Fee and Covered Drug live in the Administrative Services Agreement and PBM Exhibit, which are not part of these 38 pages, so no assessment of the definitional scheme as a whole is possible.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"PASS","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"no\n right to, or legal interest in, any portion of the rebates, either under the pharmacy benefit or the medical benefit, actually\n provided by the Pharmacy Benefit Manager (\" PBM\") or a pharmaceutical manufacturer to Claim Administrator and\nconsents to Claim Administrator' s retention of all such rebates. The Rebate Credit will be provided from Claim\nAdministrator' s own assets and may or may not equal the entire amount of rebates actually provided","rationale":"Two provisions in this document point in opposite directions and the record does not resolve which controls. Against pass-through, p. 10 states the Employer and its group health plan have \"no right to, or legal interest in, any portion of the rebates, either under the pharmacy benefit or the medical benefit,\" consents to the Claim Administrator's retention of all of them, substitutes a Rebate Credit paid \"from Claim Administrator's own assets\" that \"may or may not equal the entire amount of rebates actually provided,\" ends Rebate Credits at termination of the Prescription Drug Program, and supersedes any contrary Rebate Credit provision in the governing agreement. Toward pass-through, the PBM Fee Schedule Addendum states that \"Rebates will be trued up annually to the greater of the PEPM rebate credits, per brand Rx rebate guarantees, and actual rebates\" (p. 30, wording confirmed by rendering the scanned page at 260 dpi; the text layer degrades the last words to \"actual rebatr.\"), the addendum's own pricing section is captioned CUSTOM PASSTHROUGH PRICING (pp. 29-31), and the rebate table sets per-brand and per-employee-per-month floors by channel. Read together, an annual true-up to the greater of guaranteed amounts or actual rebates is materially better for the plan than a fixed credit and is inconsistent with pure retention, but it is also reconciled only in aggregate, subject to a long exclusion list including biosimilars, limited distribution drugs, 340B, member-paid and zero-balance claims, and contingent on BCBSTX remaining the medical administrator (p. 30). Which instrument prevails, and whether \"actual rebates\" means all manufacturer revenue received by the Claim Administrator or only what the PBM reports for guarantee purposes, is governed by the Administrative Services Agreement and PBM Exhibit, which are not supplied. Recorded as unclear with both quotations preserved rather than resolved in either direction.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 29","evidence_quote":"Guarantees are based upon a exclusive specialty network arrangement","rationale":"Nothing in the 38 pages prices any pharmacy at acquisition cost. Pharmacy pricing is expressed as AWP discount percentages and dispensing fees per channel (p. 29), with an exclusive specialty network arrangement, and mail and specialty fulfilment run through ESI Mail Pharmacy and Accredo (pp. 20-21). Whether those pharmacies are affiliates of the PBM or the Claim Administrator is not stated in this document, and the reimbursement mechanics sit in the unattached Administrative Services Agreement and PBM Exhibit, so no acquisition-cost assessment is possible.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"Members will pay the lower of the contracted rate, UBC, or their applicable copayment. Zero balance logic is not employed.","rationale":"A lesser-of rule exists at the member level (member pays the lower of the contracted rate, usual and customary, or the applicable copayment), but there is no plan-level ceiling requiring the plan to pay the lowest of contracted rate, cash price, or any other benchmark, and no cheapest-lawful-option obligation in the supplied pages. The plan-level payment methodology is set by the Administrative Services Agreement and PBM Exhibit, which are not attached.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.6,"page_ref":"p. 31","evidence_quote":"Members will pay the lower of the contracted rate, UBC, or their applicable copayment. Zero balance logic is not employed.","rationale":"The member-level lesser-of rule gives partial cash-price protection: a member never pays more than the contracted rate or usual and customary. But the same note states twice that \"Zero balance logic is not employed,\" and nothing in the 38 pages allows a member to buy at a lower cash price outside the benefit or credits such a purchase toward the deductible or out-of-pocket maximum. Claims that are 100% member-paid are expressly excluded from the discount, dispensing fee and rebate guarantees (pp. 29-30), which removes any guarantee protection from exactly those purchases.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"MAC","verdict":"unclear","confidence":null,"page_ref":"p. 29","evidence_quote":"Discounts are based on the actual NDC- 11 dispensed on the fill date.","rationale":"Not assessable on this record. MAC list construction, update frequency and appeal rights are pharmacy-network and PBM Exhibit terms, and the PBM Exhibit is incorporated by reference (p. 31) but not supplied. What this document shows is only the guarantee mechanic: generic pricing expressed as aggregate AWP discount guarantees by channel, measured on the NDC-11 actually dispensed. No MAC governance appears in these 38 pages and none is inferred to be absent from the arrangement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"unclear","confidence":null,"page_ref":"p. 29","evidence_quote":"For the purpose of reconciliation at contract year end, discount and dispensing fee guarantees are reconciled in aggregate, as long as the\n contract remains in effect.","rationale":"The addendum is captioned as pass-through pricing, but what the 38 pages actually contain is aggregate annual reconciliation of AWP discount and dispensing fee guarantees, with wide claim-type exclusions, rather than a stated commitment that the plan pays exactly what the pharmacy is paid on each claim. Aggregate guarantee reconciliation is compatible with either pass-through or spread on individual claims, and the per-claim billing rule is in the Administrative Services Agreement and PBM Exhibit, which are not attached. The retention language that does appear in this document concerns rebates rather than dispensing spread (p. 10), and even that is qualified: the addendum's annual true-up to the greater of PEPM credits, per-brand guarantees, and actual rebates (p. 30, image-verified) pulls the other way, so rebate retention should not be described as settled either. Neither reading is asserted here.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"GPO","verdict":"unclear","confidence":null,"page_ref":"p. 10","evidence_quote":"either under the pharmacy benefit or the medical benefit, actually\n provided by the Pharmacy Benefit Manager (\" PBM\") or a pharmaceutical manufacturer to Claim Administrator and\nconsents to Claim Administrator' s retention of all such rebates.","rationale":"Not assessable on this record. No group purchasing organization, rebate aggregator or affiliated purchasing entity is named or addressed anywhere in the 38 pages, and any treatment of intermediary revenue would sit in the Administrative Services Agreement or PBM Exhibit, which are not supplied. Scope-specific observation: the rebate clause in this document is written at the level of revenue \"actually provided by the Pharmacy Benefit Manager ... or a pharmaceutical manufacturer to Claim Administrator\" and says nothing about revenue retained by an intermediary before it reaches the Claim Administrator, so this document neither grants nor denies intermediary pass-through.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"FORM","verdict":"bad","confidence":0.8,"page_ref":"p. 31","evidence_quote":"Guarantees are based on adoption and adherence of an above BCBS TX drug 119, Including associated utilization management\n and clinical programs.","rationale":"Formulary control runs the wrong way. The pricing guarantees are conditioned on the Employer adopting and adhering to the Claim Administrator's drug list and its associated utilization management and clinical programs; the drug list is preselected as the Performance Drug List on the services page (p. 8); and the Employer separately \"acknowledges and agrees to utilize Claim Administrator's standard list of services and supplies for which Prior Authorization ... is required\" (p. 12). Drug list changes are also listed among the events for which the Claim Administrator may equitably adjust the guarantees (p. 31), so the sponsor cannot change the formulary without putting its own pricing at risk. (Text on this page is an OCR rendering of a scanned form; \"drug 119\" reads as \"drug list\" in context.)","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"LNC","verdict":"unclear","confidence":null,"page_ref":"p. 30","evidence_quote":"Rebates will be trued up annually to the greater of the PEPM rebate credits, per brand Rx rebate guarantees. and actual rebatr.","rationale":"Not assessable as a standard, with one material positive on the record. No lowest-net-cost obligation and no most-favorable or book-of-business net-cost comparison appears in the 38 pages, and such terms would live in the Administrative Services Agreement or PBM Exhibit, which are not supplied, so no adverse absence is inferred. What this document does contain is a floor mechanism that works in the plan's favour: an annual true-up to the greater of PEPM rebate credits, per-brand Rx rebate guarantees, and actual rebates (image-verified wording, p. 30), which guarantees the plan the best of three measures on rebate dollars even though it says nothing about total net cost, is reconciled only in aggregate, and excludes biosimilars, limited distribution drugs, 340B, member-paid and zero-balance claims. Its interaction with the rebate waiver on p. 10 is unresolved on this record.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.75,"page_ref":"p. 31","evidence_quote":"Guarantees assumes 26% ESN penetration, If that differs significantly, BCBS TX reserves the right to revise guarantees terms and financials.","rationale":"The guarantees are built on channel steering rather than protected against it: they assume a stated Extended Supply Network penetration and mail penetration, and the Claim Administrator reserves the right to revise the guarantee terms and financials if actual penetration differs significantly, which pushes the plan to drive members into the preferred channels. Specialty runs through an exclusive specialty network arrangement (p. 29). There is no any-willing-pharmacy clause, no anti-steering protection, no protection for independent or local pharmacies and no member choice guarantee in the 38 pages; the addendum instead warns that if the Extended Supply Network is not implemented, retail rates apply (p. 29).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"MFN","verdict":"unclear","confidence":null,"page_ref":"p. 31","evidence_quote":"BCBS TX reserves the right to equitably adjust the guarantees In the event the number of covered members or p^ armacy dal ms volume\n materially changes over the course of the contract.","rationale":"Not assessable on this record: most-favored-pricing and market-check rights, if any, would appear in the Administrative Services Agreement or PBM Exhibit, which are not supplied, so their absence from this application packet is not treated as an absence from the arrangement. Scope-specific observation: no such right for the Employer appears in the 38 pages, while the repricing rights that are stated here run to the Claim Administrator, which reserves the right to equitably adjust guarantees for enrollment or claim volume changes and for a long list of market events (p. 31), and to re-evaluate performance guarantee levels (p. 17).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"AUD","verdict":"unclear","confidence":null,"page_ref":"p. 16","evidence_quote":"The Claim Administrator will measure Performance Guarantees and report the\n measurement results to Employer, and any refund amounts due in accordance with this","rationale":"The supplied pages give the Employer no audit right: no right to audit claims, rebates, pricing or the PBM, no choice of auditor and no data access provision. Verification is entirely self-reported, with the Claim Administrator measuring its own performance guarantees and reporting results within 120 days after the close of the measurement periods (pp. 16-17). Audit rights, if any, would sit in the Administrative Services Agreement, which is not part of this document, so this is scored as unclear rather than as an established absence in the arrangement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"DATA","verdict":"unclear","confidence":null,"page_ref":"p. 2","evidence_quote":"Not for use or disclosure outside Claim Administrator, Employer, their respective affiliated companies and third -party representatives, except\n with written permission of Claim Administrator.","rationale":"No data ownership, data access or data portability clause appears in the 38 pages. The only data-related terms run the other way: the document is marked proprietary and confidential to the Claim Administrator and may not be disclosed outside a defined circle without its written permission, and eligibility data flows are the Employer's obligation as a condition of the guarantees (p. 17). Ownership of claims and eligibility data would be addressed in the unattached Administrative Services Agreement.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.8,"page_ref":"p. 21","evidence_quote":"Total PDP\n 34, 000","rationale":"Real performance guarantees exist and are signed: a prescription drug exhibit with per-standard dollars at risk totalling $34,000 across eligibility, plan setup, call handling, system availability, claims accuracy, geographic access, mail turnaround, dispensing accuracy and member satisfaction (pp. 18-21), plus medical guarantees at 18% of the administrative charge (p. 24) and dental at 12% (p. 27), all for five annual settlement periods from 2023 through 2027. The remedy is capped, self-measured and heavily conditioned: no measurement if enrollment falls below stated levels, if the Employer is late with data or fees, or for periods affected by Employer-requested changes, and the Claim Administrator may re-evaluate and renegotiate the levels and the amounts at risk (pp. 16-17). Several standards are measured at the Blue Plan or Prime book-of-business level rather than for Lubbock (pp. 18-20), so the plan can be paid nothing on a standard its own members experienced as a failure.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"ENF","verdict":"bad","confidence":0.7,"page_ref":"p. 17","evidence_quote":"If for any reason the Agreement is terminated prior to the end of any Settlement Period,\n the Performance Guarantees will not be measured and Employer will not receive any\n refund, based on that part of the Settlement Period in which the Administrative Services\n Agreement was in effect.","rationale":"Enforcement is not self-executing and there is no exit remedy. If the agreement terminates before a settlement period ends, the guarantees are not measured and the Employer receives no refund for that period at all, which means the vendor's exposure disappears exactly when the plan is leaving because of poor performance. There is no two-strikes provision, no escalating remedy, no cure-and-exit mechanism and no interest or liquidated damages in the 38 pages, and refunds are also withheld until the agreement and current Exhibit-PG are executed and on file with the Claim Administrator (p. 17).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"AMD","verdict":"partial","confidence":0.65,"page_ref":"p. 16","evidence_quote":"unless amended, replaced, or terminated by the parties to the Agreement in\nwriting.","rationale":"The performance guarantee addendum requires a writing between the parties to amend, replace or terminate it, which is the right rule. Two provisions cut against it: the Rebate Credit clause unilaterally supersedes any contrary Rebate Credit provision in the governing Administrative Services Agreement (p. 10), and if an external benchmark such as AWP changes or ceases to be published, the guarantees \"shall be re-evaluated and adjusted or converted to an alternative benchmark by Claim Administrator or its designee\" without any signature from the Employer (p. 17). The Claim Administrator also reserves unilateral equitable adjustment of guarantees for a long list of events (p. 31).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"TERM","verdict":"bad","confidence":0.7,"page_ref":"p. 13","evidence_quote":"The Run- off Administration amount is due and payable whether or not BCBSTX processes the run- off claims","rationale":"Exit carries a charge and no termination clause in this document offsets it. The run-off administration amount is due and payable whether or not the Claim Administrator processes any run-off claims, and it is computed by multiplying the run-off factor (2023 medical: 14.04 per Covered Employee, p. 11) by all certificates exposed in the three months before termination. The 38 pages contain no notice period, no termination-for-convenience right and no termination-without-penalty language for the Employer; termination terms would be in the unattached Administrative Services Agreement, but the charge itself is stated here.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"bad","confidence":0.7,"page_ref":"p. 29","evidence_quote":"Aggregate Spec airy discount guarantees do not include Imlted distribution drugs ( LDDs) nor any new specialty drugs brought to market and\n added to the specialty list dur ng the term of each contract year","rationale":"Specialty is the weakest priced category. The specialty guarantee excludes limited distribution drugs and any new specialty drug brought to market and added to the specialty list during a contract year, and the specialty list itself is the Claim Administrator's own \"BCBS TX specialty drug pricing file\" which is not attached, so the vendor defines the scope of its own guarantee and can add products outside it mid-year. Specialty drugs dispensed under the medical benefit are excluded from guarantee reconciliation entirely (p. 31), fulfilment is through an exclusive specialty network (p. 29), and the single stated specialty discount is a flat 24.00% with a $0.00 dispensing fee for each of 2023, 2024 and 2025 (p. 29, values read from a degraded scan). (Text reads \"Spec airy\" for \"Specialty\" in the OCR of this scanned page.)","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0047","contract_slug":"lubbock-2022-r0416-bcbstx-aso-bpa-contract-16694","entity":"City of Lubbock, Texas","vendor":"Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.85,"page_ref":"p. 2","evidence_quote":"Not for use or disclosure outside Claim Administrator, Employer, their respective affiliated companies and third -party representatives, except\n with written permission of Claim Administrator.","rationale":"Every page of the application and fee schedule carries a legend restricting use or disclosure outside the Claim Administrator, the Employer, their affiliates and third-party representatives without the Claim Administrator's written permission, and the performance guarantee and pricing pages carry the same restriction \"except under written agreement\" (pp. 16-31). Applied to a Texas home-rule city, a restriction of this breadth over its own pharmacy pricing, fee schedule and guarantee terms is the red-flag pattern the rubric targets, whatever its enforceability against a public body. The document was nonetheless published in full by the City with its resolution, so the restriction did not in fact prevent public access to these pages.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T00:21:27+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"FID","verdict":"partial","confidence":0.93,"page_ref":"p. 31","evidence_quote":"Aetna has no other fiduciary\n responsibility.","rationale":"The medical schedule delegates discretionary claims decisions but expressly limits the fiduciary responsibility. The prescription schedule also delegates particular external-review decisions. Neither supplies the rubric's comprehensive PBM loyalty, conflicts and disgorgement covenant. A limited claim-review fiduciary role must not be represented as no fiduciary role at all.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"DISC","verdict":"partial","confidence":0.93,"page_ref":"p. 29","evidence_quote":"Aetna will bill the Participating Groups an administrative fee of xxx per Claim","rationale":"The packet identifies several compensation categories, including a coalition per-claim fee, GPO administrative fees, other manufacturer services and transmission fees. The quoted fee and many economic fields remain placeholders. Pages 64–65 reserve certain revenues; complete amounts and recurring officer certifications are not established.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"OWN","verdict":"unclear","confidence":null,"page_ref":"p. 25","evidence_quote":"CaremarkPCS Health","rationale":"The posted schedule identifies the licensed PBM and affiliates, but does not establish a signed, comprehensive ownership/affiliate/GPO exhibit with a 30-day refresh obligation. This unsigned proposal expressly anticipates customer-specific final documents, so this is not a finding that such an exhibit cannot exist elsewhere.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"DEF","verdict":"partial","confidence":0.93,"page_ref":"p. 55","evidence_quote":"“Manufacturer Administrative Fees” means the administrative fees received by Aetna or its affiliate from\npharmaceutical companies for administrative services rendered in its capacity as a group purchasing organization for\nthe Plan in contracting for Rebates and administering Rebate contracts.","rationale":"The definition reaches fees received by Aetna or an affiliate acting as a GPO; page 56 also includes direct and indirect rebates and inflation protection. Those are meaningful inclusive terms. Pages 64–65 exclude other manufacturer services and medical-benefit rebates, while classification and specialty-list discretion remain; the definitions do not capture all value by economic function.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"PASS","verdict":"partial","confidence":0.93,"page_ref":"p. 26","evidence_quote":"Customer will receive the greater of the aggregate minimum rebate guarantees quoted herein or 100% of total\nrebates plus manufacturer administrative fees collected by Aetna in its capacity as a group purchasing\norganization on behalf of Customer, that are attributable to the utilization of prescription drugs by Customer’s\nmembers.","rationale":"This is an affirmative greater-of-minimum-or-100%-of-rebates-plus-manufacturer-administrative-fees promise. It must not be omitted. But pages 27 and 64–65 add coalition reconciliation, rebate-credit treatment, timing and excluded revenue categories, including separately retained manufacturer-service revenue. It is narrower than every manufacturer dollar remitted within 30 days.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"NAC","verdict":"unclear","confidence":null,"page_ref":"p. 55","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the cost basis for reimbursement established by Aetna, as modified\nfrom time to time, for the same dose and form of Generic Drugs which are included on Aetna’s applicable MAC List.","rationale":"Benchmark/MAC definitions do not establish affiliated-pharmacy net acquisition cost plus a fixed fee. NADAC is defined but its specific mandatory uses later in the packet concern Tennessee or West Virginia, not proof of a Texas pricing election. Page 25 leaves the selected pricing arrangement blank.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"CEIL","verdict":"partial","confidence":0.93,"page_ref":"p. 54","evidence_quote":"“Calculated Ingredient Cost” means the lesser of:\n\na) AWP less the applicable percentage Discount;\nb) MAC; or\nc) U&C Price.","rationale":"The lesser-of AWP-discount, MAC and U&C formula provides a real contractual comparison. Page 26 also describes the lower-of network comparison through Caremark Cost Saver. Neither establishes a universal claim-by-claim ceiling against every external transparent cash option, and finalized numerical discounts are not supplied.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"CASH","verdict":"partial","confidence":0.93,"page_ref":"p. 57","evidence_quote":"“Usual and Customary Retail Price” or “U&C Price” means the lowest price a Participating Pharmacy would charge\n to a particular member if such member were paying cash for filling an identical Prescription Drug on that particular\n day at that particular location, as submitted by Participating Pharmacy.","rationale":"The definition ties U&C to the particular member's identical cash prescription on the same day and at the same pharmacy; the following sentence includes applicable discounts. This is useful protection. It does not establish that every independent cash purchase must count toward deductible/out-of-pocket limits, and page 66 says rebates are not reflected in member prescription cost.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"MAC","verdict":"bad","confidence":0.93,"page_ref":"p. 55","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the cost basis for reimbursement established by Aetna, as modified\nfrom time to time, for the same dose and form of Generic Drugs which are included on Aetna’s applicable MAC List.","rationale":"Aetna establishes and modifies MAC, and page 67 permits decisions not to set a MAC based on Aetna's own net cost and rebate economics without necessarily lowering sponsor cost. The supplied terms do not establish the rubric's single disclosed plan/pharmacy list, scheduled updates and defined appeals process. This is a clause-level governance concern, not an observed pricing outcome.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"SPRD","verdict":"unclear","confidence":null,"page_ref":"p. 26","evidence_quote":"The amount billed to the Client will be equal to the amount paid to the participating pharmacies.","rationale":"The proposal states equality, a favorable and important term. However page 25 leaves Pricing Arrangement as xxx, and pages 59 and 66 retain both traditional/lock-in and transparent alternatives. The latter explicitly label applicability by election. It would be misleading either to declare spread authorized for San Marcos or to certify a final all-channel no-spread agreement before the signed, elected terms resolve those alternatives.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"GPO","verdict":"partial","confidence":0.93,"page_ref":"p. 55","evidence_quote":"“Manufacturer Administrative Fees” means the administrative fees received by Aetna or its affiliate from\npharmaceutical companies for administrative services rendered in its capacity as a group purchasing organization for\nthe Plan in contracting for Rebates and administering Rebate contracts.","rationale":"The definition covers Aetna or affiliate GPO fees, and page 26 promises their inclusion with rebates. Page 65 reserves other manufacturer payments and related value. Comprehensive supplier payments, purchase discounts and allocation drivers across every related purchasing entity are not established.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"FORM","verdict":"partial","confidence":0.93,"page_ref":"p. 61","evidence_quote":"change to the Formulary subject to Aetna’s ability to operationally administer such election and, if so,\n Aetna’s reservation of right to make appropriate and equitable financial changes resulting therefrom.","rationale":"The formulary provisions allow the sponsor to accept or reject proposed modifications, but subject rejection to operational ability and permit economic changes. Page 65–66 acknowledges that formulary selections can cost more even after rebates. The packet does not establish sponsor approval of every change combined with quarterly drug-level lowest-net-cost and utilization-management reporting.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"LNC","verdict":"bad","confidence":0.93,"page_ref":"p. 66","evidence_quote":"Participating Group’s actual claim expense per prescription for a particular\n Formulary Prescription Drug may in some circumstances be higher than for a non-Formulary alternative.","rationale":"The disclosure continued from page 65 expressly warns that a formulary drug's actual cost may exceed a non-formulary alternative even after rebates. Page 67 explains MAC decisions influenced by Aetna's own costs. Those terms do not impose the rubric's plan-specific lowest-net-cost standard and annual comparison with the PBM's whole book of business.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"NET","verdict":"bad","confidence":0.93,"page_ref":"p. 27","evidence_quote":"CVS Specialty mail pharmacies, including through the Specialty Connect program, will be the exclusive provider of\nspecialty pharmacy services. Claims for specialty products will not be processed through the retail network,\nexcept for those specialty drugs that CVS Specialty mail pharmacies are unable to dispense.","rationale":"The quoted specialty exclusivity clause limits retail exceptions to products CVS Specialty cannot dispense. Page 59 gives Aetna sole discretion over network additions and deletions with notice for material adverse access effects. This is not an any-willing-pharmacy or anti-steering protection; no inference about an actual member's experience is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"MFN","verdict":"partial","confidence":0.93,"page_ref":"p. 29","evidence_quote":"Should the comparison demonstrate\nthat the current market conditions would yield a savings of 1% or more in net costs (i.e. gross costs net of\nadministration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current\npricing terms and other applicable contract provisions.","rationale":"The annual, coalition-requested market check has a measurable 1% net-cost discussion trigger, an actual sponsor protection. It requires good-faith discussion and agreement before later revised terms take effect, not automatic comparable-client pricing, a mandatory credit, or a release remedy.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"AUD","verdict":"partial","confidence":0.93,"page_ref":"p. 68","evidence_quote":"This audit shall also include the Minimum Rebate Guarantee Reconciliation.","rationale":"The packet grants annual claims, pricing and conditional rebate audits, with meaningful reconciliation access. But it limits claim samples, auditor choice, manufacturer contracts and who can exercise rebate rights: coalition rights differ from individually guaranteed participating groups. Disclosure restrictions and fees prevent this from being unrestricted sponsor financial-data access. The group-specific eligibility threshold cannot be assumed satisfied for San Marcos.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"DATA","verdict":"bad","confidence":0.93,"page_ref":"p. 4","evidence_quote":"Aetna may de-identify Plan Records and use them for quality improvement,\nstatistical analyses, product development and other lawful, non-Plan related purposes.","rationale":"The express permission for product development and other non-plan uses conflicts with the rubric's prohibition on reuse of every derived dataset. Page 10 also conditions standard-format post-termination delivery on paid fees and charges the customer all release costs. These are textual ownership/access limitations, not a finding that identifiable patient information is sold.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"PERF","verdict":"partial","confidence":0.93,"page_ref":"p. 25","evidence_quote":"any underperformance, dollar for dollar, will be paid to the Participating Group.","rationale":"The proposal calls for separate reconciliation of retail, mail, specialty and rebate components and dollar-for-dollar payment for underperformance. This is more than an undefined aspiration, but the actual customer rates remain xxx and the later terms use annual aggregate/coalition reconciliation and exclusions. A complete plan-specific quarterly performance package cannot be assessed from these unsigned placeholders.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"ENF","verdict":"bad","confidence":0.93,"page_ref":"p. 70","evidence_quote":"execution of an appropriate release document covering the audit\n period.","rationale":"Audit adjustments are payable after execution of a release, and the following provisions close the year against reopening, including later-discovered related issues. The packet does not establish the rubric's automatic credits for late reporting and penalty-free second-material-breach exit. This research observation is not a legal opinion about whether a particular release is enforceable.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"AMD","verdict":"bad","confidence":0.93,"page_ref":"p. 1","evidence_quote":"Aetna may change the Services and the Service Fees annually by giving the Customer 30 days’ notice\nbefore the changes take effect.","rationale":"The master permits annual changes on 30 days' notice. Pharmacy provisions on pages 30 and 58 reserve additional financial-adjustment grounds and individual specialty-discount changes. The page-12 bilateral-writing default must be read alongside those exceptions; this is not a contract in which all economic amendments necessarily require both signatures.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"TERM","verdict":"partial","confidence":0.93,"page_ref":"p. 9","evidence_quote":"The Customer may terminate this Agreement, or the Services\n provided under one or more schedules, for any reason, by giving Aetna at least 30 days’ prior\n written notice of when such termination will become effective.","rationale":"The master provides a real 30-day convenience termination right and page 10 includes a runoff period. However the pharmacy proposal leaves notice as xxx and initial term as xxx months, while describing a five-year pricing commitment; allowance repayment and data-delivery charges may apply. Page 64 permits offsets/delay of final rebates. The unfinished packet cannot establish unqualified penalty-free exit.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"SPEC","verdict":"partial","confidence":0.93,"page_ref":"p. 28","evidence_quote":"Aetna may amend\nthe individual Specialty Drug discounts to manage the financial guarantee.","rationale":"The proposal offers aggregate specialty discount guarantees but permits individual discount changes, requires CVS Specialty exclusivity and leaves new-to-market and limited-distribution rates as xxx. The definitions allow specialty-list modification. Universal drug-level ceilings and affiliated acquisition-cost invoicing are not established, and no actual current specialty price is asserted.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"GPT 6 Astra","rubric_key":"GAG","verdict":"bad","confidence":0.93,"page_ref":"p. 68","evidence_quote":"will not be revealed in any manner or form by or to any third\n party, including Participating Groups.","rationale":"The rebate-audit confidentiality provision restricts disclosure of findings and manufacturer-contract details, including to participating groups; page 4 also restricts third-party sharing of provider payment information without consent. These clauses conflict with the rubric's open-sharing standard. This is not a conclusion that Texas public-records law is displaced or that the publicly posted packet proves a statutory violation.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-11T23:36:48.355641+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.7,"page_ref":"p. 31","evidence_quote":"It is also agreed that, as between the\n Customer and Aetna, Aetna’s decision on any claim is final and that Aetna has no other fiduciary","rationale":"The fiduciary architecture is expressly narrowed by the document itself rather than left open by a missing exhibit. Aetna is the appropriate named fiduciary only \"for the purpose of reviewing denied claims\" and is granted discretionary authority to determine entitlement, evaluate facts and construe plan terms, with its claim decisions final as between the parties and, in the same sentence, \"no other fiduciary responsibility\" (p. 31). The MSA reinforces this: the Customer as plan administrator \"retains complete authority and responsibility for the Plan,\" Aetna \"provides administrative services\" and \"is not an insurer,\" and claim fiduciary responsibility is pushed to whichever schedule addresses it (p. 2). The Coalition is disclaimed as administrator, named fiduciary or fiduciary for any purpose (p. 53). Against that framework, the pharmacy economics contain express loyalty-adverse terms that are physically present in these pages: manufacturer and other payments that are not Rebates \"belong exclusively to Aetna or CVS Caremark\" with the Participating Group holding \"no right to, or legal interest in\" them (p. 65), rebates on specialty products paid through the medical benefit are retained by Aetna (p. 65), interest and time value on rebates are retained (pp. 64-65), and, were the Participating Group to elect traditional pricing, lock-in margin would be retained by Aetna (p. 66) — an election that is not made anywhere in these pages, so that term is conditional rather than operative. There is a genuine positive to record: the Rebate Terms in the pharmacy fee schedule promise the greater of quoted minimum rebate guarantees or 100% of total rebates plus manufacturer administrative fees collected in Aetna's group purchasing capacity (p. 26). The verdict rests on the express disclaimer of any fiduciary responsibility beyond denied-claim review combined with the retained-compensation provisions quoted above, not on any inference from documents that are not supplied.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.6,"page_ref":"p. 30","evidence_quote":"This document is a summary of Aetna offer, and is not intended to be all-inclusive. Other standard Aetna terms,\nconditions and pricing may apply.","rationale":"Narrative disclosure in this document is unusually full, while the numbers are absent. Disclosed in prose: Aetna's receipt of rebates including manufacturer administrative fees in a group purchasing capacity (p. 26, p. 56); other manufacturer payments that are not Rebates and are not shared (p. 65); CVS Caremark network transmission fees not shared and excluded from discount guarantee calculations (p. 65); lock-in margin retained under traditional pricing and the negative-margin case (p. 66); the formulary conflict, namely that rebates are taken into account in formulary selection and a formulary drug may cost more than a non-formulary alternative (pp. 65-66); MAC-versus-AWP decision-making that takes rebates into account (pp. 66-67); Aetna Subrogation Program retaining 37.50% of recovered amounts (p. 20); the National Advantage Program access fee of 50.00% of Aggregate Savings (p. 21); and apportionment of provider dispute and legal-recovery proceeds after Aetna's cost of recovery (pp. 14, 19). What is not disclosed is the quantum of the customer's own pharmacy pricing, although some other figures are stated (retention percentages on pp. 20-21, late-payment interest on pp. 22-23, audit data fees on p. 70): this is an unsigned form in which Pricing Arrangement, Network, Employees, per-claim coalition administrative fee, allowances, new-to-market and limited-distribution rates and the pharmacy termination notice are all left as \"xxx\" (pp. 25, 28, 29), customer-specific fees and caveats are to be \"incorporated from the customer's finalized proposal documents\" that are not part of these 71 pages (pp. 20, 25), and the offer states on its face that it is \"a summary of Aetna offer\" that is \"not intended to be all-inclusive\" with other standard terms and pricing possibly applying (p. 30). Partial rather than adverse: the conflicts are named, the amounts are not stated, and the unstated amounts are a consequence of the document being an unexecuted form.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.55,"page_ref":"p. 25","evidence_quote":"CaremarkPCS Health, L.L.C. and/or its affiliates (CVS Caremark), each of which is an affiliated, licensed pharmacy\nbenefit manager.","rationale":"Affiliation is disclosed in plain terms but no ownership or affiliate-disclosure exhibit is supplied. The pharmacy benefit manager is named as CaremarkPCS Health, L.L.C. and/or its affiliates (CVS Caremark), each \"an affiliated, licensed pharmacy benefit manager\" (p. 25, repeated at p. 53), and the affiliated fulfilment channels are named throughout: CVS Specialty mail pharmacies as exclusive specialty provider (p. 27), Maintenance Choice claims dispensed at CVS/pharmacy (p. 59), OTC Health Solutions described as \"a CVS Health company\" (p. 43), CVS Health Solutions PLLC for virtual care (p. 46), and CVS-branded clinical buy-ups (pp. 41-42). The intercompany money flow is also described: CVS Caremark shares rebates with Aetna, which may then share with the Participating Group (p. 64), and Aetna pays CVS Caremark for covered services at prices that may differ from what the Participating Group is billed (p. 66). What is missing is any statement of the corporate ownership chain, any list of affiliated entities receiving compensation with amounts, or any exhibit of related-party interests; third-party subcontractors are also described as subject to change without notice in several places (pp. 38, 47, 48). Recorded as partial because the affiliate relationships material to pharmacy pricing are named on the face of the document even though a formal disclosure exhibit is not present.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"partial","confidence":0.6,"page_ref":"p. 54","evidence_quote":"“Brand Drugs” shall mean drugs or devices for which the Medi-Span Multisource Code field contains “M” (co-\nbranded product), or “N” (single source brand), or “O” (originator). For purposes of adjudication only, in limited\ncircumstances, Aetna may override the M, N, or O indicators and deem the drug to be a Generic Drug through\nreview of additional information including other Medi-Span data, FDA application data (NDA/ANDA) and price.","rationale":"The pharmacy schedule contains a real definitional apparatus, which is a positive relative to documents that leave these terms open: Brand and Generic keyed to the Medi-Span Multisource Code, Calculated Ingredient Cost as the lesser of AWP less discount, MAC or U&C Price, plus definitions of AWP discount, Dispensing Fee, MAC and MAC List, NADAC, WAC, U&C Price, Compound Prescription, Single Source Generics, Specialty Products, 340B Claim, DMR Claim, Rebates (expressly including price/inflation protection and Manufacturer Administrative Fees) and Rebate Guarantee (pp. 54-57). Three loopholes remain inside those definitions. First, classification can be overridden: \"in limited circumstances, Aetna may override the M, N, or O indicators and deem the drug to be a Generic Drug\" (p. 54, repeated for Generic Drugs at p. 55), which moves claims between guarantee buckets. Second, the key cost bases are set by the counterparty: MAC is \"established by Aetna, as modified from time to time\" and MAC Lists are \"developed and maintained or selected by Aetna\" (p. 55), and the Formulary is \"developed by Aetna\" (p. 55). Third, Specialty Products are those listed in a Specialty Addendum \"which Aetna may amend from time to time\" (p. 57), so the scope of the specialty channel is unilaterally adjustable. Definitions therefore exist and are precise on their face, but several of them are defined by reference to the vendor's own discretion.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.5,"page_ref":"p. 26","evidence_quote":"Customer will receive the greater of the aggregate minimum rebate guarantees quoted herein or 100% of total\nrebates plus manufacturer administrative fees collected by Aetna in its capacity as a group purchasing\norganization on behalf of Customer, that are attributable to the utilization of prescription drugs by Customer’s","rationale":"There is affirmative 100%-of-rebates language in this document, and it is materially favourable: the Customer receives the greater of the quoted aggregate minimum rebate guarantees or 100% of total rebates plus manufacturer administrative fees collected by Aetna in its group purchasing capacity, attributable to its members' utilization (p. 26). Rebates are defined broadly enough to support that, including price/inflation protection and manufacturer administrative fees (p. 56), and rebates collected on claims excluded from the guarantee are still stated to be passed to the Customer (p. 27). Four in-document limits keep this from being full pass-through. (1) Carve-outs by category: rebates on specialty products administered and paid through the medical benefit \"will be retained by Aetna as compensation\" (p. 65), and payments that Aetna characterises as not being Rebates - bona fide service fees, educational payments, value-based contracting payments and CVS Caremark network transmission fees - \"belong exclusively to Aetna or CVS Caremark\" (p. 65). (2) Timing value: Aetna retains interest and the time value of rebates before payment and may delay payment for reconciliation (pp. 64-65, p. 65). (3) Measurement level: rebates are \"paid quarterly for each channel and reconciled 120 days after year end in the aggregate,\" and separately \"reconciled annually in the aggregate across all groups within the coalition,\" with group-level reconciliation only \"[i]f a group has greater than 20,000 members and has elected group-specific rebates\"; group-specific rebate guarantees are something Aetna \"will evaluate ... for any group of 20,000 lives or greater upon request\" (p. 27). Group-level treatment therefore turns on a stated membership threshold plus an election and, for guarantees, a request. This record does not state the City's enrollment, so whether that threshold is met is not determinable here and no assumption is made either way; the level at which rebates are reconciled is also a separate question from eligibility to audit rebates (pp. 67-68). A related measurement qualification appears on the same pages: when remitting and reconciling minimum rebate guarantees Aetna \"may add 'Rebate Credit' value to the total Rebates remitted,\" computed from WAC differentials and capped by the Baseline Rebate (pp. 26-27), so guarantee attainment can be met in part with credits rather than with collected rebate dollars. By contrast, the four pricing-guarantee components on p. 25 - retail network, Aetna mail, CVS Specialty mail and rebates - are stated to be measured and reconciled separately, with the first three reconciled per Participating Group and underperformance paid dollar for dollar. (4) Conditionality: rebate eligibility requires formulary election and adherence, plan-design conformance, and no direct or indirect contracting with any other party for discounts or rebates without Aetna's written consent, breach of which permits Aetna to suspend or withhold rebates (p. 64), and Aetna reserves the right to adjust rebate guarantees if aggregate performance falls materially below projections (p. 28). Because every guarantee figure is a placeholder in this unsigned form, the dollar effect of the greater-of promise cannot be evaluated from these pages.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.6,"page_ref":"p. 66","evidence_quote":"Participating Group acknowledges that Aetna generally pays CVS Caremark for Brand Drugs dispensed by\n Participating Pharmacies whose patents have expired and their Generic Drug equivalents at a single, fixed price\n established by Aetna (Maximum Allowable Cost or MAC)","rationale":"Nothing in the pharmacy schedule prices any pharmacy, affiliated or otherwise, at acquisition cost, and the document is explicit about the alternative basis it uses. Reimbursement runs on Calculated Ingredient Cost, the lesser of AWP less a percentage discount, MAC, or U&C Price (p. 54), and Aetna pays CVS Caremark for off-patent brands and their generic equivalents at a single fixed MAC price it establishes, or on an AWP-discount basis where it decides that is better for it after taking rebates into account (pp. 66-67). The only acquisition-cost-referenced pricing in the document sits in two state-specific clauses: one \"[f]or Participating Groups contracted or headquartered in Tennessee,\" describing transparent or pass-through pricing with \"NADAC pricing where available in the Low Volume Network at both retail and specialty,\" and one \"[f]or Participating Groups contracted or headquartered in West Virginia,\" adjudicating each on-line claim \"filled in West Virginia\" at NADAC, or WAC where NADAC is unavailable (pp. 59-60); each also exempts Maintenance Choice claims dispensed at CVS/pharmacy from the transparent pricing requirement. Those clauses carry their own contract conditions as to the group and as to the pharmacy or claim location, and they do not establish the general pricing arrangement selected here, which is left as \"xxx\" (p. 25). No claim is made about their statutory background or about which fills could fall inside them. Affiliated dispensing is simultaneously made exclusive - CVS Specialty mail pharmacies as the exclusive specialty provider (p. 27) and Aetna as exclusive provider of the benefit plan design (p. 57) - while specialty discounts remain amendable by Aetna \"to manage the financial guarantee\" (p. 28) and all specialty rate values are placeholders. The adverse verdict rests on the pricing bases stated in the supplied pharmacy schedule, not on an absence inferred from unsupplied documents; the unfilled rate tables mean the magnitude, though not the methodology, is unknown.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.6,"page_ref":"p. 54","evidence_quote":"“Calculated Ingredient Cost” means the lesser of:\n\na) AWP less the applicable percentage Discount;\nb) MAC; or\nc) U&C Price.","rationale":"A lesser-of ceiling is stated and is a genuine protection, precisely scoped: \"Calculated Ingredient Cost\" is the lesser of AWP less the applicable percentage discount, MAC, or the U&C Price (p. 54), so the ingredient-cost component of a covered claim is capped at the pharmacy's usual and customary price. That test governs the ingredient-cost component, not the total amount charged, which also carries a Dispensing Fee (pp. 54-55), so it does not establish that the plan's total charge for a claim, or a member's cost share, can never exceed a price available for cash. DMR reimbursement is likewise the lesser of the invoice or the plan entitlement (p. 58). Beyond that, the only NADAC or WAC benchmarks in the document are the Tennessee and West Virginia clauses, written for \"Participating Groups contracted or headquartered in\" those states and operating on pharmacies or claims located there (pp. 59-60), which do not establish the pricing arrangement selected here; there is no requirement to select the cheapest lawful acquisition channel and no obligation to pay the lower of the pharmacy benefit price and any cash-discount price available outside the benefit. The nearest mechanism is the Caremark Cost Saver program, under which Aetna \"may compare the price available under the Aetna contracted network with the price available through a non-Aetna contracted network if available for that pharmacy\" and, where the non-Aetna price is lower \"(including an administrative fee paid to the third-party that contracts the network),\" processes the claim through that network, with such claims included in the reconciliation of all financial guarantees (p. 26) - a fee-inclusive comparison mechanism, not an external benchmark ceiling. On the medical side the analogous ceiling runs against the plan: for services accessed through a vendor's network the allowed amount is Aetna's contracted rate with the vendor rather than the amount the vendor pays the provider (p. 17). Partial: a lesser-of rule exists at the claim level, but no external benchmark ceiling or cheapest-option duty appears in the 71 pages.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.5,"page_ref":"p. 63","evidence_quote":"The RxSavings Plus Program (Core) allows Discount Program Participants to fill certain Prescription Drugs at\n discounted prices through Program Pharmacies.","rationale":"Cash-price protection is partial and one-directional. Protective elements present: the U&C Price sits inside the lesser-of Calculated Ingredient Cost test, capping the ingredient-cost component of a covered fill at the pharmacy's usual and customary price (p. 54); cost share is calculated on the rates charged to the Participating Group rather than on list (p. 54); a discount card program is included for people outside the plan and, if elected, for drugs not covered under the benefit design (p. 63); and under the Caremark Cost Saver program Aetna \"may compare the price available under the Aetna contracted network with the price available through a non-Aetna contracted network\" and processes the claim through the non-Aetna network where its price is lower \"(including an administrative fee paid to the third-party that contracts the network),\" with those claims included in guarantee reconciliation (p. 26). Because the lesser-of test governs the ingredient-cost component rather than the total charged amount, which also includes a Dispensing Fee, these terms do not establish that a member's cost share can never exceed a cash price available outside the benefit. What is absent is the term that matters most for members who find a cheaper cash price: nothing in these pages credits an outside cash purchase toward the deductible or out-of-pocket maximum, and the Choose Generics differential is expressly \"not applied to the Plan Participant's deductible\" (p. 62). Communication of the discount programs is also assigned to the employer rather than the vendor (p. 63), and member-submitted and paper claims are excluded from pricing guarantees (p. 25).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.75,"page_ref":"p. 55","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the cost basis for reimbursement established by Aetna, as modified\nfrom time to time, for the same dose and form of Generic Drugs which are included on Aetna’s applicable MAC List.","rationale":"MAC governance sits entirely with the vendor and the document says so. MAC is \"the cost basis for reimbursement established by Aetna, as modified from time to time\" (p. 55) and MAC Lists are \"developed and maintained or selected by Aetna\" for drugs \"deemed to require or ... otherwise capable of pricing management\" (p. 55). Whether a MAC price exists at all is Aetna's election, taken by comparing MAC against AWP-discount pricing \"taking into account any Rebates Aetna may receive,\" with the document acknowledging that a decision not to set a MAC price \"could mean that the cost of such Prescription Drugs for Participating Group is not reduced\" (pp. 66-67). MAC is also an explicit lever on guarantee performance: \"AWP discounts and MAC, if applicable, are managed to achieve pricing guarantees within each component\" (p. 25). Absent from the 71 pages: any MAC methodology disclosure, source-pricing basis, update frequency, notice of changes, pharmacy or plan-sponsor appeal rights, and any limit on moving drugs on or off the MAC list mid-term. The audit sections permit a pricing reconciliation audit of contracted discount and dispensing fee guarantees (pp. 67-68) but do not extend to reviewing MAC list construction, and the Customer may not retain records of provider negotiated rates (p. 5).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"unclear","confidence":null,"page_ref":"p. 66","evidence_quote":"have negotiated and agreed upon a uniform or “lock-in” price to be\n paid by the Participating Group for all claims for Covered Services dispensed by Participating Pharmacies. This\n uniform price may exceed or be less than the actual price negotiated and paid by Aetna to CVS Caremark for\n Covered Services dispensed by the Participating Pharmacy. Where the uniform price exceeds the actual price\n negotiated and paid by Aetna to CVS Caremark for Covered Services dispensed by the Participating Pharmacy,\n Aetna realizes a positive margin. In cases where the uniform price is lower than the actual price negotiated and\n paid by Aetna to CVS Caremark for Covered Services dispensed by the Participating Pharmacy, Aetna realizes a\n negative margin. Overall, lock-in pricing arrangements result in a positive margin for Aetna. Such margin is\n retained by Aetna in addition to any other fees, charges or other amounts agreed upon by Aetna and\n Participating Group, as compensation for the pharmacy benefit management services Aetna provides to\n Participating Group. Also, when Aetna receives payment from Participating Group before payment to CVS\n Caremark, Aetna retains the benefit of the use of the funds between these payments.[Applicable if Participating\n Group elects Traditional Pricing]","rationale":"Genuinely unresolved on this record, because the pricing model is unelected in an unsigned form rather than because a document is missing. The form carries both alternatives, each flagged for election. The traditional/lock-in paragraph states that the uniform price paid by the Participating Group \"may exceed or be less than the actual price negotiated and paid by Aetna to CVS Caremark,\" that where it exceeds \"Aetna realizes a positive margin,\" that \"[o]verall, lock-in pricing arrangements result in a positive margin for Aetna,\" and that Aetna keeps the use of funds between payment in and payment out - marked \"[Applicable if Participating Group elects Traditional Pricing]\" (p. 66). The transparent paragraph states that \"the amount billed to Participating Group will be equal to the amount paid to the Participating Pharmacies\" - marked \"[Applicable if Participating Group elects Transparent Pricing]\" (p. 66). The same duplication appears in the network section, where consecutive bullets describe lock-in and pass-through adjudication (p. 59). Pulling toward transparency, the pharmacy fee schedule states \"The amount billed to the Client will be equal to the amount paid to the participating pharmacies\" (p. 26); pulling the other way, \"Pricing Arrangement xxx\" is left blank on that same page (p. 25) and the medical schedule prices vendor-network services at Aetna's contracted rate with the vendor rather than the vendor's payment to the provider (p. 17). No election is recorded anywhere in the 71 pages and the signature page is unexecuted, so which regime would govern cannot be determined; both texts are preserved rather than ranked.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"partial","confidence":0.6,"page_ref":"p. 65","evidence_quote":"Coalition and Participating Group further agree that the amounts described above belong\n exclusively to Aetna or CVS Caremark, and Coalition and Participating Group has no right to, or legal interest in,\n any portion of the aforesaid amounts received by Aetna or CVS Caremark.","rationale":"Two-sided, with the positive stated first because it is unusually explicit. Manufacturer administrative fees earned by Aetna in its group purchasing capacity are inside the definition of Rebates (p. 56) and inside the greater-of pass-through promise, which covers \"100% of total rebates plus manufacturer administrative fees collected by Aetna in its capacity as a group purchasing organization on behalf of Customer\" (p. 26). That closes the intermediary-fee gap that many pharmacy contracts leave open. The counterweight is the express carve-out on p. 65: payments characterised as compensation for bona fide services, reimbursement for educational programs, or value-based rebate contracting administration \"are not considered as Rebates and are not included in rebate sharing arrangements,\" CVS Caremark's network transmission fees from pharmacies are not shared and are excluded from discount-guarantee calculations, and the Participating Group agrees it \"has no right to, or legal interest in, any portion of the aforesaid amounts.\" Because the characterisation of a given manufacturer payment as a Rebate or as bona fide service compensation is made by the recipient and no reporting of that split appears in these pages, the pass-through promise is real but bounded by a category the Customer cannot observe. The rebate audit right that would test it is limited to five or ten manufacturer contracts by member tier and, for a group that does not have its own Minimum Rebate Guarantee Reconciliation, is exercisable only at the coalition level (pp. 67-68). Whether rebates are reconciled at group level is a separate question, turning on a group having \"greater than 20,000 members\" and having \"elected group-specific rebates,\" with group-specific rebate guarantees evaluated \"for any group of 20,000 lives or greater upon request\" (p. 27); this record does not state the City's enrollment, so neither condition is assumed satisfied or unsatisfied here.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.5,"page_ref":"p. 61","evidence_quote":"Participating Group acknowledges and agrees that it has sole\n discretion and authority to accept or reject the Formulary that will be used in connection with the plan.","rationale":"Formal control is granted and then priced. The document states that the Participating Group \"has sole discretion and authority to accept or reject the Formulary\" and may elect not to implement any proposed addition or deletion (p. 61) - a real positive, and the formulary is expressly adopted as a matter of the sponsor's own plan design. But the same sentence continues that such an election \"shall be considered a Customer change to the Formulary subject to Aetna's ability to operationally administer such election and, if so, Aetna's reservation of right to make appropriate and equitable financial changes resulting therefrom\" (p. 61). The financial consequences are stated elsewhere: rebate guarantees are conditioned on alignment with one of Aetna's formularies and on plan-design requirements (pp. 26-27, p. 64); a sponsor-initiated change to the pharmacy program, plan design or formulary alignment is a listed trigger for Aetna to modify financial provisions on 30 days' notice (p. 30, p. 58); and the standard formulary assesses Tier 1 cost share on certain preferred brands, a design choice embedded in the pricing (p. 27). Formulary options are also declared Aetna's business confidential information (p. 61), which limits the sponsor's ability to have them reviewed externally. Partial: choice exists on paper, exercising it costs money.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"bad","confidence":0.55,"page_ref":"p. 66","evidence_quote":"Participating Group’s actual claim expense per prescription for a particular\n Formulary Prescription Drug may in some circumstances be higher than for a non-Formulary alternative.","rationale":"No comprehensive lowest-net-cost obligation, no net-cost or book-of-business performance standard and no most-favourable-terms guarantee appears in the 71 pages. A comparison right does exist and is not collapsed into that absence: the annual market check permits the coalition's financial terms to be compared against Aetna's offerings to similar customers across program savings, retail, specialty, administrative fee and rebate terms (p. 29). What it does not create is a net-cost standard or any duty to match. Meanwhile the document affirmatively acknowledges the higher-cost outcome as permissible: a formulary drug may be more expensive than a non-formulary alternative before rebates are considered, drugs may be selected for formulary status although they cost more, and \"Participating Group's actual claim expense per prescription for a particular Formulary Prescription Drug may in some circumstances be higher than for a non-Formulary alternative\" (pp. 65-66). It further acknowledges that a member on percentage cost share can pay more for a formulary drug, since rebates are not reflected at point of sale (p. 66), and that a generic ordered through mail could cost the plan more than the same generic at retail (p. 67). The market check, on a showing of \"savings of 1% or more in net costs,\" obliges the parties only to \"discuss in good faith a revision\" (p. 29), so a comparison may be run but no lowest-net-cost result is owed. Rated adverse on in-document language rather than on absence alone: the disclosures are express, the offsetting standard is absent, and the guarantee figures that would quantify net cost are placeholders.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.8,"page_ref":"p. 59","evidence_quote":"Any additions or deletions to the network of Participating Retail\n Pharmacies shall be made in Aetna’s sole discretion.","rationale":"Network composition and steering both run to the vendor. Additions and deletions to the retail network \"shall be made in Aetna's sole discretion,\" with notice to the group only for deletions having a material adverse access impact (p. 59). There is no any-willing-pharmacy provision, no protection for independent or local pharmacies, no network-adequacy standard and no member-choice guarantee in the 71 pages. Steering is instead built into the economics: Aetna must be the exclusive provider of the benefit plan design for claims processing, network management, clinical programs, formulary management and rebate management, and non-compliance is a material breach permitting Aetna to modify financial terms and performance guarantees (p. 57); CVS Specialty mail pharmacies are the exclusive specialty provider (p. 27); specialty rebate guarantees are contingent on a plan design that \"allows up to 90-day supply at Specialty\" and the specialty offer is conditioned on a generics-first design (pp. 26-28); Retail-90 network restrictions apply above retail day-supply limits (p. 26); and Aetna or its mail and specialty pharmacies may promote their own channels to members using coupons or other financial incentives (p. 60). On the medical side, third-party vendor services elected by the Customer are \"expressly excluded from the scope of Services,\" the Customer releases Aetna from liability including failure to meet performance guarantees, and Aetna may charge to recover coordination costs (p. 3), while non-Aetna networks come with no credentialing, no assured discounts and possibly no performance guarantees (p. 18).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.5,"page_ref":"p. 29","evidence_quote":"Should the comparison demonstrate\nthat the current market conditions would yield a savings of 1% or more in net costs (i.e. gross costs net of\nadministration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current\npricing terms and other applicable contract provisions.","rationale":"A market check exists, which is more than many contracts provide, but it is procedural rather than a most-favoured-pricing entitlement. Annually in the second quarter, at the coalition's reasonable request, the financial terms may be compared against offerings to similar customers across program savings, retail brand and generic pricing, specialty pricing, administrative fees, rebates and guarantees; if the comparison shows 1% or more in net savings the parties \"will discuss in good faith a revision,\" and any agreed revision takes effect the following January 1 with final pricing agreed at least 120 days before and a legal document signed 60 days before (p. 29). There is no obligation to match, no benchmark methodology, no baseline data access, no arbitration or termination remedy on failure to agree, and the third party conducting it must sign Aetna's confidentiality form (p. 29) while the Customer is barred from disclosing Aetna's discount or payment information (p. 4) and from retaining records of provider negotiated rates (p. 5). The right is also held by the coalition rather than the individual city, and the repricing rights running the other way are unilateral: Aetna may modify financial provisions on 30 days' notice on enumerated triggers (p. 30, p. 58), may adjust rebate guarantees for aggregate underperformance (p. 28) and may change Services and Service Fees annually on 30 days' notice (p. 1).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.65,"page_ref":"p. 70","evidence_quote":"To enable the parties to close their financial records in a timely manner, once a Contract Year has\n been audited, no further auditing activity for the Contract Year may be performed, notwithstanding that an\n issue arises in a future period that dates back to the previously audited period.","rationale":"Audit rights are present and detailed, then narrowed by a dense set of conditions, so the balance is genuinely mixed. Present: an annual plan-design/claims audit and an annual pricing reconciliation audit covering contracted discount guarantees, dispensing fee guarantees and administrative fees for the prior two contract years, plus rebate audits including a minimum rebate guarantee reconciliation (pp. 67-68); defined timelines and response windows (pp. 69-70); Aetna's right to comment on a draft report before it is finalised (p. 70); and a medical-side audit right with a stated scope (pp. 5-6). Narrowing terms, all in-document: claims samples capped at 250 for plans under 20,000 participants and 300 above (p. 67); rebate audits limited to five or ten manufacturer contracts, and available to an individual group only if it has its own minimum rebate guarantee reconciliation, which for a group below 20,000 members means reliance on a coalition-level audit (pp. 67-68, p. 27); auditor must be mutually acceptable and must sign Aetna's form confidentiality agreement, with results not disclosable \"to any third party, including Participating Groups\" (p. 68); one audit at a time and no new audit until the prior one closes (pp. 67-69); the same data and period auditable only once, and once a contract year is audited no further auditing of it is permitted even if an issue later emerges, with findings capped at three contract years where no prior audit occurred (p. 70); all audit expenses on the group plus charges for anything beyond the defined scope, data fees of $125 per month of data and $5,000 per year for multi-year requests (pp. 70, 68); and audit rights stated to be \"valid during the term of the contract and through one (1) year of termination,\" with, \"[u]nless required by state law, any audit ask after one (1) year of termination ... at Aetna's standard audit fee\" (p. 70) - a fee condition on later audits rather than an outright expiry. On the other side of the ledger, close of audit carries a payment mechanic: once the parties agree on identified financial discrepancies, \"[a]ny adjustments, payments and/or reimbursements determined to be necessary as a result of any examination or audit shall be paid by the appropriate party within thirty (30) days of execution of an appropriate release document covering the audit period\" (p. 70). On the medical side the audit is virtual only, one per year at the Customer's expense, must be completed within two years, bars any record of provider negotiated rates (p. 5), requires Aetna's executed audit request form and pre-submission of draft findings (p. 6), and bars statistical sampling or extrapolation for overpayment recovery, with the Customer having \"no right to recover any specific overpayment unless otherwise provided\" (p. 6).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.7,"page_ref":"p. 4","evidence_quote":"Aetna may de-identify Plan Records and use them for quality improvement,\nstatistical analyses, product development and other lawful, non-Plan related purposes. Such Plan Records will\nbe kept by Aetna for a minimum of seven years, unless Aetna turns such documentation over to the Customer\nor a designee of the Customer.","rationale":"No provision in the 71 pages gives the plan sponsor ownership of its claims, eligibility, pricing or rebate data, and several provisions run the other way. Aetna may de-identify Plan Records and use them \"for quality improvement, statistical analyses, product development and other lawful, non-Plan related purposes,\" retaining them for a minimum of seven years (p. 4). On termination Aetna will release claim data in Aetna's standard format with all costs paid by the Customer (p. 10), and PHI may be retained where return or destruction is infeasible (p. 5). Access to underlying price information is restricted rather than granted: the Customer may not disclose Aetna's provider discount or payment information even to its own representatives without written consent (p. 4), may not make or retain any record of provider negotiated rates (p. 5), and audit data extracts carry per-month and per-year fees (p. 70). Reporting is standard-package only - monthly funding and paid-benefit listings, online standard reports, annual accounting and renewal reports - with anything else \"priced by mutual agreement\" (pp. 15-16); rebate reporting is a quarterly remittance report with detail \"upon request\" (p. 65) and the medical legal-recovery section promises only \"a general explanation\" of recovered amounts (p. 19). Adverse on stated terms, not on silence.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"unclear","confidence":null,"page_ref":"p. 18","evidence_quote":"Performance guarantees appearing in the agreement may not apply to Services delivered by non-Aetna\n providers or networks; and","rationale":"Not assessable as a whole, and the part that is present is acknowledged expressly. The pharmacy fee schedule states that \"[p]ricing guarantees are measured and reconciled as four separate components with the components defined as retail network, Aetna mail pharmacy, CVS Specialty mail pharmacy, and rebates,\" that the first three \"will be reconciled separately for each Participating Group, and any underperformance, dollar for dollar, will be paid to the Participating Group,\" and that Maintenance Choice, if selected, is reconciled within the mail channel (p. 25); a defined exclusion list applies to the discount and dispensing fee guarantees (p. 25) and a parallel list to the rebate guarantees, with rebates on excluded claims still passed through (pp. 26-27), and the rebate side has a stated reconciliation cycle (p. 27). So a financial guarantee structure with a stated remedy does exist here - its values are unfilled placeholders (p. 25). What is not in these pages is a separate service-performance guarantee exhibit: performance guarantees are referenced in at least five places - audits of them permitted in the year following (p. 5), the Customer's release for elected third-party vendor services (p. 3), possible non-application to non-Aetna networks (p. 18), force majeure excuse (p. 12), and Aetna's right to modify \"any Performance Guarantees attached hereto\" on breach of exclusivity (p. 57) - yet no service metric, measurement method, reporting requirement or amount at risk for service performance appears in the supplied pages. The verdict stays unclear on that combination: the financial guarantee mechanism is stated but unquantified, the service-performance exhibit the document contemplates is not supplied, and no adverse inference is drawn from its absence from an unsigned form whose customer-specific terms are to be \"incorporated from the customer's finalized proposal documents\" (pp. 20, 25).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"bad","confidence":0.7,"page_ref":"p. 8","evidence_quote":"Other than in an action between the parties for third party indemnification, neither party shall be liable to\nthe other for any consequential, incidental or punitive damages whatsoever.","rationale":"Remedies are curtailed on the face of the document. Neither party may recover consequential, incidental or punitive damages (p. 8). Disputes other than injunctive relief or contract reformation go to binding arbitration before a single arbitrator under the Federal Arbitration Act, in Hartford, Connecticut, with no depositions absent agreement and with the arbitration and its outcome confidential; injunctive and reformation actions lie exclusively in the federal District of Connecticut (pp. 8-9), and the agreement is governed by Connecticut law where federal law does not apply (p. 11). Overpayment recovery must rest on documented findings or direct proof of specific claims agreed by both parties, statistical sampling and extrapolation \"may not be used,\" and the Customer \"has no right to recover any specific overpayment unless otherwise provided\" (p. 6); recoveries are credited net of Aetna's fees and the Customer may not pursue network providers directly (pp. 6-7). Aetna's liability for lost access to a National Advantage Program discount is capped at the NAP fees actually paid (p. 52), and Aetna disclaims any guarantee that any level of discounts or savings will be afforded (p. 17). No penalty, liquidated-damages or service-fee-at-risk provision and no cure-and-terminate mechanic appears in these 71 pages. Two remedies that do exist are stated here so the absence is not overstated: on close of audit, once the parties agree on identified financial discrepancies, \"[a]ny adjustments, payments and/or reimbursements determined to be necessary as a result of any examination or audit shall be paid by the appropriate party within thirty (30) days of execution of an appropriate release document\" (p. 70); and the Customer may terminate the Agreement, or the services under one or more schedules, for any reason on at least 30 days' written notice (p. 9). Pricing-guarantee underperformance is also payable \"dollar for dollar\" under the fee schedule (p. 25), although its values are placeholders. The adverse verdict therefore rests on the damages waiver, the arbitration and forum provisions, the liability caps and the overpayment-proof restrictions, not on a claim that no remedy of any kind exists. This assessment describes the stated allocation of remedies; no determination of enforceability against a Texas municipality is made.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.6,"page_ref":"p. 12","evidence_quote":"Except as provided for in the Customer’s renewal package, no modification or\n amendment of this Agreement will be effective unless it is in writing and signed by both Parties","rationale":"The written-amendment requirement is stated and then substantially undercut, in both directions of the same document. Stated: no modification or amendment is effective \"unless it is in writing and signed by both Parties\" (p. 12) - but prefaced by the carve-out \"[e]xcept as provided for in the Customer's renewal package,\" which lets renewal materials change terms outside the two-signature rule. Working against it: Aetna \"may change the Services and the Service Fees annually by giving the Customer 30 days' notice\" (p. 1); Aetna may modify or amend the financial provisions on 30 days' notice on five enumerated triggers including membership or claims volume change, sponsor-initiated plan or formulary change, manufacturer product decisions and government or industry-wide change (p. 30, p. 58); Aetna may amend individual specialty drug discounts \"to manage the financial guarantee\" (p. 28) and adjust rebate guarantees for aggregate underperformance (p. 28); the services schedule states it \"shall supersede any previous document(s) describing the Services\" and services may be modified from time to time (p. 31, p. 53); the MAC list, formulary and specialty addendum are all amendable by Aetna (pp. 55, 57, 61); and network composition changes are at Aetna's sole discretion (p. 59). The mutual-signature rule therefore governs little of what actually determines cost.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"partial","confidence":0.5,"page_ref":"p. 9","evidence_quote":"The Customer may terminate this Agreement, or the Services\n provided under one or more schedules, for any reason, by giving Aetna at least 30 days’ prior\n written notice of when such termination will become effective.","rationale":"The master agreement gives the Customer a clean exit - termination for any reason on at least 30 days' written notice, with the same right held by Aetna (p. 9) - which is a genuine positive and unusually short notice for this class of agreement. The pharmacy side is weaker and partly unfilled. The pharmacy schedule's initial term is \"xxx months\" with automatic one-year renewals (p. 53); the fee schedule's own termination right is \"without cause, anytime, with xxx days prior written notice\" (p. 29); and the pricing is expressly contingent on the Customer signing a five-year agreement, with acceptance 120 days and signature 60 days before the effective date (p. 25), so the quoted economics presuppose a term the notice provisions do not describe. Exit costs are stated: general and implementation allowances are subject to pro-rata repayment if the agreement terminates before the end of the initial term for any reason other than Aetna's uncured breach (pp. 28-29); run-off claims are administered for 12 months with the bank account kept open for a further period and claim data released only in Aetna's standard format at the Customer's cost (p. 10); provider dispute settlements and legal recoveries continue to be apportioned after Aetna's cost of recovery post-termination (pp. 14, 19); retroactive provider rate adjustments survive termination (p. 17); NAP terms continue for claims incurred before termination (p. 52); and audit rights are \"valid during the term of the contract and through one (1) year of termination,\" with later audit requests at Aetna's standard audit fee unless required by state law (p. 70). Aetna may also suspend claim payment and terminate immediately if funding requests are not met within five business days (p. 9).","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"bad","confidence":0.75,"page_ref":"p. 27","evidence_quote":"CVS Specialty mail pharmacies, including through the Specialty Connect program, will be the exclusive provider of\nspecialty pharmacy services.","rationale":"Specialty is the most vendor-controlled segment in the document. CVS Specialty mail pharmacies, including through Specialty Connect, are the exclusive provider of specialty pharmacy services, and specialty claims will not be processed through the retail network except where CVS Specialty cannot dispense (p. 27). The exclusive-distribution offer is conditioned on Aetna remaining exclusive specialty provider and on the Customer implementing a generics-first specialty design, and in the same paragraph \"Aetna may amend the individual Specialty Drug discounts to manage the financial guarantee,\" with reconciliation only in aggregate across all specialty drugs dispensed from CVS Specialty (p. 28). The specialty rebate guarantee is \"contingent upon the Customer adopting a Plan Design that allows up to 90-day supply at Specialty\" (p. 26) - a design that permits 90-day fills, which is not the same as mandating them. Scope is unilaterally adjustable because Specialty Products are those listed in a Specialty Addendum \"which Aetna may amend from time to time\" (p. 57), and Specialty Connect claims are financially reconciled as CVS Specialty claims (p. 57). Rebates on specialty products paid under the medical benefit are retained by Aetna as compensation (p. 65). Every specialty economic value - new-to-market brand, generic and limited-distribution rates - is a placeholder in this form (p. 28), and limited distribution and exclusive distribution products are acknowledged to be available only through restricted channels (p. 55). No site-of-care or white/brown-bagging protection, no specialty carve-out right and no member cost-share protection for specialty appears in the 71 pages.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0046","contract_slug":"san-marcos-2026-127r-aetna-msa-medical-pharmacy-dental","entity":"City of San Marcos, Texas","vendor":"Aetna Life Insurance Company (pharmacy via CaremarkPCS Health, L.L.C. / CVS Caremark)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.85,"page_ref":"p. 4","evidence_quote":"The Customer shall not disclose Aetna’s\n provider discount or payment information to any third party, including the Customer’s\n representatives, without Aetna’s prior written consent and until each recipient has executed a\n confidentiality agreement reasonably satisfactory to Aetna.","rationale":"Red flag present and multi-layered. The Customer \"shall not disclose Aetna's provider discount or payment information to any third party, including the Customer's representatives, without Aetna's prior written consent and until each recipient has executed a confidentiality agreement reasonably satisfactory to Aetna\" (p. 4). Reinforcing provisions: neither the Customer nor its representative \"may make or retain any record of provider negotiated rates\" during an audit (p. 5); audit findings and manufacturer contract terms reviewed in a rebate audit may not be revealed \"in any manner or form by or to any third party, including Participating Groups\" (p. 68); every auditor and market-check third party must execute Aetna's form confidentiality agreement (pp. 5, 29, 67-68); formulary options are declared Aetna's business confidential information (p. 61); the arbitration and its result are confidential (p. 9); and the pricing pages state that \"[b]y accepting this proposed pricing for review, Customer acknowledges and agrees that the information included is confidential, proprietary and trade secret to Aetna\" (p. 30). The combined effect, on the text of this form, is that a public employer could not share negotiated-rate or pricing information with advisors or the public without vendor consent. This is recorded as a rubric red flag on the document's language only; no determination is made about how such terms would interact with the Texas Public Information Act or about their enforceability against a municipality.","model_own_total":null,"model_own_grade":null,"rubric_version":2,"reviewed_at":"2026-09-12T01:00:31+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 26","evidence_quote":"United is not the Plan Administrator of the Plan. Any references in this Agreement to United “administering the Plan” are descriptive only and do not confer upon United any responsibilities or duties beyond the claim administration duties set forth herein.","rationale":"The model contract published by Mark Cuban and collaborators makes the pharmacy benefit manager a fiduciary that owes loyalty only to the plan and its members. This contract goes the other way and disclaims duties beyond claim processing. United is named a fiduciary only for initial benefit determinations and first level appeals on page 34, and elsewhere the text lets it keep spread, purchase discounts and interest, which is the opposite of a duty of loyalty. There is no disgorgement remedy anywhere in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 67","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to Lockton (“Consultant”). The Consultant Fees are included in Customer’s pharmacy financial terms. United shall provide Consultant with a monthly payment for all Consultant Fees collected in the amount(s) of $2.00 pmpm","rationale":"Some compensation is disclosed, which is better than nothing. The broker fee of $2.00 per member per month paid to Lockton is stated, and page 60 discloses that a United affiliate earns 1 percent to 3 percent of provider payment transactions. What is missing is the rest. Page 42 says only that United may receive access fees and marketing and administrative charges from network pharmacies without stating amounts, manufacturer administrative fees are described but never quantified, and no officer certifies quarterly or annually that all compensation has been disclosed and remitted.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no ownership or affiliate disclosure exhibit in this document. The exhibit list on page 2 names special terms, city standard terms, insurance and contractor terms, and the attachments to Exhibit D are medical services, pharmacy services, a business associate agreement, security, fees and guarantees. The only affiliate statements are scattered and general, such as the pharmacy definitions on pages 40 to 42 saying that home delivery and specialty pharmacies include United affiliates. The conflict of interest questionnaire on pages 85 and 86 is a Texas vendor ethics form about city officials, not a list of owners, subsidiaries, group purchasing organizations or rebate aggregators, and nothing requires United to refresh such a list when ownership changes.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 25","evidence_quote":"Medical Benefit Drug Rebate does not include any discount, price concession, administration fees, or other direct or indirect remuneration United receives from a drug manufacturer for direct purchase of a prescription drug","rationale":"The definitions are built on labels and carve outs rather than economic function, which is how manufacturer money escapes the pass through. The same exclusion appears in the pharmacy definition of rebate on pages 41 and 42, where money received by United or a group purchasing organization for direct purchase of a drug, and payments for products, services or analytical tools, are all defined out of the word rebate. Brand and generic are set by a Medi-Span label rather than by function, and the specialty drug list is maintained and updated by United. Only the specialty definition, which uses a test of at least three of eight criteria, comes close to what the model contract asks for.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.75,"page_ref":"Page 64","evidence_quote":"Minimum Rebate Guarantee (Traditional PDL) Rebate Sharing Percentage 100.0% 100.0% 100.0%","rationale":"On its face the City is credited a 100 percent rebate sharing percentage for all three years plus minimum per brand script guarantees, so the subject is addressed. The value of that promise is cut back in several ways. Manufacturer administrative fees are expressly outside the guaranteed rebate arrangement on page 66, purchase discounts and other manufacturer revenue are retained by United on page 45, and pages 64 and 65 exclude a long list of claim types from rebate eligibility. Payment timing is also far slower than the model, with the first payment due no later than 210 days after the incurred quarter and later payments within 90 days after each quarter.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service","rationale":"The model contract requires claims filled by pharmacies the benefit manager owns to be billed at net acquisition cost plus a stated dispensing fee. Here the affiliate home delivery and specialty pharmacies are network pharmacies under the definitions on pages 41 and 42, and this clause lets United keep a margin on what those pharmacies are paid. Nothing in the document gives the City acquisition cost invoices or a documentation default if records are not produced. Page 45 adds that United buys drugs from manufacturers for these affiliate pharmacies and keeps the resulting discounts.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in this contract caps what the plan pays by reference to an outside published price. The pharmacy pricing pages 63 through 69 are built entirely on average wholesale price discounts measured in the aggregate, with reconciliation across all claims rather than claim by claim. The definitions on page 42 include a usual and customary charge, but it is used only for what the member pays at the counter, not as a ceiling on the plan's cost. No transparent cash price benchmark or cheapest lawful option requirement appears anywhere in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.85,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount","rationale":"Members get part of what the model asks for. At a network pharmacy they will not pay more than the pharmacy's usual and customary charge or the discounted price. The protection stops there. The contract says nothing about crediting a purchase a member makes with cash outside the benefit toward the deductible or out of pocket maximum, and nothing about limiting accumulator adjustments against manufacturer assistance unless the City elects it in writing.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"The model contract requires one disclosed maximum allowable cost list that governs both what the plan pays and what the pharmacy is paid, updated on a schedule, with a pharmacy appeal path. This contract does the reverse by allowing multiple lists changed at United's sole discretion. Combined with the spread language on pages 43 and 67, that means one list can price what the City pays and another can price what the pharmacy receives. Neither list is disclosed to the City and no appeals timeline appears in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 67","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service","rationale":"This is spread pricing stated in plain words, in every channel, including dispensing fees. The model contract requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee. The same permission appears in the pharmacy services attachment on page 43 and again for specialty drugs on page 69, so it is not an isolated sentence. The City has no contractual way to learn how large that retained difference is.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"The model contract requires purchase discounts, volume credits and supplier payments received by the benefit manager or a related purchasing entity to flow to the plan. This contract states the opposite outcome for drug purchase discounts and purchase rebates. The pharmacy rebate definition on pages 41 and 42 also writes money received by a group purchasing organization out of the definition of rebate, and the same page says nothing prevents United from pursuing other sources of revenue from drug manufacturers. No allocation drivers or reporting of that revenue are provided.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 44","evidence_quote":"Customer will adopt one or more of United’s PDLs as the PDL","rationale":"The City chooses among United's prescription drug lists and page 44 calls the City the ultimate decision maker on design, so there is some sponsor role. Real control sits with the vendor. The same page says United makes the final classification of a drug to a tier and that rebates are among the factors it weighs, and the City may not distribute the list without approval. The City also receives no utilization management outcomes by drug, and page 43 says United's utilization management criteria will not be available for the City or its vendors to use.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard binds the vendor anywhere in this document. The formulary and rebate management provisions on pages 44 and 45 describe adoption of United's list and rebate negotiation across United's whole book of business without any promise that placement will produce the lowest net cost for Denton. The only place net cost appears is page 65, where United reserves rights over the drug list in language about achieving lower net drug cost for itself and its other customers. There is no annual comparison against United's book of business and no disclosure when a drug is placed above a cheaper equivalent.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.8,"page_ref":"Page 67","evidence_quote":"g) Customer utilizes a vendor, that facilitates steering members to different drugs or pharmacies to the extent these services impact the financial guarantees under this Agreement.","rationale":"The model contract forbids the benefit manager from steering claims into its own pharmacies and protects the plan's freedom to direct members to cheaper options. This contract lets United revise or revoke the whole pricing arrangement if the City hires a vendor that helps members move to cheaper drugs or pharmacies. Page 42 requires United or its affiliate to be the exclusive provider of pharmacy benefit services, and pages 41 and 42 place United's own home delivery and specialty pharmacies inside the network. There is no any willing pharmacy term and page 29 states the make up of the network can change at any time.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 66","evidence_quote":"market check during the Pharmacy Pricing Term to confirm its financial terms are competitive","rationale":"A market check exists, which is more than many contracts of this kind offer. It is narrow. The City gets one check for the whole pricing term, timed to the third quarter after the first anniversary, run by a third party both sides agree on, using at least four substantially similar customers and comparing aggregate value rather than claim level pricing. If the check shows more than three percent in annualized savings the only consequence is that the parties negotiate in good faith, so there is no automatic credit and no right to walk away, and there is no most favored pricing promise anywhere in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 46","evidence_quote":"The place, time, type, scope, and duration of all audits must be reasonable and agreed to by United","rationale":"The City may audit, but the vendor controls the terms of the audit. Page 46 limits the City to one audit each calendar year with an auditor both sides agree on, an eighteen month look back, no audits in December or January, up to 300 suspected erroneous claims, and City payment of all expenses, and page 10 confirms the City bears audit cost. Rebate auditing reaches only United's top five rebate agreements or those covering 75 percent of the City's rebate revenue, whichever is less, and the auditor may not copy or keep those contracts. Routine data delivery is limited to United's standard online reports under page 42, and page 36 lets United change report content and format at will.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 14","evidence_quote":"If City requests that Contractor provide information about the Plan that is in Contractor’s possession after the Agreement terminates and any applicable run out period has expired, then Contractor may, in its discretion, provide such information subject to a fee","rationale":"The model contract makes the plan sponsor the sole owner of its claims, eligibility, accumulator and rebate data with delivery on request. Here the City's own plan information is held at the vendor's discretion after termination and can be charged for. Page 39 charges a mutually agreed fee for the one time accumulated data extract, page 47 limits transition help to twelve transmissions in United's standard format, and page 27 says United keeps records only as long as the law requires. No clause states that the City owns the data or restricts United from reusing it.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 61","evidence_quote":"With respect to the aspects of United’s performance addressed in this exhibit, these Fee adjustments are Customer’s exclusive financial remedies.","rationale":"Guarantees do exist in Attachment D-6, covering service metrics with $11,000 in fees at risk each and pharmacy discount and rebate guarantees measured against City specific claims. They fall short of the model in the ways that matter. Measurement and payment on the pharmacy and service guarantees are annual rather than quarterly, remedies come as fee adjustments and credits rather than cash, and this sentence makes those adjustments the City's only financial remedy for the covered performance.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 65","evidence_quote":"reserves the right to modify or eliminate any Rebate guarantees if there are any additional changes to Rebates received from pharmaceutical manufacturers","rationale":"Guarantee shortfalls are reconciled without the City proving damages, which is the one self executing element here. Everything else is weaker than the model contract. The guarantees themselves can be modified or eliminated by United, page 61 lets United specify new guarantees and replace the exhibit for later periods, and page 67 lists many conditions under which United may revise or revoke the pricing arrangement. There is no liquidated damages clause for late reporting and no two strikes or regulatory integrity exit for the City.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"Any new Fee will be effective as of the date the change is applicable, even if that date is retroactive","rationale":"Page 16 says the contract can be modified only in a writing signed by both parties, but page 5 undercuts that for the economics. United may change fees on 30 days written notice with a replacement Attachment D-5, may change fees when benefits or laws change or when enrollment moves by ten percent, and the new fee can apply retroactively. The City's only response is to terminate. That is exactly the notice driven change to economic terms the model contract forbids.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination of pharmacy benefit services and no reconciliation of minimum rebate guarantees will apply","rationale":"Leaving early costs the City money it has already earned. This clause and a matching provision on page 59 let United keep unremitted rebates if the City ends the pharmacy benefit before the pricing term runs out, and page 34 forfeits earned but unpaid rebates as well. Page 55 also requires repayment of the $66,000 administrative credit and $100,000 wellness credit on early termination. Termination without cause is available under page 11 only after the initial term, and no regulatory integrity event is listed as grounds for termination.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"bad","confidence":0.85,"page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service","rationale":"The specialty definition on page 42 is reasonably functional, using a test of at least three of eight clinical and handling criteria, and pages 68 through 84 list the drugs covered by the guarantee. The pricing controls are the problem. Specialty is guaranteed only as an aggregate discount of 21.00 percent for listed drugs and 14.00 percent for unlisted ones rather than as drug level ceilings, United's own specialty pharmacy is a network pharmacy, and this clause lets United keep the spread on those claims. Page 68 also lets United move a drug off the specialty designation based on market conditions.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 13","evidence_quote":"pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"The confidentiality article on pages 13 and 14 treats exactly the information the public would want as confidential commercial information. When a public records request arrives the receiving party must give notice and reasonably cooperate in seeking a protective order, which is a duty to help block release rather than a clean carve out for Texas public information law. Page 17 makes any dispute and its outcome confidential, and pages 53 and 54 restrict who may see the vendor's security audit report. Page 58 does promise language supporting the City's anti gag clause attestation, but that does not undo the confidentiality of pricing and compensation terms.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.93,"page_ref":"Page 26","evidence_quote":"United is not the Plan Administrator of the Plan. Any references in this Agreement to United \"administering the Plan\" are descriptive only and do not confer upon United any responsibilities or duties beyond the claim administration duties set forth herein.","rationale":"United is not the plan administrator. It is a named fiduciary only for initial benefit determinations and first-level appeals. There is no duty of loyalty or care owed solely to the plan for formulary, network, rebate, or pricing decisions. A services warranty uses a prudent claims administrator standard, not a loyalty duty. United may keep spread, affiliate purchase discounts, and other manufacturer revenue, which is the harm the Mark Cuban and collaborators model is meant to stop.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 67","evidence_quote":"United shall on Customer's behalf, administer a fee (\"Consultant Fee\") to be paid to Lockton (\"Consultant\"). The Consultant Fees are included in Customer's pharmacy financial terms. United shall provide Consultant with a monthly payment for all Consultant Fees collected in the amount(s) of $2.00 pmpm.","rationale":"The agreement discloses some compensation, including a $2.00 pmpm Lockton consultant fee built into pharmacy terms, affiliate payment-service fees, 80 percent medical rebate sharing, and claims processor fees collected from pharmacies. It also says United may pursue other manufacturer revenue. There is no named-officer quarterly or annual certification that every dollar of compensation has been disclosed and remitted. That falls short of the Mark Cuban and collaborators model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"No signed ownership exhibit lists owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, or mail and specialty pharmacies with a 30-day refresh. Exhibit E is the Texas Form CIQ ethics questionnaire, not a PBM ownership schedule. Affiliates are mentioned in pharmacy definitions and the account-team clause, but those mentions are not a refreshable ownership exhibit. Looked in Exhibit D definitions, Attachment D-2, Attachment D-5, and Exhibit E.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"Rebate is defined to exclude manufacturer administration fees, group purchasing organization receipts, direct-purchase discounts, and payments for products, services, or analytical tools. Price protection is defined separately and is not treated as a rebate. United may maintain multiple MAC lists and change them in its sole discretion. Brand and generic status follows the Medi-Span labeler. That is the definitional structure the Mark Cuban and collaborators model warns against.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"PASS","verdict":"partial","confidence":0.9,"page_ref":"Page 64","evidence_quote":"Rebate Sharing Percentage 100.0% 100.0% 100.0%","rationale":"The pharmacy exhibit states a 100.0% rebate sharing percentage of defined Rebates, with an annual dollar-for-dollar shortfall payment. Manufacturer administrative fees are excluded from the guarantee. The first rebate payment is due 210 days after the incurred quarter, then 90 days, not 30 days. Other manufacturer revenue and affiliate purchase rebates are retained. If the City ends only pharmacy services without cause, United may keep unremitted rebates.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United or its affiliates, acting as a Home Delivery Pharmacy or a Specialty Pharmacy, purchase Prescription Drugs from Drug Manufacturers and receive certain discounts and purchase rebates from Drug Manufacturers in connection with these purchases. United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"Affiliate home delivery and specialty pharmacies are Network Pharmacies. They buy drugs, keep manufacturer purchase discounts and purchase rebates, and do not invoice the City at acquisition cost. Combined with spread retention on mail and specialty claims, this is the opposite of the Mark Cuban and collaborators acquisition-cost rule.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.87,"page_ref":null,"evidence_quote":null,"rationale":"There is no claim-level ceiling that limits plan cost to a published benchmark such as NADAC, cash, or usual and customary. Pharmacy guarantees are annual average AWP discounts. Lesser-of-three logic applies to participant payments, not to what the plan pays. Looked in Attachment D-2 pricing terms and Attachment D-6 pharmacy financials.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"CASH","verdict":"partial","confidence":0.9,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"Participants pay the lesser of the discounted price, usual and customary charge, or cost share. The contract does not credit cash-pay purchases toward deductibles or out-of-pocket maximums, and it does not let the City elect accumulator treatment. That is weaker than the Mark Cuban and collaborators cash-price model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United's periodic review and modification in its sole discretion.","rationale":"United may keep multiple MAC lists and change them in its sole discretion. There is no single published list, no scheduled disclosure to the City, and no pharmacy appeal path in this agreement. That is the MAC structure the Mark Cuban and collaborators model exists to prevent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"For home delivery, retail, and specialty, United may keep the difference between what it pays the pharmacy and what the City pays. Attachment D-6 repeats that spread applies to mail, specialty, and retail including dispensing fees. That is express spread pricing, which the Mark Cuban and collaborators model exists to prevent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The rebate definition carves out amounts United or a group purchasing organization receives for direct purchase or for products, services, or tools. Affiliate pharmacies keep purchase discounts and purchase rebates and do not pass them to the City. Those purchasing-entity dollars are not passed through as the Mark Cuban and collaborators model requires.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 44","evidence_quote":"United makes the final classification of a Prescription Drug to a certain tier of the PDL by considering a number of factors including, but not limited to, clinical and economic factors.","rationale":"The City adopts United PDL designs and is called the ultimate decision-maker on selecting the design. United still makes the final tier classification using clinical and economic factors, including rebates. Utilization-management criteria are not available to the City, and custom programs need United approval. Plan control is incomplete under the Mark Cuban and collaborators model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.84,"page_ref":null,"evidence_quote":null,"rationale":"There is no lowest-net-cost decision standard for this plan, no annual book of business comparison, and no disclosure of drugs placed above a cheaper equivalent. A D-6 condition lets United reduce or eliminate rebate guarantees if PDL changes made to achieve a lower net drug cost for the City and other ASO customers cut rebate levels. That is a vendor escape hatch, not a formulary standard. Looked in Attachment D-2 section 2.5 PDL and Attachment D-6 rebate conditions.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 42","evidence_quote":"Customer engages United or its affiliate as its exclusive provider of the prescription drug benefit services set forth in this Agreement.","rationale":"The City must use United or its affiliate as exclusive PBM, including retail, mail, and specialty. United may add or remove network pharmacies. Pricing guarantees require exclusive United networks. United collects claims processor fees from pharmacies. There is no any-willing-pharmacy rule, no anti-steering rule, and no claims-final-when-adjudicated rule. That is the network control the Mark Cuban and collaborators model exists to prevent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 66","evidence_quote":"If the market check report validates an annualized savings of greater than three (3) percent between the median of the financial terms for such substantially similar customers and Customer's financial terms for time period that is the subject of the market check, the parties will negotiate in good faith to revise the financial terms.","rationale":"The City may run one market check during the pharmacy pricing term. If the report shows more than three (3) percent annualized savings versus similar customers, the parties negotiate in good faith. There is no automatic meet, credit, or release. That is weaker than the Mark Cuban and collaborators most-favored model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.92,"page_ref":"Page 46","evidence_quote":"Once each calendar year during the term of the Agreement or any applicable runout period, a mutually agreeable entity, on behalf of Customer, may conduct a pharmacy claims audit for purposes of determining if United is administering its claims transactional services in accordance with Plan provisions.","rationale":"The City may run one pharmacy claims audit per calendar year through a mutually agreeable entity after signing a confidentiality agreement. Lookback is 18 months, December and January are off limits, and the period then closes. Rebate audits are limited to the top 5 agreements or 75 percent of rebate revenue, on site, with no copying of contracts. The City pays. That is narrower than the Mark Cuban and collaborators audit model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate's own behalf.","rationale":"The agreement never grants the City sole ownership of plan data. The business associate addendum lets United de-identify PHI and use and disclose it on its own behalf. After termination, post-runout data is provided only at United's discretion and subject to a fee. That permits the reuse the Mark Cuban and collaborators model is meant to stop.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.88,"page_ref":"Page 61","evidence_quote":"With respect to the aspects of United's performance addressed in this exhibit, these Fee adjustments are Customer's exclusive financial remedies.","rationale":"Pharmacy discount, dispensing-fee, and rebate guarantees are customer-specific and pay the annual shortfall in dollars. Medical performance guarantees are capped credits, often measured at the servicing office rather than this plan, and are the City's exclusive financial remedies. Many pharmacy exclusions apply, and United may modify or drop rebate guarantees. There is no quarterly cash settlement of the kind the Mark Cuban and collaborators model calls for.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"There are ordinary termination-for-cause rights with a 30-day cure, and guarantee credits that are exclusive financial remedies. There are no liquidated damages that pay without proving harm, and no two-strikes exit for a second material breach or regulatory integrity failure. Looked in Exhibit B default and termination, Exhibit A special terms, and Attachment D-6 guarantees.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.9,"page_ref":"Page 16","evidence_quote":"The Contract can be modified or amended only by a writing signed by both parties.","rationale":"Exhibit B says the contract can be modified only by a writing signed by both parties. Exhibit A lets the contractor change fees for each renewal with 30 days notice and replace Attachment D-5, and also change fees for plan, law, or enrollment events, including retroactive effective dates. United may specify new guarantee exhibits. Written mutual consent is not the only path.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"TERM","verdict":"partial","confidence":0.9,"page_ref":"Page 11","evidence_quote":"Either party shall have the right to terminate the Contract, in whole or in part, without cause any time upon thirty (120) calendar days' prior written notice following the Initial Term.","rationale":"Either party may terminate without cause after the initial term on thirty (120) calendar days written notice. Failure of appropriations is not a penalty event. If the City ends only pharmacy services without cause, United may keep unremitted rebates, and unused credits are forfeit with clawback if termination is before 12/31/2027. Exit is not clean under the Mark Cuban and collaborators model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"SPEC","verdict":"partial","confidence":0.88,"page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"Specialty drugs are defined by meeting at least 3 listed criteria, which is a functional definition. Pricing is not at acquisition cost. United designates the specialty list, affiliate specialty pharmacies are in network, and United keeps spread on specialty claims. Discount guarantees are annual AWP averages of 21.00 percent listed and 14.00 percent unlisted, not claim-level ceilings.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 13","evidence_quote":"(a) pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"Pricing, discounts, reimbursement terms, payment methodologies, and compensation arrangements are Confidential Information. The City may use contractor confidential information only for plan administration, and United may demand a confidentiality agreement before disclosure. The parties must cooperate in seeking a protective order on public-records requests. Fee pages are stamped Proprietary Information of UnitedHealth Group. No pharmacy-to-patient gag was found, but treating pricing as confidential in a way that can block government disclosure is a bad score under the Mark Cuban and collaborators gag item.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 34","evidence_quote":"Customer appoints United a named fiduciary under the Plan with respect to (i) performing initial benefit determinations and payment and (ii) performing the fair and impartial review of first level internal appeals.","rationale":"The only fiduciary role the contract grants United is for claim determinations and first level appeals on the medical side. Everywhere else the contract disclaims the role: Section 5.1 of Exhibit D says United is not the Plan Administrator, and the pharmacy terms let United set MAC lists, classify formulary tiers, and retain spread at its own discretion with no duty of loyalty to the plan. There is no obligation to disclose all direct and indirect compensation, no duty to disclose economic conflicts, and no requirement to give back anything retained in breach. The model contract by Mark Cuban and collaborators makes loyalty, disclosure, and disgorgement the foundation, and this contract permits exactly the self dealing that foundation exists to prevent.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 42","evidence_quote":"Claims Processor Fees. United maintains systems for processing pharmacy claims and may receive access fees and charges for marketing and administrative services as compensation for services United provides to Network Pharmacies.","rationale":"The contract does acknowledge some revenue streams: access fees from network pharmacies on page 42, a 1 to 3 percent transaction fee to a United affiliate on provider payments on page 60, the $2.00 PMPM Lockton consultant fee on page 67, and the spread United retains. But none of these disclosures carry amounts, totals, or a full accounting of direct and indirect compensation, and there is no officer certification that everything has been disclosed and remitted. The City's consultant payment is disclosed, which is more than most contracts show, but the model requires complete certified disclosure and this is piecemeal.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit lists United's owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, mail order pharmacies, or specialty pharmacies, and there is no duty to refresh ownership information on 30 days notice. The only ownership-adjacent document is the Form CIQ on pages 85 to 86, which asks only whether the vendor has conflicts with City officers; United answered that it has no conflict of interest to disclose. The words affiliate and affiliates appear in the service terms, for example in the pharmacy definitions on page 41, but only to confirm that affiliated home delivery and specialty pharmacies participate, never to enumerate them in a signed exhibit.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The definitions are built around labels rather than economic function. Brand and generic status come from Medi-Span indicator codes, MAC pricing is whatever United puts on lists it controls, and the Rebate definition affirmatively excludes anything a group purchasing organization receives and any payment tied to a product, service, tool, or data analytics. Attachment D-6 on page 66 then confirms manufacturer administrative fees are outside the guaranteed rebate arrangement, so value relabeled as a fee or pushed through a purchasing entity escapes the 100 percent sharing. This is the relabeling loophole the model contract's definitions exist to close.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.87,"page_ref":"Page 64","evidence_quote":"Minimum Rebate Guarantee (Traditional PDL) Rebate Sharing Percentage 100.0%","rationale":"Pharmacy-benefit rebates are shared at 100 percent with per-script minimum guarantees of $730.25 per retail brand script in year one rising to $1,066.98 by year three, reconciled after each contract year. That is the strongest dollar protection in the contract. But it covers only the narrow Rebate definition: manufacturer administrative fees, purchase discounts, GPO remuneration, and United's other manufacturer revenue stay with United, the first payment can arrive 210 days after a quarter instead of within 30 days, and medical-benefit drug rebates pass through at only 80 percent per page 58. One hundred percent of a carved-up definition is not 100 percent of everything.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United or its affiliates, acting as a Home Delivery Pharmacy or a Specialty Pharmacy, purchase Prescription Drugs from Drug Manufacturers and receive certain discounts and purchase rebates from Drug Manufacturers in connection with these purchases. United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"United's own home delivery and specialty pharmacies not only keep purchase discounts and rebates on drugs they dispense, they also keep the spread between what the pharmacy is paid and what the City is charged, per pages 43 and 67. Nothing prices affiliate-dispensed claims at net acquisition cost plus a disclosed dispensing fee, and there is no documentation default. The model contract's acquisition-cost rule exists to remove the incentive to fill through owned channels; this contract builds the incentive in.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.91,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the document caps the plan's claim cost at a published benchmark or a transparent cash price, and nothing tests cost claim by claim against such a ceiling. The guarantees in Attachment D-6 (pages 61 to 68) are average discounts off average wholesale price measured annually, which can sit far above any cash benchmark, and the only benchmark references on pages 67 and 68 describe circumstances that let United revise or revoke its own guarantees. The lesser-of-three rule on page 67 caps what a member pays at the counter, not what the plan pays United.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"CASH","verdict":"partial","confidence":0.85,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"Members pay the lesser of the discounted price, the pharmacy's reported usual and customary cash price, or their cost share, so a member should not pay more than the cash price the pharmacy reports. That covers half of what the model asks for. Nothing says a cash purchase counts toward the deductible or out of pocket maximum, and the contract never addresses accumulator adjustment programs at all; the word accumulator appears only in the termination-assistance file transfer clause on page 47. The member protections stop at the point of sale.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"MAC","verdict":"bad","confidence":0.94,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United's periodic review and modification in its sole discretion.","rationale":"The MAC definition on pages 40 to 41 is the classic spread-pricing setup: United may run multiple maximum allowable cost lists, each changed at its sole discretion, with no disclosure requirement, no update schedule, and no pharmacy appeals path anywhere in the document. Because the contract also lets United keep the difference between plan-side and pharmacy-side reimbursement, two different MAC lists (one billed to the City, one paid to the pharmacy) are fully permitted. The model contract's single disclosed MAC list with appeal rights is absent in every particular.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"SPRD","verdict":"bad","confidence":0.96,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"Spread pricing is not just permitted; it is stated twice. Page 43 authorizes United to keep the difference between pharmacy reimbursement and the City's payment in the home delivery, retail, and specialty channels, and page 67 repeats it for mail order, specialty, and retail pharmacy drugs and services including dispensing fees. The discount guarantees in Attachment D-6 are measured against average wholesale price, so they coexist with per-claim spread rather than replacing it. The model contract requires the plan to pay exactly what the pharmacy is paid plus a disclosed fee; this contract is the opposite.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"GPO","verdict":"bad","confidence":0.92,"page_ref":"Page 45","evidence_quote":"Nothing in this Agreement shall preclude United from pursuing, directly or indirectly, other sources of revenue from Drug Manufacturers or engaging in other revenue-producing relationships with Drug Manufacturers.","rationale":"United reserves the right to keep other manufacturer revenue streams, and its affiliates acting as home delivery or specialty pharmacies keep purchase discounts and purchase rebates without passing them to the City. The Rebate definition on page 41 separately excludes anything a group purchasing organization receives for direct purchase or for products, services, or data tools. Together these clauses move exactly the revenue categories the model contract's purchasing-entity pass-through targets outside the City's reach, with no allocation on disclosed drivers.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.86,"page_ref":"Page 44","evidence_quote":"While Customer is the ultimate decision-maker on selecting the design of Customer's PDL(s), Customer has requested that United supply and assist Customer with certain PDL development and management functions including but not limited to drug tiering decisions.","rationale":"The City is named the ultimate decision-maker on formulary design, which is real authority. In practice United makes the final classification of each drug's tier, considering economic factors including available rebates, and the City must stop using the formulary at termination and cannot share it without United's written approval. Utilization management criteria are proprietary and withheld from the City and its vendors, and any customization needs United's approval and may cost extra. Plan control exists on paper but the levers that determine net cost stay with the PBM.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"LNC","verdict":"bad","confidence":0.88,"page_ref":"Page 44","evidence_quote":"Economic factors may include, but are not limited to, the Prescription Drug's acquisition cost including, but not limited to, available Rebates, and assessments on the cost effectiveness of the Prescription Drug.","rationale":"Tier placement expressly weighs the rebates a drug generates, and page 44 also tells the City that United negotiates rebates based on its whole book of business, not this plan. There is no lowest-net-cost standard for this plan, no annual comparison against United's book of business, and no disclosure when a drug is placed above a cheaper equivalent. A formulary that counts available rebates as a reason to favor a drug is the rebate-driven placement the model contract's lowest-net-cost standard is meant to expose.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.87,"page_ref":"Page 67","evidence_quote":"All pricing guarantees require the selection of United's PBM as exclusive provider of pharmacy benefit services, including but not limited to retail, mail order, and specialty networks.","rationale":"The guarantees are conditioned on exclusive use of United's PBM across retail, mail, and specialty, and page 42 makes United the City's exclusive provider of prescription drug benefit services. There is no any-willing-pharmacy right, no bar on steering members to United's affiliated home delivery or specialty pharmacies, and no protection against retroactive claim clawbacks; the medical attachment's cross-plan offset process even lets other plans' overpayment recoveries reduce payments under this plan. United designates and can re-designate the specialty drug list, which controls which pharmacy may fill. The network protections the model contract lists are absent, and exclusivity plus affiliated steerage is affirmatively built in.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 66","evidence_quote":"Customer may conduct one market check during the Pharmacy Pricing Term to confirm its financial terms are competitive with those currently available in the market","rationale":"The City gets one market check during the three-year pharmacy pricing term, run by a mutually agreed third party against at least four substantially similar customers. But there is no most-favored-pricing promise, the remedy triggers only if the report shows more than three percent savings against the median, and even then the parties merely negotiate in good faith, with any change effective the next contract year and requiring a signed amendment 60 days ahead. The model's automatic meet, credit, or release remedy is not here.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.86,"page_ref":"Page 46","evidence_quote":"United will provide Customer's auditor with access to all relevant Customer-specific information reasonably necessary to conduct the audit, including all applicable Prescription Claims, and, in the case of a Rebate audit, access to United's top 5 Rebate agreements or Rebate agreements that account for at least 75% of the Customer's total Rebate revenue generated per year, whichever is less.","rationale":"A real audit right exists: one pharmacy claims audit per calendar year with access to the City's own claims. But the auditor must be mutually agreeable and sign United's confidentiality agreement first, look-back is capped at 18 months, audits are barred in December and January, each period can be audited only once, and rebate-contract review is limited to the lesser of the top five agreements or 75 percent of rebate revenue, on-site only, with no copying and United reviewing the auditor's notes. Ongoing reporting is just United's standard online reports with no pre-adjudication access, and any payment requires a mutually signed settlement. The model's open-data, own-auditor standard is substantially narrowed here.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.82,"page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate's own behalf.","rationale":"The contract never says the City owns its claims, eligibility, accumulator, or rebate data, and there is no right to machine-readable delivery on request; standard online reports and up to twelve transition file transmissions at termination are all the delivery the text promises. Worse, the business associate agreement lets United de-identify the City's health data and use and disclose it for United's own purposes, and page 14 says post-termination information requests are answered at United's discretion for a fee. The City gets working access but not ownership, and the vendor gets a permanent reuse right in de-identified form.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer's Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"Attachment D-6 contains both operational guarantees and pharmacy financial guarantees, including per-script rebate minimums reconciled to actual receipts, which is more than many contracts offer. But the operational guarantees put only small fixed amounts at risk, $11,000 and $5,500 per metric, measured annually at office or site level and paid as fee credits, and page 61 makes those credits the City's exclusive financial remedies. Measurement is annual rather than quarterly, force majeure and legal-change carve-outs let United escape the guarantees, and United may specify new guarantees each period. Real dollars are guaranteed, but the remedies are capped credits, not cash shortfall payments.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.82,"page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer's Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee. Unless otherwise specified, these guarantees are effective for the period beginning January 1, 2025 through December 31, 2025 (\"Guarantee Period\").","rationale":"Missed financial and operational guarantees convert into automatic fee credits without the City proving damages, which is the self-executing half of the model's enforcement design. The other half is missing: there are no liquidated damages for late reports, audit recoveries require a mutually signed settlement agreement, disputes go to confidential arbitration capped at actual damages with no punitive awards, and nothing gives the City a penalty-free exit after a second material breach or a regulatory integrity event. Termination for cause under Exhibit B requires a 30-day cure period every time. Enforcement beyond the guarantee credits depends on litigation the City must initiate.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"AMD","verdict":"partial","confidence":0.84,"page_ref":"Page 16","evidence_quote":"The Contract can be modified or amended only by a writing signed by both parties.","rationale":"Exhibit B Section 48 has the model's core rule: modification only by a writing signed by both parties. But Exhibit A Section 3 lets United change fees on 30 days notice at each renewal, and also at any time when plan terms, law, or enrollment shift by 10 percent, with new fees effective retroactively; the City's only remedy is to terminate. Attachment D-6 separately lets United revise or revoke pricing guarantees and rebate guarantees for a long list of market and legal changes. Economic terms can therefore move by notice even though the contract itself cannot formally be amended unilaterally.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 59","evidence_quote":"if Customer terminates the Pharmacy Benefit Services portion of this Agreement only during the Term of the Agreement and termination is for any reason other than for cause, United may retain all Rebates that have not been remitted to Customer as of the effective date of such termination.","rationale":"Convenience termination is only available after the three-year initial term, on 120 days notice (the text shows an OCR-garbled figure), and the contract auto-renews each year. The decisive problem is forfeiture: if the City exits pharmacy services for any reason other than cause, United keeps all rebates earned but not yet remitted, and page 66 adds that no reconciliation of the minimum rebate guarantee applies either; ending pharmacy services also lets United raise the medical fees. Earned amounts are forfeited and the guarantee vanishes, which is precisely the trap the model contract's termination clause exists to prevent.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"SPEC","verdict":"bad","confidence":0.93,"page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"Specialty is defined by a functional criteria list, which is a start, but United designates the specialty drug list, may re-designate drugs from specialty to non-specialty based on market conditions, and keeps the spread on every specialty claim. Specialty drugs dispensed through United's specialty network are excluded from the retail and mail guarantees and get their own aggregate discount target (about AWP less 21 percent for listed drugs), with no drug-level ceiling and no acquisition cost pricing at the affiliate specialty pharmacy. The model's controls on the channel where PBMs earn the most margin are absent.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"GAG","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"If a Party is requested or required to disclose Confidential Information by subpoena, legal process, or Law, including public records acts, such Party shall (to the extent permitted by Law) provide the other Party with immediate written notice of that request or requirement.","rationale":"The confidentiality clause on pages 13 to 14 defines pricing, discounts, reimbursement terms, and compensation arrangements as Confidential Information and restricts the City to using United's confidential information only for plan administration, with any further disclosure conditioned on a mutually agreed confidentiality agreement. But it does carve out disclosures required by law including public records acts, subject to notice and cooperation with the vendor's effort to seek a protective order, and Exhibit B Section 35 confirms public nature is judged under the Texas Public Information Act. The SSAE18 security report is separately locked down on pages 53 to 54. Pricing secrecy exists but is limited by the public-records carve-out, so this is a limited gag rather than a full one. Nothing restricts pharmacies from telling patients about cheaper options in this text.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 15","evidence_quote":"Nothing in this Agreement is intended by the parties, or shall be construed, to confer upon RIGHTWAY the status of a fiduciary of Client or any benefit plan maintained by Client","rationale":"Exhibit A Section B.6 on pages 15 and 16 does the opposite of the model term. It states that nothing in the agreement confers fiduciary status on Rightway, that Rightway will not be delegated discretionary authority over the plan, and that the City accepts total responsibility and final authority for the plan. The only carve out is claims and appeals administration, where page 19 delegates discretionary authority to Rightway to determine entitlement to benefits. There is no duty of loyalty, no duty of care owed to the plan or its members, and no disgorgement remedy for compensation retained in breach. The conflicts clause on page 2 is a warranty of disclosure, not a loyalty duty. The model contract published by Mark Cuban and collaborators makes the PBM a fiduciary owing loyalty solely to the plan, so this express disclaimer earns a bad verdict.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"DISC","verdict":"partial","confidence":0.7,"page_ref":"Page 26","evidence_quote":"RIGHTWAY will share with Client: (a) sources of revenue as they relate to the Client's contract, and (b) the pricing structure for pharmacy benefit management Services including rebate structure and administrative fees","rationale":"Disclosure obligations exist but are thinner than the model. Section 5.1 on page 2 has Rightway warrant that it has disclosed existing or potential conflicts in writing and will disclose new ones immediately. Exhibit A Section D.6 on page 26 promises, only upon the City's request, to share sources of revenue related to the contract and the pricing structure including rebates and administrative fees, and then labels that information Rightway's confidential information. Section 12 on page 23 requires cooperation with Consolidated Appropriations Act transparency reporting, and page 44 prices RxDC report packages at $500 each. The pass through definition on page 31 says Rightway retains no rebates or other direct financial benefits from manufacturers or pharmacies. Nothing requires disclosure of payments to consultants or brokers, nothing addresses affiliate ownership touching plan claims, and there is no officer certification on any schedule. Disclosure is reactive and unverified, so partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"OWN","verdict":"partial","confidence":0.5,"page_ref":"Page 10","evidence_quote":"Vendor must notify City's Purchasing Manager, in writing, of a company name, ownership, or address change for the purpose of maintaining updated City records.","rationale":"There is no ownership or affiliate exhibit in the document. The closest provisions are Section 28 on pages 10 and 11, a City boilerplate clause requiring written notice of a change in company name or ownership with supporting documents, and Section 9.2 on page 6, which promises a list of subcontractors on request. Page 52 asserts that the rebate aggregators Rightway uses are subcontractors and not affiliates, and page 30 admits limited distribution drug pharmacies may or may not be owned by or affiliated with Rightway. The mail service and specialty pharmacies are never named and their ownership is never stated. The model contract published by Mark Cuban and collaborators lacks this exhibit too, and the rubric asks for a signed list refreshed within 30 days of any change. The contract touches ownership change notice but delivers none of the affiliate transparency, so partial at low confidence rather than missing.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"DEF","verdict":"partial","confidence":0.7,"page_ref":"Page 31","evidence_quote":"Manufacturer Derived Revenue means any monies received by Vendor and/or Rebate Aggregator from Manufacturers directly related to Client's Claims utilization under this Agreement, including, but not limited to (i) Rebates, (ii) Manufacturer Administrative Fees","rationale":"The definitions in Attachment A-1 are mixed. The rebate side is strong: Manufacturer Derived Revenue on page 31 captures any monies from manufacturers tied to the City's utilization, including administrative fees, access, incentive, market share, price protection and value based payments, and page 32 folds Manufacturer Derived Revenue into the Rebates definition. Brand and generic are defined by Medi-Span multi source indicators, a single Pricing Source must be used for both invoicing and pharmacy payment (page 32), and Pass-Through Pricing is defined economically (page 31). The weaknesses are that Rebate Aggregator on page 32 expressly lets the aggregator retain formulary management fees, page 52 removes the aggregator's spread from the term Rebate entirely, Specialty Drug on page 33 is whatever Rightway lists from time to time, and affiliate is never defined. Value can still leak through the aggregator and the specialty label, so partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"PASS","verdict":"partial","confidence":0.75,"page_ref":"Page 51","evidence_quote":"Client will receive 100% of the Rebates earned and collected on a pass -through basis. RIGHTWAY will calculate and report the Client's Manufacturer Derived Revenue allocations quarterly.","rationale":"Attachment B-2 Section B on page 51 promises 100 percent of rebates earned and collected on a pass through basis, with quarterly reporting of Manufacturer Derived Revenue and payment of the minimum rebate guarantee within 90 days after each quarter, followed by a year to date true up at 120 days. The broad definitions on pages 31 and 32 help. It falls short of the model in several respects. Timing is 90 to 120 days rather than 30. The pass through is of amounts earned and collected, and page 51 has the City waive all losses from a manufacturer or aggregator failing to pay. Page 52 allows the aggregator to keep the difference between what it collects and what it remits and declares that difference is not a Rebate. The exclusion list on page 51 has seventeen categories, including insulins, limited distribution drugs, 340B and authorized generics. Page 52 denies the City interest on held rebates and allows offset and delay. Partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"NAC","verdict":"partial","confidence":0.5,"page_ref":"Page 49","evidence_quote":"Under the RIGHTWAY transparent, full Pass -Through model, Client pays the actual reimbursement rate (discounts and dispense fees) paid by RIGHTWAY to the Participating Pharmacy from which the Claim originates, less the Eligible Person Cost -Sharing Amount.","rationale":"The contract addresses mail and specialty channel pricing but not on the acquisition cost basis the model requires. Participating Pharmacy on page 31 includes the Mail Service Pharmacy and Specialty Pharmacy, and page 49 says the City pays the actual reimbursement rate paid to whichever pharmacy dispensed the claim, with AWP discount guarantees for mail and specialty on page 49. There is no provision pricing any Rightway owned or economically related pharmacy at net acquisition cost plus a dispensing fee, no prohibition on retained margin at such a pharmacy, and no documentation default. The contract never says whether the mail and specialty pharmacies are affiliates, though page 53 assumes Rightway's preferred mail and specialty pharmacies as exclusive fulfillment partners and page 30 concedes some pharmacies may be owned by or affiliated with Rightway. A pass through of a rate Rightway negotiates with a pharmacy it may control is weaker than the model, so partial at low confidence.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"CEIL","verdict":"partial","confidence":0.65,"page_ref":"Page 50","evidence_quote":"All Claims will adjudicate at and Client will pay RIGHTWAY (except as stated in (c) below) the lower of (i) U&C (if applicable); (ii) AWP minus the Participating Pharmacy's discount rate plus Dispensing Fee; (iii) MAC (if applicable) plus Dispensing Fee; or (iv) the Participating Pharmacy's submitted amount plus Dispensing Fee","rationale":"The pricing adjudication logic on page 50 applies a lower of test on every claim, so the City never pays more than the pharmacy's usual and customary cash price, the contracted AWP discount, the MAC price or the submitted amount. That is a genuine claim level ceiling and it applies in all channels because the logic covers all claims. Subsection (c) adds a third party discount card check that can route a claim to a lower vendor price. The model term goes further by tying the ceiling to a published external benchmark, such as a transparent cash price at a benchmark site, rather than the dispensing pharmacy's own U&C, and by making the ceiling an enforceable guarantee rather than an adjudication rule. The AWP discount guarantees on pages 48 and 49 are aggregate, not claim by claim, and page 49 acknowledges individual reimbursement may exceed the guarantee. A real but pharmacy relative ceiling earns partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"CASH","verdict":"partial","confidence":0.6,"page_ref":"Page 50","evidence_quote":"In the event the vendor's available discount price for a Claim is lower than an Eligible Person's payment amount as determined in subsection (b) above, the Claim will adjudicate at the vendor's available discount price resulting in Eligible Person paying the full Claim cost plus any applicable Taxes.","rationale":"Members get partial cash price protection. Page 50 subsection (b) has the member pay the lowest of U&C, the contracted rate, MAC, the submitted amount or the plan cost share, and subsection (c) routes the claim to a third party discount price when that is lower than the member's cost share. The Cost-Sharing Amount definition on page 29 also caps the member at U&C for certain pharmacies. Because these claims run through Rightway's adjudication system the contract implies they are tracked, but nothing states that a discount card claim or an outside cash purchase counts toward the deductible or out of pocket maximum, and page 20 only describes an accumulator feed to a single medical carrier. There is no clause barring accumulator or maximizer adjustments against manufacturer assistance absent a written election; the Care Complete Specialty programs on page 22 actively steer members to copay assistance and alternative funding. Partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"MAC","verdict":"partial","confidence":0.65,"page_ref":"Page 31","evidence_quote":"Maximum Allowable Cost (\"MAC\") means the maximum allowable cost determined by RIGHTWAY and updated at least quarterly, or more frequently as required by Law, based upon review and analysis of current pricing in the marketplace.","rationale":"MAC governance is partly addressed through definitions rather than a dedicated section. Page 31 defines MAC as determined by Rightway and updated at least quarterly, and requires the mail order MAC drug list to be identical to the retail MAC list. Page 32 requires one Pricing Source and the same national drug file for invoicing the City and paying pharmacies, and the Pass-Through Pricing definition on page 31 plus the claim level pass through on page 49 mean the City is invoiced what the pharmacy receives, which functionally rules out a second MAC list for the plan. Page 44 lists MAC program administration as included in the administrative fee. What is absent is disclosure of the MAC list to the City, a defined update cadence beyond quarterly, and any pharmacy appeals process with timelines. The single list principle is present but the transparency and appeals elements of the model are not, so partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"SPRD","verdict":"good","confidence":0.75,"page_ref":"Page 49","evidence_quote":"100% of the Participating Pharmacy negotiated pricing will be passed through to Client from RIGHTWAY on a Claim by Claim basis even if a Claim is excluded from an AWP Discount Guarantee or Dispensing Fee Guarantee hereunder.","rationale":"The contract meets the no spread standard on its face. Page 49 commits that 100 percent of the negotiated pharmacy price passes through on a claim by claim basis, that the City pays the actual reimbursement rate paid to the dispensing pharmacy less member cost share, and that this holds even for claims excluded from the guarantees. Exhibit B Section 2 on page 38 states Rightway will invoice claims at the amount it pays for those claims. Pass-Through Pricing on page 31 is defined as equality between what Rightway pays pharmacies and what it invoices the City. Participating Pharmacy on page 31 includes mail and specialty, so the promise spans all channels, and the administrative fee is separately disclosed on page 41. Two caveats keep confidence moderate: page 50 lets Rightway's vendor assess and retain transaction fees from pharmacies, and the pharmacy contracts themselves are outside the audit scope on page 4, so the equality cannot be independently verified.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"GPO","verdict":"bad","confidence":0.7,"page_ref":"Page 52","evidence_quote":"which such difference may be retained by the Rebate Aggregator and/or intermediary as its compensation, and the term \"Rebate\" as used in this Agreement does not include this compensation, which belongs exclusively to the Rebate Aggregator or intermediary.","rationale":"The contract permits the harm the model targets. Although Manufacturer Derived Revenue on page 31 reaches monies received by Rightway or its Rebate Aggregator, page 52 carves back out the difference between what the aggregator or intermediary collects from manufacturers and what it passes to Rightway, declares that difference the intermediary's exclusive compensation, and removes it from the term Rebate. Page 32 separately lets the aggregator retain reasonable formulary management fees and costs. Page 52 asserts the aggregators are subcontractors rather than affiliates, but page 4 bars the City's auditor from auditing the Rebate Aggregator, so the City cannot test either the assertion or the amount retained. There is no allocation methodology, no disclosure of the intermediary's take, and no coverage of purchase discounts or volume credits at any purchasing entity. The model contract published by Mark Cuban and collaborators requires all such value to flow to the plan on disclosed drivers, so bad.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"FORM","verdict":"bad","confidence":0.75,"page_ref":"Page 21","evidence_quote":"RIGHTWAY shall provide a recommended drug Formulary to Client and Client hereby adopts, as part of the Plan design and as Client's formulary, such Formulary (as amended from time to time).","rationale":"Formulary control sits with Rightway. Page 21 has the City adopt Rightway's formulary in advance, including future amendments, and authorize Rightway to implement prior authorization, step therapy and quantity limits under it. Page 30 defines the formulary as developed by Rightway's P&T committee. Page 53 conditions every financial guarantee and the PMPM Target on the City's complete adoption of the Rightway Comprehensive Value Formulary including exclusions and clinical edits, and page 54 lets Rightway reprice if the City fails to participate in the requisite formulary. A custom formulary is billed at $225 per hour on page 45. The quarterly account meetings on page 17 review claims data and financial outcomes generally, but no clause requires City approval of each change, delivery of lowest net cost analysis for changes, or quarterly utilization management outcomes by drug. The nominal words approved and adopted by Client on page 30 do not offset a structure that penalizes deviation, so bad.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"LNC","verdict":"partial","confidence":0.55,"page_ref":"Page 30","evidence_quote":"Formulary means the list of FDA -approved Covered Products developed by RIGHTWAY's Pharmacy and Therapeutics Committee, approved and adopted by Client and subject to Client's Plan Documents and coverage decisions. The Formulary is based on drug safety, drug efficacy, and drug cost/lowest net cost analysis.","rationale":"A lowest net cost standard is named but not operationalized. The Formulary definition on page 30 says the list is based on safety, efficacy and drug cost or lowest net cost analysis, and page 51 gives a rebate credit for low WAC biosimilar claims if the City elects the Comprehensive Value Formulary, which signals a net cost orientation. Page 17 promises quarterly reviews of claims data, financial outcomes and projected costs. The model requires more: a stated obligation that decisions meet lowest net cost for this plan, an annual comparison of the plan's results against the PBM's whole book of business, and disclosure with reasons whenever a drug is placed above a cheaper therapeutic equivalent. None of those deliverables appears anywhere in Exhibit A or the fee schedule, and the minimum rebate guarantees per brand claim on page 51 create a countervailing incentive toward rebated brands. A stated standard without measurement or disclosure is partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"NET","verdict":"bad","confidence":0.7,"page_ref":"Page 53","evidence_quote":"Guarantees and PMPM Target assumes RIGHTWAY's preferred network of Mail Order Pharmacy and Specialty Pharmacies as exclusive fulfillment partners.","rationale":"The network terms permit steering and clawbacks and offer no any willing pharmacy right. Page 53 conditions all guarantees and the PMPM Target on Rightway's preferred mail order and specialty pharmacies being the exclusive fulfillment partners, and page 16 excludes from every guarantee any claims the City routes to its own specialty pharmacy. Page 18 gives Rightway discretion to refuse pharmacies owned by or under common control with a competitor, disclaims any guarantee of network size, and sets up a pharmacy audit program under which Rightway may recover discrepancies and offset collection costs, which is a retroactive adjustment to adjudicated claims. Page 53 also lets Rightway apply a credit in its own reconciliation if a City contracted pharmacy will not accept its rates. The City can request a pharmacy be added at higher rates or excluded on 90 days notice (page 18), which is some control, but the structure as a whole routes volume to Rightway's channels, so bad.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"MFN","verdict":"missing","confidence":0.75,"page_ref":null,"evidence_quote":null,"rationale":"I looked in the body of the agreement (pages 1 to 12), the payment schedule and both fee attachments (pages 38 to 54), and the definitions (pages 28 to 33) for any most favored client promise, market check, benchmarking right or repricing remedy in the City's favor. None exists. Page 1 lets Rightway modify pricing for other governmental purchasers using the cooperative purchasing clause, page 1 defers renewal pricing to a future agreement, and pages 53 and 54 give Rightway a one sided right to change fees, guarantees and targets on eleven triggers, but nothing lets the City demand pricing at least as good as comparable clients or run an annual market check with a meet, credit or release remedy. The quarterly account meetings on page 17 discuss financial outcomes but carry no pricing consequence. Because the topic is simply unaddressed rather than redacted, the verdict is missing, and the one way repricing is covered under the amendments item.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"AUD","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"For the avoidance of doubt, Auditor shall not be entitled to audit Vendor's vendors, Manufacturers, Rebate Aggregator, pharmacies, or other providers of Services hereunder, however, Auditor will be provided access to relevant business records","rationale":"Audit and data rights exist but carry meaningful limits. Section 6 on pages 3 and 4 allows one audit per contract year and for one year after termination, with an independent external auditor, at no charge, with a three year lookback and a 30 day payment obligation after findings. The limits are that the auditor must not be one Rightway prohibits, must sign Rightway's nondisclosure agreement, must observe Rightway's client audit policy and black out period, and cannot audit manufacturers, the rebate aggregator, pharmacies or other vendors, which are exactly where pass through leakage would hide. Page 4 also deems the City to accept Rightway's objection if it does not respond within 30 days. On data, page 20 delivers a daily claims file to the City's consultant and up to six service providers, standard reports within 30 days, and page 25 authorizes release to consultants and auditors. There is no pre adjudication claims access and rebate contracts are unreachable, so partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"DATA","verdict":"bad","confidence":0.75,"page_ref":"Page 3","evidence_quote":"purposes of Vendor to improve programs and Services for City and/or other Vendor customers or future customers, in all cases subject to applicable Law (including HIPAA). Vendor shall retain full ownership rights over all resultant data.","rationale":"The contract gives Rightway broad reuse rights and ownership of derived data, the opposite of the model. Section 5.6 on page 3 permits Rightway, during and after the term, to use, reproduce, disclose and adapt claims, eligibility, medical and other health data in de identified or aggregated form for research, profiling, benchmarking, cost analysis and other business purposes benefiting other and future customers, and states that Rightway retains full ownership of all resultant data. Page 39 adds that neither the City, the plan nor members have a property interest in amounts paid to or retained by Rightway. Offsetting terms are real but narrower: Section 26 on page 10 makes the City owner of reports and work papers, page 26 says no Work Product is delivered under Exhibit A, page 20 provides daily claims files, and pages 24 and 25 promise a transition file package with twelve months of claims at termination. The sponsor is not the sole owner of derived data sets, so bad.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"Page 48","evidence_quote":"If the actual performance is less than the guaranteed amounts, RIGHTWAY will make up any Net Shortfall on a dollar -for -dollar basis as a credit to Client on a future invoice(s) within one hundred twenty (120) days of the end of each Contract Year.","rationale":"The financial guarantees are better than typical and the service guarantees are weaker. Page 48 reconciles AWP discount and dispensing fee guarantees annually by pricing category with no cross category offsets, pays shortfalls dollar for dollar as invoice credits within 120 days, and lets the City keep 100 percent of overperformance; rebate guarantees are paid quarterly with a year to date true up on page 51. Measurement is on the City's own claims. Weaknesses include reconciliation as credits rather than cash, annual rather than quarterly timing for discounts, the page 52 rule that all guarantees fall away in any year the PMPM Target is met, and page 54 voiding guarantees for a partial year. The service performance guarantees on pages 34 to 37 put only $20 per eligible person at risk, are mostly measured across Rightway's book of business, round in Rightway's favor, exclude specialty, and are the City's sole monetary remedy on page 35. Partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"ENF","verdict":"partial","confidence":0.6,"page_ref":"Page 27","evidence_quote":"The parties agree that any financial penalties determined under this Agreement payable by RIGHTWAY for failure to meet the performance standards shall be payable solely on the account of a failure to satisfy the standards. The failure to meet a performance standard shall not, in and of itself, constitute a Material Breach of the Agreement.","rationale":"Some remedies are automatic but there is no two strikes exit. Guarantee shortfalls become invoice credits without the City proving damages (page 48), performance guarantee penalties are credited within 45 days of the annual report (page 34), and page 23 lets the City terminate and report Rightway to the government if it fails to support transparency reporting. Against that, page 27 provides that missing a performance standard is never itself a Material Breach, page 35 makes the capped penalty the sole monetary remedy, and page 34 caps the total at the amount at risk. Late reports carry no liquidated damages; page 20 sets a 30 day reporting deadline with no consequence. Termination for cause on page 2 requires a Material Breach uncured after 30 days, with Material Breach defined loosely on page 31, and no clause counts repeat breaches or treats a regulatory integrity event as grounds. The City's 90 day convenience right is the practical backstop. Partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"AMD","verdict":"bad","confidence":0.7,"page_ref":"Page 53","evidence_quote":"RIGHTWAY can change the pricing (e.g., Administrative Fees, Additional Fees, Ancillary Service Fees, PMPM Targets, AWP Discount Guarantees and Dispensing Fee Guarantees, Minimum","rationale":"Section 22 on page 9 says no amendment binds a party unless in a written instrument executed by both, which matches the model on its face. The attachments then override it. Pages 53 and 54 state Rightway can change administrative fees, ancillary fees, PMPM Targets, AWP discount, dispensing fee and minimum rebate guarantees by the minimum amount necessary upon any of eleven triggers, including plan design changes, a 10 percent shift in eligible persons or claims mix, a change in drug industry practice, manufacturers discontinuing cost concession programs, or the City adding its own pharmacies. Page 16 lets Rightway modify pricing if the City breaches exclusivity, page 8 lets Rightway modify the regulatory addenda on notice, page 33 lets Rightway change the specialty list, and page 55 lets it change the high cost drug list. Page 1 ranks schedules and attachments above the body, so these unilateral rights prevail over Section 22. Economic terms can move without a signed amendment, so bad.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"TERM","verdict":"partial","confidence":0.7,"page_ref":"Page 2","evidence_quote":"City may terminate this Agreement at any time and for any reason by providing Vendor with 90 days' written notice of termination without penalty or termination fees.","rationale":"The core of the model term is present. Section 4.1 on page 2 lets the City terminate at any time for any reason on 90 days notice without penalty or termination fees, Section 4.3 adds non appropriation termination without expense, and Exhibit A Section D.2(a) on page 24 requires Rightway to pay or credit all monies owed, including rebates and reconciliations, on any termination other than one for the City's breach. Two elements fall short. Earned amounts can be forfeited: page 54 voids guarantees for any partial contract year, page 34 voids performance guarantees if termination occurs before the end of Year One or any calendar year, and page 24 lets Rightway keep rebates if it terminates for the City's Material Breach. There is no regulatory integrity event as a ground for termination, only the transparency failure right on page 23. Rightway may also walk away for convenience on 180 days notice. Partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"SPEC","verdict":"partial","confidence":0.6,"page_ref":"Page 33","evidence_quote":"Specialty Pharmaceuticals or Specialty Drug means those biotech, biological, and other Covered Products identified by RIGHTWAY as specialty pharmaceuticals from time to time","rationale":"Specialty controls are present but built on a vendor controlled label. Page 33 defines specialty as whatever Rightway identifies from time to time and reserves the right to modify the list, which is the opposite of a functional definition. Pricing controls do exist: page 49 sets specialty brand, generic and limited distribution AWP discount guarantees, page 51 sets a per claim specialty brand rebate guarantee applied regardless of dispensing pharmacy, and Schedule B-2 on pages 55 to 75 sets drug level AWP discounts for a long list of rare high cost drugs, reconciled per GPI without offsets and paid dollar for dollar (page 55). These are aggregate or annual guarantees rather than claim level ceilings, page 50 limits the specialty discount guarantee to claims originating at specialty pharmacies, and page 53 assumes Rightway's preferred specialty pharmacies as exclusive fulfillment partners. No specialty claim at any affiliate is priced at acquisition cost. Partial.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Claude Fable 5.1","rubric_key":"GAG","verdict":"bad","confidence":0.7,"page_ref":"Page 26","evidence_quote":"provided Client acknowledges and agrees that information shared with Client pursuant to this section is RIGHTWAY's Confidential Information.","rationale":"The contract contains confidentiality terms that treat pricing and revenue information as the vendor's confidential material and only a conditional public records carve out. Page 26 declares that the sources of revenue and pricing structure Rightway shares on request are Rightway's Confidential Information. Page 4 requires the City's auditor to sign Rightway's nondisclosure agreement before seeing anything, and pages 25 and 26 condition release to the City's consultants on a separate confidentiality agreement with Rightway. Page 26 also bars the City from referring to Rightway in any publication without approval, and every page is stamped confidential and proprietary. Section 5.3 on page 3 acknowledges the Texas Public Information Act but gives Rightway the opportunity to mark information as proprietary and to object, leaving the outcome to the Attorney General or a court; under the briefing that carve out does not cure the verdict. No clause restricts pharmacies from telling patients about cheaper options, and page 21 lets pharmacies discuss alternatives. Bad.","model_own_total":39,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 15","evidence_quote":"Nothing in this Agreement is intended by the parties, or shall be construed, to confer upon RIGHTWAY the status of a fiduciary of Client or any benefit plan maintained by Client as \"Plan fiduciary\" is defined under applicable Law, except as related to claims and appeals administration as","rationale":"Page 15 expressly declines fiduciary status except for claims and appeals administration, while Page 19 delegates discretionary decisions on those claims and appeals to Rightway. Page 2 requires disclosure of existing or potential conflicts, but that warranty is not a broad duty of loyalty and care solely to the City and members. Pages 31 and 32 define pass-through and rebate terms, yet do not impose disclosure of every economic conflict or automatic disgorgement of compensation retained in breach. The model contract published by Mark Cuban and collaborators requires those affirmative protections across PBM discretion, not a narrow exception to an express disclaimer. The direct contrary language controls the bad verdict.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.97,"page_ref":"Page 26","evidence_quote":"Upon Client's request and consistent with RIGHTWAY's transparent business model, RIGHTWAY will share with Client: (a) sources of revenue as they relate to the Client's contract, and (b) the pricing structure for pharmacy benefit management Services including rebate structure and administrative fees;","rationale":"Page 26 gives the City a request-based disclosure of contract-related revenue sources and pricing structure, and Page 2 warrants written disclosure of existing and later conflicts. Page 6 permits a requested list of subcontractors. These are meaningful but narrower than a full inventory of direct and indirect compensation of Rightway and related entities, ownership ties touching claims, and consultant or broker payments. Page 52 expressly allows an intermediary to retain an upstream rebate difference, reinforcing the gap. Nothing on Pages 2, 6, 26, 31, 32 or 51 through 52 provides quarterly and annual named-officer certifications of all amounts disclosed and remitted. The disclosure clauses support partial, not good.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.94,"page_ref":"Page 10","evidence_quote":"Vendor must notify City's Purchasing Manager, in writing, of a company name, ownership, or address change for the purpose of maintaining updated City records. The president of Vendor or authorized official must sign the letter.","rationale":"Pages 10 and 11 require an officer-signed notice and supporting documents when Rightway's company name or ownership changes. Page 6 also offers a subcontractor list on request. Those provisions address part of the ownership problem, but there is no signed exhibit identifying all owners, parents, subsidiaries, affiliates, purchasing organizations, aggregator, mail or specialty pharmacy relationships. The agreement identifies a rebate aggregator as an engaged party on Page 32, and Page 52 states that contracted rebate intermediaries are subcontractors, not affiliates, without naming them in an ownership schedule. The notification provision lacks the model's defined thirty day refresh obligation and does not map economically related entities. Partial reflects a limited ownership notice, not a complete disclosure exhibit.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"DEF","verdict":"partial","confidence":0.96,"page_ref":"Page 31","evidence_quote":"Manufacturer Derived Revenue means any monies received by Vendor and/or Rebate Aggregator from Manufacturers directly related to Client's Claims utilization under this Agreement, including, but not limited to (i) Rebates, (ii) Manufacturer Administrative Fees, (iii) Formulary Rebates (Access Rebates),","rationale":"Pages 28 through 33 contain detailed definitions, including manufacturer-derived revenue that reaches several fee and rebate labels and receives attention at the aggregator level. However, the Page 32 rebate definition depends on negotiated rebate contracts and direct attribution to eligible persons, while the aggregator may retain reasonable formulary management fees and costs. Page 52 then excludes from Rebates the difference between the intermediary's manufacturer receipts and what Rightway receives. Specialty classification is also controlled by a Rightway-modifiable list on Page 33. The model's economic-function approach is meant to prevent relabeling or routing value outside pass-through. These definitions make progress but leave a material intermediary boundary, so partial is the sound reading.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"PASS","verdict":"partial","confidence":0.99,"page_ref":"Page 51","evidence_quote":"Client will receive 100% of the Rebates earned and collected on a pass -through basis. RIGHTWAY will calculate and report the Client's Manufacturer Derived Revenue allocations quarterly.","rationale":"Page 51 promises all earned and collected Rebates and quarterly allocation reports, with a minimum payment after the quarter and a later true-up. That is valuable, but it is not payment within thirty days of quarter end. Page 52 permits the rebate aggregator or intermediary to retain a difference between its upstream manufacturer receipts and Rightway's receipts, expressly excluding that difference from Rebates; Page 32 allows aggregator formulary management fees and costs. Page 51 also excludes many claim types from the minimum guarantee and disclaims liability for certain upstream failures. The model contract published by Mark Cuban and collaborators demands every type of manufacturer revenue reach the plan promptly with only closed exclusions. Partial recognizes the strong promise while respecting its economic and timing limits.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"NAC","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"I examined the pharmacy network and mail and specialty provisions on Pages 17 and 18, the pharmacy and pass-through definitions on Pages 30 through 33, and the detailed channel pricing, lower-of logic and guarantees on Pages 48 through 55. They establish reimbursement pass-through and AWP-based aggregate discounts, not an invoice at an owned or economically related pharmacy's documented net acquisition cost plus a stated dispensing fee. Neither the lengthy drug-level schedule on Pages 55 through 75 nor the fee schedule on Pages 41 through 47 supplies a missing acquisition-cost formula or a documentation default. The absence is substantive, not a redacted attachment, and therefore missing rather than unclear.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"Pages 48 and 49 describe category-wide AWP discount and dispensing guarantees; Page 50 contains lower-of adjudication against pharmacy usual and customary price when applicable and a third-party discount-price route. Pages 55 through 75 list selected high-cost drug AWP discounts, reconciled annually by product rather than enforced as an external published cash benchmark on every claim. I checked the definitions on Pages 28 through 33 and the remaining payment provisions on Pages 38 through 54 as well. No term sets an all-drug, all-channel claim-level ceiling tied to a published public benchmark or requires the cheapest lawful option for plan claim cost. Existing lower-of rules are different safeguards and do not make this rubric term present.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.97,"page_ref":"Page 50","evidence_quote":"All Claims will adjudicate at and Eligible Person will pay Participating Pharmacies (except as stated in (c) below) the lower of (i) U&C (if applicable); (ii) AWP minus the Participating Pharmacy's discount rate plus Dispensing Fee;","rationale":"Page 50 protects a member against the usual and customary amount when applicable and compares several adjudication prices with cost sharing. It also sends some claims to an outside discount vendor, where a lower vendor price means the member pays the entire claim cost. The Page 29 definition of U&C concerns the pharmacy's cash or uninsured retail price, not every possible lawful discount. Pages 20 and 45 provide accumulator files, but they do not say outside cash purchases count toward both deductible and out-of-pocket maximum. The specialty assistance program on Page 22 does not prohibit accumulator adjustments absent sponsor election. These protections are useful but incomplete against all three model requirements, warranting partial.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"MAC","verdict":"partial","confidence":0.94,"page_ref":"Page 31","evidence_quote":"Maximum Allowable Cost (\"MAC\") means the maximum allowable cost determined by RIGHTWAY and updated at least quarterly, or more frequently as required by Law, based upon review and analysis of current pricing in the marketplace. The list of drugs with a MAC offered at Mail Order will be identical to the list of drugs with a MAC offered at Retail Pharmacies.","rationale":"Page 31 provides at least quarterly MAC updates and identical mail and retail lists of drugs that have a MAC. Page 50 includes MAC as one possible lower-of adjudication basis and says MAC and non-MAC generic claims enter discount reconciliation. But the text does not state that one identical MAC amount or list governs both the City's charge and each pharmacy's reimbursement, nor does it require delivery of the actual list or its updates to the City. I found no pharmacy appeal timeline in the network provisions on Pages 17 and 18 or pricing attachment on Pages 48 through 54. This is partial governance, not the model's one-list, disclosed, appealable arrangement.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"SPRD","verdict":"good","confidence":0.96,"page_ref":"Page 49","evidence_quote":"100% of the Participating Pharmacy negotiated pricing will be passed through to Client from RIGHTWAY on a Claim by Claim basis even if a Claim is excluded from an AWP Discount Guarantee or Dispensing Fee Guarantee hereunder.","rationale":"Page 49 says the City receives participating pharmacy negotiated pricing claim by claim even when a claim is outside the aggregate guarantees, and specifies payment at the actual reimbursement to the originating pharmacy less member cost sharing. Page 38 independently says Rightway invoices claims at the amount it pays for them. Page 31 defines pass-through pricing as equality between pharmacy payment and the City's invoice and disallows retaining direct financial benefits from pharmacies. The fee schedule on Page 41 separates the administrative fee from drug reimbursement. Mail and specialty are participating pharmacy channels under Page 31. The noted vendor transaction fees on Page 50 deserve monitoring but do not expressly authorize Rightway itself to retain a plan-pharmacy reimbursement spread. This meets the rubric's no-spread test.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.98,"page_ref":"Page 52","evidence_quote":"The amount RIGHTWAY receives for Rebates from Manufacturers, Rebate Aggregators and/or intermediaries may be different from the amount such Rebate Aggregators and/or intermediaries receive through their own Manufacturer or intermediary agreements, which such difference may be retained by the Rebate Aggregator and/or intermediary as its compensation, and the term \"Rebate\" as used in this Agreement does not include this","rationale":"Page 52 affirmatively permits the rebate aggregator or intermediary to retain the difference between its upstream manufacturer receipts and what Rightway receives, excluding it from the plan's contractual Rebate. Page 32 separately permits reasonable aggregator formulary management fees and costs. Although Page 31 defines manufacturer-derived revenue to include money received by Rightway or an aggregator directly related to plan claims, the specific Page 52 exclusion creates a direct economic leakage route. The document says those rebate intermediaries are subcontractors rather than Rightway affiliates, but the model asks for related purchasing-entity value to flow to the plan on disclosed allocation drivers, irrespective of routing. No upstream supplier discount or volume credit allocation is specified. This express carve-out makes bad more apt than simple absence.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.97,"page_ref":"Page 21","evidence_quote":"RIGHTWAY shall provide a recommended drug Formulary to Client and Client hereby adopts, as part of the Plan design and as Client's formulary, such Formulary (as amended from time to time).","rationale":"The Page 30 definition describes a formulary developed by Rightway's committee, approved and adopted by the City, and based partly on lowest net cost analysis. The operative Page 21 language, however, has the City adopt the recommended formulary as amended from time to time and authorizes Rightway to implement prior authorization, step therapy and quantity limits. Page 53 conditions financial guarantees on complete adoption of Rightway's comprehensive value formulary and clinical edits. The City retains general plan-design authority on Page 15, but there is no explicit advance approval for every formulary change, a delivered drug-level lowest-net-cost comparison, or quarterly drug-level utilization-management outcomes. Some sponsor control exists, but it falls short of the model.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"LNC","verdict":"partial","confidence":0.94,"page_ref":"Page 30","evidence_quote":"The Formulary is based on drug safety, drug efficacy, and drug cost/lowest net cost analysis.","rationale":"Page 30 incorporates drug cost and lowest net cost analysis into the definition of formulary. Page 17 promises quarterly account meetings reviewing claims, financial outcomes and recommendations, and Page 21 covers treatment alternatives and formulary management. None of those clauses says that every formulary decision must minimize net cost to this City after rebates. The document also lacks an annual comparison of the City's formulary economics against Rightway's whole book of business and a disclosure whenever a drug is placed above a cheaper equivalent with the reason. Page 53's complete-adoption condition strengthens Rightway's leverage rather than making the City's net cost the controlling standard. Partial acknowledges the defined analytical factor without equating it to an enforceable decision rule.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.95,"page_ref":"Page 18","evidence_quote":"RIGHTWAY may refuse to add pharmacies to its network if they do not meet RIGHTWAY's minimum credentialing criteria or are owned by, or under common control with, a direct competitor of RIGHTWAY.","rationale":"Pages 17 and 18 require a retail, mail and specialty network and reasonable efforts toward member access, and allow the City to request a custom network exclusion. Page 18 nevertheless lets Rightway reject pharmacies under a competitor-ownership exception, which is inconsistent with a broad any-willing-pharmacy right on the plan's terms. Page 16's exclusivity and Page 53's assumption of preferred mail and specialty fulfillment partners constrain alternative channels; a direct specialty carve-out requires notice and loses guarantees. I found no express prohibition on retroactive pharmacy clawbacks, volume-conditioned reimbursement, or steering into related pharmacies in the network and pricing terms on Pages 17, 18 and 48 through 54. The partial network choice does not deliver the full anti-steering package.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"I checked the three year term and renewal provision on Page 1, the pharmacy pricing guarantees and PMPM target on Pages 48 through 54, the fee schedule on Pages 41 through 47, and termination on Pages 2 and 24. Those provisions contain fixed category commitments, annual reconciliations and the City's general convenience exit, but no automatic comparison or matching of better prices given to comparable Rightway customers. No annual market check, negotiated market benchmark, meet-or-credit process, or release specifically triggered by a failed market check appears. The general right to leave on notice cannot be treated as the model's formal pricing test and remedy. No relevant exhibit is omitted or redacted, so this is missing.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.98,"page_ref":"Page 4","evidence_quote":"For the avoidance of doubt, Auditor shall not be entitled to audit Vendor's vendors, Manufacturers, Rebate Aggregator, pharmacies, or other providers of Services hereunder, however, Auditor will be provided access to relevant business records (e.g. rate sheets, contract provision excerpts, policies and procedures, invoices, etc.)","rationale":"Pages 3 and 4 give the City an annual audit during the term and one year thereafter, but impose a blackout period, advance notice, the vendor's audit policy, an independent auditor acceptable under vendor criteria, its standard nondisclosure agreement, and no direct audit of the aggregator, manufacturers, pharmacies or other providers. Page 20 promises standard reports and paid-claim files, including a daily electronic file to Prism, and Page 23 requires cooperation for legally mandated transparency reporting. Yet the files are limited to paid claims and standard layouts, with extra reports negotiable, rather than automatic full financial and pre-adjudication data. Page 81 adds conditional Texas administrator record access. The rights are real but narrower than unrestricted independent verification.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 3","evidence_quote":"Vendor may use, reproduce, disclose, and/or adapt information obtained, generated, or derived in connection with this Agreement, including Claims data information, eligibility information, medical data, and other health data, in a de -identified and/or aggregated format for research, profiling, benchmarking","rationale":"Page 10 gives the City ownership of defined work product, but Page 26 says Rightway is not providing work product under Exhibit A. More importantly, Page 3 permits use of de-identified or aggregated claims and eligibility data during and after the term for Rightway's own business purposes and gives it full ownership of resultant data. Page 20 offers standard paid-claims files, while Pages 24 and 25 restrict transition delivery to a standard package, up to twelve months of claims, scrubbed of Rightway confidential information. Page 81 provides statutory record access but subjects it to proprietary-right restrictions. The model requires the sponsor to own all raw and derived data and prohibits vendor reuse or sale. The express ownership and reuse contrary to that rule warrant bad.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"PERF","verdict":"partial","confidence":0.99,"page_ref":"Page 34","evidence_quote":"In no event will the sum of the amounts owed to Client, as a result of RIGHTWAY's failure to meet the performance guarantees exceed the total dollars stated at risk for any given calendar year.","rationale":"Pages 34 through 37 provide implementation and ongoing performance measures, but ongoing measures are generally annual and several use Rightway's book of business rather than this City's data. Page 34 caps penalties at amounts at risk, pays them as invoice credits after an annual report, and voids guarantees on early termination. Pages 48 and 51 separately provide dollar-for-dollar reconciliation credits for annual pharmacy pricing and minimum rebate shortfalls, which is stronger than the service-standard remedies. Yet Page 52's PMPM target can switch off those individual pricing guarantees if achieved, and Page 54 voids partial contract-year guarantees. The model demands quarterly, plan-specific measurements and uncapped cash shortfall payments. The mix of real guarantees and major qualifications merits partial.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.96,"page_ref":"Page 27","evidence_quote":"The failure to meet a performance standard shall not, in and of itself, constitute a Material Breach of the Agreement.","rationale":"Page 34 supplies scheduled annual performance reporting and subsequent credits for missed standards without requiring the City to prove damages, while Page 48 specifies automatic future-invoice credits for dollar-for-dollar financial shortfalls. Those are partial self-executing mechanisms. On the other hand, Page 27 makes a performance miss alone insufficient to constitute material breach, and Pages 34 and 35 cap service penalties and make them the sole monetary remedy apart from corrections and billing errors. Page 20 sets a deadline for core reports but provides no automatic late-report damages. Page 2 has a general material-breach cure and termination clause, not a second-breach or regulatory-integrity two-strikes exit. The City's Page 23 transparency-law termination right is narrower. Partial reflects automatic credits without the model's repeat-failure architecture.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.98,"page_ref":"Page 53","evidence_quote":"RIGHTWAY can change the pricing (e.g., Administrative Fees, Additional Fees, Ancillary Service Fees, PMPM Targets, AWP Discount Guarantees and Dispensing Fee Guarantees, Minimum","rationale":"Page 9 generally requires a written instrument executed by authorized representatives of both parties for amendments, and Page 78 applies mutual written agreement to the business associate agreement. But Page 53 begins a specific economic repricing clause under which Rightway can change fees, targets and guarantees for listed conditions, continued on Page 54. Those conditions include enrollment and claims-mix changes, changes in industry practice, manufacturer concessions and City carve-outs. Page 1 gives schedules and attachments priority over the body in conflicts, making the specific pricing power especially important. Page 8 also permits Rightway to modify regulatory addenda on notice for legal compliance. The model disallows unilateral economic change by notice or updated terms. The operative pricing exception makes this a bad verdict despite the general bilateral amendment provision.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.98,"page_ref":"Page 2","evidence_quote":"City may terminate this Agreement at any time and for any reason by providing Vendor with 90 days' written notice of termination without penalty or termination fees.","rationale":"Page 2 provides a clear City convenience exit without a termination fee and a separate nonappropriation exit. Page 24 ordinarily promises the City all monies owed after expiration or termination, including rebates and reconciliations. But if Rightway terminates for the City's material breach, the same page removes further rebate and other payment obligations after breach and lets Rightway offset amounts otherwise payable before termination against damages and debts. Pages 34 and 54 also void guarantees for incomplete calendar or contract years. Page 23 gives a specific termination right for material transparency-rule noncompliance, but there is no broad regulatory integrity event covering every disqualifying regulatory failure. The convenience right is substantial, while potential forfeitures prevent a good verdict.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"SPEC","verdict":"partial","confidence":0.97,"page_ref":"Page 33","evidence_quote":"Specialty Pharmaceuticals or Specialty Drug means those biotech, biological, and other Covered Products identified by RIGHTWAY as specialty pharmaceuticals from time to time, which typically include pharmaceutical products that are generally biotechnological in nature","rationale":"Page 33 describes functional attributes of specialty drugs, yet ultimately lets Rightway identify and revise its specialty list. Page 49 sets specialty brand, generic and limited-distribution aggregate AWP discount categories, and Pages 55 through 75 offer drug-specific AWP discounts for selected rare high-cost products with annual product-level reconciliation. This is meaningful specialty pricing control, but the drug-specific schedule is not a claim-level ceiling applicable to every specialty drug in every channel. Page 50 limits specialty discount guarantee treatment at retail depending on grace fills; Page 16 permits a direct specialty pharmacy arrangement but excludes those claims from guarantees. No acquisition-cost rule applies to economically related specialty pharmacies. The mismatch with each part of the model merits partial.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"GPT 6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 26","evidence_quote":"Upon Client's request and consistent with RIGHTWAY's transparent business model, RIGHTWAY will share with Client: (a) sources of revenue as they relate to the Client's contract, and (b) the pricing structure for pharmacy benefit management Services including rebate structure and administrative fees; provided Client acknowledges and agrees that information shared with Client pursuant to this section is RIGHTWAY's Confidential Information.","rationale":"Page 26 expressly classifies sources of revenue, rebate structure and administrative-fee pricing shared with the City as Rightway confidential information. Page 4 also conditions the independent auditor's access on Rightway's standard nondisclosure agreement, and Pages 25 and 26 require a separate confidentiality agreement for designated service providers. Page 3 recognizes that City-held documents are subject to Texas public information law, but gives Rightway notice and a chance to object, with an attorney general or court deciding. Page 23 supports disclosures required by transparency law, not unconditional sharing with all members or the public. The rubric's special rule says an objection opportunity does not erase a pricing-data gag. No pharmacy counseling ban is needed for the bad finding.","model_own_total":40.5,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.94,"page_ref":"Page 15","evidence_quote":"confer upon RIGHTWAY the status of a fiduciary of Client or any benefit plan maintained by Client","rationale":"Page 15 and Page 16 state plainly that nothing in this agreement confers on Rightway the status of a fiduciary of the City or any benefit plan, that Rightway holds no final discretionary authority over plan administration except claims and appeals adjudication, and that the City must not identify Rightway as a named fiduciary. The model contract published by Mark Cuban and collaborators instead obligates the PBM to duties of loyalty and care owed solely to the plan, with disgorgement of anything retained in breach. This document walks in the opposite direction: Section 7 on Page 4 adopts an independent contractor posture, no loyalty, care, or disgorgement duty appears anywhere I read, and Section 5.1 on Page 2 only requires written disclosure of conflicts, not avoidance of them. Verdict bad because the text does the opposite of the model term.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 2","evidence_quote":"Vendor hereby warrants to City that Vendor has made full disclosure in writing of any existing or potential conflicts of interest related to Vendor's Services under this Agreement.","rationale":"Page 2 Section 5.1 has Rightway warrant full written disclosure of existing or potential conflicts of interest and immediate written disclosure of any later conflicts. Page 26 Section D.6 adds a transparency clause under which Rightway will share, on Client request, sources of revenue related to the contract and the pricing structure including rebate structure and administrative fees, although that information is simultaneously designated as Rightway Confidential Information. Nothing I read on Pages 3 through 75 requires disclosure of all affiliate compensation touching City claims, payments to brokers or consultants, or a named officer certifying quarterly or annually that all compensation has been disclosed and remitted, as the model term drafted by Mark Cuban and collaborators demands. Page 50 even permits an unnamed Rightway vendor to retain transaction fees from pharmacies. Verdict partial: real disclosure duties exist, but no officer certification and material gaps remain.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement documents listed on Page 1 contain no ownership or affiliate disclosure exhibit. The defined terms in Attachment A-1 on Pages 28 through 33 define Rebate Aggregator and Participating Pharmacy but never require a signed list of owners, parents, subsidiaries, group purchasing organizations, or affiliated mail or specialty pharmacies, and no 30 day refresh obligation on ownership change exists. Page 6 Section 9.2 obligates Rightway to provide a list of subcontractors on request, and Page 10 Section 28 requires notice of a name or ownership change for City record keeping, but neither is the exhibit the model expects. Page 52 states flatly that Rebate Aggregators are subcontractors and are not affiliates of Rightway, and no exhibit lets the City verify that claim. I also checked the exhibits on Pages 14 through 82 and found nothing. Verdict missing.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"partial","confidence":0.85,"page_ref":"Page 52","evidence_quote":"the term \"Rebate\" as used in this Agreement does not include this compensation, which belongs exclusively to the Rebate Aggregator or intermediary","rationale":"Attachment A-1 on Pages 28 through 33 defines Brand Drug and Generic Drug by Medi-Span multi source indicator codes, and Specialty Drug as whatever Rightway identifies as specialty, subject to unilateral modification per Page 33. The Rebate definition on Page 32 sweeps in five rebate categories plus Manufacturer Derived Revenue defined broadly on Page 31, which is the strongest loophole closure in the document. The leaks appear on Page 32 and Page 52: the Rebate Aggregator may retain reasonable formulary management fees and costs, and any difference between what Rightway receives and what the aggregator received belongs exclusively to the aggregator and is defined out of the term Rebate altogether. Value can therefore be relabeled as aggregator compensation and escape the pass through obligations. Verdict partial because the definitions capture much manufacturer revenue but leave the aggregator carve out and a label based specialty definition open.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.85,"page_ref":"Page 51","evidence_quote":"Client will receive 100% of the Rebates earned and collected on a pass -through basis.","rationale":"Page 51 commits that the Client will receive one hundred percent of the Rebates earned and collected on a pass through basis, with minimum rebate guarantee payments due within ninety days after each calendar quarter close and a quarterly settlement and rebate report one hundred twenty days after quarter close. The seventeen item exclusions list on Page 51 carves claims out of the Minimum Rebate Guarantee, but exclusions from a guarantee do not contradict one hundred percent pass through of what is defined as a Rebate. The real problem is the definition itself: Page 32 lets the Rebate Aggregator retain reasonable formulary management fees and costs, and Page 52 defines aggregator retained differences out of the word Rebate entirely, so manufacturer revenue of every kind does not reach the City. Payment timing also runs past the model's thirty days after quarter end. Verdict partial: strong headline commitment, material definitional carve out.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Nowhere in the produced text are claims dispensed by pharmacies owned by or economically related to Rightway invoiced at net acquisition cost plus a stated dispensing fee. The Pricing Adjudication Logic on Page 50 prices every claim at the lower of usual and customary price, AWP minus discount plus dispensing fee, MAC plus fee, or submitted amount, with no acquisition cost channel. Page 53 states the guarantees assume Rightway's preferred Mail Order Pharmacy and Specialty Pharmacies as exclusive fulfillment partners, and the Specialty Pharmacy definition on Page 33 refers to a pharmacy designated by Rightway. I looked through Pages 48 to 55, the fee schedule on Pages 41 to 47, and the definitions on Pages 28 to 33 and found no cost based invoicing rule, no retained margin prohibition, and no documentation default for affiliate pharmacies. Verdict missing.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"partial","confidence":0.8,"page_ref":"Page 50","evidence_quote":"the lower of (i) U&C (if applicable); (ii) AWP minus the Participating Pharmacy's discount rate plus Dispensing Fee; (iii) MAC (if applicable) plus Dispensing Fee","rationale":"Page 50 contains a claim level lower of adjudication rule: the City pays and the member pays no more than the lesser of usual and customary price, AWP minus the pharmacy discount plus dispensing fee, MAC plus fee, or the submitted amount. That is a genuine claim by claim ceiling against the dispensing pharmacy's own cash price, applied in each channel, which partially meets the model's cheapest lawful option idea. What the model adds, a ceiling tied to a published external benchmark such as a transparent cash price site, does not appear anywhere I read. The overall PMPM Target on Pages 52 and 53 is measured in the aggregate, and under Page 52, if the target is achieved the individual AWP, dispensing fee, and rebate guarantees do not apply at all. Verdict partial: claim level U and C ceiling present, published benchmark ceiling absent.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"partial","confidence":0.75,"page_ref":"Page 50","evidence_quote":"In the event the vendor's available discount price for a Claim is lower than an Eligible Person's payment amount as determined in subsection (b) above, the Claim will adjudicate at the vendor's available discount price resulting in Eligible Person paying the full Claim cost plus any applicable Taxes.","rationale":"Page 50 gives members a lower of pricing rule that includes usual and customary cash price, and subsection (c) routes a claim to a third party discount vendor when the vendor price is lower than the member cost share, with the member then paying the full claim cost plus taxes. That routing means the discounted purchase runs outside the plan, and I found no clause crediting cash or discount card purchases toward the deductible or out of pocket maximum; the accumulator provisions on Page 20 concern integrating a file with a single Client Service Provider and say nothing about crediting outside cash transactions. Pages 22 and 46 describe copay assistance and alternative funding programs without any restriction on accumulator adjustment against member assistance. Verdict partial: members are protected from paying more than the pharmacy cash price at the counter, but the deductible credit and accumulator halves of the model term are absent.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"partial","confidence":0.8,"page_ref":"Page 31","evidence_quote":"Maximum Allowable Cost (\"MAC\") means the maximum allowable cost determined by RIGHTWAY and updated at least quarterly, or more frequently as required by Law","rationale":"Page 31 defines the Maximum Allowable Cost list as determined by Rightway and updated at least quarterly or more often as law requires, and it fixes one classic spread mechanism by making the mail order MAC drug list identical to the retail list, which aligns with the pass through pricing obligations on Pages 31 and 49. What the model adds, disclosure of the MAC list to the plan and a pharmacy appeals path with defined timelines, does not appear anywhere I read. Page 44 lists MAC program administration as included in the administrative fee, and the guarantee framework on Pages 34 through 37 never touches MAC methodology or appeal outcomes. Because the plan receives no mechanical right to the list and pharmacies receive no contractual appeal process, the clause is present but materially weaker than the model. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"good","confidence":0.9,"page_ref":"Page 49","evidence_quote":"100% of the Participating Pharmacy negotiated pricing will be passed through to Client from RIGHTWAY on a Claim by Claim basis","rationale":"Page 31 defines Pass Through Pricing to require that the price Rightway pays the dispensing pharmacy equals the amount invoiced to the City and that Rightway retains no rebates or other direct financial benefits from manufacturers or pharmacies. Page 49 repeats this claim by claim: one hundred percent of negotiated pharmacy pricing passes through even for claims excluded from the guarantees, and Exhibit B Section 2 on Page 38 confirms Rightway invoices the City at the amount Rightway pays for claims. One caveat survives: Page 50 lets an unnamed Rightway vendor assess and retain transaction fees from Participating Pharmacies, which is a retained pharmacy side amount but not a difference between what the plan pays and the pharmacy receives. The core model test, plan pays what the pharmacy is paid plus a disclosed administrative fee, is squarely met. Verdict good.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"bad","confidence":0.92,"page_ref":"Page 52","evidence_quote":"which such difference may be retained by the Rebate Aggregator and/or intermediary as its compensation","rationale":"This is the clearest violation of the model's GPO and purchasing entity pass through term. Page 32 permits the Rebate Aggregator to retain reasonable formulary management fees and costs. Page 52 then states that the amount Rightway receives from manufacturers, rebate aggregators, and intermediaries may differ from what those aggregators and intermediaries themselves receive, that the difference may be retained by the aggregator or intermediary as its compensation, and that the term Rebate as used in the agreement does not include that compensation at all. Rightway adds that aggregators are subcontractors, not affiliates. Nothing allocates these retained supplier payments to the City or subjects them to disclosed drivers. The model contract published by Mark Cuban and collaborators requires exactly this money to flow to the plan, and this contract codifies the retention the model was built to close. Verdict bad.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 30","evidence_quote":"developed by RIGHTWAY's Pharmacy and Therapeutics Committee, approved and adopted by Client and subject to Client's Plan Documents and coverage decisions","rationale":"The formulary definition on Page 30 says the formulary is developed by Rightway's Pharmacy and Therapeutics Committee and approved and adopted by the Client, and Page 21 frames it as a recommended formulary the Client adopts as its own, so plan sponsor approval exists on paper. In practice Page 53 makes all financial guarantees and the PMPM Target conditional on complete adoption of Rightway's Comprehensive Value Formulary including exclusion and clinical edits plus Rightway's standard clinical programs, which prices the City out of exercising independent formulary judgment. Rightway also controls prior authorization, step therapy, and quantity limits under the formulary per Page 21, and the quarterly utilization management outcomes by drug the model expects are not provided; the Page 20 standard report package is generic. Verdict partial: nominal client control, economically constrained, no quarterly drug level reporting.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"partial","confidence":0.75,"page_ref":"Page 30","evidence_quote":"The Formulary is based on drug safety, drug efficacy, and drug cost/lowest net cost analysis.","rationale":"Page 30 states the formulary is based on drug safety, drug efficacy, and drug cost and lowest net cost analysis, which is the token of the model standard. Beyond that sentence the document gives the City no enforcement machinery: no annual comparison of this plan's formulary costs against Rightway's book of business, no duty to disclose with reasons any drug placed above a cheaper equivalent, and no requirement that formulary decisions meet a lowest net cost standard for this plan specifically. Page 51 credits low WAC biosimilar net cost value into the rebate guarantee only if the City elects Rightway's Comprehensive Value Formulary, which shows how the formulary itself drives rebate economics. The phrase is present but the comparison and disclosure obligations that would make it auditable are absent. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.85,"page_ref":"Page 53","evidence_quote":"Guarantees and PMPM Target assumes RIGHTWAY's preferred network of Mail Order Pharmacy and Specialty Pharmacies as exclusive fulfillment partners.","rationale":"The model wants claims final at adjudication, no volume conditioned reimbursement, no steering into the PBM's own pharmacies, and any willing pharmacy access. This contract goes the other way on several counts. Page 53 conditions every financial guarantee and the PMPM Target on Rightway's preferred mail and specialty pharmacies serving as exclusive fulfillment partners, which is contractual steering softened only by a relief valve on Page 16 that lets the City carve out specialty at the price of losing all financial guarantees. Page 17 lets Rightway refuse network entry to pharmacies owned by or under common control with a competitor, Page 18's pharmacy audit program authorizes retroactive collection of audit discrepancies from pharmacies with expenses netted out of recoveries, and Page 30 acknowledges limited distribution pharmacies may be owned by or affiliated with Rightway. No clawback bar and no any willing pharmacy clause appears. Verdict bad.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No most favored client pricing clause or annual market check with a meet, credit, or release remedy appears anywhere in the document. I checked the payment and pricing provisions on Pages 2 and 38 through 55, the renewal language on Page 1, and the general provisions on Pages 9 through 12. The renewal clause actually works in the opposite direction: each of the two one year renewal terms runs under the same terms and conditions but is expressly subject to fees, pricing, and financial terms agreed by both parties as part of the renewal, so pricing drifts to whatever is renegotiated rather than being locked to market best terms. Page 1 also reserves to Rightway the right to modify fees, pricing, and financial terms for cooperative purchasing entities based on their claims detail. Verdict missing.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 4","evidence_quote":"Auditor shall execute Vendor's standard non -disclosure agreement prior to disclosure of any confidential information.","rationale":"Pages 3 and 4 give the City one audit per contract year plus one year after termination, thirty days advance notice, an independent external auditor who must first execute Rightway's standard non disclosure agreement, and an express bar forbidding the auditor from auditing Rightway's vendors, manufacturers, the Rebate Aggregator, or pharmacies, with access only to selected records such as rate sheets, contract provision excerpts, and invoices. The audit window reaches back three years. Page 20 adds daily paid claims files to the City's vendor Prism and up to six service providers, which is real data access, though Page 44 charges five hundred dollars per transparency report package. The model wants unrestricted audit access with no proprietary withholding; the aggregator and pharmacy audit bar cuts away exactly where spread and retention hide. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 3","evidence_quote":"Vendor shall retain full ownership rights over all resultant data.","rationale":"The document does not grant the City sole ownership of claims, eligibility, accumulator, or derived data. Page 10 Section 26 makes the City the owner of Work Product such as reports and documentation produced under the services, and Page 20 commits to daily paid claims files to Prism and up to six Client Service Providers, plus a post termination transition package on Page 25 covering twelve months of claims, eligibility, authorization, refill, and formulary files. Cut the other way, Page 3 Section 5.6 lets Rightway use claims, eligibility, and health data in de identified and aggregated form for benchmarking, profiling, and product development across its book of business, and states Rightway retains full ownership rights over all resultant data, with no prohibition on reuse or licensing of that derived data beyond PHI. Below the model, above silence: partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 48","evidence_quote":"RIGHTWAY will make up any Net Shortfall on a dollar -for -dollar basis as a credit to Client on a future invoice(s) within one hundred twenty (120) days of the end of each Contract Year.","rationale":"The financial guarantees in Attachment B-2 are the strongest part: Pages 48 through 51 reconcile AWP discount and dispensing fee guarantees per pricing category with dollar for dollar make up within one hundred twenty days, rebate guarantees within one hundred eighty days, and the City keeps one hundred percent of overperformance. Yet remediation is a credit on future invoices rather than cash, reconciliation is annual not quarterly, and Page 54 voids guarantees for any partial contract year. The operational performance guarantees on Pages 34 through 37 cap exposure at twenty dollars per eligible person per year, are measured across Rightway's book of business per Page 27 rather than plan specific data, and die if the agreement ends early per Page 34. Against the model's quarterly, plan specific, cash reconciliation standard this is weaker. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.78,"page_ref":"Page 34","evidence_quote":"Amounts due resulting from a RIGHTWAY failure to meet any performance guarantee, if any, shall be credited against amounts due from Client to RIGHTWAY within forty-five (45) days following Client's receipt of the report.","rationale":"Some remedies self execute: Page 34 credits performance penalty amounts against invoices within forty five days, Pages 48 and 51 credit guarantee shortfalls within fixed windows without the City proving damages, and Page 4 makes audit payables due thirty days after conclusive audit findings. For cause termination follows a conventional notice and thirty day cure model on Page 2 rather than a two strikes exit, and nothing provides liquidated damages for late reports or an automatic regulatory integrity termination trigger. Page 27 adds that a missed performance standard is not itself a material breach, and Page 34 makes the capped credits the City's sole monetary remedy for performance failures, stacking the deck further against the sponsor. Automatic credits exist; the two strikes exit does not. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"partial","confidence":0.8,"page_ref":"Page 9","evidence_quote":"No amendment, modification, or extension of this Agreement will be binding upon a party hereto unless set forth in a written instrument, which is executed by an authorized representative of each party.","rationale":"Page 9 Section 22 matches the model's written amendment rule: no amendment, modification, or extension binds a party unless set forth in a written instrument executed by an authorized representative of each party. The carve outs weaken it. Page 8 lets Rightway modify the Exhibit D Regulatory Addenda on written notice for compliance with law. Page 33 reserves to Rightway the right to modify the Specialty Drug list from time to time, Page 55 makes the high cost drug listing subject to change by Rightway, Page 16 entitles Rightway to modify pricing terms if the City breaches exclusivity, and the Page 16 Section C preamble allows non material service changes without consent. Because lists define economic outcomes here, updated exhibit style changes with economic effect remain possible without a signed amendment. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"partial","confidence":0.85,"page_ref":"Page 2","evidence_quote":"City may terminate this Agreement at any time and for any reason by providing Vendor with 90 days' written notice of termination without penalty or termination fees.","rationale":"Page 2 Section 4.1 is genuinely favorable: the City may terminate at any time and for any reason on ninety days written notice without penalty or termination fees, and Section 4.3 adds non appropriation termination without penalty, while Rightway needs one hundred eighty days. The forfeiture protections are weaker. Page 24(a) pays all monies owed after most terminations, but Page 24(b) releases Rightway from paying any rebates after it terminates for the City's material breach and lets it offset those amounts against claimed damages. Page 54 voids all financial guarantees for a partial contract year and Page 34 voids performance guarantees if the agreement ends before a year completes. No regulatory integrity termination ground appears; the change in law exit on Page 7 is mutual and conditional. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"partial","confidence":0.8,"page_ref":"Page 33","evidence_quote":"RIGHTWAY reserves the right to modify the Specialty Drug list from time to time.","rationale":"Specialty is defined by label, not economic function: Page 33 defines Specialty Drug as products identified by Rightway as specialty from time to time, with an express unilateral right to modify the list. Pricing controls are real but conventional: Page 49 guarantees specialty AWP discounts with zero dispensing fee, LDD claims carry their own discount tier, and Pages 55 through 75 list named high cost drugs with individual GPI level discount guarantees reconciled annually dollar for dollar with no cross offsets per Page 55. What is missing is the model's core protection: specialty claims at pharmacies owned by or affiliated with the PBM are not priced at acquisition cost, and Page 53 conditions all guarantees on Rightway's preferred mail and specialty pharmacies as exclusive fulfillment partners. Verdict partial.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0048","contract_slug":"city-of-fort-worth-rightway-csc-65079-executed-vsa","entity":"City of Fort Worth","vendor":"Rightway Healthcare, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 26","evidence_quote":"provided Client acknowledges and agrees that information shared with Client pursuant to this section is RIGHTWAY's Confidential Information","rationale":"Several clauses treat pricing and performance information as proprietary and restrict who may see it. Page 26 Section D.6 designates the revenue sources and pricing structure that Rightway shares under its own transparency clause as Rightway's Confidential Information. Page 25 Section D.5 lets data flow to the City's consultants and auditors only after those advisors execute a separate confidentiality agreement with Rightway itself, and Page 4 requires the City's own auditor to sign Rightway's standard non disclosure agreement before seeing anything. Page 26 Section D.8 bars the City from referring to Rightway in any publication without prior written approval. The Texas Public Information Act section on Page 3 gives Rightway the right to mark records confidential and object before the Attorney General, which is only an attempt to block release and does not redeem the designation. Net effect is a pricing gag with narrow channels. Verdict bad.","model_own_total":40,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 11","evidence_quote":"Claim Administrator is not the plan administrator of Employer’s employee benefit plan and is not a fiduciary of Employer, the plan administrator or of the Plan.","rationale":"The agreement explicitly disclaims fiduciary responsibility on Page 11, providing that the Claim Administrator is not a fiduciary of the Employer, the plan administrator, or the Plan, but only a service provider. On Page 4, Section 2.1 makes the Employer solely responsible for Plan operations and compliance, while on Page 42, the administrator disclaims fiduciary status regarding recovery litigation. This is the opposite of the model contract published by Mark Cuban and collaborators, which requires the PBM to owe fiduciary duties of loyalty and care solely to the plan and disgorge retained compensation.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"DISC","verdict":"bad","confidence":0.99,"page_ref":"Page 28","evidence_quote":"Employer acknowledges that it has negotiated for the specific Rebate Credit included as part of this Agreement and that it and its Plan have no right to, or legal interest in, any portion of the rebates, payments, discounts and/or other allowances","rationale":"On Page 28, the agreement discloses that the administrator owns a significant equity stake in Prime Therapeutics and that both entities receive rebates, manufacturer administrative fees, discounts, and other allowances. However, rather than providing transparent accounting and quarterly officer certifications, the text states that the Plan has no legal interest in those revenue streams and consents to the administrator retaining them. On Page 44, the employer is similarly reminded that it has no interest in manufacturer administrative fees. The disclosure merely acknowledges extensive economic conflicts without protecting the sponsor.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"OWN","verdict":"partial","confidence":0.93,"page_ref":"Page 12","evidence_quote":"Upon Employer request (not more than once per calendar year), Claim Administrator will provide a list of such entities to Employer.","rationale":"On Page 12, Section 6.2 acknowledges that the Claim Administrator and its affiliates may hold ownership interests in healthcare providers and service vendors, and promises to provide a list of those entities upon written request no more than once per calendar year. While this provides some transparency, it falls short of the model contract published by Mark Cuban and collaborators, which requires a comprehensive signed exhibit detailing all parents, subsidiaries, affiliates, GPOs, rebate aggregators, and mail or specialty pharmacies, along with a mandatory 30 day update requirement.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"DEF","verdict":"bad","confidence":0.98,"page_ref":"Page 49","evidence_quote":"Rebates do not include Manufacturer Administration Fees or fees retained by a group purchasing organization for its role in securing Rebates and/or Manufacturer Administrative Fees.","rationale":"On Page 49, Exhibit 7 defines Rebates to expressly exclude Manufacturer Administration Fees and fees retained by a group purchasing organization for its role in securing rebates or manufacturer fees. On Page 48, Ingredient Cost and Dispensing Fee are defined separately, while Manufacturer Administration Fees are defined on Page 48 as fees relating to rebate administration. By defining rebates and related revenues through formal contract labels rather than economic function, the document allows manufacturer compensation to be carved out and retained by the PBM and its purchasing intermediaries.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 44","evidence_quote":"Employer shall have no right, title or interest in Manufacturer Administrative Fees.","rationale":"The contract fails to pass through one hundred percent of manufacturer revenue. On Page 28 and Page 44, the agreement specifies that the Employer receives only a negotiated Rebate Credit, while Prime and the administrator retain all right, title, and interest in actual rebates, discounts, allowances, and manufacturer administrative fees. On Page 28, GPO fees may be deducted before rebates reach the administrator. The model contract published by Mark Cuban and collaborators requires complete quarterly pass through of all manufacturer monies within 30 days, whereas this agreement retains significant manufacturer revenues.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"NAC","verdict":"bad","confidence":0.97,"page_ref":"Page 44","evidence_quote":"Employer acknowledges that in negotiating the Agreement and this Exhibit, it has taken into consideration that Claim Administrator and/or Prime will keep all or a portion of the discounts and/or other allowances that Claims Administrator or its pharmacy benefits manager has negotiated with the Network Participant.","rationale":"On Page 44 and Page 46, the agreement permits the Claim Administrator and Prime to retain discounts and allowances negotiated with network participants. It also establishes that specialty medications may be dispensed by Prime, an affiliate of Prime, or other specialty pharmacies, with pricing governed by an omitted BPA Addendum rather than net acquisition cost. The document contains no requirement that affiliate pharmacies invoice claims at actual acquisition cost plus a stated dispensing fee, nor does it prohibit retained margin or establish documentation defaults as the model contract requires.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"CEIL","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the prescription drug allowable amount provisions on Page 14, the general financial terms on Pages 21 through 25, and the pharmacy benefit management pricing provisions on Pages 43 through 49 of the document. The text contains no provision establishing a claim by claim pricing ceiling tied to transparent public cash benchmarks or the cheapest lawful option. Because the contract contains no benchmark ceiling mechanism in any channel, this rubric item is missing from the produced text.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"CASH","verdict":"bad","confidence":0.92,"page_ref":"Page 49","evidence_quote":"“Usual and Customary” or “U&C” means the price, including any Dispensing Fee, that a Network Participant would charge a particular customer if such customer were paying cash for the identical prescription drug service on the date dispensed.","rationale":"On Page 49, the contract defines Usual and Customary as the cash price charged by a pharmacy, but nowhere does it ensure that members pay no more than this cash price. In addition, the agreement does not provide that cash purchases automatically count toward member deductibles or out of pocket maximums, nor does it restrict accumulator adjustment programs on manufacturer assistance. By defining cash pricing without giving members price protection or deductible credit, the contract permits members to pay more through their benefit than the retail cash price.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"MAC","verdict":"partial","confidence":0.99,"page_ref":"Page 44","evidence_quote":"Prime’s MAC Lists applicable to this Exhibit will be available for viewing by authorized representatives of Employer after 30 days’ prior written request submitted by Employer to Claim Administrator, and subject to Employer’s execution of Prime’s non-disclosure agreement(s).","rationale":"On Page 44, Section 6.c allows the Employer to view Prime proprietary MAC Lists up to four times per year, upon 30 days advance written notice, subject to executing a non-disclosure agreement, and only at Prime corporate headquarters or another secured facility. The contract does not mandate a single MAC list for both plan sponsor billing and pharmacy reimbursement, nor does it establish an objective update schedule or a pharmacy appeal process with defined timelines. These onerous viewing restrictions leave MAC governance materially weaker than the model standard.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"SPRD","verdict":"bad","confidence":0.99,"page_ref":"Page 44","evidence_quote":"Employer acknowledges that in negotiating the Agreement and this Exhibit, it has taken into consideration that Claim Administrator and/or Prime will keep all or a portion of the discounts and/or other allowances that Claims Administrator or its pharmacy benefits manager has negotiated with the Network Participant.","rationale":"On Page 44, Section 6.a explicitly acknowledges that the Claim Administrator and Prime will keep all or a portion of the discounts and allowances negotiated with network participants. On Page 27, Section 4.3 notes that for mail and specialty programs, Prime may keep a portion of discounts negotiated with pharmacies. The contract does not require pass through pricing where the sponsor pays exactly what the pharmacy receives plus an administrative fee. By expressly allowing the retention of discounts and price differentials, the agreement permits spread pricing.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"GPO","verdict":"bad","confidence":0.99,"page_ref":"Page 28","evidence_quote":"PBM may contract with pharmaceutical manufacturers through a group purchasing organization and, in such case, rebates collected by PBM and paid to Claim Administrator will be net of any fee the group purchasing organization may retain for its role in securing rebates.","rationale":"On Page 28, Section 5.2 explicitly permits the PBM to contract with manufacturers through a group purchasing organization and states that rebates paid to the Claim Administrator will be net of any fee retained by the GPO. Page 43 confirms this arrangement, while Page 49 excludes GPO retained fees from the definition of Rebates. None of the GPO discounts, supplier fees, or volume credits are passed through to the Employer, directly contradicting the model contract published by Mark Cuban and collaborators.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 43","evidence_quote":"Claim Administrator utilizes its own Drug List and Prime supports Claim Administrator in the development, maintenance and updating of such Drug List.","rationale":"On Page 43, Section 3 states that the Claim Administrator utilizes its own Drug List, supported by Prime, while the Employer selects a designated Drug List from available options. However, the agreement does not require the sponsor to approve all formulary modifications, nor does it obligate the PBM to provide lowest net cost analyses or quarterly drug level utilization management outcome reports. While the sponsor has initial plan design selection, ongoing formulary control remains with the administrator and Prime.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"I examined the Drug List and formulary provisions on Pages 43 through 49, as well as the administrative services descriptions on Pages 18 through 20 of the document. The text contains no commitment to a lowest net cost standard for this Plan, no annual comparative analysis against the PBM book of business, and no required disclosures when a higher cost product is placed ahead of an equivalent therapy. Because these standards are entirely absent, this item is missing.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"NET","verdict":"partial","confidence":0.94,"page_ref":"Page 44","evidence_quote":"Prime requires its Network Participants to not switch Covered Prescription Drug Products to a higher cost product unless requested to by the Member and/or the Member’s Physician.","rationale":"On Page 44, Section 6.a provides a helpful member protection by requiring network participants not to switch a covered prescription product to a higher cost product unless requested by the member or physician. However, the agreement lacks broader network protections found in the model contract published by Mark Cuban and collaborators, such as a complete prohibition on steering patients toward PBM-owned pharmacies, protections against post adjudication clawbacks, and an open willing provider participation guarantee.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the entire Administrative Services Agreement, focusing on the fee terms on Pages 21 through 25 and the pharmacy pricing terms on Pages 45 through 47. The contract contains no most favored nation clause guaranteeing pricing at least as favorable as any comparable customer. Furthermore, it provides no mechanism for an annual market check with a meet, credit, or release remedy. Because neither protection appears in the produced text, this item is missing.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"AUD","verdict":"partial","confidence":0.99,"page_ref":"Page 45","evidence_quote":"Subject to the audit terms elsewhere in the Agreement, Employer may also audit Prime's records as they relate to the aforementioned Claims by coordinating such audit through Claim Administrator and executing an audit agreement with Prime as a party.","rationale":"On Pages 5 and 6, Section 2.10 grants the Employer audit rights but restricts audits to one per year, caps sample sizes at 300 claims, prohibits contingency fee auditors and extrapolation, and requires 90 days advance notice. On Pages 44 and 45, Exhibit 7 allows audits of Prime records but requires coordination through the administrator, execution of an audit agreement, and payment of all costs, while prohibiting copying or removal of materials. These restrictions significantly impair full independent verification.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 7","evidence_quote":"Claim Administrator may use or disclose a limited data set or de-identified data (“Data”) as permitted by the executed BAA, HIPAA and other applicable federal and state laws for the purpose of supporting industry improvement activities","rationale":"On Page 7, Section 3.8 authorizes the Claim Administrator to use and disclose de-identified data and limited data sets for industry improvement activities and research. On Page 6 and 7, Section 3 treats plan records and claims systems as proprietary Business Confidential Information. The contract does not grant the Employer sole ownership of all claims, rebate, and eligibility data, nor does it mandate delivery of comprehensive data files in machine readable format on demand, directly contrary to the model term.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"PERF","verdict":"unclear","confidence":0.93,"page_ref":"Page 27","evidence_quote":"A portion of Prime's PBM fees are tied to certain performance standards, including, but not limited to, Claims processing, customer service response, and mail-order processing.","rationale":"On Page 27, Section 4.3 notes that a portion of Prime PBM fees are tied to performance standards such as claims processing, customer service, and mail order operations. However, the specific performance guarantees, benchmarks, measurement formulas, and financial penalties are relegated to the PBM Fee Schedule Addendum and ASO BPA, which are omitted from the document. Because the actual guarantee terms and remedies are contained in an omitted exhibit, this item cannot be evaluated from the text.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"ENF","verdict":"bad","confidence":0.98,"page_ref":"Page 46","evidence_quote":"applicable network discount and/or minimum Rebate guarantees set forth in the BPA Addendum will not be effective for such Guarantee Period.","rationale":"On Page 46, Section 9.f provides that if the Employer terminates Exhibit 7 prior to the end of a Guarantee Period, the network discount and minimum rebate guarantees become void for that period. Rather than providing self executing remedies, automatic liquidated damages, or a two strikes termination right for repeated operational failures, the contract penalizes the sponsor for early termination and subjects disputes to a 90 day cure period under Section 4.9 and confidential arbitration under Section 4.11.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"Page 12","evidence_quote":"any amendments required by law, regulation or order (“Law”) or by Claim Administrator or the Association may be implemented by Claim Administrator upon sixty (60) calendar days’ prior notice to Employer","rationale":"On Page 12, Section 6.4 states that while amendments generally require mutual written agreement, amendments required by law or by the Claim Administrator or the Blue Cross and Blue Shield Association may be implemented unilaterally by the Claim Administrator upon 60 days advance notice. If the Employer objects, the parties negotiate, but unresolved disputes must proceed to mandatory dispute resolution rather than invalidating the change. This unilateral amendment mechanism departs significantly from the model requirement of bilateral signed amendments.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"TERM","verdict":"partial","confidence":0.98,"page_ref":"Page 11","evidence_quote":"By either Party at the end of any month after the end of the Fee Schedule Period indicated in the Fee Schedule specifications of the most current ASO BPA with ninety (90) days’ prior written notice to the other party","rationale":"On Page 11, Section 6.1 permits termination for convenience with 90 days notice, but only after the expiration of the Fee Schedule Period specified in the omitted ASO BPA. Section 3.4 of Exhibit 2 on Page 22 also imposes a Termination Administrative Charge. On Page 46, terminating Exhibit 7 before the end of a guarantee period voids rebate and discount guarantees. The agreement lacks provisions allowing immediate termination without penalty for vendor regulatory integrity failures.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"SPEC","verdict":"partial","confidence":0.98,"page_ref":"Page 46","evidence_quote":"Specialty Drugs may be provided by Prime, an affiliate of Prime, or other Specialty Pharmacy that has a written arrangement with Prime or Claim Administrator.","rationale":"On Page 46, Section 10.b and Page 49, Section 11.33 recognize specialty drugs as a distinct category and permit them to be dispensed by Prime, Prime affiliates, or contracted specialty pharmacies. However, pricing is governed entirely by the omitted BPA Addendum rather than being capped at acquisition cost plus a fixed fee. The contract does not provide drug level acquisition cost protections or prevent markups by PBM affiliated specialty pharmacies, leaving substantial financial exposure for the sponsor.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Gemini 3.8 Flash","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 7","evidence_quote":"Employer shall not use or disclose such Business Confidential Information, including this Agreement, to any third party without prior written consent of Claim Administrator.","rationale":"On Pages 6 and 7, Section 3.4 designates the agreement itself and all cost and pricing information as Business Confidential Information, barring disclosure to third parties without prior written consent. If required by law to disclose records, the Employer must give advance notice so the administrator can seek protective measures. On Pages 10 and 11, Section 4.11 mandates confidential arbitration. These pervasive confidentiality restrictions impede sharing pricing and performance data with advisors, auditors, members, lawmakers, or the public.","model_own_total":15.3,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"FID","verdict":"bad","confidence":0.96,"page_ref":"Page 11","evidence_quote":"Claim Administrator is not the plan administrator of Employer’s employee benefit plan and is not a fiduciary of Employer, the plan administrator or of the Plan.","rationale":"Page 11, Section 5.2, states that Claim Administrator is not the plan administrator of the Employer's employee benefit plan and is not a fiduciary of the Employer, the plan administrator, or the Plan. Section 5.3 on the same page says the parties intend Claim Administrator to be a service provider but not a fiduciary with respect to the plan. Page 9, Section 4.6, disclaims any fiduciary obligation for directions to provide first dollar coverage. Page 42, Exhibit 6, says Claim Administrator does not pursue recoveries as a fiduciary of the Plan or covered persons. Page 28 says rebate negotiation is conducted for Claim Administrator and not for the Employer or covered persons. Page 43 says Prime contracts for rebates on its own behalf and not on behalf of the Employer. The model contract requires duties of loyalty and care owed solely to the plan and its members, disclosure of every economic conflict, and disgorgement without proof of damages. This draft rejects that status and puts vendor economics first. The verdict is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"DISC","verdict":"partial","confidence":0.78,"page_ref":"Page 28","evidence_quote":"As of the Effective Date, the maximum that a PBM has disclosed to Claim Administrator that the PBM will receive from any pharmaceutical manufacturer for manufacturer administrative fees is five and a half percent (5.5%) of the Wholesale Acquisition Cost","rationale":"The draft discloses some conflicts and does not require an officer to certify that everything was disclosed and remitted. Page 12 says Claim Administrator or its affiliates may own providers or vendors and will provide a list once per calendar year if asked. Page 27 discloses that Prime may keep a portion of mail and specialty discounts as its fee, and that a portion of Prime's fees is tied to performance standards. Page 28 discloses a manufacturer administrative fee maximum of five and a half percent of wholesale acquisition cost and says Claim Administrator will advise the Employer if that maximum changes. The same page says the Employer has no legal interest in actual rebates and consents to retention, with only a Rebate Credit from Claim Administrator's own assets. The credit amount is placed in the omitted ASO Benefit Program Application. No named officer certifies quarterly or annually, and broker payments are not disclosed. The model contract requires full compensation and conflict disclosure plus officer certification and remittance. Several streams are named. Amounts, certification, and remittance are not. That is partial.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"OWN","verdict":"partial","confidence":0.88,"page_ref":"Page 12","evidence_quote":"Claim Administrator or its subsidiaries or affiliates may also have ownership interests in certain Providers who provide Covered Services to Covered Persons, and/or in vendors or other third parties who provide services related to this Agreement or provide services to certain Providers.","rationale":"There is no signed ownership exhibit. Page 12 discloses that Claim Administrator or its subsidiaries or affiliates may have ownership interests in providers, vendors, or other third parties, and that a list will be provided on request, not more than once per calendar year. Page 28 says Claim Administrator owns a significant portion of the equity of Prime, and that mail and specialty pharmacy may be operated by a third party that may be an affiliate of or partly owned by Prime. No group purchasing organization is named. No parent, subsidiary, rebate aggregator, or specialty pharmacy is listed in an exhibit. There is no duty to refresh the list within thirty days of a change in ownership or control. The model contract calls for a signed exhibit of every related entity, refreshed within thirty days of a change in control. What is here is an annual list on request plus a narrative note on the Prime stake. That is partial.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"DEF","verdict":"bad","confidence":0.86,"page_ref":"Page 49","evidence_quote":"Rebates do not include Manufacturer Administration Fees or fees retained by a group purchasing organization for its role in securing Rebates and/or Manufacturer Administrative Fees.","rationale":"Exhibit 7 on Pages 47 through 49 defines several pharmacy terms, and those definitions leave the loopholes the model contract tries to close. On Page 49, Rebate means any discount or other remuneration attributable to member utilization, but it expressly does not include manufacturer administration fees or fees a group purchasing organization retains. Manufacturer Administration Fee, defined on Page 48, is the negotiated fee from a manufacturer, directly or through a group purchasing organization, for administering rebates. Value can be labeled a fee and fall outside Rebate. Generic Drug and Brand Drug, on Pages 47 and 48, follow the Pricing Source label, Medi-Span on the effective date, and may be otherwise designated in the omitted BPA Addendum. Specialty Drugs on Page 49 are described by use and handling, but the list is determined by Prime or Claim Administrator and may change. Affiliate is not defined by economic function. Network Participant is defined by a network contract, not by function. The model contract defines rebate, manufacturer revenue, affiliate, specialty, generic, and pharmacy by economic function so value cannot be relabeled as fees. This draft does the opposite for rebates. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"PASS","verdict":"bad","confidence":0.97,"page_ref":"Page 28","evidence_quote":"it and its Plan have no right to, or legal interest in, any portion of the rebates, payments, discounts and/or other allowances provided by the PBM or such manufacturers to Claim Administrator and consents to Claim Administrator’s retention of all such rebates, payments, discounts and/or other allowances.","rationale":"Page 28 states that the Employer negotiated a specific Rebate Credit and that the Employer and the Plan have no right to, or legal interest in, any portion of the rebates, payments, discounts, or other allowances provided by the PBM or manufacturers, and that the Employer consents to retention of all of them. The credit is paid from Claim Administrator's own assets notwithstanding the actual amount of rebates. Page 47 says Rebate Credits are paid prospectively on the monthly billing statement and shall not continue after termination of the prescription drug program. Page 27 says neither the Employer nor covered persons are entitled to pharmacy payments, discounts, or allowances except as reflected in service charges. Manufacturer administrative fees and group purchasing organization fees sit outside the rebate definition on Page 49. The model contract requires one hundred percent of manufacturer revenue of every kind, paid quarterly within thirty days of quarter end, with only a closed list of excluded claims. This draft replaces that rule with a negotiated credit and a consent to retention. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"NAC","verdict":"bad","confidence":0.9,"page_ref":"Page 27","evidence_quote":"For the administrative services that Prime provides as part of the mail order and specialty pharmacy program, Prime may keep as its fee a portion of the discounts and/or other allowances that it has negotiated with the mail-order and/or specialty pharmacy.","rationale":"Claims at related pharmacies are not priced at net acquisition cost. Page 28 says the mail order pharmacy and specialty pharmacy shall be operated through a third party, which may be an affiliate of or partly owned by Prime. Page 27 says Prime may keep, as its fee for mail and specialty administration, a portion of the discounts and other allowances negotiated with the mail order or specialty pharmacy. Page 46 says specialty drugs may be provided by Prime, an affiliate of Prime, or another specialty pharmacy, and that the Employer reimburses Claim Administrator at the pricing in the omitted BPA Addendum. There is no stated dispensing fee tied to acquisition cost, and no documentation default if records are not produced. The model contract requires related mail, specialty, and retail claims to be invoiced at net acquisition cost plus a stated dispensing fee, with no retained margin. This draft permits retained margin on the channels most likely to be related to Prime. Unseen addendum rates cannot cure that clause. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"CEIL","verdict":"missing","confidence":0.84,"page_ref":null,"evidence_quote":null,"rationale":"I looked for a claim level ceiling in Section 7, Exhibit 2, Exhibit 3, and Exhibit 7. Allowable Amount for participating pharmacies, on Page 14, is the cost mutually agreed in the omitted PBM Fee Schedule Addendum. Non-network pharmacy allowable amount on the same page is the lesser of the pharmacy's usual charge or the participating reimbursement minus twenty percent. That is a non-network method, not a rule that plan cost can never exceed a published cash benchmark in every channel. Usual and Customary is defined on Page 49 as the cash price a network pharmacy would charge, and the produced text never applies that definition as a claim by claim ceiling on what the Employer pays. Exhibit 7 is a guaranteed traditional aggregate pricing arrangement. Aggregate guarantees, whose figures are not here, are averages, not a claim level test against a published benchmark. The model contract requires plan claim cost never to exceed a published benchmark, in any channel and for any drug, checked claim by claim. Nothing in this file states that rule, and the omitted addendum is described as agreed pricing and aggregate guarantees, not as a benchmark ceiling. This is missing, not unclear.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"CASH","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"I looked through member cost sharing in Exhibit 7, the Allowable Amount definition on Page 14, and the notices in Exhibit 3. Member deductible, coinsurance, and copayment follow the benefit plan and the Allowable Amount. Page 46 says zero balance logic is not employed, but the contract does not define that phrase, so it cannot be treated as a cash price rule or as its opposite. Usual and Customary is defined on Page 49 and is not used in the produced text as a cap on what a member pays at the counter. There is no clause that a member never pays more than the pharmacy cash price or the cheapest lawful price. There is no clause that a cash purchase counts toward the deductible or the out of pocket maximum. There is no clause on accumulator adjustments or manufacturer copay assistance. The model contract requires all three protections. They are not in the produced text, and they are not placed by reference in an omitted schedule. The benefit plan document that would set copay amounts is also not in this file. This item is missing.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"MAC","verdict":"partial","confidence":0.82,"page_ref":"Page 44","evidence_quote":"MAC Lists applicable to this Exhibit will be available for viewing by authorized representatives of Employer after 30 days’ prior written request submitted by Employer to Claim Administrator, and subject to Employer’s execution of Prime’s non-disclosure agreement(s).","rationale":"Page 44 says Prime owns and maintains proprietary MAC lists. The lists applicable to this exhibit may be viewed by authorized Employer representatives after thirty days written request, no more than four times a calendar year, only after the Employer signs Prime's non-disclosure agreement, and only at Prime's headquarters or another secured location Prime designates. Page 48 defines MAC as the unit price Prime sets for a multi-source drug on the list at the time of service, updated from time to time under this exhibit and the omitted BPA Addendum. The Employer pays the BPA Addendum price, Page 46, while Prime reimburses network pharmacies under the network contract, Page 44. The text does not say one MAC list governs both amounts. It does not give pharmacies an appeals path or a timeline. The model contract requires a single disclosed MAC list for plan and pharmacy payment, a stated update schedule, and a pharmacy appeals path. A view only list under a non-disclosure agreement, without appeals and without a single list rule, is present but weaker. That is partial.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 44","evidence_quote":"Claim Administrator and/or Prime will keep all or a portion of the discounts and/or other allowances that Claims Administrator or its pharmacy benefits manager has negotiated with the Network Participant.","rationale":"Page 44 requires the Employer to acknowledge that, in negotiating the agreement and Exhibit 7, it has taken into account that Claim Administrator and Prime will keep all or a portion of the discounts and other allowances negotiated with the network participant. The Employer reimburses Claim Administrator at BPA Addendum pricing, Page 46. Prime reimburses pharmacies under the network contract, Page 44. Those are different prices, and the difference may be retained. Page 27 says retail discounts and allowances negotiated by Prime are passed through to Claim Administrator, not that the Employer pays the pharmacy price plus a disclosed administrative fee. On mail and specialty, Prime may keep a portion of the discount as its fee. The exhibit title on Page 43 is a guaranteed traditional aggregate pricing arrangement, which is an average guarantee rather than a pharmacy cost pass through. The model contract requires the plan to pay exactly what the pharmacy is paid, plus a disclosed administrative fee, with no retained difference in any channel. This draft permits the retained difference. That is bad. The addendum may state the Employer's rate. It is not needed to see that retention is authorized.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"GPO","verdict":"bad","confidence":0.93,"page_ref":"Page 28","evidence_quote":"rebates collected by PBM and paid to Claim Administrator will be net of any fee the group purchasing organization may retain for its role in securing rebates.","rationale":"Page 28 says the PBM may contract with manufacturers through a group purchasing organization and that rebates collected and paid to Claim Administrator are net of any fee the organization retains for securing rebates. Page 49 repeats the exclusion. Rebates do not include fees retained by a group purchasing organization. Page 43 says Prime negotiates directly or through a group purchasing organization, on its own behalf, and the Employer has no right, title, or interest in rebates or in manufacturer administrative fees. Even the rebates that reach Claim Administrator do not flow to the Employer. The Employer gets only the separate Rebate Credit described on Page 28, paid from Claim Administrator's own assets. No allocation driver is disclosed. The model contract requires purchase discounts, volume credits, and supplier payments received by the PBM or any related purchasing entity, including an offshore group purchasing organization, to flow to the plan on disclosed drivers. This draft lets the purchasing entity keep its fee and lets Claim Administrator keep the rest. That is the opposite of pass through. The verdict is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 43","evidence_quote":"Employer acknowledges and agrees that Claim Administrator may, in a manner consistent with the Benefit Plan, promote the dispensing of pharmaceuticals in a manner consistent with the designated Drug List selected by Employer.","rationale":"Page 43 says Claim Administrator uses its own drug list, with Prime supporting development, maintenance, and updates, and Prime performing exception reviews under the Prime agreement. The Employer agrees that Claim Administrator may promote dispensing consistent with the designated drug list selected by the Employer, in a manner consistent with the benefit plan. Selection of a designated list is some sponsor role. It is not approval of the list or of every change. There is no duty to give the Employer a lowest net cost analysis, and no duty to report utilization management outcomes by drug each quarter. Exhibit 1 on Pages 18 and 19 offers standard claim reports in Claim Administrator's format, not those analyses. Additional reports may carry a supplemental charge and must be agreed in writing. The model contract requires sponsor approval of the formulary and every change, a lowest net cost analysis, and quarterly utilization outcomes by drug. The selection sentence keeps this from being missing. Operational control of the list stays with Claim Administrator and Prime. That is partial.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I looked in the Exhibit 7 drug list and rebate sections on Pages 43 and 44, in the formulary promotion sentence, and in the reporting services on Pages 18 and 19. Nothing requires formulary decisions to meet a lowest net cost standard for this plan. Nothing requires an annual comparison against Claim Administrator's or Prime's whole book of business. Nothing requires disclosure, with a reason, when a drug is placed above a cheaper equivalent. Page 43 says rebate arrangements are based on formulary status, market share, or similar manufacturer arrangements, and that those contracts are for the vendor's benefit. That describes the vendor's incentive. It is not a lowest net cost standard and it is not a book of business report. The model contract requires the standard, the annual comparison, and disclosure of a higher cost placement with the reason. None of those terms is addressed in the produced text, and none is identified as living in an omitted attachment. This item is missing.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"NET","verdict":"partial","confidence":0.74,"page_ref":"Page 44","evidence_quote":"Prime requires its Network Participants to not switch Covered Prescription Drug Products to a higher cost product unless requested to by the Member and/or the Member’s Physician.","rationale":"Page 44 says Prime requires network pharmacies not to switch a covered product to a higher cost product unless the member or the member's physician requests it. Page 26 says the choice of a provider is the covered person's and that Claim Administrator will not interfere with that relationship. Those are limited protections. They are not a ban on steering claims into Prime affiliated mail or specialty pharmacies. Pages 28 and 46 contemplate that mail and specialty may be operated by an affiliate of Prime, and nothing forbids channel steering. There is no any willing pharmacy right. Network participation is by contract with Prime or Claim Administrator. Reimbursement is not stated to be independent of volume. Pharmacy claims are not declared final at adjudication. Section 4.2 on Page 8 authorizes recovery of overpayments by offset against future payments, including cross plan offsets. Page 44 adds pharmacy claims audits for contract integrity. The model contract requires final adjudication, no volume condition, no steering into owned pharmacies, and any willing pharmacy participation at the plan's terms. A product switch limit and a non-interference sentence are present and weaker, with the steering and finality protections absent. That is partial rather than missing.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"MFN","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"I looked in Exhibit 2 service charge provisions on Pages 21 through 25, in Exhibit 7 pricing and termination on Pages 45 and 46, and in the inter plan fee section on Page 40. Nothing says the Employer automatically receives pricing at least as good as any comparable client. Nothing gives the Employer an annual market check with a meet, credit, or release remedy. Page 40 lets the Employer terminate if inter plan arrangement fees change, after notice, and describes that path as without penalty. That is a narrow fee change exit for BlueCard and related fees, not a market check of pharmacy pricing. Page 22 lets Claim Administrator change service charges when projections, census, or producer and broker fees become outdated. That is a vendor repricing right, not a most favored pricing right for the Employer. The model contract requires both automatic comparable client pricing and an annual market check remedy. Neither is addressed, and neither is placed in the omitted fee schedule by name. This item is missing.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"AUD","verdict":"partial","confidence":0.91,"page_ref":"Page 5","evidence_quote":"Contingency fee based audits are not supported by Claim Administrator. Audit samples will be limited to no more than three hundred (300) Claims.","rationale":"Page 5 gives the Employer, or an agent subject to Claim Administrator's reasonable approval, a right to audit claim payment records on ninety days notice, during the term and for one hundred eighty days after termination. The right is heavily limited. Contingency fee audits are not supported. Samples are capped at three hundred claims. Extrapolation is barred on Page 5. The period is the current agreement year and the prior year, and no more than one audit in twelve months unless a government agency requires another. The auditor must agree not to disclose proprietary information. Pages 44 and 45 add a Prime records path, with copying forbidden without approval. Page 19 offers standard reports, not a full financial feed and not pre-adjudication access. Page 15 includes provider discounts and rates in business confidential information, which Page 7 can withhold. The model contract requires the plan's own auditor, scheduled claims and financial data without a request, pre-adjudication access, and no proprietary withholding. Audit rights exist and are materially weaker. That is partial.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"DATA","verdict":"bad","confidence":0.87,"page_ref":"Page 6","evidence_quote":"That the requested documents, records and other information (for purposes of this Section 3, “Confidential Information”) are proprietary and confidential in nature and that the release of the Confidential Information may reveal Claim Administrator’s Business Confidential Information.","rationale":"The draft does not make the Employer the owner of plan data. Page 6, in the vendor data section, says the requested documents, records, and other information are proprietary and confidential and may reveal Claim Administrator's business confidential information. The vendor must not sell or lease that information and must return or destroy it at Claim Administrator's direction within sixty days after termination. Page 7, Section 3.7, provides claim determination records on request for three years after termination, excluding business confidential information of Claim Administrator, affiliates, and vendors. Page 15 defines that information to include cost and pricing data, databases, and derivatives. Section 3.8 lets Claim Administrator use de-identified data for industry improvement. Sale for vendor profit is barred, but the Employer is not given sole ownership, and reuse is allowed. The model contract makes the sponsor the sole owner and bars reuse, license, or sale. This draft treats the records as the vendor's confidential information. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"PERF","verdict":"unclear","confidence":0.85,"page_ref":"Page 46","evidence_quote":"applicable network discount and/or minimum Rebate guarantees set forth in the BPA Addendum will not be effective for such Guarantee Period.","rationale":"Exhibit 7 is titled a guaranteed traditional aggregate pricing arrangement. Page 46 says network discount and minimum rebate guarantees are set forth in the BPA Addendum, and that those guarantees will not be effective for a guarantee period if the exhibit is terminated before that period ends. Page 27 says a portion of Prime's fees to Claim Administrator is tied to performance standards such as claims processing, customer service, and mail order processing. Those standards govern Prime's fee, not a remedy payable to the Employer. The measurement period, whether the data are plan specific, whether shortfalls are paid in cash, and whether payment is dollar for dollar or capped, are not in the produced text. They are the contents of the omitted PBM Fee Schedule Addendum. The model contract requires quarterly measurement on plan specific data, cash reconciliation, and dollar for dollar payment rather than capped credits. Because those terms are expressly placed in an attachment that is not included, the verdict is unclear. The forfeiture sentence shows that an early exit can void the guarantees. It does not reveal the guarantee math, and I will not invent it from the title alone.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"ENF","verdict":"bad","confidence":0.88,"page_ref":"Page 10","evidence_quote":"allow the notified Party ninety (90) days in which to make necessary adjustments or corrections to satisfy the complaint or concern prior to taking any further action","rationale":"Remedies are not self executing. Page 10 requires written notice of a complaint and ninety days to cure before further action, including dispute resolution under Section 4.11. For a controversy of $10,000 or less, Claim Administrator selects the arbitrator, and the same section bars a judge or jury. Page 9 indemnity requires that conduct be adjudged grossly negligent, fraudulent, criminal, or a material breach. There are no liquidated damages or automatic credits for missed guarantees or late reports. Page 46 makes discount and minimum rebate guarantees ineffective if the exhibit ends before the guarantee period. There is no second strike exit and no regulatory integrity termination right. The model contract requires automatic remedies without proof of damages and a penalty free exit after a repeat breach or a regulatory integrity failure. This draft requires a cure and adjudication, and it can forfeit guarantees on an early exit. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"AMD","verdict":"bad","confidence":0.92,"page_ref":"Page 12","evidence_quote":"Notwithstanding the foregoing, any amendments required by law, regulation or order (“Law”) or by Claim Administrator or the Association may be implemented by Claim Administrator upon sixty (60) calendar days’ prior notice to Employer","rationale":"Page 12 says the agreement may be amended only by mutual written agreement. The next sentence takes back the protection the model contract requires. Amendments required by law, or by Claim Administrator or the Association, may be implemented on sixty calendar days notice, or sooner if law requires it. If the Employer objects within thirty days, the parties negotiate, and if they cannot agree either party may go to dispute resolution. That is not a signature requirement. Economic terms also move without a joint signature. Page 22 lets Claim Administrator change service charges at the end of the fee schedule period on sixty days notice, and on other dates if benefits, government costs, enrollment mix, projections, or affiliates change. Page 32 says modifications to expected alternative provider payments are deemed approved after notice and become part of the agreement. Page 45 says an average wholesale price replacement benchmark chosen by Prime is deemed approved unless the Employer terminates the exhibit. The model contract says no amendment is effective unless signed by both parties, and economic terms cannot change by notice or an updated exhibit. This draft allows notice amendments and deemed approval of pricing changes. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"TERM","verdict":"partial","confidence":0.76,"page_ref":"Page 11","evidence_quote":"By either Party at the end of any month after the end of the Fee Schedule Period indicated in the Fee Schedule specifications of the most current ASO BPA with ninety (90) days’ prior written notice to the other party","rationale":"Page 11 allows either party to terminate at the end of any month after the fee schedule period, with ninety days written notice. Mutual termination on any date is allowed. Fraud, misrepresentation, or material breach supports termination after the Page 10 cure period. That is a convenience exit, but only after the rate period, not during it. Page 22 requires the Employer to pay a termination administrative charge set in the omitted ASO Benefit Program Application, including for services in the run off period. Page 46 says network discount and minimum rebate guarantees in the addendum are not effective if the pharmacy exhibit ends before the guarantee period. Page 25 says that after final settlement, overpayment refunds are retained by Claim Administrator. There is no termination right for a regulatory integrity event. The model contract requires convenience termination on reasonable notice without penalty, no forfeiture of earned amounts, and a regulatory integrity exit. A post period ninety day exit exists, so the right is not missing. The lock in, the termination charge, and the guarantee forfeiture are material carve outs. That is partial.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"SPEC","verdict":"bad","confidence":0.84,"page_ref":"Page 46","evidence_quote":"Specialty Drugs may be provided by Prime, an affiliate of Prime, or other Specialty Pharmacy that has a written arrangement with Prime or Claim Administrator.","rationale":"Specialty is only partly defined by function, and it is not priced at acquisition cost. Page 49 describes specialty drugs as drugs for limited populations or diseases, often injected or infused, or with special handling, and then says the list is determined by Prime or Claim Administrator and is subject to change. A vendor controlled list can move products into or out of the specialty channel. Page 46 prices specialty claims at the omitted BPA Addendum, separate from retail and mail pricing, and says specialty drugs may be provided by Prime, an affiliate of Prime, or another specialty pharmacy. Page 27 allows Prime to keep a portion of mail and specialty discounts as its fee. There is no drug level rate that acts as a ceiling in every channel, and no acquisition cost rule for affiliate specialty claims. The model contract requires a functional definition, a drug level ceiling in every channel, and acquisition cost at affiliate pharmacies. The unseen addendum may contain a rate. It is not described as acquisition cost, and the produced text authorizes retained specialty margin and affiliate dispensing. That is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0060","contract_slug":"city-of-mesquite-bcbstx-asa-2022-draft","entity":"City of Mesquite, Texas","vendor":"Blue Cross and Blue Shield of Texas (HCSC) with Prime Therapeutics","model":"Grok 4.7","rubric_key":"GAG","verdict":"bad","confidence":0.96,"page_ref":"Page 7","evidence_quote":"Employer shall not use or disclose such Business Confidential Information, including this Agreement, to any third party without prior written consent of Claim Administrator.","rationale":"Confidentiality in this draft restricts the Employer from sharing pricing and the agreement itself. Page 7 says the Employer shall not use or disclose business confidential information, including this agreement, to any third party without prior written consent of Claim Administrator. If the Employer believes law requires disclosure to any person, including a covered person or a governmental entity, it must give notice so Claim Administrator can object and seek confidentiality protections. That is an opportunity to resist a public records release, not a clean unconditional carve out. Page 15 defines business confidential information to include cost and pricing information, including provider discounts and rates, and derivatives of that information. Page 6 requires auditors and vendors not to disclose proprietary information, and Page 44 conditions MAC viewing on Prime's non-disclosure agreement. I did not find a clause that stops a pharmacy from telling a patient about a cheaper option. The pricing and agreement restriction is enough. The model contract requires that nothing stop the plan from sharing pricing, rebate, or performance data with advisors, auditors, members, the public, or lawmakers. A vendor objection right does not make this partial or good. The verdict is bad.","model_own_total":16.8,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-30T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"The fiduciary role is expressly limited to initial claim adjudication and appeals. The contract then disclaims fiduciary status for the rest of plan administration, so it does not impose loyalty and care across formulary, network, rebate, and pricing decisions as the model requires.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.96,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may have a financial relationship with such pharmaceutical companies and may receive and retain fees or other compensation from pharmaceutical companies","rationale":"The contract identifies some manufacturer compensation and affiliate purchase discounts, which is meaningful disclosure. It does not require disclosure of every direct and indirect revenue stream, affiliate ownership touching claims, broker or consultant payments, or quarterly and annual officer certification.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.94,"page_ref":"Page 21","evidence_quote":"VENDOR agrees to notify CITY of any changes in VENDOR’S ownership interest greater than 50%, or control of its business entity, not less than sixty (60) days in advance of the effective date of such change","rationale":"The City receives notice of a change exceeding 50 percent ownership or control. There is no signed exhibit listing every parent, subsidiary, affiliate, purchasing entity, mail pharmacy, and specialty pharmacy, and the notice threshold would miss smaller ownership changes.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"Rebates are narrowly defined as certain formulary payments attributable to brand drug utilization. The contract then expressly removes fees, compensation, and affiliate purchase discounts from that definition, allowing manufacturer value to be relabeled and retained.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"The contract promises remittance only of the defined Rebates and directs the detailed remittance terms to absent Exhibit B. It expressly permits the vendor and affiliates to retain other manufacturer fees and discounts, contradicting a pass-through of all manufacturer revenue.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.94,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The contract acknowledges purchase discounts tied to vendor-affiliated dispensing pharmacies and assigns that value exclusively to the vendor or affiliates. It does not invoice affiliate pharmacy claims at documented net acquisition cost plus a stated dispensing fee, and it permits retained affiliate economics that the model would eliminate.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"partial","confidence":0.94,"page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be the lowest of the discounted rate, the Participating Pharmacy’s reported U&C price, if applicable, and the VENDOR MAC rate, if applicable), plus the applicable dispensing fee","rationale":"The claim formula uses the lowest of three contract measures, including the pharmacy's reported usual and customary price. It does not impose an external published cash-price benchmark or clearly require a claim-by-claim ceiling based on the cheapest lawful option in every channel.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.94,"page_ref":"Page 4","evidence_quote":"The VENDOR’S Participating Pharmacies will dispense prescriptions to CITY plan members according to the CITY’S plan, and shall collect from the Plan Member the lowest of the applicable co-payment, the discounted price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Members receive a point-of-sale protection tied to the lowest of copayment, discounted price, MAC, or pharmacy usual and customary price. The contract does not say that an outside cash purchase counts toward the deductible and out-of-pocket maximum, and it contains no protection against accumulator adjustments.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.98,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR","rationale":"The vendor establishes and may amend the City's MAC list. The City can request a copy, but the contract does not require one identical list for plan billing and pharmacy reimbursement, a fixed update schedule, or a defined pharmacy appeal process.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The claim-cost formula on pages 4 to 5 and billing terms on pages 17 to 18 do not require the City to pay exactly what the pharmacy receives plus a disclosed fee. The audit provisions on pages 14 to 17 also do not give the City pharmacy-payment data needed to test for spread, and no no-spread covenant appears in the produced text.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.98,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The vendor acts as a group purchasing organization for the plan, but related purchase discounts may remain with the vendor or its affiliates. The contract does not pass through supplier payments received through every related purchasing entity or require allocation on disclosed drivers.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"bad","confidence":0.99,"page_ref":"Page 8","evidence_quote":"VENDOR shall provide CITY with thirty (30) days notice prior to the addition, removal or movement within tiers of a drug on the PDL","rationale":"The City adopted the vendor's PDL, but the vendor manages it and can add, remove, or move drugs with notice rather than City approval. Specialty formulary changes similarly require only quarterly notice, so the sponsor does not control every formulary change.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"partial","confidence":0.9,"page_ref":"Page 8","evidence_quote":"Changes made by VENDOR to the PDL, may be based upon, among other things, the introduction of new products, customer safety, clinical appropriateness, efficacy, cost effectiveness","rationale":"Cost effectiveness is one of several factors the vendor may consider in formulary changes. There is no binding lowest-net-cost standard for this City plan, annual whole-book comparison, or disclosure when a more expensive drug is placed above a cheaper equivalent.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"missing","confidence":0.91,"page_ref":null,"evidence_quote":null,"rationale":"The pharmacy network and claim-processing provisions on pages 4 to 6 describe participating pharmacies and vendor mail and specialty pharmacies, but they do not prohibit steering, retroactive clawbacks, or volume-conditioned reimbursement. They also do not grant any willing pharmacy participation at the City's terms.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"The pricing, performance, and term provisions on pages 4, 13 to 18, and 29 to 31 contain no most-favored pricing promise. They also contain no annual market check with a meet, credit, or release remedy.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.99,"page_ref":"Page 15","evidence_quote":"CITY, or a mutually acceptable independent third party retained by CITY, may conduct an annual Claims audit and such audit shall be limited to the prior Contract Year of VENDOR data that directly relates to Claims billings.","rationale":"The City has annual claims and rebate audit rights and can obtain prior-year claims data. Those rights are limited to mutually acceptable auditors, confidentiality agreements, narrow periods and samples, selected manufacturer contracts, and no general access to vendor agreements, so they are substantially weaker than the model.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"The City owns information produced solely and exclusively for it and receives some access and transfer rights. The vendor nevertheless may use, disclose, adapt, or sell deidentified claims and eligibility information, directly contradicting the model's ban on reuse, licensing, or sale of plan data.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"bad","confidence":0.96,"page_ref":"Page 13","evidence_quote":"The settlement of penalties will be performed on an annual basis at the time of the year-end reconciliation. With respect to the aspects of VENDOR’S performance addressed in Exhibit A, these amounts at risk are CITY’S exclusive financial remedies.","rationale":"The contract uses City claims for claims-operations measures and provides performance amounts at risk, but settlement is annual rather than quarterly. The remedy is expressly exclusive and capped in aggregate, while the detailed standards in Exhibit A are withheld from the posting, so it is not a dollar-for-dollar cash reconciliation.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.95,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform","rationale":"A failed performance standard produces an adjustment against amounts due without a separate damages lawsuit. The adjustment depends on the withheld Exhibit A, is an exclusive capped remedy, and the contract has no defined two-strikes exit for repeated material breach or regulatory integrity failure.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"good","confidence":0.99,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"Amendments must be later-dated writings duly executed by both parties. The produced text does not permit the vendor to change economic terms through notice, a portal update, or an unilaterally revised exhibit.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.99,"page_ref":"Page 29","evidence_quote":"in the event of Termination by Notice initiated by CITY, a pro rata share of any credits disbursed by VENDOR for the calendar year in which the termination occurred as well as a pro rata share of the actual implementation credit amount disbursed by VENDOR (prorated over the initial term of the Contract) would be repaid by CITY to VENDOR.","rationale":"The City may terminate without cause on 90 to 120 days notice. It must repay prorated annual credits and the prorated implementation credit, which functions as an exit cost, and there is no express regulatory integrity termination right beyond a law that makes performance prohibited.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"partial","confidence":0.86,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease, including but not limited to, injectible, infused, or oral medication, or product that otherwise require special handling.","rationale":"The contract gives a functional, though awkward, definition of specialty drugs and applies a general lowest-of claim formula to claims processed through vendor specialty pharmacies. It does not require drug-level ceiling schedules or net acquisition cost pricing for affiliate specialty claims, and the vendor controls the specialty formulary.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data","rationale":"The confidentiality definition expressly covers costs and pricing data, and disclosure is generally barred without consent. Advisors and auditors can receive information only under confidentiality restrictions, while the Public Information Act clause lets the vendor seek to block release and limits disclosure to what is legally compelled.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The responsibilities provisions on pages 2 to 4 and the relationship clause on page 9 do not impose duties of loyalty or care on IPM. The agreement contains no fiduciary duty, conflict disclosure duty, or disgorgement remedy.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"The compensation and fee provisions on pages 4, 5, and 11 do not require disclosure of IPM or affiliate compensation, consultant payments, or economic conflicts. The interested-party filing language on page 12 is a general government contracting requirement, not quarterly and annual officer-certified disclosure of PBM revenue.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.91,"page_ref":"Page 12","evidence_quote":"Bidder agrees to provide Grayson County Purchasing Age nt, and/or requesting department, the \" Certificate ofrnterested Parties,\" Form 1295 as required, within ten (10) business days fro m notification of pending award, renewal , amended or extended contract.","rationale":"The agreement requires a Texas Certificate of Interested Parties around award, renewal, amendment, or extension. This is narrower than the signed ownership and affiliate exhibit contemplated by the model because it does not list every parent, affiliate, purchasing entity, mail pharmacy, and specialty pharmacy or require updates within 30 days of ownership changes.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.94,"page_ref":"Page 1","evidence_quote":"\"Average Wholesale Price\" or \"A WP\" will mean the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"The definitions give IPM sole discretion to select the AWP source and let IPM determine brand and generic status. They omit rebate, manufacturer revenue, affiliate, specialty, and purchasing-entity definitions, leaving the core economic terms open rather than closing relabeling and classification loopholes.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The compensation sections on pages 4 and 5, Exhibit A on page 11, and the brief rebate references on pages 4 and 10 do not require any manufacturer revenue to be paid to the county. There is no percentage, payment schedule, or closed list of excluded claims.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 states only retail AWP, U&C, and Generic MAC formulas. No provision identifies an IPM-owned or related pharmacy or requires any affiliate pharmacy claim to be invoiced at acquisition cost plus a stated dispensing fee.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"The retail fee schedule on page 11 mentions U&C only as one component of the generic formula. It does not cap every claim in every channel at a published cash benchmark or require a claim-by-claim cheapest lawful price test.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The member payment language on pages 2, 4, and 5 addresses copayments, deductibles, and balance billing but never compares member cost with the pharmacy cash price. It also does not credit cash purchases to deductibles or out-of-pocket limits and does not address accumulator adjustments.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"partial","confidence":0.94,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"Exhibit A uses Generic MAC as a possible retail pricing basis. The agreement does not disclose the MAC list, require the same list for county billing and pharmacy reimbursement, set an update schedule, or provide a pharmacy appeal process with deadlines.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":0.9,"page_ref":"Page 11","evidence_quote":"Retail Pharmacy Fees: Brand: AWP less 16% plus $2.00 dispensing fee","rationale":"The county is charged under an AWP-based retail formula, while the agreement never ties that charge to the amount IPM pays the dispensing pharmacy. This structure permits IPM to retain a difference instead of limiting compensation to the pharmacy payment plus a disclosed administrative fee.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The definitions on pages 1 and 2, compensation provisions on pages 4 and 5, and Exhibit A on page 11 do not identify a group purchasing organization or related purchasing entity. No clause passes through purchase discounts, volume credits, or supplier payments.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.87,"page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans.","rationale":"The county retains sole authority to control and administer its plans, which gives it general authority over benefit design. The agreement does not expressly require county approval of the formulary and every formulary change, nor does it require lowest-net-cost analysis or quarterly drug-level utilization management outcomes.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The benefit design provisions on pages 3 and 4 and Exhibit A on page 11 contain no lowest-net-cost standard. They also require no comparison with IPM's book of business and no explanation when a costlier drug is placed above a cheaper equivalent.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"bad","confidence":0.97,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"IPM has sole discretion to add or remove network pharmacies and promises no access to any particular pharmacy. The agreement provides no any-willing-pharmacy right, anti-steering protection, ban on retroactive clawbacks, or volume-neutral reimbursement standard.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The fee schedule on page 11 and renewal and pricing provisions on page 4 contain no most-favored pricing promise. The county also receives no annual market check or meet, credit, or release remedy.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.95,"page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement.","rationale":"Exhibit B gives either party and its representative an audit right, but the right verifies compliance with the business associate agreement and focuses on PHI practices. It does not grant a full PBM financial and claims audit, routine claims-level delivery, pre-adjudication access, or protection against proprietary-data withholding.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"The agreement expressly permits IPM to reuse covered-person information broadly, including for product research and development. It also says IPM owns its databases and compilations, while never making the county sole owner of claims, eligibility, accumulator, rebate, and derived data or requiring machine-readable delivery.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"Neither the service provisions on pages 2 and 3 nor the fee exhibit on page 11 states measurable performance guarantees. There is no quarterly plan-specific measurement, cash reconciliation, or dollar-for-dollar shortfall payment.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.93,"page_ref":"Page 4","evidence_quote":"If there is a material breach of any provision of this Agreement, and that breach remains uncured for thirty (30) days after the breaching party receives written notice of the breach , the non-breaching party may terminate this Agreement","rationale":"The agreement allows termination after an uncured material breach, so it provides a conventional enforcement path. It does not impose automatic credits or liquidated damages for missed guarantees or reports, and it has no two-strikes exit or defined regulatory-integrity trigger.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.98,"page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"Although page 9 generally calls for mutually signed amendments, this express exception lets IPM change fees or other pricing after the initial term by advance documentation. That unilateral economic change right contradicts the model's requirement that both parties sign every amendment.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.96,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"The county may give 90 days' notice without a stated termination fee, but termination becomes effective only at the end of the current one-year term or renewal. The agreement lacks a general midterm convenience exit and does not make a regulatory-integrity event an express ground for termination.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The definitions on pages 1 and 2 and Exhibit A on page 11 do not define specialty drugs or state specialty rates. No clause imposes drug-level specialty ceilings or acquisition-cost pricing at an affiliated specialty pharmacy.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"The confidentiality clause expressly treats pricing information and the entire agreement and exhibits as confidential. Disclosure requires consent or a subpoena process, with no clear carveout for Texas public records, the county's advisors or auditors, members, the public, or lawmakers, so it can obstruct disclosure of contract economics.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the\n          purpose of initial Claim adjudication and appeals relating to the coverage of\n          prescription drug benefits.","rationale":"The vendor agrees to be a fiduciary only for initial claim adjudication and appeals. The same section says it is not the plan administrator, not a named fiduciary, and has no discretionary authority over the plan. That contradicts the loyalty and care duty in the model contract published by Mark Cuban and collaborators. The vendor can still put mail, specialty, and manufacturer revenue ahead of the City and its members.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 10","evidence_quote":"administrative fees that range between one percent\n                  (1%) and four percent (4%) of the Wholesale Acquisition Cost\n                  (“WAC”) of the products dispensed across VENDOR’s book\n                  of business.","rationale":"The contract discloses that the vendor and affiliates may receive and keep manufacturer administrative fees of 1 percent to 4 percent of WAC, plus purchase discounts at affiliated pharmacies. There is no named officer certification and no quarterly or annual attestation that every related entity payment was disclosed and remitted. The conflict of interest article on pages 27 to 28 is City ethics, not a full PBM compensation inventory.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no signed exhibit listing owners, parents, subsidiaries, affiliates, GPOs, rebate aggregators, or mail and specialty pharmacies. Section 14.3 on page 21 only requires notice of a greater than 50 percent ownership or control change. The exhibit list on page 32 names performance guarantees, fees, the BAA, SBEDA, the RFP, and the proposal, not an ownership schedule.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 2","evidence_quote":"“Rebates” means the formulary rebates, including base and market share rebates, collected\n    by VENDOR in its capacity as a group purchasing organization for the Plan from various\n    pharmaceutical companies that are attributable to the utilization of brand, prescription\n    drugs by Plan Members.","rationale":"Rebate is limited to formulary base and market share rebates on brand drugs collected as a group purchasing organization. Page 10 then says Rebates do not include administrative fees or affiliated pharmacy purchase discounts, which belong exclusively to the vendor. Brand, generic, MAC, and specialty are identified or set by the vendor, so value can be relabeled and kept.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"term “Rebates” as used in this CONTRACT does not include\n                  the fees, compensation, and concurrent or retrospective\n                  discounts associated with the purchase price of products\n                  described in this Section which belong exclusively to\n                  VENDOR or its affiliates.","rationale":"Page 9 says the vendor will remit Rebates for the prior quarter under Exhibit B, which is not posted. The body already lets the vendor keep 1 percent to 4 percent WAC administrative fees and concurrent or retrospective purchase discounts, and says those sums belong exclusively to the vendor and affiliates. That is not 100 percent pass through of manufacturer revenue of every kind.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.92,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive\n                  concurrent or retrospective discounts from pharmaceutical\n                  companies which are attributable to or based on products\n                  purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The vendor processes claims at its own mail and specialty pharmacies under the same lowest of discounted rate, U&C, and MAC formula on page 4. Affiliates may receive and retain purchase discounts on products those pharmacies buy. There is no net acquisition cost plus dispensing fee invoice and no documentation default if cost records are withheld.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"CEIL","verdict":"partial","confidence":0.82,"page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be\n    the lowest of the discounted rate, the Participating Pharmacy’s reported\n    U&C price, if applicable, and the VENDOR MAC rate, if applicable),\n    plus the applicable dispensing fee","rationale":"Plan claim cost is the lowest of the discounted rate, the pharmacy U&C, and the vendor MAC, plus a dispensing fee. That is a claim level usual and customary check, not a published independent cash benchmark that the plan can never exceed. The City can still pay more through the contract than a transparent cash price at a public benchmark site.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"CASH","verdict":"partial","confidence":0.84,"page_ref":"Page 4","evidence_quote":"shall collect from\n    the Plan Member the lowest of the applicable co-payment, the discounted\n    price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Participating pharmacies collect the lowest of copay, discounted price, MAC, or, as continued on page 5, the pharmacy usual and customary price. That is limited cash price protection at network pharmacies. Nothing credits an outside cash purchase toward the deductible or out of pocket maximum, and nothing bars accumulator adjustment against member assistance.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.93,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by\n    VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the\n    MAC drug list applicable to CITY, which list may be amended from time to time by\n    VENDOR in maintaining its generic pricing program.","rationale":"The vendor establishes the City MAC list and may amend it from time to time while running its generic pricing program. A copy is available before execution and on reasonable request, and the City is told it is not the CMS list. There is no single list for plan payment and pharmacy payment, no update schedule, and no pharmacy appeals path. Vendor discretion over MAC is the classic spread tool.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.9,"page_ref":"Page 4","evidence_quote":"the lowest of the discounted rate, the Participating Pharmacy’s reported\n    U&C price, if applicable, and the VENDOR MAC rate, if applicable),\n    plus the applicable dispensing fee","rationale":"The plan pays an adjudicated ingredient cost of lowest of discounted rate, U&C, and vendor MAC, plus a dispensing fee. The contract never says the City pays exactly what the pharmacy is paid plus a disclosed administrative fee. Page 15 also bars the City from auditing pharmacy network agreements. That structure permits spread in retail, mail, and specialty.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"GPO","verdict":"bad","confidence":0.94,"page_ref":"Page 9","evidence_quote":"CITY authorizes VENDOR to contract\n       with pharmaceutical companies for Rebates as a group\n       purchasing organization for the Plan.","rationale":"The City authorizes the vendor to contract with manufacturers as a group purchasing organization for Rebates. Page 10 then assigns manufacturer administrative fees and affiliated pharmacy purchase discounts exclusively to the vendor and affiliates. Purchase discounts, volume credits, and supplier payments at the GPO or purchasing entity do not flow to the plan.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"FORM","verdict":"bad","confidence":0.93,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL,\n     as in effect from time to time, which the CITY has adopted as\n     part of the Plan design and as CITY’s formulary.","rationale":"The City adopted the CVS Health PDL as its formulary, and the vendor manages that list as in effect from time to time. The vendor gives 30 days notice before adding, removing, or moving a drug, which is notice rather than City approval of each change. Page 9 lets the vendor add or remove drugs on the Advance Control Specialty Formulary with quarterly notice.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Formulary management on pages 8 to 9 lists cost effectiveness as one factor among safety, efficacy, new products, and industry changes. That is not a lowest net cost standard for this plan. There is no annual comparison against the vendor's book of business and no duty to disclose a drug placed above a cheaper equivalent. Account management on page 4 also lacks that standard.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"NET","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Pages 4 to 5 describe vendor contracts with independent participating pharmacies and claims at the vendor mail and specialty pharmacies. Page 5 gives the vendor the sole right to audit pharmacies. Customer service on page 7 helps members locate a retail network pharmacy. Nothing makes claims final at adjudication, forbids steering into vendor pharmacies, forbids volume conditioned pay, or requires any willing pharmacy at the plan's terms.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Consideration and billing on pages 17 to 18, the term article on pages 18 to 19, performance standards on pages 13 to 14, and the exhibit list on page 32 do not contain most favored pricing or an annual market check. There is no meet, credit, or release remedy if another comparable client has better pricing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 15","evidence_quote":"it shall not be entitled to audit agreements with vendors, pharmaceutical\ncompanies, Participating Pharmacies or other providers of products or services to VENDOR as\npart of a Claims audit.","rationale":"The City may run limited annual claims and rebate audits, and page 7 gives portal access to claims data. Audits are one on site review per plan year, need a mutually acceptable auditor who signs the vendor confidentiality form, cannot reach pharmacy or manufacturer contracts, and limit rebate review to 10 contracts. That is weaker than the plan's own auditor, full financial data on a schedule, and no proprietary withholding.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"DATA","verdict":"partial","confidence":0.88,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is\n    deidentified in accordance with HIPAA and other applicable law, and which is not identifiable\n    on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by\n    VENDOR only as allowed by federal or state law.","rationale":"Section 8.1 says the City owns information produced solely and exclusively for the City, and page 29 says files are City property. The same section lets the vendor use, disclose, adapt, or sell deidentified claims and eligibility data and reserves vendor trade secrets. The City is not the sole owner of all claims, rebate, and derived data with a ban on reuse or sale.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.86,"page_ref":"Page 13","evidence_quote":"these amounts at risk are CITY’S\nexclusive financial remedies. The Total Dollars at risk will be $175,000 as set forth in Exhibit A.","rationale":"Performance standards exist and, for claims operations, are measured on City claims. The total dollars at risk are $175,000 under Exhibit A, which is not posted, and those amounts are the City's exclusive financial remedies. Settlement is annual rather than quarterly cash, dollar for dollar. The missing exhibit hides the metrics, but the body already caps and annualizes the remedy.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"ENF","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted\n    from amount due VENDOR no later than 60 days after the reporting by VENDOR of any\n    failure to perform as defined in Exhibit A Performance Guarantees","rationale":"Missed guarantees adjust the amount due the vendor within 60 days, which is an automatic credit of sorts. Those credits are capped at $175,000 and are exclusive remedies, so the City cannot recover more without proving other damages. Termination for cause on page 29 uses a 30 day cure and has no second strike or regulatory integrity exit without penalty.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.84,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the\n       terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent\n       to the date hereof and duly executed by the parties hereto.","rationale":"Amendments must be written, dated after this contract, and signed by both parties, and page 34 repeats that entire agreement rule. The vendor may still change the MAC list from time to time on page 2, change the PDL on 30 days notice on page 8, and change the AWP source after notice on page 1. Economic terms can therefore move without a signed amendment.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"TERM","verdict":"partial","confidence":0.9,"page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause\n         upon written notice, provided such notice specifies an effective date of termination, which\n         shall be not less than 90 calendar days nor more than 120 calendar days after the date of","rationale":"The City may cancel without cause on 90 to 120 days notice, which is a convenience right. On that exit the City must repay a pro rata share of credits and of the implementation credit prorated over the initial term. Page 9 also lets the vendor delay rebate remittance on termination or City breach. Those are penalties and a rebate holdback the model does not allow.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"SPEC","verdict":"bad","confidence":0.88,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are\n     Covered Drugs and that are used by VENDOR, that are used in the management of chronic\n     or genetic disease, including but not limited to, injectible, infused, or oral medication, or\n     product that otherwise require special handling.","rationale":"Specialty is defined as products the vendor uses for chronic or genetic disease and special handling, so the vendor draws the line. The vendor runs mail and specialty pharmacies and an Advance Control Specialty Formulary it can change on page 9. Affiliated pharmacies keep purchase discounts under page 10. There is no acquisition cost pricing and no drug level ceiling in the posted text.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.94,"page_ref":"Page 34","evidence_quote":"costs and pricing\n       data, trade secrets, know-how, processes, plans, designs and other information of or\n       relating to either party’s business. VENDOR asserts that certain information contained in\n       this Contract constitutes Confidential Information.","rationale":"Confidential Information includes costs and pricing data, and the vendor asserts that parts of this contract are confidential. Rebate audit terms on page 15 cannot be revealed even to the City. The Public Information Act clause on page 36 requires the City to notify the vendor and not oppose vendor efforts to block release. Pricing, rebate, and audit material are treated as proprietary in a way that can stop public disclosure.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and does not mention whether the PBM owes a fiduciary duty or duty of loyalty to the plan.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The summary memo states Envision will deliver full transparency of pharmacy costs. However, the base agreement is absent, so there are no terms requiring a named officer certification or the disclosure of compensation and conflicts.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement or an ownership exhibit listing the PBM's affiliates and subsidiaries.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and provides no definitions for critical terms like rebate, affiliate, or specialty.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"partial","confidence":0.9,"page_ref":"Page 10","evidence_quote":"agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The agenda backup states the PBM passes through 100% of all monies received, which is a strong standard. It earns a partial score because the executed agreement is missing, making it impossible to verify quarterly payment timing and the absence of excludable claims.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup mentions a partnership with Costco for mail and specialty pharmacies but does not include the contract language necessary to verify if affiliate pharmacies are priced at acquisition cost.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and does not address benchmark ceilings or cheapest lawful option pricing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The document does not mention cash price protections or whether cash purchases count toward the deductible.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Although MAC pricing is mentioned in the summary tables, the lack of the base agreement means MAC list governance rules and appeals paths are completely missing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"good","confidence":0.9,"page_ref":"Page 10","evidence_quote":"agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The backup memo explicitly states there is no spread pricing on retail, mail, or specialty pharmacy. While the base agreement is missing, the plan also pays a fully disclosed administrative fee, meeting the standard for transparent pricing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no mention of group purchasing organizations or the pass-through of purchasing entity revenues in this backup memorandum.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The memo mentions the PBM's flexibility through formulary management but lacks the executed agreement to confirm if the plan sponsor has final approval control over the formulary.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not address lowest net cost standards or book of business comparisons.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The text notes the PBM contracts directly with pharmacies but the executed contract is needed to verify protections like any willing pharmacy and anti-steering rules.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Most favored nation pricing and market check rights are not addressed in the provided summary documents.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Because the executed agreement is missing, audit rights, claims-level data access, and reporting schedules are not detailed.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The subject of data ownership is not addressed in the agenda backup memorandum.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 10","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan.","rationale":"The agenda backup mentions substantial performance guarantee monies and a spend reduction guarantee. It earns a partial score because the full contract is not provided, making it impossible to check if guarantees are reconciled in cash without caps.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Self-executing enforcement and two strikes exit rights are not addressed in the summary memorandum.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The executed agreement is absent, so rules regarding how amendments are processed are missing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The backup memo states the contract term but lacks the underlying agreement to show termination rights and penalties.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"While the memo mentions a partnership with Costco for specialty pharmacy and no spread pricing, the executed agreement is missing and specific specialty drug pricing controls and functional definitions are not provided.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and does not address confidentiality. It is impossible to determine if the final contract contains gag clauses.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"FID","verdict":"partial","confidence":0.75,"page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA. Aetna has complete authority to determine whether and to what extent eligible individuals and beneficiaries are entitled to coverage and to construe any disputed or doubtful terms under this Group Agreement.","rationale":"The only fiduciary language in the file is narrow, covering claim determinations under Section 503 of ERISA, and it is paired with complete discretionary authority and a deferential standard of review. Nothing extends a duty of loyalty to the financial side of the arrangement, and page 47 states that manufacturer payments belong exclusively to Aetna and its affiliate with no legal interest for the county. A model style duty to act solely in the interest of the plan and its members would need to cover formulary, network and pricing discretion, not just benefit appeals.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.7,"page_ref":"Page 85","evidence_quote":"Aetna has various programs for compensating producers (agents, brokers and consultants). If you would like information regarding compensation programs for which your producer is eligible, payments (if any) which Aetna has made to your producer, or other material relationships your producer may have with Aetna","rationale":"Disclosure here is category level and reactive rather than a standing certified accounting. Page 46 tells the county that categories of manufacturer administrative fees, other manufacturer payments and network transmission fees exist, and this application page offers producer compensation information only if the county asks. There is no annual certified statement of all revenue Aetna and CVS Caremark derive from the county business, and no officer certification requirement anywhere in the file.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.75,"page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"The file does disclose the main affiliate relationships, naming CVS as parent of Aetna and SilverScript and naming CaremarkPCS Health as the affiliated pharmacy benefit manager on page 36, with CVS Caremark mail and CVS Specialty as the dispensing channels. What is absent is any ongoing obligation to disclose new affiliate relationships, any arm's length pricing standard for affiliate transactions, or any disclosure of affiliate margins. Disclosure of the corporate family is present but the protections that should follow it are not.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"The definition of rebates is built by exclusion rather than by capturing all manufacturer value. Administrative fees, other manufacturer payments and network transmission fees are each defined out of the rebate pool, which is the exact carve out pattern the model contract from Mark Cuban and collaborators is written to close. The controlling definition itself sits in the Prescription Drug Services Schedule, which is referenced but not attached, so the county has agreed to exclusions from a definition that is not in the file.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"Page 47","evidence_quote":"Customer further agrees that the amounts described above belong exclusively to Aetna or it's affiliate, CVS Caremark, and Customer has no right to, or legal interest in, any portion of the aforesaid amounts received by Aetna or CVS Caremark.","rationale":"Instead of full pass through of manufacturer value, the county gets minimum per script rebate guarantees and an express disclaimer of any interest in the rest. Guaranteed amounts are floors, not a share of what is actually collected, and the surplus above the floor stays with Aetna along with the carved out fee categories. Rebates for specialty drugs paid under the medical benefit and value based contracting recoveries are also retained by Aetna on this same page.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.85,"page_ref":"Page 40","evidence_quote":"Aetna may amend the individual Specialty Drug discounts to manage the financial guarantee. The financial guarantee is measured and reconciled annually across all specialty drugs dispensed by CVS Specialty Pharmacy, including through the Specialty Connect process","rationale":"Nothing in the file prices any drug at the acquisition cost of the dispensing pharmacy plus a stated markup. Every channel, including the affiliate mail and specialty pharmacies, is priced as a discount off average wholesale price, and Aetna reserves the right to move the individual specialty discounts to protect its own aggregate guarantee. The result is a benchmark based price for affiliate purchases with no visibility into what CVS actually pays for the drug.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.8,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall give the Plan Participant the benefit of the lesser of (i) the Participating Pharmacy's Usual and Customary Charge, (ii) MAC (where applicable) or (iii) discounted AWP cost.","rationale":"There is a lesser of test, so the plan and the member are protected against paying more than usual and customary or the maximum allowable cost at the counter. It is not a true ceiling against outside benchmarks, because it never references acquisition cost, a national average price, or any published cash program. Specialty drugs dispensed at retail are excluded from the discount guarantees, and Aetna may re-evaluate pricing when assumptions change, so the effective ceiling is contingent.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.7,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy's Usual and Customary Charge, (iii) MAC (where applicable) or (iv) discounted AWP cost.","rationale":"Member cost share is capped at the pharmacy usual and customary charge, which prevents the classic clawback where a member pays more than the cash price. The file goes no further, since nothing lets a member buy at an outside cash price and have it credited to the deductible or out of pocket maximum, and page 79 confirms that certain drug costs do not apply toward the deductible or the true out of pocket threshold. The Caremark Cost Saver description on page 57 is framed as a plan pricing tool rather than a member right.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"partial","confidence":0.75,"page_ref":"Page 40","evidence_quote":"MAC: Certain dosage forms and strengths may not be included on the MAC list and shall be priced at the Specialty Product default rate.","rationale":"Maximum allowable cost appears only as an input to pricing and to the lesser of test, with a note that items off the list default to a different rate. The file never requires the list to be disclosed to the county, never sets update timing or sourcing standards, and gives no appeal path for pharmacies or the plan. Because the arrangement is lock in pricing, nothing requires the list used to bill the county to be the same list used to pay the pharmacy.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"This is an explicit spread pricing arrangement, described in the contract as traditional or lock in pricing. The county pays one amount, the pharmacy is paid another, and the vendor keeps the difference as part of its compensation on top of the stated administrative and per claim fees. A traditional pricing auxiliary fee of 1.50 dollars per retail claim on page 52 sits on top of that retained spread.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.85,"page_ref":"Page 46","evidence_quote":"Aetna may also receive network transmission fees from our network pharmacies for services we provide for them. These amounts are not considered Rebates and are not shared with Customers.","rationale":"The file confirms that revenue flows to Aetna and its affiliates from manufacturers and from network pharmacies and then removes all of it from what the county sees or shares in. There is no obligation to disclose or pass through amounts collected by any group purchasing or rebate aggregation entity, and no audit right reaching those entities. This is the aggregator leakage the model contract is designed to prevent, stated affirmatively in the vendor's favor.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.75,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"The county can accept or reject a formulary, but only from options Aetna proposes, and the pricing on page 40 assumes the Aetna standard formulary and the choose generics program. Aetna may propose modifications based on rebates and other factors, treats the formulary as its own confidential business information, and charges 100,000 dollars for a custom formulary per page 53. Nothing requires formulary placement decisions to be made on a lowest net cost basis or disclosed with their rebate drivers.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"I looked at the formulary management section on page 46, the rebate terms on pages 41 and 42, the market check language on page 43 and the additional services list on pages 53 through 57. Nothing states a lowest net cost standard for coverage or placement decisions, and nothing gives the county a comparison of its pricing against the vendor book of business. A net cost analysis appears only as a feature of the priced custom formulary service, not as a contractual standard, and the base agreement that would ordinarily hold such a standard is not in the file.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Members are steered into pharmacies owned by the vendor's parent, with retail fills barred for specialty and an exclusive specialty arrangement stated on the same page. There is no any willing pharmacy provision, no protection for independent pharmacies against differential reimbursement, and no limit on effective rate reconciliation or pharmacy clawbacks. Network composition and pricing are controlled entirely by the vendor, with a stated right to amend pricing if retail leakage rises.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.8,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"There is an annual market check, which is more than many contracts give, but it is not a most favored nation guarantee. It only triggers a good faith discussion, requires a 2 percent net savings threshold before anything happens, and any change must be mutually agreed and applied prospectively from a future January. The reviewer must be a mutually agreed third party under a non-disclosure agreement, so the county cannot unilaterally choose its benchmark or force a price reset.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule. Customer is entitled to an annual electronic claim audit subject to standard pharmacy benefit audit practices","rationale":"Audit rights exist but are rationed and expensive. The county gets one rebate audit and one electronic claim audit a year, audits are at the county's own expense unless otherwise agreed, and the governing terms sit in a Prescription Drug Services Schedule that is not attached to this file. The fee schedule on page 54 charges 5,000 dollars per file for audit claim files covering data older than 24 months, and there is no stated right to reach manufacturer contracts or affiliate pharmacy records.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.8,"page_ref":"Page 54","evidence_quote":"Refill Transfers upon termination $4,500 Per file Precertification history $3,500 Per file Accumulator files $1,000 Per file Historical claims data $1,000 Per file","rationale":"The county is charged per file for its own historical claims, accumulator and transition data, including at termination, which is inconsistent with plan sponsor ownership of plan data. No clause anywhere in the file states that the county owns the data or restricts the vendor from using or monetizing it, while page 46 describes payments to Aetna for the analysis or provision of aggregated data and page 84 gives Aetna inspection rights over county data. The base agreement is not in the file, but the fee schedule in this amendment affirmatively prices access to the county's own information.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 42","evidence_quote":"Rebate guarantees are measured individually by component and reconciled in the aggregate on an annual basis within 12 months following the end of the Plan year; a surplus in one or more component Rebate guarantees may be used to offset shortages in other component Rebate guarantees.","rationale":"There are real financial guarantees for discounts, dispensing fees and rebates, and page 39 keeps discount and dispensing fee components from offsetting one another. The rebate side is weaker, since surpluses offset shortfalls in the aggregate and reconciliation can take a full year after the plan year ends. Long exclusion lists for compounds, limited distribution drugs, coordination of benefits, vaccines and 340B claims further shrink the base on which any guarantee is measured.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.65,"page_ref":"Page 43","evidence_quote":"CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"Some remedies are self executing, since guarantee shortfalls and program savings misses produce credits against future billing without the county having to prove damages. Those remedies are capped, the drug savings review credit on page 56 is limited to the fees paid for the program, and there is no two strikes exit, no penalty interest and no fee at risk for compliance failures. The strongest liquidated damages provision in the file runs the other way, as an early termination fee payable to Aetna.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"by Aetna upon 30 days' written notice to the Contract Holder. The parties agree that an amendment does not require the consent of any Member or other person.","rationale":"Section 9.17 lets Aetna amend the group agreement unilaterally on 30 days written notice, without county consent. The pharmacy schedule adds further one sided change rights, including equitable adjustment of pricing on stated triggers effective 30 days after notice on page 44 and the right to amend individual specialty discounts on page 40. A public plan sponsor should have mutual written amendment only, with a right to terminate if terms change.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 47","evidence_quote":"prior to December 31, 2028 (an \"Early Termination\") Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein","rationale":"Although section 5.1 allows either party to end the group agreement on 90 days notice, the pharmacy terms attach heavy penalties to leaving before December 31, 2028. Aetna keeps earned but unpaid rebates, the pharmacy guarantees become null and void and are not reconciled, unused allowances must be refunded, and an early termination fee is payable as liquidated damages. Transition of data is also priced per file on page 54, which raises the practical cost of exit further.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"partial","confidence":0.8,"page_ref":"Page 39","evidence_quote":"Only Specialty Products dispensed by a Specialty Pharmacy are included in the Specialty Pharmacy Discount guarantee listed above. Specialty Products dispensed by Participating Retail Pharmacies are not included in any Discount guarantee listed above.","rationale":"Specialty pricing is unusually detailed, with a drug level discount table across pages 59 through 71 and a stated default rate of 17.00 percent with a zero dispensing fee on page 71. The protections are still weak, because the guarantee only covers drugs dispensed by the affiliate specialty pharmacy, discounts are set off average wholesale price rather than acquisition cost, and Aetna may change individual drug discounts to protect its own aggregate result. Specialty is defined by an Aetna maintained product list, so the vendor controls which drugs fall under which economics.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna's prior written consent.","rationale":"A Texas county is told that pricing and financial terms cannot be released to any third party without vendor consent, which cuts directly against public accountability for public money. Section 9.20 of the group agreement sweeps the agreement itself, costs and pricing data into confidential information, page 22 requires the county to notify Aetna of public records requests and not to oppose Aetna efforts to obtain a declaratory judgment blocking disclosure, and pages 17 through 21 carry a not for distribution trade secret legend. This is a broad gag on a public body rather than a narrow trade secret protection.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The PBM recommendation on pages 8 to 11 and the consultant notes on page 17 contain no fiduciary duty, duty of loyalty, duty of care, conflict standard, or disgorgement remedy. The executed Envision agreement is not included in this agenda backup, so any fiduciary language that may exist there cannot be scored from this file.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.93,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"The packet identifies a single compensation stream and rejects other money associated with County drug spending. It does not require disclosure of related-entity compensation, affiliate ownership, consultant payments, conflicts, or quarterly and annual officer certification. The executed agreement is absent, so those additional disclosure duties cannot be confirmed.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The Envision recommendation on pages 8 to 11 identifies a Costco partnership but does not provide a signed ownership and affiliate exhibit. No page lists owners, parents, subsidiaries, rebate aggregators, mail pharmacies, specialty pharmacies, or a 30-day update duty. The executed agreement and its exhibits are not in the packet.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"Pages 8 to 11 discuss rebates, pharmacy discounts, mail order, specialty, and administrative fees but contain no definitions article. The packet therefore does not close relabeling loopholes for manufacturer revenue, rebates, affiliates, specialty drugs, generics, or pharmacies. Any definitions in the executed agreement are not provided.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"partial","confidence":0.95,"page_ref":"Page 2","evidence_quote":"Envision’s business model is focused on delivering full transparency of pharmacy costs and has agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The backup states a broad 100 percent pass-through and the page 11 pricing table also labels retail and mail rebates as 100 percent pass-through. Page 17 adds that rebates can be received at the point of sale. The packet does not define all manufacturer revenue, provide a closed exclusion list, or state a quarterly remittance deadline, and the executed agreement is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"partial","confidence":0.85,"page_ref":"Page 10","evidence_quote":"which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The no-spread commitment protects the County in mail and specialty channels, including the stated Costco partnership. However, pages 10 and 11 price channels through AWP discounts and dispensing fees, not documented net acquisition cost plus a stated fee. The absent executed agreement provides no documentation default for an owned or economically related pharmacy.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The pricing tables on pages 10 and 11 use AWP discounts and dispensing fees. They do not cap each claim at a published cash benchmark or the cheapest lawful option, and no claim-level ceiling appears elsewhere in the packet. The executed agreement that might contain such a ceiling is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The member access discussion on page 10 addresses 90-day retail fills but not cash-price protection. The packet does not say members pay no more than a pharmacy cash price, that cash purchases count toward deductibles and out-of-pocket limits, or that accumulator adjustments require written election. Those terms cannot be assessed without the executed agreement.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"Page 11 mentions MAC pricing only in the current mail-order comparison, while Envision's proposed generic prices are stated as AWP discounts. No Envision clause requires one disclosed MAC list, scheduled updates, or a pharmacy appeal process with deadlines. The executed agreement is absent.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"good","confidence":0.96,"page_ref":"Page 10","evidence_quote":"Envision’s proposal includes a partnership with Costco for mail and specialty pharmacy and has agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The packet expressly bars spread pricing in every named dispensing channel and requires complete pass-through of pharmacy discounts. Page 17 reinforces this by limiting Envision to its per employee per month fee and rejecting other money associated with County prescription drug spending. These stated terms meet the model's core no-spread protection, although the executed agreement is not supplied.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"partial","confidence":0.83,"page_ref":"Page 2","evidence_quote":"has agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The phrase all monies received or earned is broad enough to point toward pass-through beyond labeled rebates. The packet does not expressly bind group purchasing organizations, affiliates, rebate aggregators, or offshore purchasing entities, and it gives no allocation method. The missing executed agreement may contain those details, but they are not stated here.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.81,"page_ref":"Page 10","evidence_quote":"Envision also has the flexibility through formulary management and pharmacy network management to meet the County’s current and future needs.","rationale":"Formulary management is part of the proposed service and is described as responsive to County needs. The language gives Envision flexibility rather than reserving approval of the formulary and every change to Travis County. No lowest-net-cost analysis or quarterly drug-level utilization management reporting duty is shown in the absent agreement.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The formulary discussion on page 10 does not require decisions based on lowest net cost for Travis County. Pages 8 to 11 also contain no annual comparison with Envision's full book of business and no disclosure duty when a drug is placed above a cheaper equivalent. The executed agreement is not available to supply these standards.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.88,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"Allowing 90-day retail fills avoids one form of mandatory mail steering and preserves member choice. The packet does not prohibit retroactive pharmacy clawbacks, volume-conditioned reimbursement, steering to any related pharmacy, or exclusion of willing pharmacies. Those broader network protections are not visible because the executed agreement is absent.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The pricing discussion and tables on pages 10 and 11 contain no most-favored pricing promise and no annual market-check procedure. There is no meet, credit, or release remedy tied to market results. The executed agreement is not included, so any such right cannot be assessed.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"Page 9 lists reporting, transparency tools, and claim-level repricing as proposal evaluation criteria, while page 17 describes pricing as transparent. None of those passages grants Travis County an audit by its chosen auditor, scheduled claims-level financial data, pre-adjudication access, or a ban on proprietary withholding. The executed agreement and any audit article are not in the packet.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"Pages 9 and 10 mention reporting and integration of prescription and medical data, but they do not state that Travis County solely owns claims, eligibility, accumulator, rebate, or derived data. The packet also lacks machine-readable delivery rights and restrictions on reuse, licensing, or sale. Any data ownership article in the executed agreement is not provided.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"partial","confidence":0.92,"page_ref":"Page 10","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan. In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"The proposal includes monetary performance guarantees and a specific spend reduction guarantee. The packet does not state quarterly plan-specific measurement, cash reconciliation, or dollar-for-dollar uncapped payment of shortfalls. The executed guarantee schedule is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"Pages 2 and 10 state that guarantee money was proposed, but no passage makes damages or credits automatic after a missed guarantee or late report. The packet also has no two-strikes termination right for repeated breach or regulatory integrity failure. Those enforcement mechanics depend on contract language not included in the backup.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The contract-period references on pages 3 and 16 do not govern amendments. No page says economic or other terms may change only through a writing signed by both parties, and no language bars unilateral changes by notice, portal, or updated exhibit. The executed agreement is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.74,"page_ref":"Page 16","evidence_quote":"Term of Contract: Three (3) year effective October 1, 2014 ending 12:00 a.m. on September 31, 2017, unless changed by Travis County.","rationale":"The phrase unless changed by Travis County suggests the County retained unilateral control over the stated three-year term. It does not clearly grant termination for convenience, set reasonable notice, waive penalties, preserve earned rebates, or identify regulatory integrity events. Because the executed termination article is missing, the protection is only partial and confidence is lower.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"partial","confidence":0.86,"page_ref":"Page 10","evidence_quote":"Envision’s proposal includes a partnership with Costco for mail and specialty pharmacy and has agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The packet expressly extends no-spread pricing to specialty pharmacy and identifies Costco as the proposed specialty partner. It does not define specialty by function, impose drug-level ceiling rates in every channel, or require acquisition-cost pricing for a related specialty pharmacy. The executed specialty terms are not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"No passage in the agenda backup restricts Travis County or pharmacies from sharing information or discussing cheaper options. However, the packet contains no confidentiality article, pharmacy communication clause, or executed agreement, so it cannot establish that such restrictions are absent from the contract itself. This is missing rather than unclear because nothing is redacted or unreadable.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"}],"license":"Public record. Attribution appreciated: BetterBuy Rx PBM Commons, betterbuyrx.com/commons"}